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Abstract 
PURPOSE:  To propose a method for estimating the effective lifetime risk of radiation-induced 
cancer from different brain CT scan protocols in both paediatrics and adults and to develop a 
prospective method for estimating the number of cancer cases for patients undergoing CT brain 
scans when using different scanning parameters. 
MATERIALS AND METHODS:  A series of CT dosimetry experiments were conducted at 
the University of Salford.  Both adult and paediatric ATOM phantoms were imaged using 
standard CT head protocols across a wide range of protocol variations.  Dose measurements 
were made using metal oxide semiconductor field effect transducers (MOSFETs).   Effective 
doses and lifetime attributable cancer risks were calculated from MOSFETs organ and tissue 
absorbed dose measurements in both phantoms.  The method for lifetime cancer risk 
prospective estimation allowed the production of prospective risk data (Excel spreadsheet). 
This can predict attributable lifetime cancer risk, before undertaking a CT scan, and is of critical 
importance in order to predict more accurately the radiation risks from CT.  Whilst such a tool 
has benefits for all patient ages, it would have particularly value for children - due to their 
increased radio-sensitivity. Using such a tool, dose optimisation can then occur on a more 
informed basis, by adjusting protocol parameters with a view to minimising organ and eye dose. 
Together with advanced image quality preserving techniques, like ACTM, the tool would allow 
for more informed clinical decisions to be taken to balance image quality and radiation dose on 
a patient by patient basis. 
RESULTS:  The brain, thyroid, thymus, lung, salivary glands, oral mucosa, extrathoracic 
region and bone marrow all receive more than 0.03 mSv during CT brain scanning.  The range 
in effective dose across a range of CT brain protocols were 0.27 to 1.13 mSv and 0.34 to 1.55 
mSv for adult sequential and helical protocols, respectively.  For paediatric helical protocols, 
the effective dose ranged from 0.30 to 2.06 mSv.  In addition to scan parameters, differences in 
risk are also attributed to patient age at the time of scanning and gender.  As an example, the 
lifetime attributable cancer risk for a 30-year-old patient when undertaking either an adult 
sequential or helical CT brain scan were 8 females and 6 males per 106 and 16 females and 9 
males per 106, respectively.  By contrast, for the two paediatric helical CT brains protocols the 
effective risk (using 3 months to 3 years CT protocol) were 71 females and 36 males per 106 at 
birth and for the 3 years to 5 years protocol this decreases to 69 females and 35 males per 106 
when aged 5.  Using the risk data, a novel interactive spreadsheet has been developed and is 
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reported within this thesis, which allows the proactive / prospective estimation of radiation risk 
for CT head examinations.      
CONCLUSION:  Data collected within this thesis has identified that the most dominant factors 
effecting absorbed dose are tube current, tube rotation time, detector configuration and helical 
pitch.  When these factors increase the absorbed dose to body organs and tissues increases as 
well.  The only effect of gantry angle is in decreasing the dose to the lens of the eye, this quantity 
does not factor into effective dose estimates due to the nature of the lens tissue. 
This thesis proposes a novel method to estimate effective lifetime risk of radiation-induced 
cancer from CT brain examinations in order to compare different brain CT protocols 
(acquisition parameters).  Absorbed dose measurements when considered in relation to the age 
and gender of the patient can help provide estimations of effective risk, a potentially more useful 
indicator of the possible effects of radiation exposure from CT head examinations.  This risk 
estimation method can be used to compare different CT brain protocol parameters immediately 
prior to imaging.  Risk should be prospectively taken into account when planning a CT brain 
examination, especially for young ages and those undergoing serial imaging.  Using the 
prospective risk data (spreadsheet) provided in this thesis can help to estimate the probability 
of cancer induction from specific CT brain protocols and can be considered by practitioners and 
manufacturers when developing CT examinations in the future. 
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Overview and Structure of the Thesis  
The structure of this thesis is presented in (Figure 7-1) on page XXVII.   The PhD thesis is 
divided into seven chapters:  
Chapter one, is to introduce and provide an overview of the key issues and also provide an 
outline of the structure of the thesis in order to orientate the reader.  In this chapter, an overview 
of the problem of CT radiation dose and its impact on patients and the awareness of radiation 
risk has been explained.  This also includes a selection of relevant information including 
reviewing the literature which describes the role of CT in head injury, the rationale for the thesis 
and aims for the work, thesis scope, objectives and the research question.  
Chapter two, provides an overview of the nervous system including a detailed description of 
the relevant anatomy and embryology.  This chapter will highlight the main areas of the brain 
and provide detailed information on the anatomy of the key areas relevant to radiation 
dosimetry.  
Chapter three, includes a brief history of CT, a literature review of the evolution of CT 
technology.  Details on the CT acquisition factors and mA modulation technology is also 
provided within this section.  Also, this chapter explains the radiation dosimetry options 
including metal oxide semiconductor field effect transistors (MOSFETs) which are used 
extensively throughout this PhD thesis.  The associated risks from ionizing radiation are 
discussed together with the methods for estimating the radiation dose from CT examinations.  
Computational and direct measurement methods for obtaining organ absorbed dose, effective 
dose and effective risk for adult and paediatric CT are explored within this section.    
Chapter four, provides an overview of medical radiation exposure.  The current knowledge of 
risk associated with exposure to low radiation doses is explored and worldwide trends in CT 
imaging are considered.  These issues are further discussed in relation to adult and children and 
CT dose reduction techniques for adult and paediatrics patients are reviewed. 
Chapter five, provides a description of the main experiment work (MOSFET experiments) 
using the ATOM phantom representing an adult and a one-year old child.  Organ and tissue 
absorbed doses are quantified for CT brain examinations across a range of acquisition 
parameters.  Chapter five also provides estimates of effective dose for the different types of CT 
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examinations / protocols included within the work.  In this chapter, using the BEIR VII data, 
the method for lifetime attributable risk estimation will be explained.   
Chapter six, the results of both experiments using the adult and paediatric ATOM phantoms, 
for a range of different CT protocols, will be presented using descriptive and inferential 
statistics.  There will also be a comparison of a subset of the different protocols parameters with 
dose measurements made using MOSFETs.  In addition, the absorbed dose to the eye and the 
results from the cancer risk calculations are presented. 
Finally,  Chapter seven, provides the overall discussion and conclusion of the thesis.  In 
addition, there are limitations and suggestions for future work.  The novelty of the work in 
thesis will be highlighted in this section.  
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Figure 7-1: Flowchart explaining the structure of the thesis. 
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Chapter 1 : Introduction and Background 
1.1 Introduction and rationale  
An incredible opportunity was given to medical scientists following the discovery of X-rays by 
the German scientist Dr. Wilhelm Roentgen in 1895.  X-rays being electromagnetic radiation 
can penetrate through the body and help produce images of organs and body parts under 
investigation (Graham & Cloke, 2003).  Diagnostic imaging, using X-rays, is one of the most 
useful and valuable medical tools available today.  It provides opportunities to study anatomy 
and physiology, and to diagnose and investigate disease.  Advances in technology have led to 
improved image quality and the ability to gain added diagnostic information that can affect 
patient management.  However, there are notable risks from the use of ionising radiation and 
one of the main concerns is the induction of cancer.  This risk arises not only from higher 
radiation dose techniques, but also from the increased use of medical imaging using X-rays.  As 
with all fields of medicine, diagnostic imaging involves an element of risk that must be fully 
understood and balanced against the benefits that it provides. 
Computed Tomography (CT) plays an important role in diagnostic radiology.  Since its 
introduction in 1972, CT scanners have greatly increased in technological complexity 
(Bushberg & Boone, 2011; Fuchs, Kachelrieß, & Kalender, 2000; A. J. van der Molen, 
Schilham, Stoop, Prokop, & Geleijns, 2013).  The introduction of spiral CT in 1989 opened the 
door to many applications of CT that were not previously possible, such as CT angiography 
(Fuchs et al., 2000).  With the continued advancement, particularly the introduction of multi-
detector CT in 1998, the number of CT scans performed annually has continued to rise (D. J. 
Brenner & Hall, 2007 & 2008).  CT is a non-invasive method of acquiring cross-sectional 
images inside the human body without superimposition of overlapping anatomical structures. 
Many authors have investigated the association between radiation exposure and the risk of 
cancer.  Epidemiological studies, such as the Life Span Study of atomic bomb survivors; 
medical studies and experimental animal research have established a relationship between 
radiation exposure, cancer induction and cellular damage.  However, as reported by ICRP 
(2007) there is a lack of consensus on the effects of radiation at low doses and low dose rates, 
with the linear no threshold hypothesis being widely accepted and the basis of the international 
system of radiation protection (ICRP, 2007b).  Medical radiation exposure for diagnostic 
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purposes usually falls into this low dose category, where the radiation risks are yet to be 
observed and modelled by epidemiological studies. 
CT has been shown to account for the highest contribution to population radiation dose amongst 
diagnostic imaging modalities (Lehnert & Bree, 2010; NCRP., 2009b).  Despite the 
uncertainties inherent in risk assessments for low dose exposures, some researchers (D. J. 
Brenner, Elliston, Hall, & Berdon, 2001a; D. J. Brenner & Hall, 2007) have stated that when 
considering population health, the lifetime cancer risk attributable to CT examinations is not 
negligible.  Furthermore, this risk is higher in children who are more radiosensitive than adults 
and have a longer remaining lifetime for cancer to become evident.  Since 2001 and the 
publication of a series of articles (D. J. Brenner et al., 2001a; Donnelly et al., 2001) about the 
risks of radiation induced cancer in children from diagnostic CT scans, there has been a strong 
international focus on reducing paediatric CT dose (Vassileva et al., 2013). 
CT scans of the brain are one of the most common CT examinations performed in Europe (30-
40% of all CT scans), and they also contribute significantly to total collective effective dose of 
the population (Lehnert & Bree, 2010; T. Mulkens, Salgado, & Bellinck, 2007).  This 
contribution is inevitable, as it results from a combination of high radiation dose per 
examination and frequent use of CT examinations in diagnoses of head trauma and suspected 
intracranial pathology.  The increased use of this high dose procedure has been of great concern 
globally because of the high possibility of inducing undesired health effects in patients, such as 
cancer.  Furthermore, the significant radiation dose delivered to superficial radiosensitive 
organs such as the lens of the eye, which is often irradiated during CT examinations of the head, 
is of great concern (Korir, Wambani, & Korir, 2012; Ngaile & Msaki, 2006; Zarb, McEntee, & 
Rainford, 2012). 
The Head Injury guidelines produced by the National Institute for Health and Care Excellence 
(NICE) in 2014 (NICE Clinical Guideline 176) defines a head injury as any trauma to the head 
other than superficial injuries to the face.  This guideline indicates that in the UK head injury is 
the dominant cause for death and disability among the people aged from 1 to 40 years.  In 
England and Wales, 1.4 million people attend the Emergency Departments each year as a result 
of a head injury.  Children under 15 years account for 33% to 50% of these cases.  In total, the 
annual number of people admitted to hospital with a head injury is around 200,000.  Based on 
these figures one-fifth of those who are admitted have evidence of skull fracture or brain injury 
(Davis & Ings, 2014; Wood & Boucher, 2012).  
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Farrell et al., (2013) indicates that brain injury is an important cause of morbidity and mortality 
in childhood.  Injury severity is related to the mechanism of trauma, which itself varies with 
age.  For paediatric patients, reporting the incidence of head injury varies amongst authors 
because of differences in definitions and methodologies.  Canadian studies by Gordon et al., 
(2006) and Mehta (2007) reported that the annual rate ranges from 130 to 200 cases per 100,000 
population.  These authors further reported that head injuries lead to at least 20,000 Emergency 
Department (ED) visits.  Data from physician groups across the United States have reported 
that head injuries account for nearly 650,000 ED visits per year, 80% of these admissions 
presented as minor head injuries often involving loss of consciousness, amnesia and/or a 
Glasgow coma scale (GCS) score between 13 and 15.  With increasing access to CT scanners, 
nearly 27,000 CT scans are now performed per year (Mehta, 2007).  A study by Miglioretti et 
al., (2013), investigating the use of CT for children aged 15 years or younger, reported that head 
CT scans were the most commonly scanned body part, increasing by approximately 50% from 
1996 to 2010. 
CT scans require high radiation doses to produce diagnostic images and it is known that 
childhood exposure to ionizing radiation can influence adult cognition.  Paediatric literature has 
also reported that exposure to ionizing radiation at an early age can increase the risk of 
developing tumours during adulthood (D. J. Brenner et al., 2001a; Donnelly & Frush, 2001; 
Mehta, 2007; Preston, 2008; Thomas et al., 2006).  As a result, it is common practice for all CT 
examinations to adopt the "as low as reasonably achievable" approach to radiation exposure 
with strong enforcement that scans should not be overused (D. J. Brenner & Hall, 2007; Thomas 
et al., 2006).   
There has been an increase not only in the absolute number of CT examinations, but also in the 
size of anatomical coverage and the number of acquisition phases obtained while scanning 
(Bushberg & Boone, 2011; Fuchs et al., 2000).  In some places, this is the product of an 
expedient exchange of the ease and speed of acquisition against appropriateness; however, there 
is misuse of the technique.  There are some suggestions that for some examinations, due to the 
rapid introduction of new CT technologies and its wider application that suboptimal protocols 
have been adopted (Bushberg & Boone, 2011).  The problem is confounded by scanners that 
seem simple to operate, but are in fact becoming increasingly complex, favouring the adoption 
of new practices without giving full regard to the optimal use of dose reduction strategies or 
algorithms.  It is thus possible that a given CT system, in a single department, as used by various 
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operators for examination of a single body area may yield radiation doses that no longer depend 
predominantly on the limits of the machine but are operator dependent, with the important 
implications that some choices of the practitioners and radiologists may not be justifiable from 
diagnostic or dose limitation perspectives (Bushberg & Boone, 2011). 
There is no doubt that CT investigations are increasing from every point of view: numbers of 
requests, extension, and scan phases (Bushberg & Boone, 2011; Fuchs et al., 2000).  In light of 
the growing awareness of the issue of radiation dose and the possible risk for the individual and 
population there is a need for all concerned to take on an active role in dose management.  
While there have been technological advancements in CT to reduce dose, such as automatic kV 
selection and iterative reconstruction, patient dose is an important issue, especially for 
paediatric patients.  The estimated lifetime attributable risk of death from cancer is much higher 
in paediatric patients than in adult patients.  For a head scan, the risk of death from cancer for 
a 5-year-old patient is more than 6 times greater than that for a 30-year-old patient (D. J. Brenner 
& Hall, 2007).  With this knowledge, the importance of accurately measuring or estimating 
paediatric CT dose is vital.  CT plays important role in diagnostic radiology.  Even though, MRI 
is widely used in brain imaging, CT continues to be on the rise due to its varied advantages 
such as fast image acquisition with wide clinical applications (Livingstone, Eapen, Dip, & 
Hubert, 2006).   
Radiographers face a universal problem in decision-making in clinical practice because of a 
lack of radiation risk data.  Little is known about the difference in radiation risks between 
different CT acquisition protocols which makes optimisation (from a dose minimisation 
perspective) challenging.  Various uncertainties are associated with these risk estimates, both 
in terms of the radiation dose for a given CT examination and in terms of the cancer risk per 
unit dose.  Worldwide, there is a large volume of published material on CT and radiation 
attributable risk, although there is a lack of specific information for people that combines these 
aspects, particularly for children.   As stated by Mathews et al., (2013), practitioners will 
increasingly need to weigh the undoubted benefits of CT scanning in clinical practice against 
the potential risks in order to justify each CT scan decision.  Fortunately, many radiologists are 
now aware of the risks, and technological advances have already allowed CT scan doses to be 
reduced below those used in earlier decades.  However, decision tools to objectively assess the 
need for CT are still not used routinely—for example, minor head trauma or suspected 
appendicitis are often managed using CT, rather than by observation, ultrasound, or magnetic 
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resonance imaging.  Imaging for head trauma still accounts for the most CT scans in children.  
It is timely to alert the wider community, as well as the non-radiology healthcare professionals 
who refer patients for CT examinations, to the potential risks.  All parties, including patients 
and families, need to work together to ensure that CT scans are limited to situations where there 
is a definite clinical indication, and where every scan is optimised to provide a diagnostic CT 
image at the lowest possible radiation dose.  Within in practice, it has been observed that there 
is limited understanding of the magnitude of radiation doses and associated risks.  Therefore, 
there is a strong research interest in this area and there is a gap in the current knowledge and 
understanding, which would inform decision-making, and potentially policy in the medical, 
public and government sectors.  
1.2 Thesis Aims 
Although CT scans are very useful clinically, potential cancer risks exist from the associated 
use of ionising radiation, in particular for children who are more radiosensitive than adults.  The 
primary research aim is to estimate the lifetime attributable cancer risk for brain CT 
examinations in adults and children.  Secondly, to investigate by using direct dosimetry 
measurements, the effect of varying CT brain protocols parameters on effective radiation dose 
and risk for adult and paediatric patients.  This PhD thesis estimates the radiation dose from 
brain CT scans across a range of scanning parameters using ATOM phantoms representing a 1-
year old and adult.  In doing so, this thesis seeks to investigate dose variations due to changes 
in rotation times, gantry angulations and detector configurations using both sequential and 
helical protocols. The thesis provides an estimate of effective dose and evaluates the stochastic 
risk.  A key ambition of this thesis is to provide a prospective risk modelling tool that could be 
used by practitioners in proactively evaluating the potential radiation risk prior to undertaking 
the CT examination.  This risk tool may also have potential as an educational aid to assist in 
learning about CT parameters and their effects of radiation dose and risk.  
1.3 Thesis Objectives  
This thesis seeks to evaluate experimentally the radiation dose and risk for adult and paediatric 
CT brain examinations.  The objectives of the thesis are: 
1. Comparing between TLDs and MOSFET data to validate the method of using MOSFETs 
for direct CT brain dosimetry. 
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2. To use direct dose measurements and two ATOM phantoms to measure absorbed dose to 
organs/tissues, estimate the effective dose and eye dose for a range of brain CT scanning 
protocols for adult (helical and sequential) and paediatric (helical) patients.  
3. Determine the lifetime attributable radiation risk (cancer induced per million people having 
the brain CT examination) for ages from 0 to 80 years from CT brain scanning for adult 
(helical and sequential) and paediatric (helical) protocols. 
4. To develop a prospective risk calculation tool to estimate the lifetime attributable radiation 
risk and eye dose for adults and paediatrics for a variety of brain CT protocols. 
This thesis addresses these objectives by: 
1. Developing and implementing a method of organ dosimetry for adult and paediatric CT 
exposures using ATOM phantoms and MOSFET dosimeters. 
2. Quantifying organ absorbed doses for typical adult and paediatric CT examinations of the 
brain for clinically employed protocols. 
3. Projecting cancer risks for the population due to adult and paediatric CT examinations 
based on measured organ absorbed doses and radiation risk coefficients. 
1.4 RESEARCH QUESTION 
How can changes in CT protocols affect the effective risk from CT head scans in adults and 
children?     
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Chapter 2 : Overview of Brain Anatomy and Pathology  
2.1 Chapter Overview 
This chapter serves to provide an overview of two main areas, 1) an introduction to the 
neurological anatomy of the brain and 2) an illustration of the common pathology and 
radiological anatomy of the CT brain.  The brain in the primary anatomical region which is the 
focus of this thesis and as such it is useful for the reader to have a basic anatomical and 
pathological overview. 
The anatomy and pathology discussed in this chapter are relevant when considering the 
acquisition parameters investigated in this thesis and the potential radiation dose absorbed by 
the brain.  There are many factors, such as the number of CT scans, total scanning time, 
irradiated volume and imaging protocol parameters, which will lead to an increase in the total 
absorbed and cumulative dose to organs and tissues irradiated directly or from scattered 
radiation. 
The first section provides information on the basic anatomy of the central nervous system 
(CNS) and its development, and then the basic organisation of the brain.  Secondly, this chapter 
addresses, in brief, the CT radiological anatomy of common CNS structures as well as an 
overview of the common pathologies that CT of the brain can be used to diagnose in both 
paediatric and adult patients.      
2.2 Basic Development and Organisation of the Brain  
The brain is the largest part of the CNS and consists of three main general areas which are: the 
brainstem, the cerebellum, and the cerebrum and the cerebral cortex which the outer surface of 
the cerebral hemispheres (Nowinski, 2011).  The basic structural unit of the nervous system is 
the nerve cell (neurone), which is responsible for conducting the information away from the 
neuronal cell body and receiving the information from the other neurons.  The main function of 
nervous tissue is to receive stimuli and transmits signals from one part of the organism to 
another (Van De Graaff, Morton, & Crawley, 2012).   The brain itself lies within the cranial 
cavity resting on the bony skull and protected by cerebrospinal fluid (CSF) (Error! Reference 
source not found.) (Kandel & Tollet, 2016; Nowinski, 2011; Van De Graaff et al., 2012).  
8 
 
 
Figure 2-1: Position of the brain within the cranial cavity (Pearson Education, Inc., 2012). 
Brain size is one of its most impressive features and our distinctively human mental capacity is 
commonly attributed to this.  At birth the brain weighs around 400g, and this weight during the 
first three years of life triples as illustrated in (Table 2-1, Figure 2-2 and Figure 2-3). 
The relative size of the brain in children is of paramount importance when calculating the 
radiation dose and risk for imaging examinations in children due to the paediatric head and 
brain being much larger when compared to the overall size of the body (Dekaban & Sadowsky, 
1978; Giedd, 2008). The disproportionately large head size, together with a relatively small 
body, leads to an increased absorbed radiation dose to other organs and tissues compared with 
adults. Consequently these differences should be taken into account when selecting acquisition 
parameters for adult and particularly paediatric brain CT examinations.  The general trend it 
that organ dose is inversely related to patient size; as patient size decreases, organ absorbed 
dose increases. The location of the organ with respect to the scan’s start and stop locations and 
the angular position of the tube relative to the organs, are all factors that contribute to the 
average organ dose.  This will obviously vary from individual to individual, even when using 
the same relative start and stop locations among the scanning volume.   
After three years the rate of brain growth becomes slower and at the age of eighteen the 
maximum brain weight is approximately 1400g (Gray, 2014).  The weight of the brain holds 
steady until about the age of fifty when a slow decline sets in.  In adults, the average weight of 
1400g can vary and studies have demonstrated that normal individuals will have brain weights 
from 1100g to around 1700g (Nolte, 2002). 
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Table 2-1: Relation of brain weights to body heights and body weights (Dekaban & 
Sadowsky, 1978). 
Age 
group Age (yrs) 
Male Female 
Brain 
Weight 
(g) 
Body 
weight 
(Kg) 
Body 
Height 
(cm) 
Brain 
Weight 
(g) 
Body 
weight 
(Kg) 
Body 
Height 
(cm) 
1 Newborn 380 2.95 50 360 2.88 49 
2 1 year 970 9.47 76 940 8.89 72 
3 2 years 1,120 13.20 85 1,040 11.58 84 
4 3 years 1,270 15.55 94 1,090 14.10 94 
5 6 – 7 years 1,330 22.94 116 1,210 21.28 116 
6 10 - 12 years 1,440 39.45 143 1,260 39.37 137 
7 19 - 21 years 1,450 68.58 174 1,310 51.11 161 
8 56 - 60 years 1,370 70.52 174 1,250 60.32 162 
9 81 - 85 years 1,310 67.01 1.73 1,170 53.42 159 
 
 
Figure 2-2: Average brain weight for both male and females at different ages (Dekaban & 
Sadowsky, 1978). 
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Figure 2-3: Average body weight for both male and females at different ages (Dekaban & 
Sadowsky, 1978). 
2.3 The Central Nervous System (CNS) Anatomy 
On the anatomic basis the CNS consisting of the brain and the spinal cord.  Also, can be 
subdivide into parts that are concerned primarily with the regulation of visceral organs and the 
internal milieu and parts that are concentrated mainly with the more or less conscious adaptation 
to the external world (Brodal, 2004).   
2.3.1 Cerebral Hemispheres 
This part of brain is the largest and most highly developed part of the human brain.  The cerebral 
hemispheres consist of the cerebrum and the structures hidden beneath of it.  The cerebrum 
includes the two cerebral hemispheres (left and right) that are connected to each other through 
white matter tracts called the corpus callosum (Figure 2-4) (Rohen, Yokochi, & Lütjen-Drecoll, 
2006).  These cerebral hemispheres are the largest major division of the brain that are separated 
from each other by the longitudinal fissure which contains a crescent-shaped fold of the dura 
matter, the falx cerebri.  The other hidden structure of the telencephalon is the diencephalon 
which is hidden from view by the cerebral hemispheres as shown in (Figure 2-4), (Figure 2-5) 
and (Figure 2-6). Each hemisphere consists of an external highly convoluted cortex, beneath 
which lies an extensive internal mass of white matter that partly encloses the basal ganglia.  
Each hemisphere also contains a lateral ventricle that is continuous with the third ventricle 
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through the interventricular foramen.  The commissural fibres of the corpus callosum are linked 
the two cerebral hemispheres (Standring, 2008).   
 
Figure 2-4: Brain cerebral hemispheres, superior and anterior views (Martini, Timmons, & 
Tallitsch, 2005). 
 
Figure 2-5: The cerebral hemispheres posterior and lateral views (Martini et al., 2005). 
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Figure 2-6: Right hemisphere together with brain stem and cerebellum (lateral aspect), the 
connection of the brain stem with the cerebellum is dissected. The amygdala of the left 
hemisphere is shown. The corpus callosum has been partly removed (Rohen et al., 2006). 
2.3.2 Cerebral Cortex 
Key features of the cerebral hemispheres are the shape and the degree to which their surface is 
folded and convoluted.  Each ridge is called a gyrus; and each groove between ridges is called 
a sulcus (Figure 2-4, Figure 2-5 and Figure 2-6).  Particularly deep sulci are often called 
fissures.  Cortext foldings into the gyri and sulci is a mechanism for increasing the total cortical 
area; each human has about 2.5 sq ft of cortex, two thirds of which is hidden from view in the 
walls of sulci (Nolte, 2002).  The gyri and sulci provide part of the basis for the division of the 
hemisphere into lobes.  The frontal, parietal, temporal, and occipital lobes approximately 
correspond in terms of surface location to the overlying cranial bones from which they take 
their names.  The anterior and posterior extremities of the hemispheres from the frontal and 
occipital poles respectively and the temporal pole are the anterior extremity of the temporal 
lobe.  The cortical regions hidden within the depths of the lateral fissure by overlying parts of 
the frontal, parietal and temporal lobes is known as the insula.  The key features on the 
superolateral cerebral surface of the brain are two prominent furrows, the lateral (sylvian) 
fissure and the central sulcus (Figure 2-5).  The lateral fissure is a deep cleft on the lateral and 
inferior surface. It separates the frontal and parietal lobes above from the temporal lobe below 
and accommodates the middle cerebral vessels.  The central sulcus is the boundary between the 
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frontal and parietal lobes and demarcates the primary motor and somatosensory areas of the 
cortex, located in the precentral and postcentral gyri, respectively (Standring, 2008).  
2.3.3 Cerebral Lobes 
The surface of each cerebral hemisphere has folded aspects which makes it possible to identify 
the lobes.  Each cerebral hemisphere is divided into several lobes, namely frontal lobe, parietal 
lobe, temporal lobe, and occipital lobe and the insular cortex see (Figure 2-7 & Figure 2-8).  
These lobes are separated by sulci: the central sulcus also known as the Fissure of Rolando, the 
lateral sulcus or Sylvain Fissure, the parietooccipital sulcus and the temporal-occipital sulcus.  
For a functional prospective each hemisphere has its own specific functions especially for the 
most complex functions for instance language in the frontal and temporal areas of the dominate 
hemisphere, spatial orientation in the right parietal lobe, the organisation of complex gestures 
in frontal lobe, etc. (Kandel & Tollet, 2016). 
Frontal lobe: this extends from the anterior tip of the brain to the central sulcus, inferiorly, it 
ends at the lateral sulcus.  On the medial surface of the brain it extends posteriorly to an 
imaginary line from the top of the central sulcus to the corpus callosum, the area of frontal lobe 
anterior to the precentral sulcus is divided into the superior, middle and inferior frontal gyri 
(Figure 2-7), the frontal pole lies in front of these gyri.  The ventral surface of the frontal lobe, 
the orbitofrontal cortex, overlies the bony orbit.  The medial surface extends from the frontal 
pole to the paracentral lobule and consists of the medial frontal cortex and the anterior cingulate 
cortex (Nolte, 2002; Standring, 2008).  
Parietal lobe:  this extends from the central sulcus to an imaginary line connecting the top of 
the parietooccipital sulcus and the preoccipital notch (Figure 2-7).  Inferiorly, it is bounded by 
the lateral sulcus and the imaginary continuation of this sulcus to the posterior boundary of the 
parietal lobe.  On the medial surface of the brain it is bounded inferiorly by the corpus callosum 
and calcarine sulcus, where anteriorly by the front lobe and posteriorly by the parietooccipital 
sulcus (Nolte, 2002; Standring, 2008).  
Temporal lobe: this extends superiorly to the lateral sulcus and the line forming the inferior 
boundary of the parietal lobe; posteriorly it extends to the line connecting the top of the 
parietooccipital sulcus and the preoccipital notch.  On the medial surface its posterior boundary 
is an imaginary line from the preoccipital notch to the splenium of the corpus callosum.  Its 
lateral surface is divided into three parallel gyri by the superior and inferior temporal sulci.  The 
superior temporal sulcus beings near the temporal pole and slops slightly up and backwards 
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parallel to the posterior ramus of the lateral sulcus.  Its end curves up into the parietal lobe.  The 
inferior temporal sulcus is subjacent and parallel to the superior and is often divided into two 
or three short sulci.  Its posterior end also ascends into the parietal lobe posterior and parallel 
to the upturned end of the superior sulcus (Figure 2-7) (Nolte, 2002; Standring, 2008). 
Occipital lobe: this is bound anteriorly by the parietal and temporal lobes on both the lateral 
and medial surfaces of the hemispheres (Nolte, 2002). The occipital lobe is more or less 
exclusively concerned with visual functions. Primary visual cortex is contained in the walls of 
the calcarine sulcus and a bit of the surrounding cortex. The remainder of the lobe is referred to 
as visual association cortex and is involved in higher order processing of visual information 
(Standring, 2008).   
 
Figure 2-7: Lateral aspect of left cerebral hemisphere (Rohen et al., 2006). 
 
Figure 2-8: Brain superior aspects, right hemisphere with arachnoid and pia matter and lobes 
of the left hemisphere indicated by colour (Rohen et al., 2006). 
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The limbic lobe is an additional area of the cerebral cortex not usually included in any of the 
four lobes discussed above and lies buried in the depths of the lateral sulcus, concealed from 
view by portions of the frontal, parietal, and temporal lobes.  This cortex, called the insula, 
overlies the site where the telencephalon and diencephalon fused during embryological 
development. It can be revealed by prying open the lateral sulcus or by removing the overlying 
portions of other lobes.  The portion of a given lobe overlying the insula is called an operculum; 
there are frontal, parietal, and temporal opercula.  The circular sulcus outlines the insula and 
marks its borders with the opercular areas of cortex.  The cingulate gyrus, immediately superior 
to the corpus callosum, can be followed posteriorly to the splenium of the corpus callous, where 
it turns inferiorly as the narrow isthmus of the cingulate gyrus and continues as the 
parahippocampal gyrus of the temporal lobe.  These two gyri give the appearance of the 
encircling the diencephalon and they are together with the olfactory bulb, olfactory tract, and 
certain other small cortical areas are often referred to separately as the limbic lobe.  As indicated 
by the red colour in (Figure 2-9) the limbic lobe therefore contains portions of what would 
otherwise be considered frontal, parietal, and temporal cortex.  The limbic lobe and many of 
the structures with which it is interconnected make up the limbic system, which is important in 
emotional responses and drive-related behavior (Nolte, 2002; Standring, 2008).   
 
Figure 2-9: Limbic lobe as seen on the medial surface of a hemisected brain from which the 
brainstem and cerebellum were removed (Nolte, 2002). 
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2.4 White and Gray Matter 
The brain and spinal cord are composed of two kinds of nervous substances known for their 
colour as the white and grey matter, respectively.  This difference in their arrangement that in 
the brain the grey matter is situated chiefly in the outside forming the brain cortex whilst in the 
spinal cord the white matter substance is located externally and the grey matter forms the central 
core.  The cortex which is located on the surface of brain hemispheres is composed of gray 
matter that contains neuron cells bodies and is organized into six layers.  The basal ganglia are 
located at the base of hemispheres.  These are also composed of gray matter.  White matter 
contains myelinate axons from CNS neurons and it makes it possible to establish connections 
between different parts of the CNS through associative fibers that connect parts of the cortex to 
each other or to the basal ganglia and through fibres that stretch out toward the spinal cord 
(Kandel & Tollet, 2016).  (Figure 2-10) provides an illustration of the arrangement of gray and 
white matter in the brain. 
 
Figure 2-10: Coronal brain section showing the gray and white matter (Martini et al., 2005). 
2.5 CT Radiological Anatomy 
Gray and white matter structures are differentiated on CT images by differences in density 
(Butler & Mitchell, 2012; Johns, 2014).  White matter consists of high content of myelinated 
axons while gray matter contains a relatively few axons and a high number of cell bodies.  Due 
to myelin being a fatty structured substance it has low density compared to the cellular gray 
matter (Figure 2-11) (Hofer, 2010; Mary, 2016). 
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Figure 2-11: Gray and white matter (Mary, 2016). 
In general, the various shades of grey demonstrated on CT images are summarized in the 
following (Table 2-2) which illustrates the white to black densities seen in selected tissues in 
CT (Haines, 2004; Johns, 2014). 
Table 2-2: The brain and related structures in CT (Haines, 2004 & CrashMaster, 2011). 
Structure / Fluid / Space Gray Scale 
Bone, acute blood Very white 
Enhanced tumour Very white 
Subacute blood Light gray 
Muscles Light gray 
Gray matter Light gray 
White matter Medium gray 
Cerebrospinal fluid Medium gray to black 
Air, fat 
On CT, structures are assigned a Hounsfield 
unit representing their relative density. Air is 
assigned a value of -1000 UH, water 0 HU, 
and bone +1000 HU. Fat, being less dense 
than water but more dense than air has a 
value of approximately -50 HU. 
 
2.6 CT Brain Pathologies and Clinical Aspects in Adults and Paediatrics 
The use of CT is of growing importance in children and adults; however, it is also a major 
source of radiation dose too.  In general brain CT scanning is typically used in adult and 
paediatric to detect and provide information on haemorrhage, brain injury and skull fractures in 
Gray Matter 
White Matter 
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patients with head injuries.  Over the last few decades the introduction of increasingly 
sophisticated imaging techniques has been transferred to neurological diagnosis.  CT based 
imaging techniques play an essential part in assessment and management of neurological 
disease in both paediatric and adult patients (Renowden, 2012). 
Non-contrast CT (NCCT) is the standard brain imaging technique for the initial evaluation of 
patients with acute stroke symptoms; CT is currently the modality of first choice for imaging 
patients with acute stroke.  Worldwide stroke is the main cause of neurologic morbidity and 
mortality and it constitutes the second or third most cause of death with cardiovascular disease 
and cancer in industrialised countries and also in older age group it composes the second most 
common cause of dementia after Alzheimer disease (de Mendivil et al., 2013).  There are 
effective treatments for patients with embolic occlusion of cerebral arteries by using systemic 
or local fibrinolysis with the aim of turning strokes from fatal to treatable.  For patients with 
suspected stroke there is also a need to exclude cerebral haemorrhage, CT is used routinely in 
most situations as the primary imaging modality due to its ability to detect early signs of stroke.  
Cerebral ischemia is the cause of about 70% of acute strokes due to regional reduction of 
perfusion (Klotz & König, 1999, Hua et al., 2009).  Furthermore, it is also used to assess 
bleeding caused by a ruptured or leaking aneurysm in patients with a sudden severe headache.  
Further assessment of brain tumours, enlarged brain cavities (e.g. ventricles) in patients with 
hydrocephalus and disease or malformations of the skull vault (Broder & Preston, 2011; de 
Mendivil et al., 2013) are indications for CT.   
CT has been reported to have a sensitivity of 90% and a specificity of 100% to accurately detect 
the type and the extent of the under lying ischemic process (de Mendivil et al., 2013).  The 
advantage of CT scan is that it is rapid which is extremely important in trauma situations.  CT 
clearly shows acute and subacute haemorrhages into the meningeal spaces and the deep brain 
tissues (Haines, 2004).  
Although NCCT is initially used to exclude intracranial hemorrhage and other non-stroke 
pathologies, advanced CT techniques are increasingly recognized as a modality to characterize 
early signs of ischemia (Rossaint et al., 2016; Nagel et al., 2017). 
CT perfusion (CTP) is an imaging technique for detecting functional abnormalities by 
measuring tissue-level blood flow, which can be assessed by utilising variety of parameters: 
cerebral blood flow, cerebral blood volume (CBV) and mean transit time (de Mendivil et al., 
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2013).  With the use of multislice CT scanners, the potential information available from a CT 
scan has increased.   CT angiography and CT perfusion techniques can refine the current clinical 
criteria for patient selection for thrombolysis.  CT angiography–source images (CTA-SI) can 
be rapidly obtained with minimal delays after a NCCT in the emergency room.  Although CTA 
has been shown to have value in identifying vessel occlusion, CTA-SI may also aid in the 
assessment of tissue status (Coutts et al., 2004).   
CTA-SI can also be useful in predicting final infarct volume.  Brain tissue with a low cerebral 
blood volume appears as a region without enhancement on CTA-SI, effectively delineating the 
regions of ischemia.  The Alberta Stroke Program Early CT Score (ASPECTS) was developed 
as a grading instrument to assess early ischemic changes on pre-treatment CT scans in patients 
with acute ischemic stroke of the middle cerebral artery (MCA).  The ASPECTS divides the 
MCA territory into 10 regions of interest.  With training and experience, the early changes of 
acute ischemia can be reliably detected.  One advantage of ASPECTS is that it combines a 
semiquantitative estimate of volume along with localization.  It weights smaller volumes in the 
basal ganglia and internal capsule equally with larger volumes of brain designated M1 through 
M6.  This approach is useful because lesion volume alone on NCCT is only weakly correlated 
with neurological outcome (Coutts et al., 2004; Rossaint et al., 2016).   
CT is also helps diagnosis and management of many head and neck disorders (Kidwell et al., 
2004; Metter et al., 2011; Tijssen et al., 2014).  The detection of acute intracranial haemorrhage 
in paediatric and adult populations is highly sensitive and specific using CT scanning for 
pathologies such as subdural hematoma, subarachnoid, and intraventricular haemorrhage and 
haemorrhagic contusions.  Also, CT is useful in the diagnosis of secondary parenchymal low 
density cerebral oedema, ischemia and fractions (Dubbins et al., 2008).  CT is a useful and 
necessary tool which helps to establish the diagnosis and to determine the treatment for urgent 
surgical intervention (Younis et al., 2002).  
CT can be performed quickly, thus it is useful in emergency/trauma situations illustrating many 
abnormalities in brain structure including: swelling, bleeding arising from ruptured aneurysms, 
haemorrhagic stroke and head injury (Asbury, 2011).  CT is also used prior to brain surgery in 
order to improve the positioning accuracy and guidance of delicate surgical instruments (Kwoh 
et al., 1988).   
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In addition to the above indications, CT scanning can also be performed to determine the 
following:  
 Evaluate the extent of bone and soft tissue damage in patients with facial trauma and 
planning surgical reconstruction by providing more details to the region of interest through 
acquiring thinner slices or changing the patient position in the scanner during image 
acquisition.  
 Diagnose diseases of the temporal bone on the side of the skull which may be causing hearing 
problems. 
 Determine whether inflammation or other changes are present in the paranasal sinuses. 
 Plan radiation therapy for cancer of the brain or other tissues. 
 Guide the passage of a needle used to obtain a tissue sample (biopsy) from the brain. 
 Assess aneurysms or arteriovenous malformations through a technique called CT 
angiography (Broder & Preston, 2011).   
CT scanning has provided the most valuable information to date regarding the evolution of 
brain edema after head injury.  Modern CT scanners are able to clearly define areas of low 
density in relation to focal brain injury such as contusions and hematomas, and some authors 
have sought to relate increases in CT density values to brain engorgement by correlating those 
values with cerebral blood volume and cerebral blood flow measurement (Orrison et al., 2011). 
General radiological information can be obtained from non-contrast head CT, while contrast 
enhanced head CT is performed usually following non-contrast CT and then the two procedures 
are compared.  As illustrated in (Table 2-3) the pathological signs on non-contrast head CT 
images can be used to indicate different abnormalities within the brain region (Broder & 
Preston, 2011). 
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Table 2-3: Interpretation of pathology from non-contrast CT head images (Broder & 
Preston, 2011). 
Brain pathology Signs of this pathology 
Air-filled space  
Mastoid air-cells  
Sinuses 
Fractures 
Infections 
Bones Fractures 
Blood 
Epidural haemorrhage 
Intraparenchymal haemorrhage 
Subarachnoid haemorrhage 
Subdural haemorrhage 
Brain 
Midline shift or mass effect 
Edema 
Infarction 
Masses 
CSF spaces 
Cisterns 
Sulci 
Ventricles 
Atrophy 
Edema 
Hydrocephalus 
Subarachnoid haemorrhage in these  
structures 
2.7 Chapter Summary  
While the benefits of CT exceed the harmful effects of radiation exposure in patients, increasing 
radiation doses to the population have raised a compelling case for reduction of radiation 
exposure from CT. This chapter has explored important anatomical and radiological factors 
which make brain / head CT imaging demanding in relation to radiation dose optimisation and 
risk. This is related to the relative differential size of paediatric and adult head/brain in relation 
to overall body size. Also outlined in this chapter are potential conditions that can be 
demonstrated in CT.
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Chapter 3 :  CT Scanning: Development, Physical Principles and 
Radiation Dose Parameters  
3.1 Chapter Overview 
The key focus of this thesis is radiation dosimetry from CT scans.  Consequently, the purpose 
of this section is to provide an introduction to the theoretical concepts and processes of CT 
scanning.  Within this discussion there will be commentary on the key technology developments 
as well the CT acquisition factors that influence radiation dose.  The CT image reconstruction 
process will be described briefly as there are a number of methods, each having an effect on 
image quality and radiation dose.  This section is related directly to the thesis aims; to 
investigate organ and tissue absorbed doses (directly) and use the acquired values to estimate 
the effective dose and radiation risk. The radiation exposure for patients undergoing CT 
examinations are determined by two main factors: 1) equipment related factors such as the 
design of the scanner and 2) acquisition parameters chosen by the radiographers and 
radiologists.  This chapter also, provide an overview of how to use Metal Oxide Semiconductor 
Field Effect Transistors (MOSFETs) for direct radiation dose measurements in human 
phantoms.  The option for using CT derived estimations of radiation dose, dose length product 
(DLP) and volume CT Dose Index CTDIvol will also be explored.  Monte Carlo simulation for 
mathematical dose estimation will be discussed.  The final element of this chapter will be to 
discuss the utilisation of lifetime attributable risks relevant to CT radiation doses.  
Currently there is no definitive method for undertaking CT dosimetry and multiple 
experimental and computational approaches exist.  The choice between dosimetry methods is 
often more difficult when considering children, since the dose estimates need to be age-specific 
or reflect the range of ages necessary to accurately represent the paediatric population.  
Furthermore, with a wide variety of methods available, there is potential for radiation doses to 
differ.  Since organ and tissue absorbed doses are used for risk assessment and effective dose 
for radiation protection purposes, it is important to explain the extent of the variability between 
different methods and identify the most suitable. 
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3.2 CT History and Technology Development    
The first CT scanner was developed in 1972 by Sir Godfrey Hounsfield, an engineer at THORN 
EMI Central Research Laboratories in the United Kingdom (UK).  Since then CT scanner 
technology has rapidly evolved in terms of both technical performance and clinical use, and has 
resulted in five developmental generations of equipment.  The novelty of CT is to reconstruct 
images mathematically from measured attenuation data and to display and archive them in 
digital form.  The renaissance period of CT followed the introduction of spiral (helical) imaging.  
This meant a transition from slice-by-slice imaging to true volume imaging and by the 1990s 
CT had the ability to image whole organs or even the whole body within 5 to 20 seconds with 
sub-millimeter isotropic resolution.  As a result, most of the commercially available CT 
scanners today are based on a third-generation design.  The evolution of CT technology is 
illustrated in (Table 3-1). 
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Table 3-1: The evolution of CT technology (Kalender, 2011;  Romans, 201;  Halliburton et al., 2008;  Ulzheimer & Flohr, 2009;  Goldman, 
2008;  Seeram, 2015;  Nagel, 2005;  Romans, 2011;  Hsieh, 2009;  Mohan et al., 2011). 
CT generation & 
developments Year 
Number of 
Detectors Scan Time Movement Type Tube Rotation Degree 
Beam 
Dimensions 
First 1970 Single detector 3 - 5 min/slice Translate - Rotate 
1o at a time (together 
translate through 180o) Pencil Beam 
Second 1972 
Curved array of 
more than 30 
detectors 
30 sec / slice Translate – Rotate Rotate through 180
o  Fan Beam 
Third 1976 
Large curvilinear 
row of hundred 
detectors 
1 sec / slice Rotate - Rotate Rotate through 360o Wider Fan Beam 
fourth 1976 Ring of thousand detectors 1 sec / slice Rotate - Fixed Rotate through 360
o Wider Fan Beam 
Fifth 1984 Hundred of curved detectors Millisecond / slice No moving parts No rotation Wider Fan Beam 
Helical or spiral CT 
scanners  1990 
Hundred of curved 
detectors Sub-second Rotate - Rotate Rotate through 360
o Wider Fan Beam 
Multislice CT 
scanners (MSCT) 1998 
Multi rows of 
detectors up to 320 Sub-second Rotate - Rotate 
Angle of rotation of 
360o   Wider Fan Beam 
Cone shaped  
x-ray beam 1996 & 2001 Flat panel detector Sub-second Rotate - Rotate 
Angle of rotation of 
360o   Cone Beam 
Dual source CT 
scanners  2006 
Hundred of curved 
detectors Sub-second Rotate - Rotate Rotate through 90
o Wider Fan Beam 
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3.3 Factors Influencing Radiation Dose in CT 
CT scanners are a major contributor to the radiation dose received in radiology departments. 
CT protocols are not set by regulation authorities but are followed locally in hospitals, but they 
are audited through Dose Reference Level (DRL) analysis (Colagrande et al., 2014).  The 
setting of CT acquisition parameters such as tube current, tube rotation time, peak tube voltage, 
pitch, and collimation is a major contributor to the radiation dose received during a CT 
examination.  Typically, if one of these parameters is decreased, another needs to be increased 
to maintain the radiation dose to an acceptable level in order to generate an image with sufficient 
diagnostic information.  The majority of CT scanners used in developed countries are multi-
slice CT (MSCT) and therefore this chapter focuses primarily on acquisition parameters and 
their effect on dose in relation to MSCT only.  There are many variables within each 
examination procedure that influence radiation dose, in particular: 
Tube Voltage (kVp): Higher peak voltages will result in more X-rays passing through the 
body; hence increases the dose and the ratio of dose at depth to surface dose, however, there is 
lower image contrast.  Because of image noise and beam-hardening artifacts (which appear as 
nonuniformities in the CT numbers), sometimes the trend to decrease tube voltage (and 
correspondingly, the radiation dose) was not successful (Cody et al., 2004; Nakayama et al., 
2005). So, tube voltage reduction is allowed only on the condition that it does not affect the 
ability to detect low-visibility structures (Akhlaghi et al., 2014). 
Tube Current (mA): mA is directly proportional to radiation dose, as tube current increases, 
more X-rays are incident onto the patient leading to higher patient dose. 
Pitch: For MSCT, the most commonly used definition is the table feed/distance (mm/s) of the 
CT table per 360o rotation of the X-ray tube, divided by the X-ray beam collimation width.  
This parameter has a direct influence on patient radiation dose.  The radiation dose is inversely 
proportional to pitch when all other factors are held constant.  This is essentially because as 
pitch increases, the time that any one point in space spends in the X-ray beam is decreased.  
Effective mAs: The effective mAs takes into account pitch.  As stated patient doses are directly 
proportional to mAs since the photon fluence, as influenced by the tube current–time product 
(milliampere-seconds), has a direct influence on patient radiation dose.  On some CT scanners, 
the user inputs a parameter labelled mAs, but that parameter is really the effective mAs, which 
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is milliamperage multiplied by time/pitch.  On these scanners, when pitch is varied, mAs varies 
in a corresponding fashion to keep effective mAs constant.  The effects of pitch are discussed 
in (Section 3.3.2.3) on page 30 (McNitt-Gray, 2002; Huda et al., 2007).  
Slice Collimation (mm): Defines the thickness of the slice to be imaged.  The wider collimation 
has more mass being irradiated than a thinner one, thus indicating that the radiation dose for 
wider and thin collimations may be close to equivalent (the difference is attributed to the higher 
scatter expected in the thicker section).  
Beam Collimation (MSCT only): This is the product of the number of active detector channels 
used and the effective detector row thickness.  The number of active detectors determines 
MSCT slice thickness.  In single slice CT (SSCT) the slice thickness is determined alone by the 
collimation width.  In fact, early reports from early versions of MSCT showed significant 
dependence on X-ray beam collimation.  These effects result from differences in X-ray beam 
collimation, even when the same reconstructed section thickness is used (McNitt-Gray et al., 
2002).  
Feed: The table travel (or movement) per rotation.  An increased table movement can decrease 
the radiation dose to the patient if all other parameters remain constant. 
Tube Rotation: The speed of gantry rotation.  This parameter has an inverse effect on radiation 
dose. 
Gantry Angulation: The craniocaudal angle of the X-ray tube and detector array relative to 
the table.  In clinical situations, a patient’s head is adjusted to avoid irradiating eye lenses 
whereas in laboratory studies using phantoms this is not possible and instead the CT gantry is 
tiled.    Also, in some clinical situations where patient’s cannot effectively move their head and 
hence the additional need for angulation. 
The parameters described above can be divided into three categories: 1) factors related to CT 
scanner design, 2) helical CT protocol related factors and 3) CT scan acquisition parameters.  
3.3.1 CT scanner design factors (equipment-related factors) 
These factors include X-ray tube filtration, X-ray beam shaping filters, collimator design and 
focus to axis distance, which are explained in detail elsewhere in the literature (McNitt-Gray, 
2002; Ulzheimer & Flohr, 2009; Nagel, 2007). 
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3.3.2 CT helical protocol related factors (spiral interpolation) 
As reported by Lewis, 2005, two major technological developments have led to an increase in 
patient radiation dose and image quality: helical scanning and the changes to the detector array 
in the Z-axis of the patient (Lewis, 2005).  
Data acquisition in spiral/helical scanning mode requires an additional interpolation step to 
obtain axial slices and is called “over-ranging”.  These extra rotations are needed for helical 
interpolation; as a result, there is additional irradiated tissue outside of the selected imaging 
volume.  In helical scanning, extra image data is required at each end of the image plane in 
order to interpolate the required axial image slices (Nagel, 2007).  There are also other sources 
of excess radiation from helical scans, termed over-beaming, which are described in detail by 
Cody and Mahesh (2007); it refers to the radiation delivered by the “penumbra” which is not 
used for image date reconstruction.  This over-beaming radiation passes through the patient and 
contributes to the patient dose but not to the generation of images (Cody & Mahesh, 2007; 
Sorantin et al., 2013).   
 
Over-ranging is the increase in dose-length product due to the additional rotations at the 
beginning and at the end of a spiral/helical scan required for data interpolation to reconstruct 
the first and the last slice of the imaged body region, because the reconstruction algorithm 
requires additional raw data on both sides of the planned scan (Figure 3-1).  Over-ranging 
effects can be expressed both in terms of the additional number of rotations and the increase in 
scan length (Nagel, 2007; Schilham, van der Molen et al., 2010; van der Molen & Geleijns, 
2007).  These extra rotations will lead to exposure of tissue above and below the planned scan 
length.  This adds to the radiation dose to the patient and is therefore important for accurate 
dose calculations.  In single-section spiral CT, the number of over-range rotations is well 
known—for example, 1.0 and 2.0 for the 180° and 360° linear interpolation algorithms, 
respectively (Kalender, 2011).  In MSCT, image reconstruction algorithms are more variable 
and scanner specific and little data on over-ranging currently exists (Nicholson & Fetherston, 
2002; Tzedakis, Damilakis, Perisinakis, Stratakis, & Gourtsoyiannis, 2005; Aart J van der 
Molen & Geleijns, 2007). 
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Figure 3-1: This figure illustrates how at least an extra half rotation (red) is needed before the 
start and beyond the end of the imaged volume (green); and the second image shows how a 
user would plan a brain CT scan so that the imaged area (green) excludes the eyes. If the scan 
is helical, however, over-ranging will cause exposure to an additional area (red). 
In clinical practice, over-ranging can mean that any organs that were carefully positioned just 
outside the imaging volume could, in fact, be exposed to primary beam radiation. The exact 
extent of over-ranging depends on several scanning parameters as well as on the manufacturer 
and the type of CT scanner.  As reported by Schilham et al., (2010) the extent of additional 
irradiation increases as scan length (table feed) per rotation increases.  Over-ranging becomes 
a serious problem since the current trend in CT scanner development is to decrease scanning 
time by increasing the scan length covered in one rotation, this makes a substantial contribution 
to patient radiation dose, even though this dose portion is not used for imaging (Schilham et al., 
2010).  As described by Schilham et al., (2010) the only two scanning parameters that influence 
over-ranging are pitch and detector collimation, assuming that the rotation time and the effec-
tive milliamperage are kept constant.  The over-range length and dose have to increase (linearly) 
with increasing pitch (Figure 3-2); pitch and detector collimation vary, from a pitch of 2 and a 
small detector collimation (left), to a pitch slightly larger than 1 and a small detector collimation 
(middle), to a pitch slightly larger than 1 and a large detector collimation (right).  In 
(Figure 3-2), the top row illustrates the helical motion of the detector array around the patient, 
the middle row shows X-ray–like images that indicate the region where enough data are present 
for image reconstruction while the bottom row shows the relative dose profiles as functions of 
scan position along the direction of table motion (Schilham et al., 2010).  A large detector 
collimation has the same effect on over-ranging as a higher pitch.  At least one extra over-
ranging rotation is still needed, meaning that over-range length and radiation dose have to 
increase (linearly) with increasing detector collimation (Figure 3-2) (Schilham et al., 2010).  
The contribution of over-ranging to the total CT dose is, therefore, considerably higher for CT 
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examinations with shorter scan ranges such as paediatric and cardiac CT.  Fortunately, adaptive 
section collimation technology was developed, as reported by Goo (2012), to eliminate over-
ranging during spiral CT scanning.  This useful collimation technology is currently available 
only in some of the CT models. 
 
Figure 3-2: Diagram illustrating how over-ranging is influenced as pitch and detector 
collimation vary (Schilham et al., 2010). 
 
Over-beaming is the excess dose beyond the edge of the detector rows of a MSCT slice per 
rotation that results if focal spot penumbra falls outside the area of active detector and is not 
used for imaging purposes (Figure 3-3).  The magnitude of over-beaming is inversely 
proportional to the number of detector rows, therefore, it contributes unnecessary radiation 
exposure to patients (Goo, 2012; Sorantin et al., 2013).  There is no need to exclude the 
penumbra from imaging with SSCT because most single slice scanners make full use of the 
entire dose profile.  Only at collimator settings below 2 mm, some scanners employ restrictive 
post-patient collimation.  However, different situations arise with MSCT, as more than one 
active detector channel is used; there is a need to serve all channels equally well. Consequently, 
penumbra must either totally or partially be excluded from detection. As a result the detectors 
are ‘over-beamed’, and a certain portion of the radiation that exposes the patient remains unused 
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(Figure 3-3), where N is the number of slices acquired simultaneously and hcol is the slice 
collimation (Nagel, 2005; Sorantin et al., 2013). 
 
Figure 3-3: Dose profile in free-in-air for a quad-slice scanner (dark grey: umbra, light grey: 
penumbra); over-beaming is characterized by the parameter dz (Nagel, 2005). 
Over-beaming can be determined for a particular type of scanner by a set of CTDI 
measurements made free-in air at the axis of rotation for all of the collimator settings available.  
Over-beaming characteristics can be fairly well described by a single parameter (the over-
beaming parameter dz) that usually represents the combined width of both penumbra triangles, 
(Figure 3-3).  Typically, for the majority of single-slice scanners (dz) amounts to 0 mm, to 1 
mm for single-slice scanners with restrictive post-patient collimation and most dual-slice 
scanners, and to 3 mm for MSCT scanners with four and more slices acquired simultaneously 
(Nagel, 2005; Sorantin et al., 2013). 
 
Most manufacturers report a pitch value with respect to the nominal slice thickness instead of 
the total active collimation length in the z-axis.  In helical CT protocols, the pitch parameter 
has a direct influence on patient radiation dose.  This is essentially because as pitch increases, 
the time that any one point in space spends in the X-ray beam is decreased.  Selecting a higher 
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pitch will reduce the DLP of the patient but not the CTDI, by reducing the number of rotations 
over the same plane (GE Medical Systems, 2001; Seeram, 2015). 
The determinants of pitch are beam collimation and table speed, both parameters are 
intrinsically linked to image quality and radiation dose (Rehani, 2010; Paterson & Frush, 2007; 
Valentin, 2007).  A beam-pitch of 1.0 facilitates an acquisition with no overlap or gap, a beam-
pitch of less than 1.0 facilitates an overlapping acquisition, and a beam-pitch of greater than 1.0 
facilitates an interspersed acquisition.  Pitch has a smaller effect on image quality with the use 
of MSCT scanners than it does with use of SSCT scanners (Flohr et al., 2005).  There are three 
modes of helical pitch (HP) or pitch factor (PF) used in the Toshiba Aquillion 16 CT scanner: 
HP 11.0/(detail PF 0.688), HP 15.0/(standard PF 0.938) and HP 23.0/(fast PF 1.438) (Toshiba 
Medical Systems).  Generally, radiation dose is inversely proportional to pitch when all other 
factors are held constant.  Therefore, increasing pitch is one consistent way to reduce radiation 
dose.  A study by Michael, (2002), showed that as the pitch decreased the CTDIvol (which is the 
only CTDI descriptor that takes pitch into account) increased and the radiation dose acquired 
in head phantom was doubled compared to that acquired in body phantom. 
3.3.3 Dose effects relating to CT acquisition parameters (application-related factors) 
This section will discuss the main CT scan parameters of interest that have a direct influence 
on radiation dose, such as the X-ray beam energy (kilovolt peak), tube current (in milliamperes), 
rotation or exposure time, dose reduction techniques such as tube current variation or 
modulation and CT gantry angulation.  Patient doses in CT examinations depend on the choice 
of radiographic parameters used to perform the scanning.  Key parameters that affect patient 
dose, and which need to be defined in CT protocols, are the following (Raman et al., 2013; 
Szczykutowicz et al., 2015 and AAPM Practice Guideline 1.a., 2015):  
 
X-ray tube voltage is the electrical potential applied across the X-ray tube to accelerate electrons 
toward the target material.  The radiation dose increases approximately proportionally to the 
percentage change in tube voltage.  The tube voltage values for routine CT brain scans for adult 
patients typically range from 110 kVp to 140 kVp (Dowsett et al., 2006; Livingstone et al., 
2006; Smith, et al.,  2007; Tsapaki  et al., 2006). 
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The tube potential determines the energy of the incident X-ray beam.  This parameter has not 
routinely been adjusted in the past for body CT exams in infants and children, with the majority 
traditionally being performed at 120-140 kVp (Paterson & Frush, 2007).  Increasing tube 
potential improves both the tube output and penetrating ability of the beam, while image 
contrast is decreased.  Increased tube voltages have been reported to improve tube loading and 
image quality due to both the tube output and the penetrating ability of the beam being 
improved, while image contrast is adversely affected.  Contrary to the case for mAs, the 
consequences of variations in kV cannot easily be assessed (Galanski et al., 2007).  
As illustrated by Galanski et al., (2007) the relationship between radiation dose and tube 
potential is not linear.  Studies have shown an exponential relationship which varies according 
to specific circumstances, such as factors related to CT machine design and patient size.  
Reducing the peak kilovoltage can result in a substantial drop in the radiation dose, though the 
exact dose saving is in part related to the geometry of individual CT machines, and thus, varies 
between different manufacturers (Paterson & Frush, 2007). Tack and Gevenois, (2004) 
highlighted the additional CT acquisition factors which include the inherent tube filtration and 
the physical distance between X-ray tube and patient.  As tube filtration increases the beam 
becomes harder; this results in lower energy photons being removed and therefore a larger 
proportion of higher kVp values are emitted.  X-ray beam intensity reduces as filtration 
increases.  A report by Huda et al., (2002) demonstrates a four-fold decrease in the radiation 
dose when the tube kilovoltage was reduced from 140 kVp to 80 kVp for body and head CT 
protocols.  
Generally, higher kV photons are used in diagnostic imaging to increase photon penetration of 
the patient.  This will result in increasing the high contrast resolution of the images (Matsumoto 
et al., 2011).  In CT brain imaging, a high kV (e.g. 120 kV) is used because it yields lower noise 
in the acquired image and lower noise is required to maximize the resolution of the brain image.  
It has been determined that an increase in tube potential will decrease the noise of the image, 
however the patient dose will increase (Duzenli et al., 2005). 
 
The photon flux during image acquisition is controlled by tube current (mA) and time (s); the 
CT operator can adjust the tube current-time (mAs) in order to reduce the dose (i.e. reduce the 
number of incident photons) or reduce the noise (i.e. increase the number of incident photons).  
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The number of photons that are produced in X-ray filament will increase linearly with 
increasing mAs and the load on the tube also increases. On the other hand, increasing the 
photons that are incident on the object will allow more photons to reach the image detector 
(assuming that the beam has adequate penetrating power through appropriate kVp selection).  
The reduction in noise follows statistical photon counting, and is approximately 1/√N, where 
N is the number of incident photons (Seeram, 2015). 
There is a linear relationship between tube current and radiation dose (Paterson & Frush, 2007).  
The typical mAs values for a routine brain CT scan for adult patients, as reported by Livingstone 
et al. (2006), Smith et al., (2007) and Tsapaki  et al. (2006), are 100, 200 – 350 and 250 – 270, 
respectively (Livingstone et al., 2006; Smith et al., 2007).  Whereas typical mAs values for 
routine peadiatric brain CT scans range from 180 – 230 and 90 – 320, as reported by Huda et 
al., (2007) and Mazonakis et al., (2007), respectively.  As reported by Huda et al., (2004; 2007); 
for head CT examinations, the mAs can be reduced substantially when scanning infants, and 
that use of the lowest X-ray tube voltage will generally reduce patient doses.  For reasonable 
dose management in paediatric applications, however, smaller volumes are scanned and tube 
load parameters can be reduced.  Lower mAs can be applied routinely and it is appropriate to 
reduce the mAs value of adult CT head scan by approximately a factor of 2 to 2.5 when scanning 
newborns.  Manual adjustment of tube current based on patient weight or dimensions can aid 
in establishing an appropriate balance between image noise and radiation exposure.  However, 
these adjustments do not guarantee constant image quality throughout the entire volume 
scanned and are not necessarily widely implemented into clinical practice.   
For single sequential CT scans the mA time-product (Q) is obtained by multiplying the tube 
current (I) and exposure time (t).  In spiral scanning mode, Q can be calculated as the product 
of tube current (I) and tube rotation time (trot) for a single slice, which is different from total 
scan mAs product that accounts for the product of tube current (I) and total scan time (T) (Nagel 
H D., 2007).  
Tube current-time product is often used as surrogate of measuring patient radiation dose when 
compared to computed tomography dose index (CTDI), which is defined as the average dose 
imparted by a single axial acquisition to a standard 100 mm pencil chamber dosimeter inside 
a PMMA phantom over the width of 14 CT slices (McCollough et al., 2008).  As presented by 
Galanski et al. (2007), this is highly misleading as the normalized values of CTDI and thus the 
radiation dose resulting from the same mAs settings can vary by up to a factor of 6 between 
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different scanners.  It is not realistic to communicate dose information or related 
recommendations on the basis of mAs values.  Instead, only CTDIvol (and DLP) should be used 
for this purpose.  CTDIvol is the volume computed tomography dose index and specifies the 
radiation intensity used to perform a specific CT examination. CTDIvol simply indicates the 
intensity of the radiation being directed at that patient, whereas DLP is the dose length product 
and defined as the number of slices acquired multiplied by the total scan length (Huda et al., 
2011).  Further details of CT dose descriptors are discussed in (section 3.5) page 41. 
With advancement of technology additional ambiguity has been introduced from MSCT 
scanners with the introduction of pitch-corrected mAs (effective mAs or mAs per slice).  Most 
MSCT scanners benefit from a multipoint spiral interpolation scheme and effective mAs is the 
most appropriate notation.  Nonetheless, some scanners still prefer the traditional mAs notation, 
for example General Electric and Toshiba, and this introduces an additional complexity when 
comparing mAs settings between vendors (Galanski et al., 2007). 
In paediatric CT, as reported by Paterson and Frush (2007), tube current should be reduced 
since there is no need for the same number of X-ray photons when imaging a child.  A decrease 
in tube current will lead to higher image noise and the operator must balance savings in radiation 
dose against increased noise.  Studies by Shah et al., (2005); Mathias Cohnen et al., (2000); and 
Rustemeyer et al., (2004) support a reduction in tube current for head CT scans.  A further two 
studies suggest that a simple way to decrease the radiation dose is by reducing the values of the 
tube current and peak voltage used to generate the scout images, below those recommended by 
the manufacturer (O'Daniel et al., 2005; Perisinakis et al., 2001; Matsumoto et al., 2011). 
 
This is an automated technique used in CT to adjust the X-ray tube current in real-time in 
response to variations in X-ray intensity received at the detector array caused by different body 
thicknesses / densities.  As reported by Galanski et al., (2007) the mA modulation is used for 
both body and head CT examinations.  The tube current is modulated instead of remaining fixed 
in order to meet a particular image quality/noise level along the full scan length.  Large 
variations in attenuation can occur both with projection angle and along the anatomical volume 
(z-axis).  Consequentially there is a strong rationale for moving away from using a fixed tube 
current (FTC).  mA modulation can be achieved in near real-time by using a feedback 
mechanism or incorporate pre-programming and a feedback loop, it can also occur angularly 
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about the patient or along the long axis (z) of the patient (McCollough, 2005 & 2009).  The 
basic idea behind tube current modulation is to adapt the tube current to attenuation of the body 
region by increasing the tube current for more attenuating areas and decreasing it for less 
attenuating areas.  Extremely large variations in patient radiation absorption occur with 
variations in projection angle and anatomic region.  Since the projection with the most noise 
primarily determines the amount of noise on the final image, it is possible to reduce the radiation 
dose (photons) for other projections without increasing the noise on the final image (Graser et 
al.,  2006; McCollough, 2005, 2006 & 2009; Mulkens et al., 2005).  Most currently used 
scanning protocols, which involve manual selection of tube current for radiation dose 
optimization and image quality, need to be modified (Tian et al., 2015; Strauss et al., 2010).  
Within the literature there are three reported methods for automatically modulating the tube 
current:  
- Angular (x, y) mA modulation: in this type of modulation the tube current varies as the X-
ray tube rotates around the patient (e.g in the A.P. versus lateral direction) as shown in 
(Figure 3-4).  The initial mA value should be chosen by the operator then the mA is modulated 
upward or downward from the initial value within a period of one gantry rotation.  The mA can 
be varied as the X-ray tube rotates between the AP and lateral positions according to the 
attenuation information determined from the CT scout image or in near real-time according to 
the measured attenuation from the 180o previous projection (Graser et al., 2006; Kalra et al., 
2004 & 2005; Marco, 2013; McCollough et al., 2009; Raman et al., 2013). 
 
Figure 3-4: mA angular modulation (Marco, 2013). 
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- Longitudinal (z) mA modulation: The longitudinal (z-axis) mA modulation involves the 
variation of the radiation dose along the anatomical regions according to its attenuation by 
varying the tube current along the z-axis of the patient (e.g. shoulders versus abdomen) as 
illustrated in (Figure 3-5).  This is different from angular tube modulation in which the tube 
current is varied cyclically in relation to the starting tube current value.  The main function of 
the z-axis modulation is to produce uniform noise levels across the various regions of the 
anatomy.  To achieve this, the operator must select the desired level of image quality by using 
scanner presets which are relatively manufacturer-specific (the reference noise index, reference 
image acquisition, reference tube current–time product value, or reference standard deviation 
or image quality level as recommended by Toshiba Medical Systems, Tokyo, Japan) (Graser et 
al., 2006; Kalra et al., 2004 & 2005; Marco, 2013; McCollough et al., 2006 & 2009).   
 
Figure 3-5: Longitudinal (z) modulation (Marco, 2013). 
- Angular and longitudinal (x, y, z) modulation: This modulation technique combines the 
two methods mentioned above to vary the mA both during gantry rotation and along the z-axis 
of the patient (i.e from the anteroposterior direction to the lateral direction and from shoulder 
to abdomen (Figure 3-6)).  The desired level of image quality must be selected by the operator 
using one of the following methods: the reference noise index (GE Healthcare Technologies, 
Waukesha, Wis), reference image acquisition (Philips Medical Systems, Best, the Netherlands), 
reference tube current–time product value (Siemens Medical Solutions, Forchheim, Germany), 
or reference standard deviation or image quality level (Toshiba Medical Systems, Tokyo, Japan) 
(Kalra et al., 2005; Marco, 2013; McCollough et al., 2009; Raman et al., 2013).  This type of 
mA modulation is used by the Toshiba CT machine employed in this thesis.    
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Figure 3-6: Longitudinal (z) and angular modulations (Marco, 2013). 
All modern CT systems are now delivered with ATCM systems that modulate tube current in 
three dimensions.  Each of these systems has different specifications and operates somewhat 
differently.  However, the main principle is to manage the required image quality and radiation 
dose in a reproducible manner by adapting the tube current to the patient’s size, shape, and 
attenuation.  Since the radiographers are asked to avoid inferior images, they usually select scan 
parameters that are ‘on the safe side’.  This often leads to exposures higher than necessary to 
achieve the required diagnostic image quality.  ATCM systems have a number of benefits: 
better control of the absorbed dose to the patient, improved consistency of image quality among 
patients, reduction of certain image artefacts, and reduced load on the X-ray tube, which 
increases its lifetime (Keat, 2005).  With these benefits in mind, users should learn how to use 
and apply the systems properly (Lee et al., 2008). 
Radiographer rely on ATCM systems to reduce dose to patients.  The AEC relies on constant 
noise levels, however, the desired noise levels cannot be easily predicted and the necessary 
noise levels are not constant for all anatomical regions.  If a constant noise level were required 
for all organs, the dose for regions with high attenuation would increase, while in these regions 
higher noise levels can be usually tolerated.  The tube current is modified relative to normal 
data for the attenuation of the different organs.  But if the required level of noise cannot be 
predicted the ATCM will set mAs values to the maximum which will lead to a dose increase to 
the patient (Suess & Chen, (2002).  
Optimization of CT scanning protocols involves many parameters, including tube voltage, tube 
current, section thickness, collimation, and pitch. The image reconstruction kernel is also 
important.  Changing even one of these parameters can affect ATCM systems in different ways, 
depending on the CT scanner being used.  For example, changing the reconstruction kernel will 
38 
 
alter the tube current used by the Toshiba Sure-Exposure system, which tries to maintain the 
image noise in response to variations in scanning and reconstruction parameters, but will not 
alter the tube current used by other systems.  Therefore, users should know about each of their 
system’s characteristics and the effect that changing scanning and reconstruction parameters 
will have on the image quality and radiation dose.  Nevertheless, in the use of ATCM systems, 
selecting an appropriate noise index, standard deviation, reference milliamperage, or reference 
image is vital. This process is not straightforward, however, as stated by Lee et al., (2008), there 
are two ways to determine appropriate values for the use of ATCM systems.  The European 
Guidelines on Quality Criteria for CT are a good standard for optimizing scanning protocol 
with reasonable radiation dose.  These guideline values are provided in relation to technique 
for a standard-sized patient for each type of CT examination considered.  Another way to 
optimize protocol is to use simulation software before scanning, although this technique is not 
currently available to most CT practitioners. This software can simulate the effect of increasing 
image noise, and the resultant simulated data can be reconstructed.  Thereafter, users will be 
able to evaluate image quality with radiation dose modulation (Lee et al., (2008). 
In general, the introduction of ATCM techniques in modern CT scanners represents an 
important step toward standardization of tube current protocols, with elimination of arbitrary 
selection by radiologists and radiographers.  As reported by McCollough et al., (2009), the use 
of ATCM greatly enhances and simplifies efforts to decrease patient dose.  It has demonstrated 
reductions in dose of about 20–40% when image quality is appropriately specified.   
 
The tube rotation time determines the speed at which the tube rotates around the patient.  In 
conjunction with table speed it defines the length of table movement for each rotation of the X-
ray tube.  The X-ray tube in CT irradiates only a narrow section of the anatomy when it makes 
a full rotation around the patient and does so for multiple rotations along the length of the 
patient.  In general, tube rotation times should be kept as low as possible in order to yield 
minimal movement artefacts, short scan time (and hence short breath-hold), and the opportunity 
for scanning a range that is as large as possible.  Longer rotation times might be necessary if 
the required radiographic exposure cannot be achieved for the shortest scan time.  In principle, 
the radiation dose is proportional to rotation time when all other CT scan parameters remain 
constant. Standard paediatric CT head clinical protocols are usually obtained with 0.5 or 0.75-
second rotation times and for adults this is increased to 1-second tube rotation times.  However, 
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for some clinical indications where specific information is needed and to reduce the motion 
artefacts such as centrum semiovale, corona radiata at the lateral ventricles, middle cranial 
fossa/skull base, and posterior fossa/palate, the rotation time is reduced and this leads to an 
increase in radiation absorbed dose (Mullins et al., 2004). 
Current MSCT machines have sub-second gantry rotation times. Since there is a linear 
relationship between tube current (mAs) and radiation dose, if the rotation time is reduced from 
1 to 0.5 seconds then the radiation dose will be halved.  Both rotation time and tube current are 
important in paediatric CT.  The reduction in examination time has been an important factor for 
reducing the need to use sedation or general anaesthesia for children undergoing this type of 
imaging.  On the other hand, faster imaging times mean images are less likely to show motion 
artefact, which in the past may have required an examination to be repeated, with an obvious 
increase in the radiation dose to the patient.  Reducing the tube current will increase image 
noise, and this must be factored in, when selecting these parameters (Paterson & Frush, 2007). 
 
Commonly, for CT brain scans, the examination is undertaken in an axial (sequential) mode in 
order to allow angulation of the gantry in order to reduce the radiation dose to the lens of the 
eye (Stewart et al., 2012).  The lens of the eye does not need to be considered for stochastic 
effects.  However, it is useful to consider the deterministic effects, such as cataracts, which have 
a threshold of about 0.5 Gy (ICRP Publication 118, 2012) (Stewart et al., 2012).  Evidence from 
within the literature commonly advocates the need to angle the CT gantry in order to avoid 
direct irradiation of the eye lens (Schilham et al., 2010).   
In CT, the radiation dose at the surface of the patient depends upon the distance from the x-ray 
target to the beam entrance, together with the contribution from the primary and secondary X-
ray photons entering the patient from other points.  The major contribution to the absorbed dose 
at any point superficially located arises from the entrance dose.  For the eye lens, the frontal X-
ray projections contribute to the major part of the absorbed dose. In head scanning, if the frontal 
90o is omitted and the scan is performed with an angular rotation rather than this angle (in head, 
partial rotation degree of 270o), then the eyes receive a reduced dose (ICRP Publication 87, 
2000; Rehani et al., 2000). 
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3.4 Radiation Dosimetry 
Radiation dose can be defined as the amount of energy absorbed in the body from radiation 
interactions.  Early measures of radiation dose were non-quantitative; based on skin erythema, 
and were subsequently replaced by measures of absorbed dose (e.g. energy absorption, 
measured initially in radiation absorbed dose or (rad) and more recently in gray (Gy) or 
milligray (mGy) [1 Gy = 100 rad; 1 rad = 10 mGy or 0.01 Gy] (Linet et al., 2012). 
Dosimetry is the act of measuring or estimating the radiation doses and calculating those doses 
to individuals or populations undergoing radiation procedures.  There are two types of radiation 
exposure; namely external exposure, which occurs when the radiation source or nuclear 
substance is outside of the body and internal exposure, which occurs when the radiation is 
emitted by nuclear substances inside the body.  External exposures are typically monitored by 
the use of small radiation detectors such as thermoluminescence phosphors, which are worn on 
the person or patient.  Monitoring a patient for external exposure is called patient dosimetry 
(Attix & Tochilin, 2016; Hine & Brownell, 2013).  When discussing the results from dosimetry 
experiments and calculations the following terminology may arise: - 
Absorbed dose: this is the mean energy imparted to the material (tissue) by ionizing radiation 
per unit mass of that material, expressed as absorbed dose measured with unit of Gray (Gy) 
(Sabarudin & Sun, 2013). 
Equivalent Dose: is referred to as the amount of absorbed radiation dose multiplied by a 
radiation weighting factor.  It is measured in Sieverts (Sv) and can be used to compare all types 
of ionizing radiation equally against the biological effect (Sabarudin & Sun, 2013). 
Effective Dose (ED): accounts for the biological effect of ionizing radiation received during a 
specific examination. It is also reflects the absorption of non-uniform radiation from partial 
body exposure relative to whole body radiation dose that is received.  ED calculations allow 
risk to be compared amongst different radiological imaging examinations. The unit of 
measurement for effective dose is the Sievert (Sv) or Millisieverts (mSv) (Morin et al., 2003; 
Sabarudin & Sun, 2013).  
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3.5 CT Dose Descriptors (Quantities for Assessing Radiation Dose in CT)  
Radiation doses for patients undergoing CT scan examinations can be measured directly using 
MOSFETs or TLDs and dosimetry phantoms.  Dose estimations, on the other hand, can be 
carried out indirectly by obtaining indices from the CT scanner which may include CT Dose 
Index (CTDI), Volume CT Dose Index (CTDIvol), Dose Length Product (DLP) or Multiple-
Scan Average Dose (MSAD), which is the primary metric used in CT to describe the radiation 
output from a scanner (McCollough et al., 2008 & 2011).  The most commonly used metrics 
for radiation dose estimates for CT examinations are the CT volume dose index (CTDIvol), dose-
length product (DLP) and ED.   
3.5.1 Computed Tomography Dose Index (CTDI) 
As defined by the Food and Drug Administration (FDA or USFDA) in 1984, the original 
incarnation of the CTDI was based on an axial CT scanner.  This original definition represented 
the dose from the primary beam plus scatter from surrounding slices measured in Milligray 
(mGy).  Variations in CTDI have been defined due to developments in technology and these 
have been introduced into MSCT equipment.  These CTDI variations include CTDI100, CTDIw 
and CTDIvol.  A summary of CTDI radiation dose parameters described in this section are 
provided in (Table 3-2), whereas (Table 3-3) gives short summary of the CT dose parameters 
definitions and their effects on radiation dose, the first three parameters are discussed in chapter 
three section (3.3) on page 25 (Goo, 2012).  
Table 3-2: Parameters of radiation dose (Gerber et al., 2005). 
Variable Parameter Physical equivalent SI unit 
Radiation exposure CTDI100 
Number of ions produced in air 
by photons 
coulomb/kg 
(C/kg) 
Absorbed radiation 
dose 
CTDI, 
CTDIw, 
CTDIvol 
Radiation energy absorbed by 
patient’s body 
Gray (Gy) 
Cumulative radiation 
dose 
DLP 
Total radiation energy absorbed 
by patient’s body 
mGy x cm 
Effective dose ED 
Biological effect of radiation 
dose received 
Sievert (Sv)
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Table 3-3: Definitions of CT parameters and their effects on radiation dose (Goo, 2012). 
Dose Parameter Definition Effects on Radiation Dose Unit 
Tube potential or 
voltage  X-ray beam energy 
Proportional to square of tube 
voltage change  kV 
Product of tube 
current and time 
Photon fluence; number of photons 
in defined exposure time  
Directly proportional to 
radiation dose  mAs 
Pitch 
Ratio of table feed per gantry 
rotation to nominal width of beam 
collimation  
Inversely proportional to 
radiation dose - 
CTDIw 
Average radiation dose in scan 
volume measured in standard CT 
phantoms; 1/3 CTDI center + 2/3 
CTDI periphery  
Directly proportional to 
radiation dose in unit volume, 
influenced by pitch factor 
mGy 
CTDIvol CTDIw/pitch 
Directly proportional to 
radiation dose in unit volume, 
irrespective of pitch factor  
mGy 
Dose-length 
product CTDIvol x scan length (cm) 
Directly proportional to total 
scanned radiation dose  mGy·cm 
Effective dose 
Overall risk-related radiation 
exposure; Σ WT (tissue weighting 
factor) x HT (tissue equivalent 
dose)  
Directly proportional to total 
scanned radiation dose and 
overall risk of irradiated tissue 
 
mSv 
 
3.5.2 CTDI: 
CTDI is the fundamental parameter of absorbed radiation dose in CT.  During its calculation, 
most manufacturers use a 16 cm phantom for head and 32 cm phantom for body examinations.  
As reported by Shrimpton and Wall, (2000), the smaller phantom is also used for dose 
assessment in paediatric examinations.  The CTDI dose is measured at the centre and near the 
periphery of the phantom (Figure 3-7).  Thus, the dose values obtained are denoted as CTDIH, 
C and CTDIH, p and also CTDIB, c and CTDIB, p with H = head, B = body, c = centre, p = periphery 
(Gerber et al., 2005; Nagel, 2007; Shrimpton & Wall, 2000).  
  
Figure 3-7: Cylindrical standard CT dosimetry phantoms (16 and 32 cm in diameter) and 
arrangement of the locations A to E for the determination of CTDI in a standard CT dosimetry 
phantom (Nagel, 2007). 
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The CTDI is derived from the dose distributed along a line parallel to the axis of rotation for 
the scanner (= z axis) that is recorded for single rotation of the radiation source as represented 
by (Figure 3-8).  This means CTDI is the equivalent dose value inside the irradiated slice 
(beam) that would result if the absorbed radiation dose profile were entirely concentrated to a 
rectangular profile of width equal to the nominal beam width N·hcol, with N being the number 
of independent (i.e. non-overlapping) slices that are acquired simultaneously.  Accordingly, all 
dose contributions from outside the nominal beam width, i.e. the areas under the tails of the 
dose profile, are added to the area inside the slice (Nagel, 2007). 
The mathematical definition corresponding to CTDI describes the summation of all dose 
distributions along the z-axis:  
࡯ࢀࡰࡵ ൌ 	 1ܰ. ݄௖௢௟ 	 . න ܦሺݖሻ. ݀ݖ
ାஶ	
ି	ஶ
 
Where D(z) is the value of the dose at a given location, z, and N·hcol is the nominal value of the 
total collimation (beam width) that is used for data acquisition.  CTDI is therefore equal to the 
area of the dose profile (the dose profile integral) divided by the nominal beam width.  In 
practice, the dose profile is accumulated in a range of –50 mm to + 50 mm relative to the centre 
of the beam, i.e. over a distance of 100 mm (Nagel, 2007). 
 
Figure 3-8: Radiation dose profile (left image) of a single computed tomographic slice 
(Nagel, 2007).  The second image denotes the axis system used in CT (Gerber et al., 2005). 
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For (Figure 3-8), the first image illustrates CTDI, which is the equivalent of the dose value 
inside the irradiated slice (beam) that would result if the absorbed radiation dose profile were 
entirely concentrated to a rectangular profile of width equal to the nominal beam width N·hcol 
(Nagel, 2007).  There are tails at the edges of the slice of the radiation dose profile which are 
caused by the divergence of the X-ray beam and scattering photons by the body tissue.  For the 
estimation of radiation dose these tails have important implications because, depending on the 
width of the individual slice in the z-axis and distance between adjacent slices, the tails can 
overlap and lead to an accumulation of radiation dose.  For (Figure 3-8), the second image is 
the CT axis system used to acquire the slice profile.  The x- and y-axes (transaxial) represent 
the two dimensions of each individual slice.  The z-axis (axial, ‘‘third’’ dimension) is the axis 
along which successive slices are arranged (Gerber et al., 2005). 
3.5.3 CTDI100: 
The CTDI100 reflects the dose contribution from a 100 mm range centred on the index slice over 
the z-axis in the phantom and is expressed in the SI units of coulomb/kg (C/kg).  It can be 
measured by using a 100 mm long pencil-shaped ionization chamber in two different cylindrical 
acrylic phantoms (16 and 32 cm diameter) which is placed at the isocenter of the CT scanner.  
The CTDI100 varies within the slice plane and for body imaging is higher at the periphery than 
at the centre of the field of view (Gerber et al., 2005). 
3.5.4 CTDIw: 
The weighted CTDI (CTDIw) is expressed in the SI units of gray (Gy), and was introduced to 
account for the non-uniform dose delivery when using CTDI100.  When applying an X-ray beam 
to a patient the beam often passes directly on to entire surface of the patient's body.  The primary 
bean contains the most photons and is mostly attenuated by a patient's tissues.  As a result, the 
energy received by patient's skin is higher than in the centre of the body.  Even though the X-
ray beam irradiates 360o around the patient's body and passes through the ioscentre.  
Accordingly, the surface is exposed to more photons than the centre portion (Cody & Mahesh, 
2007; McCollough et al., 2011).  
The CTDIw reflects the weighted sum of two thirds peripheral dose and one third central dose 
in a 100 mm range in acrylic phantoms locations.  This quantity reflects the average absorbed 
dose over the two-dimensions (x and y) of the average radiation dose to a cross-section of a 
patient’s body (Cody & Mahesh, 2007; Coursey & Frush, 2008; Cretti & Perugini, 2016; 
45 
 
Einstein et al., 2007; Sabarudin & Sun, 2013; Tootell et al., 2014).  The CTDIw parameter 
combines the values of CTDI at central and peripheral of the phantoms into one single name 
represented mathematically by the following equation: 
࡯ࢀࡰࡵ࢝ ൌ 	2 3	ൗ . ܥܶܦܫଵ଴଴	ୟ୲	୮ୣ୰୧୮୦ୣ୰୷ ൅	1 3ൗ 	. ܥܶܦܫଵ଴଴	ୟ୲	ୡୣ୬୲ୣ୰		 
3.5.5 CTDIvol: 
CT scans commonly consist of more than one slice, this means that the radiation dose received 
from a complete CT examination consisting of multiple parallel slices is higher than the sum of 
the CTDI100’s of the individual slices due to the overlap of the tails of the individual radiation 
dose profiles (Commission, Medicines, & Healthcare, 2010; Gerber et al., 2005).  The volume 
CTDI (CTDIvol) was introduced to adjust for pitch (the gap or overlap of the helical pattern of 
radiation) by calculating what is known as volume CTDI (CTDIvol).  It is the most commonly 
cited index for modern MDCT equipment and defined as CTDIw divided by the beam pitch 
factor (CTDIvol = CTDIw/pitch).  It's distinctly different from CTDIw in that it represents the 
average radiation dose over the volume scan (x, y, and z directions).  It is a useful tool for 
radiologists and radiographers because it specifies the radiation intensity used to perform a 
specific CT examination and not to quantify how much radiation that each patient receives from 
the CT examination.  CTDIvol provides a method for comparing the absorbed radiation dose 
received from different scanning protocols because incorporates all information specific to a 
scanning protocol and, expressed in SI units of gray (Gy) (Cody & Mahesh, 2007; Coursey & 
Frush, 2008; Rehani et al., 2000; Sabarudin & Sun, 2013; Tootell et al., 2014; Valentin, 2007).  
࡯ࢀࡰࡵ࢜࢕࢒ ൌ 	ܥܶܦܫ௪/ܲ݅ݐ݄ܿ 
                                                                      ൌ	ܥܶܦܫ௪	ݔ	 ୲୭୲ୟ୪	୬୭୫୧୬ୟ୪	ୱୡୟ୬	୵୧ୢ୲୦ୢ୧ୱ୲ୟ୬ୡୣ	ୠୣ୲୵ୣୣ୬	ୱୡୟ୬ୱ 	 
The equation demonstrates that the numeric value of the CTDIvol is directly related to the degree 
of overlap between adjacent slices.  This degree of overlap is determined by the width of the 
individual slices and by the distance between the slices in the z-axis (Commission, Medicines, 
& Healthcare, 2010; Gerber et al., 2005). 
The distance between adjacent slices in the helical scanning mode is dependent on how far the 
patient table moves during one gantry rotation; this is known as pitch.  Pitch is defined as the 
46 
 
patient table increment (expressed in millimetres) during one CT gantry rotation divided by the 
combined width of all simultaneously acquired slices and can hence be expressed as: 
 ࡼ࢏࢚ࢉࢎ ൌ 	 ூே	ൈ	் 
Where I is the distance between slices defined by the table advance during one gantry rotation 
(mm) in helical scanning mode, N is the number of slices, and T is the nominal width of one 
slice (Commission, Medicines, & Healthcare, 2010; Gerber et al., 2005). 
Thus, CTDIvol for the axial scanning mode can be expressed mathematically as following:  
࡯ࢀࡰࡵ࢜࢕࢒ ൌ 	ܰ	 ൈ ܶܫ 	ൈ	ܥܶܦܫ௪ 
According to pitch definition above, the CTDIvol for the helical scanning mode can be expressed 
as: 
࡯ࢀࡰࡵ࢜࢕࢒ ൌ 	 1ܲ݅ݐ݄ܿ	 	ൈ 	ܥܶܦܫ௪ 
CTDIvol can be used in turn to determine the dose-length product (DLP).  Measured in SI units 
of mGy·cm, DLP reflects the integrated radiation dose for a complete CT examination. 
CTDIvol represents the radiation produced by the CT scanner, not the radiation dose to an 
individual patient.  The limitations of CTDIvol include using index-based values to describe 
dose in CT, modified by a series of adjustments to reflect the dose of radiation that the scanner 
delivers to a plastic phantom.  Although customized dose calculations for individual patients 
theoretically can be generated by using data present in the CT images themselves, no automated 
method has been developed that can recognize and segment the various tissues and organs for 
individual patients (Strauss & Goske, 2011).  However, the CTDIvol, by definition, assumes the 
patient is either the 16-cm or 32-cm diameter cylindrical plastic phantom However, the CTDI 
phantom is rarely a reasonable model for an individual patient with respect to attenuation.  In 
addition, clinical structures, e.g., bone and lung, will change the dose distribution relative to 
that found in a cylindrical, homogeneous, plastic phantom. 
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3.5.6 Dose Length Product (DLP) 
In most CT scanners, the values of CTDIvol and Dose Length Product (DLP) are displayed on 
the scanner console during the CT examinations, which is the most commonly quoted value of 
the radiation dose received by a patient.  The DLP is calculated to account for the differences 
in the scan extent for a CT examination (Cody & Mahesh, 2007). 
The Dose Length Product (DLP) is defined as the CTDIvol multiplied by the scan length (slice 
thickness × number of slices) in centimetres and can be calculated using the following formula, 
where CTDIvol, is the volume CT dose index and L, is the length of the scanned volume of the 
anatomical region being scanned. 
DLP = CTDIvol × Irradiated Scan Length (L) 
These parameters are precisely defined to allow comparisons of the radiation doses among 
different CT imaging protocols (Cretti & Perugini, 2016; Einstein et al., 2007; Gerber et al., 
2005).  
3.6 Radiation Dose Measurement Instrumentations 
In many situations, i.e. legislative requirements, measurements of CTDI and DLP or absorbed 
dose are required. It is also required to optimise image quality and patient radiation dose 
(Simantirakis et al., 2014).  Since the radiation doses from diagnostic radiology are small, 
accurate and long-term stability dosimeters are required (IAEA, 2007).  In diagnostic radiology, 
there are several types of radiation dosimeters that can be used.  The most frequently used 
dosimeters are either ionisation chambers or solid state detectors which include thermo-
luminescence detectors (TLD), optically stimulated luminescence dosimeters (OSL), 
semiconductors detectors, and more recently, scintillation phosphors coupled with optical fibre 
(Bushong, 2013).  The choice of the most suitable dosimeter depends on the clinical situation 
in which the measurements are required (Lemoigne & Caner, 2011).  For instance, the 
measuring instrument should have the same properties (absorbed the same amount of energy) 
as the medium in which the dose is measured (Hobbie & Roth, 2007; Hendee & Ritenour, 
2002).  
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3.6.1 Ionisation Chambers 
An ionisation chamber detector consists of two electrodes within an air-filled chamber.  An 
electric field across the two electrodes is used to collect the charges produced in the air by the 
ionisation due to incidence radiation.  Since the ionisation chambers used in diagnostic 
radiology are vented air, correction factors should be applied to the readings.  The correction 
factor is calculated using the following equation:  
KTP = (P0.T) / (P.T0) 
Where P, T are the pressure and temperature of the ambient and P0, T0 are the pressure and 
temperature of the reference condition – 101.3 kPa and 293.2 k.  The ionisation detectors are 
available in different types such as: free-air ionisation chambers, chambers for dose or air kerma 
measurement, and kerma area product (KAP) chambers (Hourdakis & Nowotny, 2014). 
3.6.2 Semiconductor Detectors 
These types of detectors are widely used in diagnostic radiology because of the small size and 
instantaneous response of the detectors (IAEA, 2007).  There are two types of semiconductor 
detectors, namely, silicon diodes and metal oxide semiconductor field effect transistor 
(MOSFETs) (Hourdakis & Nowotny, 2014). 
 
Electron-holes are formed in the diode body when a silicon p-n junction diode dosimeter is 
exposed to X-rays, resulting in an electrical current in the reverse direction.  The magnitude of 
generated electrical current is proportional to the radiation dose.  The main advantages of diode 
dosimeters over ionising chambers are their higher sensitivity and reproducibility.  However, 
the sensitivity of the diode dosimeter is dependent on dose rate and diode temperature 
(Lemoigne & Caner, 2011).   
 
MOSFET dosimeters have several advantages, including small size, immediate readout, high 
sensitivity and ease of use (Siebel et al., 2015).  The first applications of MOSFET dosimeters 
to radiotherapy were in the late 1990s and since then they have been widely used in various 
medical applications such as dose verification in radiotherapy and diagnostic procedures (Wang 
et al., 2005).  As reported by various researchers the metal oxide semiconductor field effect 
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transistor (MOSFET) is a measurement device which is finding increasing applications in 
diagnostic radiation field dosimetry (Frush & Yoshizumi, 2006; Hollingsworth et al., 2007; 
Hurwitz et al., 2007 & 2009; Jones et al., 2005; Miksys et al., 2010; Mukundan Jr et al., 2007; 
Sessions et al., 2002; Wang et al., 2005; Yoshizumi et al., 2003). 
This type of detector consists of silicon transistor capacitors.  One of the capacitor electrodes is 
replaced by semiconductor material.  The basic structure of a MOSFET dosimeter is presented 
in (Figure 3-9).  The MOSFET comprises of a four-tier based structure with a source, drain, 
gate and body.  The source and drain are about 1µm apart and metalized contacts are made to 
the both source and drain, generally aluminum. The rest of the substrate surface is covered with 
a thin oxide film, typically about 0.05 μm thick.  On top of the insulating oxide layer, the gate 
electrode is laid.  The body electrode is mounted against the gate as shown in (Figure 3-9) 
below.  The detectors physical dimensions are approximately 3 mm diameter and 3 mm thick 
and are encapsulated in solid water material to produce a tissue equivalent protective layer 
around the detector.  The types of MOSFET gate can be divided into two categories according 
to the polysilicon material (N–type or P– type), which consider the resistance of polysilicon 
gate power trench MOSFET.  The N–type trench power MOSFET is usually lower gate 
resistance than P–type, due to lower sheet resistance of N-type in situ doped polysilicon (Baliga, 
2008; Galup-Montoro & Schneider, 2007; Koivisto et al., 2015; Liou & Schwierz, 2003; 
Oktyabrsky & Peide, 2010).  
 
Figure 3-9: Basic schematic of a MOSFET dosimeter (Galup-Montoro & Schneider, 2007). 
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The main idea behind the operation of a MOSFET detector is the charging of the gate of the 
MOSFET detector by a build-up of charge produced by ionizing radiation (Oktyabrsky & Peide, 
2010; VanDam & Marinello, 2006).  The incidence of the X-ray in the gate region of the 
MOSFET will produce electron-holes pairs.  The holes will move towards the silicon-gate 
interface producing a charge in the current of the n-type channel.  Consequentially, a shift in 
the threshold voltage of the gate bias will occur.  The value of this shift is directly proportional 
to the amount of the absorbed dose.  Therefore, during irradiation MOSFET requires a 
connection to a bias voltage.  This type of detector is mostly used for patient dosimetry 
(Hourdakis & Nowotny, 2014).   
3.6.3 Thermo-Luminescence Dosimeters (TLDs) 
 
Thermo-Luminescence is a phenomena of light emission from an insulator or a semiconductor, 
resulting from previous energy absorption from a source of ionising radiation.  It was initially 
discovered in 1663. Since then, many theories have been proposed to explain the thermo-
luminescence of semiconductors or insulators.  The explanation which depends on the electric 
energy band theory is the most acceptable one (Rivera, 2012).     
There are many crystal materials which have the phenomenon of thermoluminescence when 
exposed to radiation.  The crystal absorbs a fraction of the incidence radiation and it stores this 
in its lattice.  If the crystal is heated then this absorbed energy can be released in the form of 
visible light.  The TLD measures ionizing radiation exposure by measuring the visible light 
intensity emitted from the detector’s crystal when is heated (Rivera, 2012).  In a perfect 
semiconductor or insulator crystals, most electrons occupy the valance band which is detached 
from the conduction band, the highest energy level, by a forbidden gap (Bos, 2007).  According 
to one trap-one centre model, there are two levels in the forbidden band gap: T level, which is 
located down to the conduction band above the Fermi level of equilibrium, and R level which 
is located above the valence band and below the equilibrium Fermi level.  At equilibrium, both 
these levels are empty (Bos, 2007).    
In brief, and as indicated by Bos, (2001), the thermoluminescence process occurs in several 
steps: a) the production electron-hole pairs in thermo-luminesce material by the absorption of 
ionising radiation energy, b) the trapping of the charge carriers in R and T levels, c) the de-
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trapping of charge carriers by temperature rising, d) light production by recombination of 
charge carriers in luminescence centres at R level (Bos, 2001; Khan & Gibbons, 2014). 
 
In the middle of the twentieth century, tissue equivalency of some thermoluminescence 
materials led to the first utilisation of thermoluminescence as a radiation dosimeter.  The perfect 
dosimetric materials should have an atomic number similar to that of human tissue which is 
7.42 (Bos, 2001; Kitis et al., 2000).  In addition to tissue equivalency, several characteristics 
are required for thermoluminescence which make it of interest as a dosimeter in clinical 
radiation dosimetry are the following: a) linearity, a linear response over wide range absorbed 
radiation dose; b) sensitivity, the amount of light produced per unit absorbed dose; c) 
independency of radiation energy; d) simple glow carve, resulting in a simple heating protocol; 
e) good mechanical strength and static chemical activity; f) low fading (Kortov, 2007; Rivera, 
2012).  The fading comprises of two components: pre-fad, which the decrease in 
thermoluminescence dosimeter response to radiation; and post-fad, which is the reduction in 
the storage signal in thermoluminescence dosimeter with time (Luo, 2008). 
Currently, there are several commercial types of TLD.  These TLD groups or types are divided 
according to the materials from which dosimeters are manufactured.  Owing to this they are 
classified into three groups: LiF, CaF2, and Al2O3.  The first group (LiF) include TLD-100, 
TLD-100H, TLD-600, and TLD-600H.  TLD-100; LiF was the first used TL dosimeter.  It has 
good tissue equivalency (Zeff TLD = 8.04 compared to Zeff tissue = 7.42) which makes them have 
similar response to radiation as human tissue, also it is sensitive to low doses of radiation, it has 
a wide range of linear response (10µGy-10Gy) and also its low fading rate of around 5-10% 
per year (Bartolotta, & Marrale, 2006).  Whereas TLD-100H dosimeters can be used in 
diagnostic radiology and are around 20 times more sensitive than TLD-100 detectors.  They 
have a wide dose range (1 µGy – 20 Gy), and lower fading rate of around 3% per year.  The 
TLD-600H dosimeter is used for neutron dosimetry.   The dosimeter that is made of Al2O3 is 
the TLD-500 which has a useful dose range of 0.05 µGy – 10 Gy, with a 3% per year fading 
rate (Kortov, 2007).  The chosen of the dosimeter depends on the dose range and which field to 
be used in.  As reported by Rivera (2012), in diagnostic radiology the required dose range is of 
the order of 0.001 to 10 mSv, while that for radiotherapy is 0.1 to 100 mSv (Rivera, 2012). 
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3.6.4 Optically Stimulated Luminescence Dosimeters (OSLD) 
These type of detectors were developed in the late 1990s.  The operating principle of these 
dosimeters is similar to that of TLDs but the luminescence process is stimulated by laser light 
rather than heat (Canadian Nuclear Safety Commission [CNSC], 2012).  These detectors are 
made of aluminium oxide (Al2O3) which emits visible light.  The amount of emitted light is 
proportional to the absorbed radiation dose.  For occupational radiation monitoring purposes 
OSLDs are preferred over TLDs (Bushong, 2013). 
3.7 CIRS ATOM Dosimetry Phantoms 
Phantoms made of tissue substitutes have been used extensively to physically represent human 
anatomy and mimic its radiation characteristics in dosimetric studies (Winslow et al., 2009).  
The purpose of using phantoms in dosimetric studies is to simulate patient’s radiation exposure 
during specific radiological producers in order to measure dose or to mimic conditions for 
reference calibration of a dosimeter system or beam (e.g. radiotherapy beam calibrations by the 
use of water phantoms).  In diagnostic imaging procedures, materials that have similar X-ray 
scattering and absorption to tissue are useful phantom materials, where such measurements 
have been used by several authors to calculate average organ doses as well as effective dose in 
both adult and paediatric diagnostic radiology examinations.  Additional requirements for 
phantom materials are that they should remain stable/consistent over time, especially those with 
complex designs which need to be used for a long time.  Phantoms are also necessary for the 
evaluation of radiographic equipment by the interpretation of phantoms images (Byng et al., 
1998). 
Quantifying organ doses in physical phantoms offers a distinct advantage over computational 
methods (Monte Carlo and DLP) because knowledge of the exact photon energy spectrum or 
irradiation geometry is not required.  This is especially useful considering the increasing use of 
proprietary scanning techniques that are difficult to model, such as automatic tube current 
modulation in CT and automatic exposure control (AEC) in fluoroscopy.  The majority of organ 
dose studies in diagnostic imaging utilise commercially available phantoms such as RANDO 
(The Phantom Laboratory, Salem, NY) or CIRS ATOM phantoms (Computerized Imaging 
Reference Systems, Inc, Norfolk, VA).  In order to provide a representation of the human 
anatomy, these commercially available phantoms typically use three tissue equivalent materials 
imitating bone, lung, and soft tissue.  To allow access to organ locations for the placement of 
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dosimeters, the RANDO and ATOM phantoms are assembled in axial slices 2.5 cm thick 
(Hurwitz, Yoshizumi, et al., 2007).  Unfortunately, the widespread clinical use of these 
phantoms has been limited by their prohibitive costs (Winslow et al., 2009). 
For organ dose or whole body dose measurements, Computerized Imaging Reference Systems 
(CIRS) currently produce different ATOM dosimetry phantom models covering a wide range 
in sizes (newborn to adult).  Six models are available: newborn, 1-year, 5-year and 10-year old 
paediatric phantoms as well as adult male and female phantoms.  The phantoms are made of 
tissue-equivalent epoxy resins, offer superior tissue simulation by covering a wider range of 
energy levels from diagnostic to therapeutic.  Each phantom is sectional in design with 
traditional 25 mm thick sections.  The sectional surfaces are extremely flat and smooth and do 
not require any special coatings or treatment. This results in minimal interfaces between the 
slabs when viewed in a scout or projection X-ray.  The ATOM line also differs from other 
dosimetry phantoms by providing optimized TLD locations specific to 22 inner organs (CIRS, 
2013).   
3.8 Absorbed Dose Measuring Methods 
According to the guidelines of national and international authorities, e.g. EU directives, the 
absorbed doses from diagnostic radiology to patients exposed to ionising radiation need to be 
determined.  Therefore, in vivo dose estimations from patients undergoing radiological 
examinations or nuclear medicine procedures are performed.  In addition, in diagnostic imaging 
anatomical phantoms are often used for direct absorbed dose measurements or indirectly via 
using software simulations (Hine & Brownell, 2013). 
There are two main methods of measuring/estimating absorbed and effective doses.  The first 
method uses dosimeters such as TLDs or MOSFETs and is known as direct measurement 
methods, the second method uses computer based simulations and is known as mathematical or 
Monte Carlo methods.     
3.8.1 Direct Methods  
As previously stated, in clinical dosimetry the main detectors used for absorbed dose 
measurements are ionisation chambers, TLDs and semiconductors.  This direct approach of CT 
dosimetry uses a physical phantom.  Radiation doses are measured in the location of organs or 
tissues of interest either by using TLDs or MOSFETs, the effective dose and effective risk can 
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then be calculated.  This is can be an intensive laborious procedure but the time can be reduced 
by switching from TLDs to a near real-time MOSFET based dosimetry system (Hashemi-
Malayeri & Williams, 2003). 
3.8.2 Mathematical Modelling Methods to Estimate Dose 
During a radiographic procedure there are many aids which may be to help estimate the 
radiation dose from an examination.  For CT based acquisitions the two incides that are the 
most commonly used in day to day clinical practice are CTDIvol and DLP (Tootell et al., 2014).  
Other methods exist and estimate the absorbed dose to a patient using Monte Carlo software in 
order to simulate the CT scan geometry, protocol parameters and geometric patient models. 
As reported by Hashemi-Malayeri and Williams, (2003), the first approach is the standard 
method based on the Food and Drug Administration (FDA) definition of Computed 
Tomography Dose Index (CTDI).  This method is normally used for QA measurement and does 
not provide a direct assessment of the risk to the patient resulting from CT examinations 
(Hashemi-Malayeri & Williams, 2003).  However, it is used to derive DLP which can be 
converted to patient dose using a set of conversion factors previously calculated for different 
regions of the body to give a value for effective dose (Paul et al., 2010), see (Section 3.8.2.1) 
on page 54.  
A second approach is the ImPACT method which uses the Monte Carlo (MC) computer 
technique that is combined with free in air values of CTDI.  The MC computer techniques are 
used to simulate the absorption and scattering of x-ray photons within a mathematical phantom.  
This gives organ doses normalised to the free in air dose on the axis of rotation of the scanner, 
from which effective dose could be derived (Hashemi-Malayeri & Williams, 2003). 
 
The CT-specific dose descriptors (CTDI and DLP) do not allow for comparisons with other 
sources of radiation exposures e.g. general radiography, nuclear medicine or natural 
background radiation.  The only common factor which can achieve such comparisons is the 
effective dose which can be estimated mathematically using the value of DLP displayed on the 
scan console and the conversion factors which depend on the region of the body being scanned 
(Elbakri & Kirkpatrick, 2013; Nagel, 2007).  
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Effective dose can be calculated by multiplying the DLP by a conversation factor (k).  The k 
coefficients are related only to the tissue involved in the volume being scanned and have been 
derived from Monte Carol (MC) simulation techniques and experimental measurements 
(Christner et al., 2010; Galanski et al., 2005; McCollough).  Such k values are averaged over a 
number of CT systems and calculations are limited in that this provides only large determination 
of effective dose for a thin patient size and as noted by McCollough et al (2011), this standard 
patient is a little thin by today’s standards (nominal body mass of 70 kg).  Conversion 
coefficients are available in several publications including the American Association of 
Physicists in Medicine (AAPM) Report 96 and the National Council on Radiation Protection 
and Measurements (NCRP) Report 160 (McCollough et al., 2008; Prins et al., 2011; Schauer 
& Linton, 2009).  Effective dose calculations in this way are limited in that they are independent 
of age, gender and scanner model (Kalender, 2014).  During the 1990s, the k coefficient values 
were derived using ICRP report 60; however, in 2007, the ICRP published updated tissue 
factors.  Owing to this, new k factor values were updated according to the new tissue weighting 
factors released by ICRP in 2007.  The use of ICRP 103 weighting factors increased EDs in the 
head by ~11%, increased EDs in the chest by ~20%, and decreased EDs for pelvic scans by 
~25% (Huda et al., 2011; Huda & Mettler, 2011; Kobayashi et al., 2015).  Further limitations 
of this method include the possible underestimation of calculations in CT dose from differences 
in beam geometry between physical phantoms and the computer simulation software (Tootell 
et al., 2014).  When estimating effective dose for helical scanning, using DLP and CTDIvol, 
there will be a possible underestimate of effective dose values due to the actual scan length 
which often exceeds the prescribed scan length.  Most modern CT scanners calculate and 
display the values of DLP, with respect to integral scan length instead of prescribed length 
indicated with by the laser lights (Christner et al., 2010).  The DLP cannot be used to estimate 
effective dose or detrimental cancer risk to individual patients, because as mentioned the k 
coefficients are for standard sized patients (Bauhs et al., 2008; McCollough et al., 2011) and 
calculations do not take into account the actual anatomy included within the scan volume.  
 
With the continued growth and development of CT as a diagnostic imaging tool, as well the 
increasing utilization of MSCT and the complexity of MSCT scanning protocols, there is a 
greater need for accurate dose calculation tools.  Owing to this, there is continued motivation 
to develop methods to accurately estimate absorbed radiation dose and, ultimately, the 
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radiological risk from CT examinations.  While methods of radiological risk estimation using 
the effective dose approach have been developed (ICRP, 1991a; McCollough & Schueler, 
2000), these methods require knowledge of the radiation dose delivered to each radiosensitive 
organ during CT scan examinations.  However, direct measurements of CT organ doses in vivo 
are not possible, and estimates may be problematic because of the highly localized patterns of 
exposure in CT.  These exposure patterns are characteristic of the scanning protocol and 
location, and yield variable doses to different organs (DeMarco et al., 2007).   
Commercially available software for dose modelling is relatively quick and easy to use.  The 
software employs Monte Carlo modelling techniques which are mathematical in origin and they 
simulate as closely as possible the real interactions suffered by photons.  Such a technique 
allows for both organ and effective dose values for conventional radiographic techniques and 
CT imaging examinations to be estimated (Tootell et al., 2014).  
The earliest methods of calculating the dose to the organs from CT scan examinations applied 
Monte Carlo simulation methods that used the mathematical geometric hermaphrodite model 
of a standard man MIRD phantom or they use the results of these methods to derive it (ImPACT, 
2006; Kalender et al., 2011 & 2014). 
One of the earliest attempts was by Zankl et al.; (1995) who investigated organ doses to 
paediatric patients using voxelized models (the GSF tomographic paediatric models).  Both 
baby and child models were available and were generated from whole body CT data of real 
patients.  Within this work they created a catalogue of organ dose exposures normalized to air 
kerma free-in-air on the axis of rotation by simulated CT scans; they tabulated these for two 
beam energies and two scan geometries (tube voltage: 80 and 125 kv, total filtration: 2.2 mm 
Al + 0.2 Cu, mean photon energy: 50.5 kev and 64.4 kev, half-value layer: 5.38 mm Al and 
7.98 mm Al) (Zankl et al., 1995).  The effective dose has been estimated by Caon et al.; (1999), 
using a voxelized model of a 14-year-old female and different CT scan protocols.  In this work 
fifty-four consecutive CT scans were used to construct a tomographic computational model of 
a 14-year-old female torso suitable for the determination of organ doses from CT (Caon et al., 
1999).  In 2002, Schmidt and Kalender developed a fast voxel-based Monto Carlo simulation 
program known as (ImpactMC) to calculate dose distributions specifically for both the 
respective CT scanner and the individual patient anatomy.  The calculations were performed on 
a 3-D voxel volume that can be filled with either the CT data of patients or mathematical 
phantoms converted to voxel volume data (Schmidt & Kalender, 2002).  The effects of scan 
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protocol, specifically over-scanning; on voxelized cylindrical and anthropomorphic phantoms 
from a MSCT were been simulated by Tzedakis et al.; (2005).  They estimated the effective 
doses for four standard CT examinations, (head and neck, chest, abdomen and pelvis, and trunk 
studies).  The boundaries of these regions at the z axis were 0–70, 0–43, 43–70, and 70–95 cm 
for trunk, abdomen and pelvis, chest, and head and neck, respectively.  Data were obtained for 
both axial and helical modes of operation taking into account the helical z-axis over-scanning.  
The validity of the MC simulation was verified by a comparison of calculated and measured 
standard computed tomography dose index (CTDI) dosimetric data, and a comparison of 
calculated and measured dose profiles along the z axis (Tzedakis et al., 2005). 
Advances in computer technologies have led to the introduction of MC methods to simulate 
complex problems (Guimaraes, Moralles, & Okuno, 2008).  The MC simulation methods 
applied to calculate the organ dose from CT examinations uses a CT dose spreadsheet 
developed by the UK's ImPACT group (ImPACT, UK).  The ImPACT work is based on the 
simulations performed by the National Radiological Protection Board (NRPB) (ImPACT, 
2006) using a standard mathematical anthropomorphic model (MIRD V) model and voxelized 
patient data.  Although some of these methods allow the user to input either axial or spiral CT 
scanning protocols, radiation dose estimates from the helical scan protocols are approximated 
from the contiguous axial scan data and are not derived directly from simulations of a spiral 
acquisition (DeMarco et al., 2007; Jansen & Shrimpton, 2011; Jarry et al., 2003). 
 
The dose modelling process involves the computer simulation of a phantom being exposed to 
a large number of photons of varying energies emitted from a point source (Tootell et al., 2014).   
Calculation of photon transport is based on stochastic mathematical simulation of interactions 
between photons and matter.  By following the path of the photons that are emitted from a point 
source into the solid angle specified by the focal distance and the X-ray field dimensions, while 
they interact with the phantom according to the physical processes that they may undergo photo-
electric absorption, coherent (Rayleigh) scattering or incoherent (Compton) scattering.  This 
chain of interactions forms a so-called individual photon history. The deposition of energy to 
the organ at each interaction point is calculated and stored for dose calculation.  A large number 
of independent photon histories is generated, and estimates of the mean values of energy 
depositions in the various organs of the phantom are used for calculating the doses in these 
organs  (Tapiovaara et al, 1997; Tootell et al., 2014).  
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ImPACT software is a quick and easy method for calculating of both organ and effective dose.  
(Figure 3-10) shows a sample of the dose report generated using the ImPACT CT Dosimetry 
software, as calculations take into account specific features of each CT unit (e.g. radiation 
quality and field geometry), the results are dependent on selecting the correct imaging 
parameters and CT model (Tootell et al., 2014).  The NRPB have published organ doses for 
several models of CT scanners normalised to CTDI measured in air.  Effective dose can be 
easly calculated using these data, however, as the new CT scaning technology and systems are 
constantly being introduced which makes it not always possible to select the correct scanner.  
Currently, the dose simulation software does not include many new systems and in this situation 
means dose simulations often have to rely on a "best fitting" approach to the attributes of these 
scanners to those of a similar design (Huda et al., 2011; Tootell et al., 2014).  As reported by 
Groves et al., (2014) this can lead to the potential of introducing a significant error in the 
estimated dose (Groves et al., 2014).  Also, automatic manipulation of mA by the scanner 
(ATCM) can introduce an error as the software only allows a single value to be used (Tootell 
et al., 2014).  The main objectives of this simulation software are to determine the effective 
dose.  In order to achieve a calculation of effective dose the average equivalent dose to 12 
organs and tissues for which weighting factor have been assigned and other of eight reminder 
organs must be assigned (ICRP, 1991a).  The total average of the equivalent dose multiplied by 
the relevant weighting factor is summed to give the effective dose. 
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Figure 3-10: Example of an ImPact CT Dosimetry software dose report (Tootell et al., 2014). 
As reported by Tootell et al., (2014) computer simulation is frequently reported as 
underestimating CT doses in the range of between 18 and 40% (ICRP, 1977, 1991a; Tootell et 
al., 2014).  Explanations for these underestimations are due to the differences in the physical 
dosimetry phantoms and the virtual phantoms used by the dose modelling software and the 
simplified geometric shapes of the organs. 
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Salvado et al. (2005) used MC based methods to estimate doses to both phantoms and some 
patient-based voxel models and compared these to CTDIw.  They demonstrated that CTDIw 
values significantly underestimate organ doses to both phantoms and patients.  They reported 
the percentage differences in the normalized effective dose between contiguous axial and 
helical scans with a pitch =1, many reach 13.1%, 35.8%, 29.0%, and 21.5%, for head and neck, 
chest, abdomen and pelvis, and trunk studies, respectively (Tzedakis et al., 2005). 
   
Figure 3-11: ImPACT image showing a typical brain scan acquisition volume, staring at 80 
cm and ending at 93 cm (Elbakri & Kirkpatrick, 2013) and an anterior-posterior scout view of 
the adult ATOM phantom (CIRS, 2013). 
3.9 Risk from Exposure to Low Radiation Doses 
The term risk according to the epidemiologists is utilised to describe the association of data of 
cancer incidence and radiation exposure in two different patterns: relative risk that relates to 
the ratio of cancer incidence rate in an exposed population to that in an unexposed population; 
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and absolute risk which is the simple rate of cancer incidence in a specific population (NAS, 
2006).  To express the lifetime risk several methods can be used: 
1. Excess Lifetime Risk (ELR), this type of risk compares cancer incidence or mortality in 
two groups of the same population - one of them is theoretically exposed to radiation 
and the other is not; 
2. Risk of Exposure Induced-death (REID), that compares the death rate of specific causes 
in theoretically unexposed and exposed groups of a certain age and gender; 
3. Loss of Life Expectancy (LLE), which gives an impression of the period of life lost due 
to radiation; 
4. Lifetime Attributable Risk (LAR), which gives an account of excess mortality or 
incidence of cancer over a study period, with the backgrounds defined by a theoretically 
unexposed population (ICRP, 2007).   
As stated by Statkiewicz-Sherer, et al., (2010), the damage produced by ionising radiation due 
to energy deposition in tissue is referred to as the radiation risk.  This energy may result in 
ionisation within the tissue if the photons pass near an orbital electron and provide sufficient 
energy for the electron to be liberated from the atom.  The amount of damage to tissue is related 
to radiation dose, type of radiation, whether it is internal or external, time of exposure, radiation 
distribution (type of exposed tissue) and the individual’s sensitivity which influenced by gender 
and age (HPA, 2011). Females are at higher risk of radiation induced cancer than males 
(Balonov & Shrimpton, 2012).  Young patients are at higher risk because they have a longer 
remaining life span.  For example, as illustrated by Lin, (2010) the risk of radiation damage for 
a 20 years old patient is twice to that of a 40 years old patient.  The latter has double the risk 
when compared to a 60-year-old patient.  The radiosensitivity of young children is 3-4 times 
more than that of adults. 
Generally, the interactions of radiation with tissue are either direct, when the radiation energy 
is directly transferred to the DNA causing structural change in its molecules; or indirect 
interaction, wherein the radiation energy is absorbed by water molecules forming free radicals 
which in turn cause damage to the DNA molecules.  As reported by Suzuki & Yamashita 
(2012), it has been found that for X-ray exposures of 100 mGy, 30-40% of the DNA damage is 
due to direct interaction and the remaining 60-70% of the damage results from indirect 
interactions.  The adverse health effects of radiation can be classified into two groups: 
deterministic effects, that follow high radiation doses and result in relatively immediate and 
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predictable tissue reactions and damage (this damage can occur within minutes, hour, days and 
even weeks); and stochastic effects, which follow low radiation doses and may result in cancer 
development (ICRP, 2007).  Development is based on probability, the lag period between 
irradiation and cancer development for stochastic effects is at least 5 years and may reach to 10 
or 20 years (Lin, 2010). 
Stochastic effects usually occur due to mutations in DNA which occur randomly.  In general, 
the probability of stochastic effects occurrence increases as the radiation dose increases.  The 
dose-response curve determines the probability of stochastic effects occurrence with radiation 
dose being the root cause.  Both linear and linear-quadratic dose-response carves are used to 
describe the relationship.  However, the severity of the resultant disease is not related to 
radiation dose because the cancer produced by 2 Sv radiation dose is not more severe than 
cancer produced by 0.2 Sv radiation dose.  Stochastic effects are classified into radiation-
induced cancer and reproductive cell damage which affects sperm and ova and causes defects 
in offspring (Statkiewicz-Sherer, et al., 2010).  As stated by Brenner, (2014), for radiological 
doses ranged from 5 to 100 mSv, data from life-span studies (LSS) of atomic bombs survivors 
revealed that the risk of radiation-induced cancer was strongly related to the radiation dose 
received.  However, for low doses and since more than 60% of the LSS cohort received 
radiation doses between 5 and 100 mSv, no strong evidence available to describe the 
relationship between the risk of radiation-induced cancer and these low doses.   
Persistent controversy exists in the literature regarding the risk of radiation-induced cancer from 
low dose ionising radiation.  This creates big challenge for epidemiological studies.  In this 
context controversy arises in questions about the dose threshold of cancer production, linearity 
and gradient of dose-response curves (Griffery & Sodickson, 2009).  Overall there are two 
opposing risk models to estimate the risk of low radiation doses.  The first one adopt the linear 
no-threshold principle (Griffery & Sodickson, 2009).  Based in this model any dose however 
small can result in cancer incidence.   Whereas the second model propose that there is a specific 
threshold for radiation induced cancer and below this threshold the radiation dose can be 
considered as safe (Prasad et al., 2004).  Although, the ICRP (2007), and the National Academy 
of Sciences (NAS) (2006), have adopted the linear no-threshold (LNT) model, United Nations 
Scientific Committee on the Effects of Atomic Radiation UNSCEAR (2008), considered the 
LNT to be uncertain at radiation doses less than 100 mSv and it is no longer recommended for 
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radiation-induced cancer assessment from such doses.  This has motivated many researchers to 
investigate the reliability of this model using different data sources.  
A study conducted by Dobrzynski et al., (2015), evaluated the risk of radiation-induced cancer 
and early childhood death for populations living in regions with different natural background 
radiation.  They concluded that the risk of radiation-induced cancer due to such small doses and 
dose rates tends not to exist or is lower than expected by the LNT model.  This can be explained 
by the adaptive physiological mechanism of tissue.  In conclusion, they reported that for low 
doses and low dose rates the LNT model is exaggerating the risk of radiation-induced cancer.  
The analysis of LSS cohort data for participants who received radiation doses ranging between 
0-150 mSv illustrated that the risk of radiation-induced solid cancers is linear but at less than 
100 mSv the cancer incidence increment is statistically insignificant (Suzuki & Yamashita, 
2012).  
The feasibility of LNT model has been investigated by Kleinerman, (2006); Linet et al., (2009) 
using risk data in children after diagnostic and/or therapeutic radiation exposure.  Several major 
studies that investigated childhood cancers following benign disease radiation treatment and 
diagnostic procedures were reviewed by Kleinerman, (2006).  The study reported that the rates 
of brain, thyroid, breast, skin (non-melanoma) cancers, and leukemia, were seen to be increased 
due to childhood irradiation.  This study also found that cancer risk increases with dose 
increment (Kleinerman, 2006).  More recently Linet at al., (2009) highlighted studies that 
investigated the association of maternal prenatal and postnatal newborn radiation with 
childhood cancers.  They stated that the data about this relationship is limited and more research 
is required (Linet et al., 2009).  
The low dose risk of radiation-induced cancer in patients subjected to recurrent CT 
examinations has been evaluated by several investigators.  Pearce et al., (2012) carried out a 
retrospective cohort study for patients who had CT examinations and the subsequent risk of 
radiation-induced leukemia and brain tumours.  In their cohort they analysed data for patients 
younger than 22 years who had attended CT scan examinations within the UK NHS between 
1985 and 2002, with the follow-up process continuing until the end of 2008.  They found that 
when the patient radiation cumulative dose increased from 5 mSv to approximately 50 mSv the 
relative risk of radiation-induced leukemia became 3.18, and 2.82 for brain tumours when the 
cumulative dose increased from 5 mSv to approximately 60 mSv.  Similarly, Mathews et al., 
(2013), evaluated the cancer incidence in 680.211 patients (0-9 years old) who had undergone 
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CT scan examinations between 1985 and 2005 with follow-up until 2007.  A 24% increase in 
different tissue cancers was noted when compared to the general Australian population within 
the same age range (Mathews et al., 2013).  
In conclusion, as stated by Brenner (2014); and de Gonzalez & Darby (2004), the accurate 
determination of radiation-induced cancer from low radiation dose is not easy.   The limited 
data available about the risk from low radiation dose has resulted in controversy and 
uncertainty.  According to the available data, the risk of radiation-induced cancer from low dose 
radiation is very small but unlikely to be zero (Wall et al., 2006).  Therefore, the linear no-
threshold (LNT) model may be the best reasonable risk model for describing the relationship 
between the exposure to low energy radiation and solid cancer incidence (ICRP, 2007; Little et 
al., 2009; NAS, 2006).  To overcome uncertainty about the LNT model (Dobrzynski et al., 
2015), Wall et al., (2006) recommended the classification of low dose radiation cancer into four 
categories, as illustrated below in (Table 3-4).  
Table 3-4: X-ray examinations divided into four broad risk bands (Wall et al., 2006). 
Risk Band Risk Range Typical type of X-ray examination 
Negligible < 1 in a million Radiography of chest, limbs and teeth 
Minimal 1 in a million to 1 in 100 000 Radiography of head, neck and joints 
Very low 1 in 100 000 to 1 in 10 000 Radiography of spine, abdomen and pelvis 
Low 1 in 10 000 to 1 in 1000 CT, angiography, contrast studies of the 
alimentary, biliary and urinary tracts, and 
interventional radiology 
 
3.10 Chapter Summary 
This chapter gave an overview of CT scanner history and technology developments.  This 
chapter also discusses the most important parameters within each CT examination that 
influences the radiation dose, as well the different CT physical dose measurement parameters.  
The examination protocol used in imaging procedures is the decisive factor that determines the 
radiation dose.  It is important to note that it is extremely difficult for radiographers or 
radiologists to predict the amount of dose the patient will receive based on the chosen protocol 
and therefore they may not always be using the lowest dose practically possible.  It is therefore 
possible that a new proactive way of estimating dose to patient is rapidly needed.  
All modern CT scanners display CTDIw which takes all scan parameters into account, including 
the pitch in helical scans and a series of axial scans.  It is a reasonable representation of the 
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average dose in the scanned volume.  However, the displayed dose is for a specific phantom 
setup, e.g., the 32-cm or 16-cm PMMA phantoms in body and paediatric or head scans, 
respectively.  As reported by Suess & Chen, (2002), in many cases these phantoms used to 
determine the displayed CTDIw may not represent the actual patient.  This is also true in 
paediatric CT: because of the significantly smaller cross-sectional diameter, the patient receives 
a higher dose than indicated by the displayed reading.  Also, they indicated that depending on 
object size the dose in phantoms/patients of, for example, 16-cm diameter can be two times 
higher than the displayed CTDIw of that obtained using 32-cm phantom.  Knowledge of the 
dose in the scanned volume is essential to optimize scan protocols, but for reasonable dose 
management one has to consider the biological effect of this dose, i.e. the radiation risk caused 
by the CT examination. The deterministic radiation risk is best represented by the ‘‘effective 
dose’’. However, for low radiation doses such as doses from CT scans examinations, the best 
way to consider that is to estimate the life time cancer risk inductions.  This takes into account 
the dose to all sensitive organs and their radiation risk factors for both genders at different age.  
This is the focus of this thesis, which aims to provide prospective way to estimate the lifetime 
cancer induced per 106, effective dose and eye dose for adult (helical and sequential) and 
paediatric (helical) CT protocols.  This prospective risk method, is essential for analysis of 
radiation dose and risk versus benefit and should be used to give risk estimates to patients and 
help justify the examination. Presently, no CT manufacturer provides such information on the 
scanner console to either the radiographer or radiologist.  
 Radiation risk has been regularly reviewed by a variety of organisations nationally and 
internationally.  At the international level, there are the ICRP and the United Nations Scientific 
Committee on the Effects of Atomic Radiation (UNSCEAR).  At national levels, there are the 
UK Radiation Protection Division of the Health Protection Agency and the US National 
Council on Radiological Protection and Measurements (NCRP), as well as the US National 
Academy of Sciences Biological Effects of Ionizing Radiation (BEIR) committees (Hall & 
Brenner, 2014).  All of these bodies agreed that, for doses < 100 mSv, the most appropriate risk 
model for radiation protection purposes is one in which the risk of radiation induced stochastic 
effects, is particular cancer induction, is assumed to decrease linearly with decreasing dose with 
no threshold which so-called linear no-threshold (LNT) model (Hall & Brenner, 2014; ICRP, 
2007c; NCRP., 2001).  The risks to individuals from diagnostic radiation exposures are 
generally small; it is often difficult to study them directly.  However, because of the large 
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number of people exposed annually, even small risks could translate into a considerable number 
of future cancers.  
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Chapter 4 : Literature Review  
4.1  Chapter Overview 
The largest contributor to population radiation dose from diagnostic imaging is CT, this will 
now be considered in further detail including an examination of the global frequency of CT 
examinations and the resultant radiation doses.  CT scans are an extremely useful part of modern 
medical practice although it is well acknowledged that potential cancer risks exist from the use 
of ionising radiation.  The discussion reported in this chapter reviews the current status of 
opinion regarding the perceived risks (lifetime attributable risks) from radiation exposure at the 
low dose levels relevant to diagnostic CT examinations.  Also within this chapter there is a 
focused discussion of the radiation risks associated with paediatric CT imaging and a summary 
of the current attitudes within this area.   
4.2 Research Strategy 
A comprehensive literature search was conducted of scientific online databases, in order to 
identify literature relevant to this thesis using the following search engines: EBSCO 
Information Services, CINAHL, Ovid-Medline, Cochrane, SCOPUS, Pub-med, and Google 
Scholar.  In addition, books were also used for background information relevant for the 
purposes of this thesis.  To acquire scientific literature on the radiation dose from adult and 
paediatric CT scan head/brain examinations, lifetime attributable cancer risk, the following key 
words were used: CT brain examinations, CT brain radiation dose or high radiation dose among 
imaging modalities, CT acquisition protocols, CT head/brain protocol parameters and 
techniques for CT dose reduction and CT organs and tissues absorbed dose or CT effective dose 
or X-ray radiation risk calculation and estimation.  
To ensure that important seminal studies conducted many years ago were also captured in the 
search results, there was no time limit on the search.  The entire search was limited to English-
language journals, and related to human and animal subjects.  The search operators (AND, OR, 
NOT) were used where necessary to refine the search.  For the purposes of this thesis, the 
literature review was presented in a narrative format, under a series of key themes. 
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4.3 Radiation from Medical Exposures 
The use of ionising radiation in modern medicine is necessary for both diagnosis and treatment.  
As reported by the United Nations Scientific Committee on the Effects of Atomic Radiation, 
UNSCEAR, (2010), there is now more than one diagnostic examination performed per person 
across the population every year in countries with advanced health care systems (UNSCEAR, 
2010).  The UNSCEAR reported that globally, there are approximately 3.6 billion diagnostic 
examinations and six million therapeutic treatments performed annually.  These medical 
practises involving the use of ionising radiation include diagnostic examinations, interventional 
procedures and radiotherapy treatments and are typically undertaken in radiology, nuclear 
medicine and radiation oncology departments or clinics (UNSCEAR, 2010).  For medical 
purposes, the people exposed to ionising radiation are the patients themselves.  Recent figures 
demonstrate that diagnostic medical exposures, including radiology and nuclear medicine, 
account for about one-fifth of the average annual per caput dose to the global population from 
all sources (UNSCEAR, 2010).  The National Council on Radiation Protection & 
Measurements (NCRP) (2009) reported that from all of the diagnostic imaging modalities, CT 
is the highest contributor to population dose, even though it accounts for a much smaller 
proportion of the total number of examinations (Schauer & Linton, 2009). 
Evidence from epidemiological studies prove that it is impossible to deny the association 
between an increase in cancer incidence and morbidity and ionising radiation exposure (ICRP, 
2005).  By contrast, quantifying the risk associated with low dose radiation exposures, such as 
a typical CT scan, is more complex and contentious.  As reported by Brenner and Hricak, (2010) 
and Brenner et al., (2003) despite the uncertainty surrounding risk associated with low dose 
exposures, the societal risk may not necessarily be negligible and must still be considered, this 
concern arises when an increasingly large population is exposed to small individual risks 
(Brenner et al., 2003; Brenner & Hricak, 2010; Wall et al., 2014).  Children are more 
radiosensitive than adults thus; the risk of radiation exposure is even higher than for adults.    
The difficulties involved in quantifying the risks of low dose radiation are well known, two 
important questions have been addressed by many researchers, firstly, what is the lowest 
radiation dose which provides good evidence regarding increasing existing cancer risks in 
humans? According to the most recent literature and epidemiological evidence this is 
approximately 10 – 50 mSv for an acute exposure and approximately 50 – 100 mSv for a 
protracted exposure (Hendee & O’Connor, 2012).  The second question is what is the most 
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appropriate way to extrapolate such cancer risk estimates to even lower doses? As supported 
by experimentally grounded, quantifiable, biophysical arguments, a linear extrapolation of 
cancer risks from intermediate to very low doses currently appears to be the most appropriate 
methodology (Brenner et al., 2003; Brenner & Hall, 2012; Hricak et al., 2011; Wall et al., 2006). 
4.4 CT Usage and Radiation Exposure 
Introducing CT into routine care has improved healthcare outcomes, however, CT delivers 
higher radiation dose than conventional diagnostic X-ray examinations.  The radiation dose to 
a patient from CT, for some examinations, can reach more than 100 times the dose received 
from routine radiographic examinations (de González et al., 2009).  In the last decade, a number 
of research studies have focused on the cancer risk associated with radiation exposure due to 
medical diagnostic imaging modalities.  These discussions focused on CT being a relatively 
high dose modality, which is potentially over-utilised and due to lack of understanding of the 
risk associated with certain acquisition parameters (Brenner, 2002; Brenner et al., 2001a; 
Brenner & Hall, 2007; de González et al., 2009; Einstein, Henzlova, & Rajagopalan, 2007; 
Fazel et al., 2009; Hall & Brenner, 2008; Hammer et al., 2011; Smith-Bindman, 2010; Smith-
Bindman et al., 2009; Brenner, 2010).  Even deterministic effects, as reported by the US Food 
and Drug Administration (FDA), such as hair loss, have been reported in incidents in the US 
from apparent erroneous over-doses due to CT brain perfusion scans (FDA, 2009, 2010).  
CT imaging procedure delivers approximately 70% of the overall radiation dose to the 
paediatric population.  Crude estimations showed that the ED ranges from between 6 and 100 
mSv for paediatric patients.  CT is a major source of medical radiation and its availability and 
frequency of scanning is responsible for increasing the population dose. Due to the high ED of 
CT, an effort to minimize it is critically important.  This is especially important in children, 
because the younger the patient is at the time of exposure to radiation, the greater the risk (BEIR 
VII Phase 2, 2006).  Due to the higher radiosensitivity of children’s cells, the lifetime cancer 
risk associated with an individual CT examination is higher in children than in adults (ICRP, 
2007a) and there is an increased risk for thyroid, skin, brain and breast cancer in children 
(UNSCEAR report, Annex I, 2000).  In addition, due to a child’s longer lifetime to manifest 
radiation-induced cancer, and the fact that cancer risk is cumulative over a lifetime, radiation 
risk from CT in children is one of the major current concerns in CT dosimetry (Akhlaghi, 
Hakimabad, & Motavalli, 2014). 
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Over the years, CT technology has evolved, with various impact on the radiation dose.  After 
the introduction of conventional CT, helical CT became commercially available in 1991. 
Because of its new advantages, the use of CT imaging increased in the paediatric population. 
Although helical technology provides additional opportunities for CT in children, the radiation 
dose associated with helical CT is much greater than the radiation dose associated with 
sequential CT. 
In all developed countries the use of CT scans has increased rapidly since its inception in the 
1970s, although its usage rates vary greatly from one country to another.  A worldwide survey 
conducted by UNSCEAR from the mid-1990s, has shown increases in the number of CT 
machines per million population in nine countries as shown in (Figure 4-1), the number of CT 
scanners per million populations was 64 in Japan, 26 in the US and 6 in the UK (Hall & Brenner, 
2008; UNSCEAR, 2000c, 2010). 
 
Figure 4-1: Number of CT scanners per million population in selected countries in the 1990s 
(Hall & Brenner, 2008). 
A retrospective study was conducted by Miglioretti et al., (2013), the use of CT for children up 
to 15 years old from 1996 to 2010, including 4,857,736 child-years of observation.  Radiation 
doses were calculated for 744 CT scans performed between 2001 and 2011.  As stated in 
(Figure 4-2), their results showed that the use of CT increased between 1996 and 2005, 
remained stable between 2005 and 2007, and then began to decline.  The solid lines show rates 
for children younger than 5 years of age; the dashed lines show rates for children 5 to 14 years 
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of age.  The gray lines show rates at each health system, and the red lines show the average 
rates across health systems. 
 
Figure 4-2: Trends in the use of CT over time, by age group and year (Miglioretti et al., 
2013). 
De Gonzalez et al., (2009) pointed out that the total number of CT scan examinations performed 
annually in the US has increased approximately sevenfold between 1981 to 1995 (from 2.8 
million to 20 million).  By 2007, the number of CT examinations had increased to 
approximately 70 million scans per year, including at least 4 million for children.  In Britain, it 
has been estimated that about 11% of diagnostic radiology procedures are CT examinations, 
however, their contribution to the collective dose is approximately 70% (Brenner & Hall, 2007; 
de González et al., 2009; Elliott, 2009; Dougeni et al, 2012).   
There is a substantial variation in the radiation dose for the same type of CT examination 
between sites, this information was identified by a number of studies and surveys and 
potentially means that using the average radiation dose as an indicator of CT dose levels may 
be misleading.  Their results show there is a large variability in scanning technique and a 
resultant large range of ED obtained, reflecting the increasing complexity of CT scanning.  High 
radiation doses were observed in some centres that carry out limited paediatric studies (Moss 
and McLean, 2006).  Effective dose was closely associated with mAs, with most centres using 
lower mAs for younger patients, but few centres reducing the kVp for paediatric patients.  It is 
often difficult to achieve a balance between radiation dose and the attainment of diagnostic 
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information.  The indication for the CT often affects the protocol and scanning parameters 
chosen.  Feedback and education for these centres is needed to avoid inappropriate high 
radiation doses in the potentially susceptible paediatric patient population.  It is important that 
CT technique is tailored to the child and that CT is only used when there are good clinical 
indications.  Surveys of practice in the UK suggested a 40-fold variation of ED for a given 
examination between departments, and an Australian survey found up to 36-fold variation in 
ED for comparable studies between centres (Moss and McLean, 2006).  A survey was 
conducted to investigate the frequency of CT examinations for paediatric patients below 15 
years of age in 128 CT facilities in 28 developing countries of Africa, Asia and Eastern Europe 
and to assess the magnitude of CT doses (Muhogora et al., 2010).  Eleven CT facilities in six 
countries were found to use adult CT exposure parameters for paediatric patients, thus 
indicating limited awareness and the need for optimisation.  The results of the studies and 
surveys emphasize the need for continuing education and protocol review, particularly in 
paediatric CT examinations, in a complex and fast changing environment (Moss & McLean, 
2006; Muhogora et al., 2010; Shrimpton et al., 2006; Smith-Bindman et al., 2009; Wallace et 
al., 2010).   
Brenner, (2002) suggests that more attention should be given to the radiation dose from multiple 
CT examinations.  This increase in radiation dose from CT is partially due to the increased 
speed of image acquisition allowing multiphase examinations, all associated with higher doses 
(Smith-Bindman et al., 2009).  There has been evidence linking the exposure from low level of 
ionising radiation, at doses used in medical imaging, to development of cancer (Smith-Bindman 
et al., 2009).  The risks to individuals are likely to be small, but because of the large number of 
persons exposed annually, even small risks could translate into a considerable number of future 
cancers.  There has been a comprehensive reviewed by The National Academy of Sciences’ 
National Research Council into the biological and epidemiological data related to health risks 
from exposure to ionising radiation, published as the Biological Effects of Ionizing Radiation 
(BEIR) VII Phase 2 report (Smith-Bindman et al., 2009).  The radiation doses associated with 
a given CT scan may vary considerably between different machines and institutions as reported 
by the US Food and Drug Administration (FDA) in their survey during 2000 – 2001.  This 
included data on CT head scans from 203 facilities and found that the institution-to-institution 
multiple-scan average dose varied by as much as a factor of 10 (Hall & Brenner, 2008).  
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Since children and adolescents are more sensitive to radiation than adults, it is meaningful to 
analyse paediatric CT doses and imaging trends (Radiation, 2013; UNSCEAR, 2010).  There 
are already some surveys that have been conducted on paediatric CT utilisation rates (Blackwell 
et al., 2007; Dorfman et al., 2011; Larson et al., 2011; Mettler Jr et al., 2000; Townsend et al., 
2010), and the IAEA is assessing paediatric CT utilisation in developing countries (Muhogora 
et al., 2010).  The main purpose of these surveys were to collect information regarding the dose 
levels during the most common CT examinations in adults and paediatrics.  Whereas the key 
messages of the studies were that the exposure parameters are not always adjusted appropriately 
to the clinical question or to patient size, especially for children.  Dose reduction techniques, 
such as tube-current modulation, low-tube voltage protocols, and iterative reconstruction 
algorithms can substantially decrease radiation doses.  A summary of the the key points 
discussed above are:  
‐ Number of CT scans are increasing and they contribute most to the radiation dose 
received by patients, as they are in general higher dose procedures. 
‐ There is variability in practice and, therefore, the dose received by patients at different 
sites/within different countries will vary. 
‐ Children are more radiosensitive and, therefore, it is particularly important to consider 
the radiation dose to children and understand ways in which the dose can be reduced. 
4.5 CT Dosimetry and Concerns Regarding Radiation Dose 
Medical imaging represents the major source of man-made ionising radiation to people 
(Olarinoye & Sharifat, 2010; Zenone et al., 2012).  Therefore for all radiographic procedures 
image quality should be produced with the least possible radiation dose; as low as reasonably 
achievable (ALARA) principle (Uffmann & Schaefer-Prokop, 2009).    
As indicated in the literature due to advances in technology and improvements in training the 
radiation dose from diagnostic X-ray procedures has generally decreased with just two 
exceptions: CT and Interventional Radiology (Dawson, 2004; Lumbreras et al., 2016; Paterson 
& Frush, 2007).  Also as reported by the UK National Radiation Protection Board (NRPB) 
survey in 2003, CT scans accounted for 9% of all medical radiological examinations, this type 
of imaging modality was responsible for approximately 47% of the total radiation patient 
effective dose (Shrimpton et al., 2006; Pearce et al., 2012; Dougeni et al, 2012).  The more 
recent report in the UK is the third national CT survey by the NRPB (2011).  The review 
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included data from nearly a third of all CT scanners (all MSCT) and provides a substantial 
snapshot of the UK CT practice in relation to 13 common types of examination on adults and 
also head examinations for children (collated into three age bands).  This survey focused on 
establishing dose indicators CTDIvol and DLP, for 47,000 individual patients, representing some 
900 examination protocol/scanner combinations and 24,000 separate scan sequences 
(Shrimpton et al., 2014).  Whereas the previous two national reviews focused on standard CT 
protocols (Shrimpton et al., 2006; Shrimpton, Hillier, Lewis, & Dunn, 2005).  This more recent 
survey found there are still variations apparent in typical practice between CT centres for similar 
procedures.  For adults typical examination doses are reported higher than the previous results 
from the 2003 review in connection to overall national practice that is includes both SSCT and 
MSCT.  The increases for levels of CTDIvol are within 20% and those for DLP within 40%, also 
more significant changes are in relation to high resolution scans of the chest, where two quite 
different techniques are currently used; typical doses for axial-only scanning are significantly 
lower by factors of more than three compared with those for helical-only scanning.  In children, 
the survey found slight differences in typical values of CTDIvol for examinations of head were 
between -10% and + 20%, where those for DLP are between +40% and +50%, with the smallest 
changes for the youngest age band (0–1 year) and the largest for the oldest age band (>5 years) 
(Shrimpton et al., 2014). 
Lockwood et al., in 2007, reported the ED for common diagnostic imaging tests (Table 4-1), 
on page 76.  The use of CT is categorized by Brenner and Hall, 2007 according to the population 
of patients either adult or paediatric and the purpose of imaging: diagnosis in symptomatic 
patients or screening of asymptomatic patients. The largest of these categories are CT-based 
diagnostic tests in adults; about half of diagnostic CT examinations in adults are scans of the 
body, and about one third are scans of the head.  Approximately 75% of scans are obtained in 
a general hospital setting and 25% in a single-specialty practice setting.  In CT, exposure to 
ionising radiation is a problem that is becoming progressively more important as CT has 
acquired the role of a rapid, total-body exploratory examination; it is very popular with both 
patients and clinicians and is considered a ‘‘defensive’’ tool in the diagnostic setting.  An 
increase not only in the absolute number of CT examinations, but also in terms of both length 
of coverage and number of phases obtained while scanning (arterial, venous) has been observed 
(Colagrande et al., 2014).  The largest increase in CT use has been observed in the categories 
of paediatric diagnosis and private whole body adult screening, for example ‘Life Scan’ and 
these trends can be expected to continue.  This is primarily due to the decrease in time needed 
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for the scan and the superior detection capabilities e.g. solitary lung nodules.   A large part of 
the projected increase in CT scanning for adults will probably come from new CT-based 
screening programs for asymptomatic patients.  The four areas attracting the most interest are 
CT colonography (virtual colonoscopy), CT lung screening for current and former smokers, CT 
cardiac screening, and CT whole body screening.  An average adult CT scan of the head or 
abdomen delivers a radiation dose to the organ being scanned typically in the range of 15 mSv, 
and for neonate 30 mSv for a single CT scan, with an average of 2 to 3 CT scans per study 
(Brenner & Hall, 2007). In the US, a study conducted by Mettler and colleagues (2008) reported 
that among all patients undergoing CT, at least three scans were obtained in 30% of patients, 
more than five in 7%, and more than eight in 4% of patients.  Within this work it was identified 
that repeat scans were conducted because some of the patients had a prior CT examination on 
an earlier date, others had pre- and post-contrast scans.  In addition, a single CT examination 
often consists of multiple scan sequences (phases) across the same anatomical range.  This is 
further illustrated within the literature where a single CT scan gives radiation doses in the range 
of 10–30 mSv.  In relation to multiple CT scans on the same patient, benefits should be 
considered relative to potential carcinogenesis since tissue doses are in the range of 50–200 
mSv, which have been shown to cause an increase in cancer rate among the Japanese atomic 
bomb survivors (Mettler et al., 2008; Brenner, 2010).  These references directly relate the 
average CT dose with the magnitude of doses found in the atomic bomb survivors (ABS) and 
large-scale radiation worker (LSR) studies.  Risks at these dose levels are real, with dose and 
risk increasing simultaneously. With improvements in CT dosimetry more accurate and reliable 
information can be provided regarding the ED to patients. 
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Table 4-1: Estimated effective radiation dose for common diagnostic imaging tests 
(Lockwood D. et al., 2007; Table 1, p 122). 
Imaging Study Effective Dose (mSv) 
 Chest radiography (PA and lateral)  0.06 
 Screening mammography  0.6 
 Gastric emptying study  1.4 
 Kidney-ureters-bladder radiography  1.7 
 CT of the head  1.8 
 Lumbar spine radiography  2.1 
 Background radiation, annual dose  3.6 
 Radionuclide bone scan  4.4 
 Ventilation-perfusion (V/Q) scan  6.8 
 CT of the pelvis  7.1 
 CT of the abdomen  7.6 
 CT of the chest  7.8 
 Barium enema radiography  8.7 
 CT angiography of coronary arteries  10 
 Positron emission tomography (whole body) 14 
 Small bowel series (barium swallow x-ray study)  15 
 Intravenous urography  10.0 - 20.0 
 Whole-body screening CT  22.5 
 Three-phase hepatic CT scan  29.9 
 Dual-isotope myocardial rest and stress perfusion CT study  32.5 
 CT urographic study  44.1 
As reported by Lockwood et al., (2007), quantifying the radiation dose is not a simple matter.  
The energy and quantity of the photons, the size of the patient, and the vulnerability of irradiated 
tissues must be factored into any estimate.  The concept of ED allows many of these factors to 
be compared and controlled.  On the other hand everyone is constantly exposed to naturally 
occurring ionizing radiation, commonly called background radiation. Background radiation 
comes from radioactive elements present in the earth since its formation is primordial 
radionuclides, such as uranium and the natural products of its decay, radium and the gas radon. 
Other background radiation is in the form of cosmic rays, high-energy particles that constantly 
bombard the atmosphere and create radioisotopes of carbon and nitrogen. The average annual 
ED from background radiation is estimated at 3.6 mSv (Lockwood et al., 2007).  As showed in 
(Table 4-1) some diagnostic procedures involve an ED that is a tiny fraction of background 
radiation, whereas many impart several times that amount.  
Lockwood et al., (2007) further pointed out that CT examinations account for two thirds of the 
cumulative patient dose from diagnostic radiologic procedures, and the cumulative dose from 
CT scanning is rising as advances in technology increases the number of indications for and the 
capabilities of CT.  For instance, new CT scanners are faster than old machines due to multiple 
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detector rows that have increased the speed of scanning and enabled high-resolution 
reconstruction of images in all anatomical planes, permitting consideration of volume CT 
acquisition.  Also, development of iterative reconstruction algorithm software packages also 
have been developed to utilise these benefits, with modern scanners being able to reconstruct a 
study of 1000 images in less than 30s rotation time which allow imaging in multiple phases 
after contrast administration (Elliott, 2009).  CT urography typically consists of three 
consecutive CT examinations of the abdomen and pelvis, and it exposes the patient to the 
highest radiation dose of any commonly used diagnostic imaging studies (Table 4-1), on page 
76.   
To quantify radiation risk the International Commission on Radiation Projection (ICRP) uses 
the concept of ED.  Generally, as reported by ICRP (2007) in the annual publication report 
(103) the risk of fatal cancer for adults is estimated at 5% Sv but is higher for children.  There 
is some debate about the use of ED, but it remains the useful tool to estimate risk (Borrás et al, 
2010; Ma et al., 2013; Martin, 2014).  In vivo, the ED cannot be directly measured but it can be 
estimated by measuring organ dose in representative phantoms or MC simulations as discussed 
in (Section 3.8) on page 53 of this chapter.  
Brenner, (2008), has argued that there are three major problems with the concept of ED: 
1. Tissue weighting factors represent a committee determined subjective balance between the 
different stochastic endpoints of cancer incidence, mortality, life shortening and hereditary 
risks.  These weighting factors, for some organs, are changing over a period of time and make 
historical ED estimates unreliable (D. Brenner, 2008).  
2. The other major problem with ED is that it is independent of age at the time of exposure, 
whereas data suggest that attributable radiation risks, supported by experimental data, are often 
highly age-dependent (D. Brenner, 2008). 
3. The third major problem with the ED is that it is often confused and misused.  The equivalent 
dose that refers to a given tissue and ED that is a weighted average over the entire body are 
both measured in Sieverts.  So, the equivalent dose and even the absorbed dose have been 
confused with one another (Brenner, 2008).    
The risk associated with radiation exposure is related to the biological effects induced due to 
that amount of radiation deposit in the body.  These types of effects are measured by using the 
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direct data from human epidemiological studies of atomic bomb survivors in Hiroshima and 
Nagasaki in Japan in 1945.  For a long time, a large group of survivors were studied and as time 
passes the statistical confidence of estimating the cancer risk improves.  As reported by Brenner 
and Hall, (2007), Cardis et al., (2007) and Preston et al (2008), the number of survivors who 
received doses of radiation less than 50 mSv is around 25,000 people, this amount of radiation 
is similar to the doses received by those undergoing some CT examinations (Brenner & Hall, 
2007; Cardis et al., 2007; Preston, 2008).  
The main key points that should be understood are that CT examinations are among the highest 
sources of radiation to population.  CTDIvol and DLP are the most common parameters for 
computing the radiation dose delivered to the scan volume from particular CT examinations.  
Also, dose to particular organs are depend on the scan parameters used.  Effective dose is not a 
suitable quantity for considering stochastic risk from low radiation dose procedures.  The new 
quantity should take into account patient age and gender at the time of scanning. 
4.6 Paediatric and Adult CT Scanning 
The clinical value of CT is unquestioned, and the uses of newer helical and multislice units are 
growing.  The dose received by some patients, particularly children, is higher than desired and 
must and can be reduced without any significant loss of diagnostic information (Linton & 
Mettler Jr, 2003).  
A US conference talk in 2002, on the subject of CT dose reduction, described adult CT scanning 
as being incredibly effective and has become a routine part of radiology because it provides 
much more detail than conventional X-ray imaging.  It also increases the confidence of our 
referring physicians in our contributions in almost every clinical area.  In paediatric CT, there 
has been a 200% increase in utilisation over the past few years (Donnelly et al., 2001; Linton 
& Mettler Jr, 2003). 
For medical imaging modalities, especially CT diagnostic reference levels (DRLs) are 
becoming more common.  DRLs represent the lower bound of potentially unacceptable practice, 
rather than being an upper limit not to be exceeded.  These can be set at a practice, regional 
and/or national level and are calculated by surveying doses for standard patients across practices 
and generally established on the basis of the rounded third quartile value of the dose 
distributions (Shrimpton & Wall, 2000).  Dose surveys can then be conducted at a practice level 
and compared with national DRLs to determine when local practice should be reviewed, 
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particularly when the DRL is consistently exceeded.  DRLs have been used for some time in 
European countries (Bongartz et al., 2004) but fail to take into account the quality of the 
resultant images. 
Diagnostic reference levels (DRLs) have been defined in European guidelines for CT 
examinations since 2000 (McCollough, 2010).  DRLs, appropriate to CT in examinations in 
adult patients have already been specified, utilising the dosimetric concepts of weighted 
computed tomography dose index per slice in serial scanning or per rotation in helical scanning, 
and dose-length product per complete examination. This methodology can also be applied to 
CT examinations on children, with reference dosimetry for all types of examination on children 
of all ages being based solely on measurements involving the smaller (16 cm diameter) of the 
two standard CT dosimetry phantoms.  Some initial DRLs for paediatric CT have been set on 
the basis of the rounded third quartiles of the dose distributions provided by a survey of typical 
practice at over 40 scanners from seven European countries. Values are presented in relation to 
three patient ages (<1 year, 5 and 10 years) and five types of procedure (Shrimpton and Wall, 
2000). 
Even though DRLs should not be applied to individual exposures but are reference doses for 
common examinations, they can help to optimise radiation protection to avoid unnecessarily 
high doses to the patient.  The DRLs are provided for four major anatomical regions, they are: 
head, chest, abdomen, and pelvis whereas for CT, the CTDIW and the DLP were suitable 
quantities to be used as DRLs.  These DRLs are derived from a European document based on 
a British study performed in the early 1990s (McCollough, 2010).  Since that time the CT 
machines have undergone major evaluation and CTDIw has been replaced by the CTDIvol which 
is commonly displayed by the CT scanner console (Colagrande et al., 2014).  A national survey 
was published in 2006 by Shrimpton et al., which reviewed the radiation dose from CT 
examinations in the UK in 2003.  Data reported is based on data received from over a quarter 
of all UK scanners, of which 37% had MSCT capabilities.  The study included data collected 
from the protocols established on each scanner for 12 common types of CT examination on 
adults and children.  The study concluded that, the mean UK doses for adult patients were in 
general lower by up to 50% than previous ones for 1991, although doses were slightly higher 
for MSCT relative to SSCT scanners.  The relative increase in reference dose was larger for 
scans of the head and the chest (high resolution) (Shrimpton et al., 2006).  A similar study was 
conducted in Italy in 2004 and published in 2006; the study aimed to establish the first Italian 
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survey of radiation dose in CT prior to the widespread adoption of MSCT.  The study was 
carried out in 29 Italian hospitals, covered 48 CT scanners and 232 examinations for seven adult 
clinical CT protocols, and showed that CTDIw and DLP were always below the DRLs set by 
the European guidelines (Origgi et al., 2006).   
Analysis of the risks associated with paediatric CT mainly refers to the study by Brenner et al., 
(2010), which highlighted the increase in the probability of occurrence of tumours when the 
patient’s age is decreased.  It should be noted that some CT examinations in a child could 
increase the probability of tumour occurrence to more than 20% (Brenner et al., 2010a; 
Colagrande et al., 2014).  However, the main dosimetric aspects connected with the use of CT 
in paediatrics are still poorly standardised due to following: Firstly, the weighting factors for 
effective dose are not age specific, and therefore, some authors suggest estimating them on an 
organ-by-organ basis (Huda & Vance, 2007) and secondly, the classic CT dose descriptors are 
based on phantoms with diameters simulating the geometry of an adult and introducing 
significant uncertainties in the evaluation of organ doses in children (Colagrande et al., 2014). 
Different research groups have used various tools to perform size-dependent dose evaluations. 
Two studies, one by Axelsons et al., (1996) and the other by Giacco et al., (2001) used a physical 
anthropomorphic phantom (Axelsson et al., 1996; Giacco et al., 2001), while other investigators 
used MC voxelized phantoms (Lee et al., 2007).  In both methodologies, unlike for adults, the 
phantoms are size and age specific (the new-born baby (0-year-old) and the 1-, 5- and 10-year-
old child, the 15-year-old adolescent and adult to represent the age groups) (Varchena, 2002).  
Another study by Khursheed et al., (2002) used the MC N-particle (MCNP) radiation transport 
code to calculate normalised ED values for three different scanners and mathematical 
anthropomorphic phantoms with ages ranging from new-born to adult.  They demonstrated the 
high dependence on patient age and size: the ED in a new-born was 1.5 times greater than that 
of an adult for all types of examinations, as well in all cases an inverse trend is observed between 
normalised effective dose and phantom age, with the dose to the new-born from head and neck 
scans being 2.2–2.5 times higher than that to the adult, depending on scanner model.  Other 
dosimetric aspects associated with paediatric CT have been focused on optimisation procedures 
(Kalra et al., 2004; Khursheed et al., 2002).  Brady et al., (2011) noted paediatric CT imaging 
trends in Australia from 1994 – 2009; they illustrated that 2.1 million CT examinations were 
performed in Medicare in Australia for children and adults.  The average annual growth in the 
number of CT scans provided since 1994 was 8.5% which was more than the population growth 
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of 1.4%.  Combining the data sets showed that over the last 20 years, there has been an average 
annual increase of 5.1% in the CT imaging rate for 0 to 18-year-olds, which accounts for more 
than the increase seen in adult CT protocols (Brady et al., 2011). 
As reported by Brenner & Hall, (2012), a number of pioneering researchers publishing in the 
Journal of the American College of Roentgenology have raised concerns regarding the 
possibility of cancer induction from paediatric CT scans.  This in turn attracted attention from 
the media in the US regarding the radiation dose to children from CT scanning (Brenner & Hall, 
2012).  This resulted in a strong public reaction and also encouraged the medical community to 
become more aware of paediatric CT dose.  This focused the efforts of the CT manufacturers 
to reduce dose and previous endeavours in this area were limited (Donnelly, 2005).   
As mentioned by Paterson et al., (2001) and Ghotbi et al., (2006) one of the important 
conclusions was that CT protocols for adults were in some cases being used on children.  In 
early CT scanners operators were not allowed to adjust the scanner parameters, however, 
advancing technology provided operators with the ability to lower the dose for younger or 
smaller patients although it appeared that this was not being utilised in some cases.  There is a 
large variability in body size in the paediatric population, so adjustments of acquisition 
parameters are necessary because they are the main determinants of radiation dose received by 
the child.  Paterson et al., in 2001 indicated in their paediatric CT survey that no appreciable 
adjustment of parameters were being made based on the examination type or patient age 
(Paterson et al., 2001).  According to Blackwell et al., (2007); Brenner et al., (2001a) and Wiest 
et al., (2002) the number of CT scans being performed on children appeared to be increasing, 
this can be attributed to advances in technology that allow faster scanning times and hence 
greater feasibility for conducting scans on uncooperative children and (or) sick patients as well 
the availability of CT scanners makes them readily accessible (Blackwell et al., 2007; Brenner 
et al., 2001a; Wiest et al., 2002).   According to Brenner et al., (2001a), compared with adults 
the combination of using adult parameters and the higher radiation risk for children leads to a 
significantly higher attributable lifetime cancer mortality rate in children, for example in the 
US 600,000 abdominal and head CT scans are performed annually on children under the age of 
15 years, approximately 500 of these children might ultimately die of radiation induced cancer.  
It must be noted that Brenner’s work reflected the status of paediatric CT over a decade ago.  
Scanner technology and clinical protocols have adapted, however, paediatric CT is still a high 
dose examination and highly prevalent.  It is also important to make comparisons with other 
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causes of cancer than simply radiation induced cancer rates.  Approximately 140,000 of the 
600,000 children will eventually die from cancer from non-radiation related causes and the 
radiation induced cancer risk increases this rate by only 0.35% (Brenner et al., 2001a). 
Moreover, the wider benefits of using CT scans in healthcare must be considered.   Brenner et 
al., (2010) has calculated the radiation attributable cancer rate equates to about 1 in every 1,200 
abdominal and head CT scans leading to a fatal cancer in the age group under 15 years.  The 
significant proportion of these examinations as expected would have a diagnostic benefit 
changing patient management and even being lifesaving.  Thus, the ratio of benefit to risk must 
be considered in this context and is ultimately a decision that the child's clinician must make.  
Furthermore, Brenner et al., (2001a & 2010) stated that risks calculated are likely to be high 
since it was based on the use of adult scanning parameters.  In fact, these risks are lower for a 
properly optimized and clinically justified examination (Brenner et al., 2001a & 2010). 
Following the press coverage of the articles published in 2001, the Society for Paediatric 
Radiology (SPR) responded stating that the views were unbalanced and potentially dangerous, 
they further stated that the benefits of CT imaging had not been highlighted sufficiently 
(Paediatric Radiology, 2001).   This agreed with that reported by Brenner et al., (2001c), the 
risks are almost always outweighed by the benefits, but when the risks are applied to such a 
large population they become a public health issue.  For an individual patient the benefits are 
justified, but from a population perspective the risks must be considered (Brenner et al, 2001c). 
As mentioned by Picano, (2004) in terms of radiation risk it will always be a challenging 
question of defining what is acceptable.  Better knowledge of such risks will help us to avoid 
small individual risks translating into substantial population risks.   Radiological awareness is 
essential to help doctors in the difficult task of balancing what is good for the individual patient 
against what is acceptable for society.  Human nature tends to lead us to overreact when 
presented with a small risk, while larger risks, such as dying from lung cancer due to smoking 
are often disregarded (de Gonzalez & Darby, 2004; Picano, 2004a, 2004b). 
Donnelly (2002) discusses issues related to radiation exposure from an historic perspective and 
draws the parallel with the introduction of X-ray imaging in medicine and the delay in realising 
its harmful effects.  It also raises caution that over-utilization can result from the successful 
introduction of new technology, without realizing its unforeseen dangers which leads to belated 
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optimization of techniques and implementation of appropriate safety and protection measures 
(Donnelly, 2002). 
In 2003, Linton and Mettler published an article on dose reduction in CT and concluded that 
the clinical value of CT is unquestioned, and the uses of newer helical and multidetector units 
are growing but that further optimisation of the radiation dose to children and adults is necessary 
(Linton & Mettler, 2003).  Particularly from 2001 onwards it was becoming apparent in the 
literature that dose reduction was needed for paediatric CT, despite the known controversy 
regarding quantifying the risk associated with low radiation doses. 
Dose reduction is one of the main problems in CT, and many techniques have been developed 
to face this problem.  However, radiation dose is linked to image quality and the factors 
contributing to each should be balanced to ensure images have sufficient diagnostic information 
and the radiation dose is minimised (Colagrande et al., 2014).  CT dose reduction will require 
a combination of approaches.  These include user education for physicians and radiologic 
technologists, development of technique charts by medical physicists, development of 
automatic exposure control devices by manufacturers, and possible retrofits of these devices for 
older machines.  It also will require creation of a climate of opinion in which radiologists will 
demand attention to dose reduction in their purchase of new CT scanners, one industry 
participant commented.  There is the added possibility that radiation dose from paediatric CT 
can be reduced further using alternative image reconstruction methods (Singh et al., 2012; 
Tricarico et al., 2013; Vorona et al., 2011).  Within adult CT scanning iterative reconstruction 
techniques have emerged as significant dose reducing methods, in patients, low-dose CT with 
adaptive statistical iterative reconstruction was associated with CT dose index reductions of 
32–65% compared with routine imaging and had the least noise both quantitatively and 
qualitatively (Hara et al., 2009; Korn et al., 2012; Silva et al., 2010; Singh et al., 2011).  It 
should now be standard practice of adjusting the examination parameters for children based on 
age, weight, size or a combination of these and there is much in the literature about addressing 
these techniques (Boone et al, 2003; Donnelly et al., 2001; Haaga, 2001; Huda et al., 2000; 
Lucaya et al., 2000; Paterson & Frush, 2007; Suess & Chen, 2002; Verdun et al., 2004).  An 
excellent review has been provided by Paterson et al., (2007) for some of the suggested 
protocols for children and manufacturers which provide age- or weight-based technique charts.  
These technique charts / tables provide guidelines for MSCT parameters in paediatric CT chest, 
abdomen/pelvis, extremity skeletal examination, and CT angiography (Paterson & Frush, 
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2007).   However, there is no direct method that can help practitioners to assess the radiation 
risk prospectively prior to undertaking a CT scan.  Thus, there is a need for a method that can 
aid the radiographers and CT users to obtain risk data on possible cancer induction for specific 
CT protocols and when changing acquisition parameters.     
4.7 CT Brain Acquisition Protocols and Radiation Dose 
The choice of scanning protocol in CT will affect the radiation dose delivered to the patient. 
There are two types of CT protocols commonly used to scan the brain, sequential and helical 
or spiral.  For the Toshiba Aquilion 16 CT scanner used in this study, the standard sequential 
protocol parameters are: axial scanning with a 120kVp tube potential, 320 mAs, and a rotation 
time of 1 second and the detector width x rows = beam collimation is 0.5 mm x 16 = 8 mm.  
Whereas the standard helical protocol uses 120kVp and 1 second rotation time, mA is controlled 
automatically (100 – 450) and the detector width x rows = is 0.5 mm x 16 = 8 mm. 
As reported by McCollough (2006 & 2011), most radiation dose reduction efforts have been 
focused on alterations in tube current by using ATCM.  Wide variations in patient radiation 
absorption occur with changes in the CT projection angle and anatomic region, and the 
projection with the most noise initially determines the amount of noise on the final image 
(McCollough et al., 2006 & 2011).  Mettler Jr. et al, 2000 and McCollough et al., 2006 argued 
that differences in patient doses from CT can be linked to multiple causes.  A systematic review 
study by Dougeni et al., (2012), reported on evaluating patient dose from CT scan examinations 
using a variety of published literature.  The report investigated the ED during common CT scan 
examinations in adult and paediatric patients.  The CT dose is still the highest among the 
radiation diagnostic modalities and there is variation in dose reported for similar producers for 
different scan types that is because different scanner types by different manufacturers and 
different scan protocols (kVp, mAs), the variations are also related to the selected length of the 
region to be scanned, tube rotation speed, helical pitch, collimation, filtration, and patient 
weight (Dougeni et al., 2012; Kubo et al., 2008; McNitt-Gray, 2002).  The ED values for adult 
and paediatric CT examinations obtained from the report are illustrated in (Table 4-2) and 
(Table 4-3), on page 85 and 87, respectively. 
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Table 4-2: Adult head CT ED (mean values in brackets) (A. Cohen et al., 2016; Dougeni, 
Faulkner, & Panayiotakis, 2012; Rapalino et al., 2012). 
Reference Effective doses from CT scanning in Adult (mSv)
Clarke et al., 2000  0.98 – 2.1 (1.9 3rd quartile) 
Tsapaki et al., 2001 1.4 
Huda et al., 2001 1.2 – 1.5 (1.3) 
Papadimitriou et al., 2003  0.7 – 3.7 (2.1) Greece 1.6 Italy 
Hatziioannou et al., 2003  0.4 – 2.5 (1.6) (2.00 3 [rd] quartile) 
Cohnen et al., 2003  2.8 (neck) 
Shrimpton et al., 2003   1.5 mean, 1.7 3 [rd] quartile 
Brix et al., 2003  2.2 
Yates and Pike., 2004  0.9–2.4 (1.7) 
Heggie, 2005 1.5 
Ngaile et al., 2006 2.2 
Tsapaki et al., 2006 1.2 
Moss and McLean, 2006 1.6 – 2.8 
Aldrich et al., 2006 1.7 –  4.9 (2.8) 
Origgi et al., 2006 0.5 – 3.1 (1.7) Experimental 0.6 – 4.1 (1.8) Monte Carlo 
Muhogora et al., 2006 6.1 – 7.9 
Cohnen et al., 2006 1.7 head CT 1.9 intracranial angiography 2.8 cervical angiography 1.1 – 5.0 cerebral perfusion 
Huda and Vance, 2007 0.9 
Van der Molen et al., 2007 1.9 
Teeuwisse et al., 2007 0.6 – 2.4 (1.4) acute stroke 0.2 – 1.9 hearing loss 
Tsai et al., 2007 1.6 
Kharuzhyk et al., 2010 0.9 – 2.0 (1.4) 
E. Dougeni et al., 2012 0.4 – 7.9 
O. Rapalino et al., 2012 1.95 – 2.66 ±   0.04  
Andrew et al., 2016 2.0 – 2.3 ± 0.7 
World Health Organization 2016 2 
Overall Mean: 2.0                            SD: 1.2 
 
Advances in CT technology have increased and extended the use of CT clinically, this has 
resulted in two advantages, more frequent CT examinations (short scan time, improve in speed 
of image acquisition, also the technique of retrospective image acquisition scanning with 
overlapping of slices) and the introduction of new CT protocols such as spectral CT (Budoff, 
2009; Dawson, 2014).  In comparison to projection radiography, where technological 
developments have steadily driven dose down, patient doses in spite of CT technological 
evolutions have still remained among the highest in diagnostic radiology.  The widespread 
introduction of MSCT resulted in a considerable increase in both the frequency of CT 
procedures and patient exposure levels.  The associated increase in radiation dose with MSCT, 
see (Sections 3.3.2.1 and 3.3.2.2) on pages 27 and 29, is partly due to the need to scan a slightly 
larger volume than is planned.  Over-beaming occurs in order to get sufficient data interpolated 
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to reconstruct the first and last slice.  Usually there is an additional half rotation at the beginning 
and the end of the intended scan length, which may account for an increase in dose 10–20% for 
head–neck and trunk studies and may reach up to 30–35% for chest and abdomen pelvis studies 
(Dawson, 2014; Kalender, 2006, 2011, 2014; Tzedakis et al., 2005; Brix et al., 2003; Budoff, 
2009; Dawson, 2014; Huda & Vance, 2007; ICRP Publication 102, 2007; Mayo et al., 2003; 
UNSCEAR, 2000a, 2000b; U. N. S. C. o. t. E. o. A. R. UNSCEAR, 2008).   
A review was completed by Dougeni in (2012), about the ED from CT scanning in paediatric 
patients for head CT examinations and the results as illustrated in (Table 4-3).  It was observed 
that there were large dose variations and some individual clinical sites exceeded the 
recommended DRLs.  On this basis alone, it is clear that there is potential for CT dose reduction, 
this is especially true for exposure factors which are not always adjusted appropriately for the 
clinical question or to patient size, especially for children.  Dose reduction techniques, such as 
ATCM, low-tube voltage protocols, prospective echocardiography-triggered coronary 
angiography and iterative reconstruction algorithms can substantially decrease dose. 
Verdun F R. et al., (2008) and Shrimpton et al., (2005 & 2014) have reported large variations 
in doses in adult and paediatric CT for a similar type of procedure, especially in paediatric 
examinations where the range of patient size is wider within the same age band (Shrimpton et 
al., 2005 & 2014; Verdun et al., 2008; Wall et al., 2011).  The variation in patient dose from 
CT is more dependent on scan protocols than on scanner type.  For example, for the same head 
CT scan (140 kVp, 340 mAs, 5 mm contiguous section) with a single and multi-detector row 
CT scanner, the dose is 205% higher for the spiral scan (increase from 60 mGy to 123 mGy).  
This arises not only from geometrical differences but also from differences in beam filtration, 
X-ray spectrum and beam profile but could be eliminated by applying an optimised protocol 
(Hamberg et al., 2003). 
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A report by Hara et al., (2010), reported on the radiation dose delivered from CT brain 
examinations using CTDIvol indices measured using a PMMA head phantom.  These values 
were then compared with actual measured values using TLDs and an Alderson RANDO 
anthropomorphic phantom.  The X-ray tube voltage and current were varied and included 90, 
120, and 140 kVp and 25 to 300 mAs.  Conclusions from this study indicated that there were 
no real differences between CTDIvol and TLDs based dose estimations at 90 kVp.  Study 
findings did indicate that as the tube voltage increased (120 and 140 kVp) the actual TLDs 
values were less than the CTDIvol based values.  (Table 4-4) and (Table 4-5) report the 
measured doses from Hara et al., (2010) using TLD and CTDIvol with tube currents of between 
Table 4-3: Effective dose from CT scanning in paediatric patients for head examination (mean 
values in brackets) (Dougeni et al., 2012; Miglioretti et al., 2013; Vilar-Palop, Vilar, 
Hernández-Aguado, González-Álvarez, & Lumbreras, 2016; WHO, 2016) 
Effective doses from CT scanning in children (mSv) Reference 
Neonate 1 year 5 years 10 years 15 years
1.6 – 2.4 
[2 months] 
1.7 – 2.7 
[2 years] 
1.60 – 2.5 
[7 years]  1.3–2.2 Papadimitriou et al., 2000 
3.5–14.5 (7.6)     Huda et al., 2001 
8.4 2.3 1.5 1.7  Chapple et al., 2002 
6 4.9 4 2.8 1.7 Huda et al., 2003 
 0.3–1.5 0.5–1.6 0.6 – 2.3  Pages et al., 2003 
 2.5 1.5 1.6  Shrimpton et al. 2006 
1.3–2.3 
[2 months]  
1.5 – 2.0 
[5–7 years]   Moss and McLean, 2006 
0.8–2.4     Staton et al., 2006 
3.6     Huda and Vance, 2007 
2.0–5.0 (4.2) 2.7–5.6 (3.6) 2.0–3.6 (2.4) 1.6 – 2.7 (2.0)
1.0 – 2.1 
(1.4) 
Thomas KE, and Wang B., 
2008 
  0.7   Feng et al., 2010 
4.3 ± 2.6 3.9 ± 0.6 4.1 ± 1.2 3.6 ± 0.5 3.9 ± 0.7 Papadakis et al. 2011 
(3.5) [< 5 years] (1.5) [5-9 years] 
(1.1) [10-14 
years]  
Miglioretti et al., 2013 
1.7 [< 1 year] 1.6 [1-5 years] 1.8 [6-10 years] 
1.6 [11-
15 years]
Vilar-Palop et al. 2016 
6 3.7 2 2.2 2 [< 15 years] 
World Health Organization 
2016 
3.3  2.4 2.4  EU DRL, 2000 
2.6 [battered 
child-trauma]  
1.8 
[hydrocephal
us] 
  EU DRL, 2004 
3.0  1.9 2.0  UK DRL, 2003, 2006 
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25 and 300 mAs for the three different values of tube voltage (90, 120, and 140 kVp) (Hara et 
al., 2010).   
Table 4-4: Absorbed doses to the brain during CT head scans (Hara et al., 2010). 
kVp mAs Measured dose using TLD (mGy) CTDIvol (mGy) % Different 
90 25 1.39 1.8 12.9 
90 300 17.00 21.2 11 
120 25 3.21 3.8 8.42 
120 300 37.79 47.7 11.6 
140 25 5.08 5.5 4 
140 25 65.07 65.6 0.41 
 
Table 4-5: Eye exposure dose from CT head scans (Hara et al., 2010). 
kVp mAs Measured dose using TLD (mGy) CTDIvol (mGy) % Different
90 25 1.94 1.8 3.74 
90 300 20.31 21.2 2.14 
120 25 3.71 3.8 1.20 
120 300 49.72 47.7 2.07 
140 25 5.44 5.5 0.55 
140 25 69.76 65.6 3.07 
With a dosimetry phantom, the measured values of the brain gradually deviated from the 
corresponding index values as the current increased, whereas no deviations from the index 
values were observed for the measured values of the eyes as the current increased.  Scans of the 
brain and eyes in the head region were acquired under the same conditions.  In the head region 
the calculated TLD value–to–CTDIvol ratios, show the TLD values of were lower than the 
CTDIvol (TLD value–to–CTDIvol ratio, 0.93 ± 0.12) as illustrated in (Table 4-4) (Hara et al., 
2010). 
4.8 Chapter Summary 
The use of ionising radiation in modern medicine is necessary for both diagnosis and treatment.  
As reported by the UNSCEAR, (2010), there is now more than one diagnostic examination 
performed per person across the population every year in countries with advanced health care 
systems (UNSCEAR, 2010).  The UNSCEAR reported that globally, there are approximately 
3.6 billion diagnostic examinations and six million therapeutic treatments performed annually.  
These medical practises involving the use of ionising radiation include diagnostic examinations, 
interventional procedures and radiotherapy treatments and are typically undertaken in 
radiology, nuclear medicine and radiation oncology departments or clinics (UNSCEAR, 2010).  
For medical purposes, the people exposed to ionising radiation are the patients themselves.  
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Recent figures demonstrate that diagnostic medical exposures, including radiology and nuclear 
medicine, account for about one-fifth of the average annual per caput dose to the global 
population from all sources (UNSCEAR, 2010).  The National Council on Radiation Protection 
& Measurements (NCRP) (2009) reported that from all of the diagnostic imaging modalities, 
CT is the highest contributor to population dose, even though it accounts for a much smaller 
proportion of the total number of examinations (Schauer & Linton, 2009). 
Evidence from epidemiological studies prove that it is impossible to deny the association 
between an increase in cancer incidence and morbidity due to ionising radiation exposure at 
high doses (ICRP, 2005).  By contrast, quantifying the risk associated with low dose radiation 
exposures, such as a typical CT scan, is more complex and contentious.  As reported by Brenner 
and Hricak, (2010) and Brenner et al., (2003) despite the uncertainty surrounding low dose 
exposure, the societal risk may not necessarily be negligible and must still be considered, this 
concern arises when an increasingly large population is exposed to small individual risks 
(Brenner et al., 2003; Brenner & Hricak, 2010; Wall et al., 2014).  Children are more 
radiosensitive than adults thus; the risk of radiation exposure is even higher than for adults.  The 
risks from low doses of radiation are likely to be lower, progressively larger epidemiological 
studies are required in order to quantify the risk to a useful degree of precision and establish a 
low dose response.  On the other hand, the necessary sample size increases approximately as 
the inverse square of the radiation dose in order to maintain statistical precision and power 
(Brenner et al., 2003; ICRP, 2005).  The difficulties involved in quantifying the risks of low 
dose radiation are well known, two important questions have been addressed by many 
researchers, firstly, what is the lowest radiation dose which provides good evidence regarding 
increasing existing cancer risks in humans?   According to the most recent literature and 
epidemiological evidence this is approximately 10 – 50 mSv for an acute exposure and 
approximately 50 – 100 mSv for a protracted exposure (Hendee & O’Connor, 2012).  The 
second question is what is the most appropriate way to extrapolate such cancer risk estimates 
to even lower doses? As supported by experimentally grounded, quantifiable, biophysical 
arguments, a linear extrapolation of cancer risks from intermediate to very low doses currently 
appears to be the most appropriate methodology (Brenner et al., 2003; Brenner & Hall, 2012; 
Hricak et al., 2011; Wall et al., 2006).  
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Chapter 5 : Materials and Methods 
5.1 Chapter Overview 
This thesis assessed effective dose directly, using MOSFETs, to provide an understanding of 
the radiation dose variations across a range of helical and sequential CT brain imaging protocols 
(432) for both paediatric and adult patients, respectively.  Absorbed dose was used to calculate 
both effective dose (ED) and the lifetime cancer risk induction for both males and females of 
different ages, ranging from 0 to 80 years.  It was initially the intention to carry out the 
experiments using TLDs, however, due to the huge number of protocols utilised and the long 
time required to collect the data and analyse the results (which was beyond the PhD time frame) 
a decision was made to use only MOSFET dosimeters.  Comparing the doses measured between 
MOSFET and TLDs was undertaken for number of CT brain protocols to valid the MOSFET 
method. 
Organ and tissue absorbed doses were directly measured using MOSFETs for CT examination 
of the adult brain (sequential and helical) and paediatric (helical) using a Toshiba Aquilion 16 
CT scanner and ATOM phantoms representing both adult and paediatric patients.  Within the 
method a series of acquisition parameters were varied which included tube potential, rotation 
time, gantry angulation, mA modulation (ATCM), detector configuration and helical pitch.   
5.2 Thesis Aim/Rationale 
The aim of this study was to measure the organ and tissue absorbed dose and to estimate the 
ED during a CT scan of the brain using two dosimetry (ATOM) phantoms, then provide further 
estimations of the attributable lifetime cancer risk.  The main reason behind carrying out this 
study was to develop a great understanding of a CT radiation dose and its effect in inducing 
cancer risk due to stochastic effects and developing excel spreadsheet/tool to estimate cancer 
risk from CT brain examinations cases/106 for male and females aged from 0 to 80 years, see 
thesis aims and objectives (Sections 1.2 and 1.3) on page 5. 
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Figure 5-1: A flowchart illustrating the methods used in this PhD thesis. 
5.3 MOSFET validation using TLD data 
TLDs are traditionally the gold standard dosimeter generally employed for diagnostic 
radiology.  As indicated in the literature, TLDs are used extensively in many medical dosimetry 
and personal monitoring applications, owing to their suitable dosimetric characteristics, 
reliability, small size and tissue equivalence as well as their accuracy and precision (Moscovitch 
& Horowitz, 2007; Rivera, 2012; Mukundan et al., 2007; Yoshizumi et al., 2007).  The use of 
TLDs are particularly labour intensive and time consuming.  It typically takes around 7 hours 
for routine dosimetry due to the additional steps of annealing and read out which are needed in 
• Checking TLDs sensitivity.
• MOSFETs and TLDs calibration against a solid
state dosimeter.
• Determining MOSFET and TLD reproducibility.
MOSFETs and TLDs 
preparation
• Compare for validation purposes MOSFET data
against TLDs data and determine the percentage
different between them.
Validating MOSFETs aganst 
TLDs
• Other organs dose measurement for a variety of
adult and paediatric CT brain protocols.
• Eye dose measurments. 
• Estemitaing absorbed dose to the substituted 
organs that don't have measuring points in 
ATOM phantom.
• Measuring absorbed dose to active bone 
marrow.
Organ dose measurement
• Effective dose calculated for 162 and 54 adult
helical and sequantial protocols, respectively and
for 216 paediatric protocols.
Effective dose calculation
• Totall effective risk calculations for all the adult
and paediatric protocols for both male and
females according to the data represented by
BEIR VII report.
• Creating a tool for estimating effective risk.
Effective risk calculation
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order to generate accurate results.  As a result, within this thesis due to the large number of 
protocol evaluations (n=432), it was necessary to explore a new method for organ dose 
measurement.  Within the literature MOSFETs have been introduced as an alternative to TLD 
but with the advantage of a much faster dose acquisition time.   
Some of the known limitations of MOSFETs are the energy and angular dependence, 
particularly for lower energies typically encountered in diagnostic radiology (Dong et al., 2002; 
Ehringfeld et al., 2005; Jones et al., 2005; Wang et al., 2005).  However, these may be addressed 
to some extent with consistent positioning and appropriate correction factors.  Dong et al. 
(2002) have demonstrated an increased sensitivity of MOSFET sensors at low doses (below 
about 5 mGy) compared with TLD-100H chips which varied less than 3% over the same dose 
range, suggesting that TLDs may be more suitable at the very low doses typically used in 
conventional radiography.  The MOSFET dosimeter is small and has several advantages, such 
as multiple point dose measurements, real time readout, and ability to immediately reuse.   
This section serves two main purposes: (1) to validate the MOSFET dose measurement method 
by comparing with TLDs as the standard of reference and (2) to compare the calculated ED of 
both method against values published in the literature to compare the accuracy of the measured 
results from MOSFETs.    
In this study both the TLDs and MOSFETs detectors were calibrated against a solid-state 
dosimeter using a conventional X-ray machine (Varian) with an X-ray beam equivalent in 
quality to that of a Toshiba Aquilion 16 CT scanner (half-value layer, ≈ 5 mm Al at 120 kVp).  
The MOSFETs were experimentally evaluated against TLDs by placing them in an ATOM 
dosimetry phantom model representing an average adult male and measuring the absorbed and 
calculating ED for 54 CT brain protocols at three different CT gantry angulations, 0o, 15o and 
27o.   
The absorbed doses measured with the MOSFETs in the scanned volume demonstrated 
reasonable agreement (on average within 6% to 13%) against the TLD measurements.  The 
percentage difference between absorbed dose measured with MOSFET over TLD for organs in 
the scan volume were as follows: brain, 13% (23.82 mGy for TLD compared to 27.48 mGy for 
MOSFET); active bone marrow of the cranium 6% (2.25 mGy for TLD compared to 2.11 mGy 
for MOSFET).  A study by Yoshizumi et al. (2007) compared the same high sensitivity 
MOSFETs against TLD-100H chips for CT examinations in an adult phantom.  They found the 
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difference between the dosimetry methods ranged from 1% to 27% in the scanned volume 
(Yoshizumi et al., 2007).  The disparity was much greater for organs outside of the field of 
view, due to the lower limit of detection for MOSFETs compared with TLDs (Yoshizumi et al., 
2007).  For the individual TLDs which measured absorbed doses to body organs from the brain 
CT, only 48% of the measured doses were greater than 1.4 mGy.  This was for all TLDs, 
including those placed at a distance from the scanned volume (e.g. testes for a CT brain 
examination).  However, for the TLDs placed in the directly irradiated volume, the measured 
absorbed doses were predominantly above 5 mGy.  For this thesis the measurements for 
selected organ doses and the percentage difference for TLDs and MOSFETs, respectively, were 
as follows (thyroid, 0.36 mGy & 0.42 mGy, difference=16.6%; active bone marrow of the 
thoracic spine, 0.02 mGy & 0.023 mGy, difference=13%; breast, 0.12 mGy & 0.10 mGy, 
difference=16%; testes, 0.004 mGy & 0.011 mGy, difference=63%).  Overall, ED estimates for 
adult CT brain examinations are on average 10% higher for MOSFET (mean ED 0.82 ± 0.07) 
than the TLD (mean ED 0.74 ± 0.04) measurements.  As such, MOSFETs appear to be a 
reasonable alternative to TLDs for measuring CT organ absorbed doses in the scanned volume.   
In these validation measurements the lower limit of MOSFET detection was 0.0018 mGy and 
the majority of the measurements taken were above this threshold.  It was decided that the dose 
in the primary beam was most important for the experiments and it was for this reason that 
MOSFETs were considered to be a reasonable alternative to TLDs.  But the potential impact 
would be on risk is that the ratio of MOSFET to TLD effective dose (ED) estimates for adult 
CT brain examinations are on average 10% higher than the TLD measurements, which mean 
the estimated risk of lifetime cancer induced will be overestimated by 10%.  Intraclass 
correlation coefficients were used to quantify the reliability, an ICC value of 0.949 (95% CI 
0.805 to 0.991) was obtained.  The TLD EDmean was 0.74 ± 0.04 with 95% confidence interval 
(CI) (0.49 – 0.98 mGy) and MOSFET EDmean was 0.82 ± 0.07 with 95% confidence interval 
(CI) (0.54 – 1.1 mGy).  Overall, there was good agreement between MOSFET measurement 
and the TLD method.   
5.4 CT Equipment 
A Toshiba Aquilion 16 CT scanner (Toshiba Medical Systems, Tokyo, Japan), as shown in 
(Figure 5-2) below, was used throughout this study.  The Toshiba Aquilion 16 is a third-
generation multi-slice helical CT scanner, featuring a 60-kW generator, 7.5 MHU tube and a 
minimum standard gantry rotation time of 0.5 seconds.  In helical mode, it is capable of 
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acquiring 16 parallel rows of data per rotation, with collimations of 16 x 0.5 mm, 16 x 1.0 mm 
and 16 x 2.0 mm.  A full specification of the Toshiba Aquilion 16-slice CT scanner is illustrated 
in (Table 5-1) (TOSHIBA, 2004). 
 
Figure 5-2: Toshiba Aquilion 16 CT Scanner (TOSHIBA, 2004). 
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Table 5-1: Specification: Toshiba Aquilion 16-slice Computed Tomography (CT) scanner  
Operating parameters Acceptable Preferred 
Fastest 360o rotation time (s) ≤ 0.6 + other  
Min nominal imaged slice width 
in axial mode (mm) 
≤ 0.6 + 4 other  
Min kV range (kVp) ≥ 80 – 130  
Min mA range  ≥ 30 – 345 (10 mA steps)  
Pitch range available for routine 
scanning 
0.6 – 1.5  
Scanner gantry Acceptable Preferred 
Min aperture diameter (cm)  ≥ 70  
Min ranging gantry tilt (degrees) ≥ ± 30 (with gantry control)  
Laser positioning lights  Scan plane (internal & external) Sagittal, coronal 
Coincidence of laser light with 
scan plane (mm) 
≤ ± 2 ≤ ± 1 
Gantry and couch controls On both left & right of gantry  
X-ray tube Acceptable Preferred 
Minimum filtration (mm Al)  ≥ 2.5  
Continuous scan time (s) ≥ 100  
Detection system Acceptable Preferred 
Detector type  Ceramic, solid state  
Scan field of view: extent of x-ray 
fan beam at isocentre in x-ray 
plane (cm) 
≥ 50  
No. simultaneous z-axis data 
channels acquired per rotation 
≥ 16  
Length of z-axis coverage per 
rotation (mm) 
≥ 19  
Dose Acceptable Preferred 
Display of CTDIvol on main 
console  
Prospective   
Display of Geometric efficiency 
if < 70% on main console 
Prospective  
Automatic control of tube current
To account for patient 
attenuation variation in x-ray 
plane 
To account for 
patient attenuation 
variation in z-axis 
Display monitor Complies with RCR SIG (TOSHIBA, 2004) 
Screen size 19" 
Image display matrix 1024x1024 
The CT scanner was warmed up prior to each scanning session and was checked at regular 
intervals by a team of engineers from the manufacturer and local medical physicists (once 
96 
 
yearly by the engineers and twice yearly by a medical physicist as part of planned physics and 
manufacturer contracts).  Within this process quality assurance tests were undertaken and the 
results were within acceptable levels recommended by the manufacturer and also complied with 
the radiation protection legislation of the international committee on radiation protection 
(ICRP) (ICRP, 2007a).  (Table 5-2) and (Table 5-3) illustrates the list of the specific tests 
which were carried out by Medical Physics and Toshiba Medical Systems.  
Table 5-2: List of Measurements Performed (Christie Medical physics & Engineering, 
2015) 
Measurement Tolerance 
Outcome 
Pass Fail Ref 
General Radiation Safety     
Operation of controls and warning 
devices 
Functioning as expected  Pass   
CT System     
Dosimetry CTDI Baseline ±15% Pass  2.1.1* 
Variation of output with helical pitch Mean ±20% Pass   
Image noise analysis 
Inter slice mean ±10% 
Baseline ±10% 
Pass 
  
CT number values 
Baseline ±5HU(water) or 
±10HU 
Pass 
  
CT number uniformity 
Difference between 
centre/periphery 
Body: Small ±10HU, 
Large ±20HU 
Pass  
 
Artefacts No visible artefacts Pass   
Automatic Exposure Control/Dose 
Modulation 
Functioning as expected Pass 
  
* Computed Tomography Dose Index (CTDI) 
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Table 5-3: 2.1.1 Computed Tomography Dose Index (CTDI), the measured CTDI100 
at the isocentre in air (Christie Medical physics & Engineering, 2015) 
kV Beam/detector collimation (mm) Mode/SFOV CTDI100 (mGy/100 mAs)
120 12 (4x3) Head/Small 28.7 
“ 2 (4x0.5)  71.5 
“  4(1x4)  46.7 
“  8 (4x2)  33.8 
“  16 (4x4)  29.1 
“  24 (4x6)  27.9 
“  32 (4x8)  28.3 
80 12 (4x3)  12.1 
100 12 (4x3)  19.5 
135 12 (4x3)  36.3 
120 12 (4x3) Body/Large 96.0 
“  2 (4x0.5)  63.9 
“  4(1x4)  46.2 
“  8 (4x2)  43.3 
“  16 (4x4)  39.8 
“  24 (4x6)  40.7 
“  32 (4x8)  38.5 
80 12 (4x3)  21.7 
100 12 (4x3)  32.2 
135 12 (4x3)  53.4 
 
5.5 Experimental Equipment 
MOSFET (TN-RD-70-W Best Medical Canada, Ottawa, Ontario, Canada) and two 
Computerised Imaging Reference Systems (CIRS) ATOM dosimetry phantoms were used to 
carry out the dosimetry measurements.  The two ATOM phantoms were representative of an 
adult patient and a one-year old child (CIRS, Inc, Norfolk, Virginia, US).  There are several 
commercially available phantoms, including a number of paediatric options.  The adult phantom 
represented the dimensions of an average adult person (ATOM Model 701-D; height: 173 cm, 
weight: 73 kg, and thorax dimensions: 12 x 14 cm, Figure (5-3)).  The one-year old child was 
an ATOM Model 705-D with a height of 75 cm, weight: 10 kg, and thorax dimensions: 23 x 32 
cm), (Figure 5-3) (Xu & Eckerman, 2010).  ATOM phantoms are made from epoxy resin, with 
photon attenuation values within 1% for bone and soft tissue and 3% for lung tissue at photon 
energies from 30 keV to 20 MeV, as claimed by the manufacturer (CIRS, 2006; CIRS, 2010; 
Varchena, 2002); (Figure 5-4).  The adult phantom provides 281 dosimetry locations and the 
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phantom model representing the paediatric has 167 locations for dosimeters; for both the adult 
and paediatric phantom the locations are within 22 organs (CIRS, 2006; CIRS, 2013).   
 
Figure 5-3: Illustrations of the adult and child ATOM dosimetry phantoms (Models: 701-D 
and 705-D CIRS, Inc., Norfolk, Virginia, US, 2013) (CIRS, 2013). 
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Figure 5-4: Anterior-posterior and lateral views of the dosimetry phantom of an adult and 
anterior-posterior view of the paediatric phantom (CIRS, 2013; Huda, Ogden, Lavallee, 
Roskopf, & Scalzetti, 2012). 
CIRS currently produce five different paediatric phantoms each representative of an age bracket 
as shown in (Table 5-4).  Organ dimensions for children within each bracket do not vary by 
more than 15% and the phantoms are representative of age variations and both sexes (Varchena, 
2002).  For children, height is more indicative of body size than age, particularly when 
considering children suffering from an illness who may be undergoing CT examinations in a 
hospital.  Hence, for dosimetry purposes, children falling within the height ranges specified in 
(Table 5-4) are best represented by the corresponding phantom.  The phantom used in this 
experiment represents children 66-95 cm tall, which broadly corresponds to 0.5 to 3 years old 
(Varchena, 2002). 
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Table 5-4: CIRS paediatric anthropomorphic phantom range (Varchena, 2002). 
Height Range (cm) Age Range (years) Phantom Name 
Up to 66 0 - 0.5 Newborn 
66 - 95 0.5 - 3 1-year-old 
95 - 124 3 - 7 5-year-old 
124 - 156 7 - 13 10-year-old 
156 – 168 13 - 17 15-year-old 
(Table 5-5) displays the parameters of each tissue type used in the phantoms (CIRS, Norfolk, 
VA) (CIRS, 2013). 
Table 5-5: Parameters of Anthropomorphic Phantom (CIRS, Norfolk, VA) (CIRS, 2013). 
Tissue Type Physical Density (g/cc) Electron Density (g/cc) 
Bone 1.60 5.030 x 1023 
Soft Tissue 1.05 3.434 x1023 
Spinal Cord 1.07 3.448 x 10 23 
Spinal Disks 1.15 3.694 x1023 
Lung 0.21 0.681 x 1023 
Brain 1.07 3.470 x 1023 
The phantom representing an adult used in this thesis consisted of 39 sections each 25-mm thick 
(legs and arms are not included); and the phantom representing a 1-year old child consisted of 
29 sections each 25-mm thick (arms and legs included).  Dosimetry measurement locations are 
provided in holes drilled within these sections; these holes are plugged when not in use with 
soft tissue, bone or lung equivalent material depending on their location.  The pre-drilled holes 
are 5mm; each hole is spaced in a 30 x 30 mm matrix.  Within each hole plugs which are 5 mm 
diameter x 25 mm long can sit and accommodate TLD chips, TLD rods, TLD bars, TLD cubes, 
MOSFET detectors, and Landauer OSL Micro Dot and Nano Dot holders (Figure 5-5).  The 
selection of hole position is supported by detailed anatomical information about the average 
position of the 22 organs.  A set of maps outlining the most frequently observed organ locations 
and also the optimised detector hole distributions within each organ accompanies each phantom 
with “-D” configuration.  The hypothetical outline of the internal organs appropriate for each 
section is shown on an organ map.  The map also shows the drilled holes into each section along 
with the corresponding unique hole ID as shown in (Figure 5-6).  These holes are in optimised 
locations in order to allow precise calculations using the minimum number of detectors 
necessary.   
101 
 
     
Figure 5-5: Standard solid tissue equivalent (TE) plugs, TLDs and chip rod holders and 
MOSEFT cartridges (CIRS, 2013). 
  
Figure 5-6: Model 702-D Section 23 organ map, the first image showing theoretical organ 
outlines and the second image showing organ dosimetry option (CIRS, 2013). 
The organ map is used in conjunction with a lookup table that indicates for each organ, the 
number of detectors to insert, the hole number for each inserted detector and the corresponding 
detector depth for each hole.  This can help the user for minimising the quantity of detectors to 
be used.  
As indicated by CIRS, the ATOM phantoms manufacture company, the Model 701 adult 
ATOM male can also represent a larger female patient than the Model 702.  For this reason, 
breast attachments are available for use with the Model 701 to calculate the absorbed dose to 
the female breast.  One standard shaped size, 350cc, is available and is provided drilled with 
5mm diameter thru holes in a 2cm X 2cm grid pattern (Figure 5-7) (CIRS, 2013).  These breasts 
were used to measure absorbed dose to female breasts and facilitate ED and risk calculations. 
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Figure 5-7: Female single breasts attachment (350cc) 701-BR-350 (CIRS, 2013).  The 
unplugged holes were used for MOSFET accommodation. 
(Table 5-6) and (Table 5 -7) show the number of dosimeters located in each organs and tissues 
for adult and paediatric ATOM phantoms, respectively.  More details of the location and 
number of dosimeters within the slices of the Adult and paediatric ATOM phantoms are 
illustrated in Appendix (A) within (Table A - 1) and (Table A - 2) on pages 197 and 199, 
respectively. 
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Table 5-6: Location and number of dosimeters within the organs and tissues of 
the ATOM phantom model representing an Adult person. 
No Organs Number of Dosimeters No 
Remainder 
Organs and tissues 
Number of 
Dosimeters
1 Brain 11 13 Adrenals 2 
2 Eyes* 2 14 Thymus 4 
3 Breast male/female 2/8 15 Heart 2 
4 Thyroid 6 16 Spleen 12 
5 Oesophagus♠ 3 17 Pancreas 5 
6 Lung 36 18 Gall bladder 5 
7 Stomach 14 19 Small intestine 5 
8 Liver 29 20 Kidney 16 
9 Colon 11 21 Prostate 3 
10 Bladder● 16 22 Ovary 2 
11 Tests 2  
 
12 Bone marrow 85  
  Cranium 4  
  Cervical Spine♠  2  
  Clavicle  10  
             Scapular             10  
  Sternum  4  
  Femora  4  
  Mandible ♣ ◊  6  
  Pelvis  18  
 Ribs  18  
 Thoraco-lumber 
 Spine 
 9  
Total number of 
dosimeters 281 
* Not included in effective dose calculations. 
♠ Dosimeters located in the anterior of C2 and upper oesophagus were used to calculate extra 
thoracic organ dose.  
● Dosimeters located in the bladder were used to estimate the dose to the uterus.  
♣ Dosimeters located in the left and right lingula of the mandible and to the left and right of the 
sublingual fossa were used to calculate salivary gland organ dose.  
◊ Dosimeters located in the left and right lingula of the mandible were used to calculate oral 
mucosa organ dose (Tootell et al., 2014). 
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Table 5 -7: Dosimeter location in organs and tissues within ATOM phantom 
model representing one year child.  
Organs and Tissues Number of detectors 
Organs and 
Tissues 
Number of 
detectors 
Brain 9 Thymus 2 
Bone Marrow (ABM)♣ ◊ 64 Spleen 4 
Eyes* 2 Kidneys 8 
Thyroid 2 Adrenals 2 
Oesophagus♠ 3 Heart 2 
Lungs 25 Pancreas 3 
Breasts 2 Gall Bladder 2 
Stomach 6 Prostate 4 
Bladder 6 Oral Mucosa 3 
Colon 8 Small Intestine 4 
Salivary Glands 3 Extrathoracic 2 
Testes 2   
Total number of 
dosimeters 167 
* Not included in effective dose calculations. 
♠ Dosimeters located in the anterior of C2 and upper oesophagus were used to calculate extra 
thoracic organ dose.  
♣ Dosimeters located in the left and right lingula of the mandible and to the left and right of the 
sublingual fossa were used to calculate salivary gland organ dose.  
◊ Dosimeters located in the left and right lingula of the mandible were used to calculate oral 
mucosa organ dose (Tootell et al., 2014). 
5.5.1 Mobile MOSFET Dosimetry System 
For brain scans using the phantoms dose measurements were made using a mobile MOSFET 
wireless dosimetry system (Model TN-RD-70-W, Best Medical Canada Ltd., Ottawa, Canada) 
(MobileMOSFET, 2007).  The mobile MOSFET device TN-RD-70-W comprises a TN-RD-38 
wireless Bluetooth transceiver, four TN-RD-16 reader modules, twenty high-sensitivity TN-
1002RD-H dosimeters, and TN-RD-75M software.  In this study, TN-RD-16 reader modules 
that can be independently set to control five dosimeters were operated using the high bias 
voltage, 13.6 V, to obtain the best possible accuracy (Figure 5-8).  A TN-RD-38 wireless 
transceiver was used for data communication between the TN-RD-16 reader modules and a PC 
(Ottawa, Best Medical Canada Ltd.) (Koivisto et al., 2015).  The MOSFET system measures 
the difference in threshold voltage before and after an X-ray exposure.  This difference in 
voltage is proportional to the absorbed dose (Carvajal et al., 2010).  Threshold voltages were 
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read immediately after each exposure.  Four readers can be simultaneously used during a single 
procedure if required, allowing for a total of 20 dosimeters to be in operation.  More information 
about the structure of the MOSFETs response to ionising radiation are illustrated in 
(background) chapter section (3.6.2.2) on page 48. 
 
Figure 5-8: MOSFET reader with five dosimeters and the calibration jug (Best medical 
Canada Ltd.) (MobileMOSFET, 2007). 
5.5.2 MOSFET Calibration 
Five individual MOSFETs were connected to each reader module, which transferred data 
wirelessly to a laptop.  Four reader modules with 20 high sensitivity MOSFETs were calibrated 
and used.  The MOSFETs were calibrated using a general radiography X-ray tube (Wolverson 
Arcoma, Willenhall, UK X-ray tube and CMP 200 DR generator) matched to the CT scanner 
beam quality to be used during the measurements.  This was achieved on the general X-ray tube 
by using 120 kVp and adding 1 mm Al filter.  When measured with a calibrated solid state 
detector, the Unfors Mult-O-Meter (Unfors RaySafe, Billdal, Sweden) digital dosimeter; Model 
503L (Unfors Instruments, AB).  For calibration, each set of five MOSFETs connected to a 
reader module was placed adjacent to the solid-state detector (Figure 5-9).  The MOSFETs 
were placed at a source-to-dosimeter distance of 60 cm, as recommended by the manufacturer 
with the black bulb side of the dosimeters facing the beam and with no build-up material on the 
dosimeter (Best Medical Canada, 2007). 
Each MOSFET wire was colour coded and connected to the same terminal in the same bias 
reader for calibration and subsequent measurements.  Three exposures were made at different 
tube currents of 100, 160, 250, 360 and 450 mAs and millivolt to milligray (mV/mGy) 
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conversion factors were computed using the MOSFET software (DXPOSURE Software, 
Version 2.2, Best Medical Canada, Ottawa, Ontario, Canada) (MobileMOSFET, 2007).  All 
MOSFET measurements were read out immediately after exposure to avoid any additional 
charge build up.  All the steps mentioned above have been repeated for all four readers and the 
calibration factors obtained for all 20 dosimeters are summarised in (Table 5-8) on page 107.  
 
Figure 5-9: First image shows MOSFET reader and 5 dosimetries and the second image 
illustrates calibration set up. 
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Table 5-8:  Calibration factors summarised across all four readers (1, 2, 3 & 4) and for all 20 
dosimeters. 
mAs 100 160 250 360 450 
Solid State 
Entrance Surface 
Dose (ESD) mGy 
9.875 15.430 24.110 34.780 43.660 
Reader 1 (0737) 
Calibration 
Factors mV/mGy 
MOSFET #1 MOSFET #2 MOSFET #3 MOSFET #4 MOSFET #5
1.66 1.76 1.67 1.59 1.65 
mAs 100 160 250 360 450 
Solid State 
Entrance Surface 
Dose (ESD) mGy 
9.875 15.45 24.14 34.84 43.73 
Reader 2 (0738) 
Calibration 
Factors mV/mGy 
MOSFET #1 MOSFET #2 MOSFET #3 MOSFET #4 MOSFET #5
1.54 1.62 1.62 1.69 1.67 
mAs 100 160 250 360 450 
Solid State 
Entrance Surface 
Dose (ESD) mGy 
10 15.65 24.44 35.26 44.26 
Reader 3 (0735) 
Calibration 
Factors mV/mGy 
MOSFET #1 MOSFET #2 MOSFET #3 MOSFET #4 MOSFET #5
1.70 1.76 1.73 1.72 1.65 
mAs 100 160 250 360 450 
Solid State 
Entrance Surface 
Dose (ESD) mGy 
9.947 15.53 24.27 35.04 43.96 
Reader 4 (0736) 
Calibration 
Factors mV/mGy 
MOSFET #1 MOSFET #2 MOSFET #3 MOSFET #4 MOSFET #5
1.61 1.70 1.67 1.65 1.61 
 
5.5.3 Determining MOSFET Reproducibility 
The reliability of an instrument is the ability of that instrument to produce consistent results 
under the same measurement conditions over time (Field, 2013, Pallant, 2010).  To ensure that 
the findings of the study are valid, and to increase confidence in the results, it is important to 
perform a reliability study on the MOSFET dosimetry system.  To achieve this, similar to TLDs 
and before collecting all experimental data, MOSFET dosimeters were checked for dose 
measurement reproducibility.  After obtaining the calibration factors for all the 20 dosimeters, 
before exposure in the CT scanner, the 20 MOSFET dosimeters were deployed throughout the 
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paediatric ATOM phantom organs and tissues for 167 locations.  The dosimetry phantom was 
scanned using a commercially available 16-MDCT scanner (Toshiba Aquilion 16).  The helical 
axial brain (5.0-mm-thick slices, ATC mAs, 100 kVp) paediatric protocols were selected.  CT 
scanning was repeated three times (same protocol) and each time the absorbed dose was 
recorded and then the ED calculated for each of the three examinations and the results are 
illustrated in (Table 5-9).  Intraclass correlation coefficients were used to quantify the 
reliability, an ICC value of 0.998 (95% CI 0.987 to 0.997) was obtained. 
Table 5-9: MOSFET method reproducibility testing results (model phantom representing 
adult data). 
Scan 
No Angle 
Rotation 
Time 
(Secs) 
Detector 
Configuration 
(mm) 
kV 
mAs 
(fixed)
Scan Length 
(mm) 
Effective 
Dose 
(mSv) 
1 0 0.5 0.5x16 100 ATCM 136 1.3 
2 0 0.5 0.5x16 100 ATCM 136  1.4 
3 0 0.5 0.5x16 100 ATCM 136  1.4 
 
Obtaining and calculating the average absorbed dose for large organs or tissues can be a 
challenge.  MOSFETs need to be placed at all available locations within the phantom.  Multiple 
MOSFETs at each location improves the accuracy of measurement (Scalzetti et al., 2008).  In 
an adult male phantom, Scalzetti et al., (2008) recommend a system involving 187 measurement 
points in order to properly obtain the average organ absorbed dose.  Whereas other studies used 
a varying number of measurement locations ranging from 20 to 66 in order to make an 
assessment of ED in CT examinations (Groves et al., 2014; Hollingsworth et al., 2007; Hunold 
et al., 2003; Hurwitz et al., 2007; Kawaura et al., 2006; Scalzetti et al., 2008). 
5.6 CT Protocols 
The experiment conducted within this thesis utilised two different brain protocols (helical and 
sequential for adult) and helical for paediatric with various scan parameters.  Within clinical 
practice a CT brain examination is commonly undertaken in sequential mode in order to allow 
angulation of the gantry to reduce the dose to the lens of the eye.  Depending on the clinical 
indication in adult patients both helical and sequential modes can be used but more commonly 
only a helical mode is used for paediatric CT examinations.  Justification for helical modes in 
paediatric examinations is based on the need to eliminate or reduce any movement (motion) 
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artefacts.  With helical CT, eye dose can be reduced by using a faster helical scanning protocol 
or by utilising shorter rotation time.     
5.6.1 Adult CT Protocols 
As mentioned previously two standard brain protocols (adult sequential and adult helical) were 
assessed together with changes in the different scan parameters as shown in (Table 5-10) and 
(Table 5-11) for helical and sequential protocols, respectively.  The standard helical protocol 
scan parameters used by Toshiba Aquilion 16 protocol (Brain 5mm Helical) are: 120 kV, mA 
range: 300, rotation time: 1.0 seconds, range: 140 mm, D-FOV: 240.0 (S), effective mAs: 437, 
total scan time: 28.365, CE: off, thickness: 16 rows – 0.5x16, detail: PF. 0.688 / HP 11.0. Head 
brain axial, image thickness: 5.0 mm, reconstruction interval: 5.0 mm, Sure Exp. 3D: high 
quality: SD: 1.80, max range: 310.0, max scan time: 59.274 focus: small.  Whereas the main 
scans parameters of sequential protocol (Head Brain Axial 4mm) are: kV: 120, mA Range: 280, 
rotation time: 1.0, range: 8.0, D-FOV: 240.0 (S), effective mAs: 280, couch movement: out 8.0, 
direction: out, image thickness: 4.0 mm, sure Exp. 3D: off, slice thickness: standard 2.0x4, CE: 
off, focus: small.  Full details of CT scan protocols parameters are shown within (Table B - 1) 
and within (Table B - 2) in Appendix (B) on pages 204 and 211, respectively. 
Table 5-10:  Adult brain helical CT protocol scans parameters examined using MOSFETs. 
Rotation 
Time (S) 
Gantry Angle 
(Degrees) 
Detector 
Configuration (mm)
Pitch Factor / Helical 
Pitch 
Sure Exp. 3D 
(ATC) 
0.5 and 
1.0 0, 15 and 27 
0.5x16, 1.0x16 and 
2.0x16 
Detail PF 0.688/HP11.0, 
 
Standard PF 0.938/HP15.0 
 
and Fast PF 1.438/HP 23.0 
High Quality 
SD 1.80, 
Standard SD 
2.00 and 
Low Dose SD 
2.20  
 
Table 5-11:  Adult brain sequential CT protocol scans parameters examined using MOSFETs. 
Rotation Time (S) Gantry Angle (Degrees) Detector Configuration (mm) Sure Exp. 3D 
0.5 and 1.0 0, 15 and 27 0.5x4, 1.0x4 and 2.0x4 
High Quality SD 1.80, 
Standard SD 2.00 and 
Low Dose SD 2.20  
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5.6.2 Paediatric Protocols 
Using the paediatric ATOM phantom, the brain was scanned using a helical protocol only with 
changes in scanning parameters as illustrated in (Table 5-12) and (Table 5-13).  The main scan 
parameters of Toshiba Aquilion 16 paediatric protocol (Brain Infant 0-3 Yrs HCT 5mm) were 
as follows: KV: 120, mA: 150, rotation time: 0.5 Secs, range: 125.0 mm, D-FOV: 240.0 (S), 
effective mAs: 110, total scan time: 12.819, direction: out, CE: off, thickness: 16 row – 0.5x16: 
detail: Pitch Factor 0.688/Helical Pitch 11.0, paediatric brain baby, image thickness: 5.0 mm, 
reconstruction interval: 5.0 mm, max range: 1080.0, max scan time: 99.638, focus: small.  Full 
details of CT scan protocols parameters are shown within (Table C - 1) and (Table C - 2) in 
Appendix (C) on pages 213 and 220. 
Table 5-12: Paediatric brain infant CT helical protocol scans parameters. 
Rotation 
Time (S) 
Gantry Angle 
(Degrees) 
Detector 
Configuration (mm) 
Pitch Factor / Helical 
Pitch Sure Exp. 3D 
0.5 and 
0.75 0, 15 and 27 
0.5x16, 1.0x16 and 
2.0x16 
Detail PF* 0.688/HP♠ 
11.0, Standard PF 
0.938/HP15.0  and Fast 
PF 1.438/HP 23.0 
High Quality SD 
4.00, Standard 
SD 6.00 and Low 
Dose SD 8.00  
PF*= Pitch Factor, HP♠= Helical Pitch, ATC= Automatic Tube Current, SD= standard deviation.  
 
Table 5-13: A detailed of paediatric protocol changes examined using MOSFET. 
No Gantry Angle (Degrees) 
Rotation 
Time (S) 
Detector 
Configuration (mm) kV mAs 
1 
0, 15 and 27 0.5, 0.75 and 1.0 0.5x16 100 & 120 
120, 160, 180 & 
200 2 3 
 
5.7 Quantification of Absorbed Radiation Dose Method 
5.7.1 Adult CT Head Acquisitions 
The adult phantom scanning procedure is outlined in the following flow chart diagram for 
MOSFET dosimeters, (Figure 5-10). 
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Figure 5-10: Illustrates adult ATOM phantom experiment procedure flow chart. 
For the adult phantom, following each of the CT acquisitions (Figure 5-11), the radiation dose 
was measured using the twenty MOSFET dosimeters pre-loaded in different locations 
(Figure 5-12).  With only 20 dosimeters available the phantom was loaded and irradiated in the 
order of locations 1-20, then 21-40 and so on.  The obtained values (mV/mGy) were sent to the 
computer via wireless network and saved as an Excel file.  This was then repeated until all of 
the 281 dosimetry locations had mV readings.  Once the data had been gathered they were 
automatically divided via mobile MOSFET software by the respective calibration factors 
(Table 5-8) on page 107, section (5.5.2) for each MOSFET dosimeter in order to determine 
organ and tissues absorbed dose.  These were then multiplied by tissue weighting factors as 
recommended by ICRP 103 report (2007) in order to allow the estimation of ED (ICRP, 2007c).  
This procedure was repeated for all parameters of the CT adult protocols (helical and sequential) 
Experimental Procedure
Adult ATOM Phantom and MOSFETs Dosimeter
Examined Protocols
Helical
n = 162
‐ Rotation time: 0.5 & 1 seconds.
- Gantry angulation: 0o, 15o & 27o.
- Detector configuration: 0.5x16, 1.0x16 &
2.0x16.
- Pitch factor: Detail PF 0.688 / HP 11.0,
Standard PF 0.938 / HP 15.0 & Fast PF
1.438 / HP 23.0.
- Automatic Tube Current: High Quality
SD 1.80, Standard SD 2.00 & Low Dose
SD 2.20.
- Tube potential: 120 kVp.
Organ Dose, Effective Dose & 
Effective Risk
Sequential 
n = 54
- Rotation time: 0.5 & 1
seconds.
- Gantry angulation: 0o, 15o &
27o.
- Detector configuration:
0.5x4, 1.0x4 & 2.0x4.
- Automatic Tube Current:
High Quality SD 1.80,
Standard SD 2.00 & Low
Dose SD 2.20.
- Tube potential: 120 kVp.
Organ Dose, Effective Dose & 
Effective Risk
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at three different gantry angles (0º, 15º & 27º) 162 and 54 acquisitions for helical and sequential 
protocols respectively (Figure 5-13).  
 
Figure 5-11: Brain CT scanning acquisitions. 
 
Figure 5-12: MOSFET dosimeters pre-loaded at different locations within adult ATOM 
phantom. 
    
Figure 5-13: CT image of scout view showing the three angles of scan acquisitions at 0º, 15º 
and 27º, respectively. 
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5.7.2 Paediatric CT Head Acquisitions 
Paediatric organs and tissues absorbed doses were obtained using MOSFETs and helical CT 
scanning protocol as illustrated by the follow flow chart diagram, (Figure 5-14).  
 
Figure 5-14: Paediatric brain CT scanning experiment procedure flow chart. 
For the paediatric dosimetry 20 MOSFETs were loaded in the phantom at define of different 
locations.  Locations of the MOSFETs are displayed in (Table 5 -7) section (5.5) on page 104.  
The combination of the MOSFET wire and tape resulted in a small gap between adjacent 
phantom slabs.  Care was taken when moving the phantom for the experimental set up as the 
MOSFET wires protruded when the phantom was fully assembled. For measurements of 
absorbed dose for CT examinations, the MOSFETs were placed inside the provided locations 
Paediatric Experiment Procedure
Paediatric ATOM Phantom (1-year)
Dosimeter [MOSFET]
Helical Protocol
n= 216
Automatic Tube Current (ATC)
n= 162
- Tube rotation time: 0.5 & 0.75 seconds.
- Gantry angulation: 0o, 15o & 27o.
- Detector configuration: 0.5x16, 1.0x16 & 2.0x16.
- Pitch factor: Detail PF 0.688 / HP 11.0, Standard 
PF 0.938 / HP 15.0 & Fast PF 1.438 / HP 23.0.
- Automatic Tube Current: High Quality SD 4.00, 
Standard SD. 6.00 & Low Dose SD 8.00
- Tube potential: 120 kVp.
Organ Dose, Effective 
Dose & Effective Risk
Fixed Tube Current
n= 54
‐ Tube rotation time: 0.5, 0.75 & 
1seconds.
.o27& o 15, o0Gantry angulation: -
- Detector configuration: 0.5x16.
- Pitch factor: Detail PF 0.688 / HP 11.0.
- Tube Current: 120, 160 & 200.
- Tube potential: 100 &120 kVp.
Organ Dose, Effective 
Dose & Effective Risk
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of tissues and organs within the dosimetry phantom which is a total of 167 locations 
(Figure 5-15), whereas (Figure 5-16) illustrated the scout view of the three gantry angles used 
for all the measurements.  The calibration factor calculated for each MOSFET relative to the 
solid-state dosimeter measurement already takes into account the conversion from mV to cGy 
then converted to mGy. 
Full paediatric head CT dosimetry measurements were taken with tube potential of 100 and 120 
(kVp), mAs of 100, 120, 160 and 200.  Whereas the angulation and rotations time varies from 
0, 15 & 27 and 0.5, 0.75 and 1 seconds respectively at slice thickness of 0.5 mm x 16 to account 
in total for (54) acquisitions are illustrated in Appendix (C) within (Table C - 2) on page 220.  
Additionally, the 0 to 3 years clinical paediatric protocol was also tested and a detailed list of 
(162) acquisitions of this protocol changes are illustrated in Appendix (C) within (Table C - 
1) on page 213.  The protocol parameters were manipulated to assess all of the available options 
for each parameter, except the tube voltage which was kept consistent (kVp: 120).  The 
following parameters were used; Sure Exposure automatic tube current (High Quality SD 4.00, 
Standard SD 6.00, and Low Dose SD 8.00), helical pitch factors (Detail pitch factor 0.688 / 
helical pitch 11.0, Standard pitch factor 0.938 / helical pitch factor 15.0 and Fast pitch factor 
1.438 / helical pitch 23.0), also three different detector configurations (0.5x16 mm, 1.0x16 mm 
and 2.0x16 mm) as well as two rotation times and three gantry angulation (0.5 & 0.75 seconds) 
and (0o, 15o and 27o), respectively.  
 
Figure 5-15: Paediatric phantom MOSFET loading and scan set up. 
115 
 
 
Figure 5-16:  Scout view of the paediatric brain showing the three angles of scan acquisitions 
at 0º, 15º and 27º respectively. 
5.8 Measuring Absorbed Dose and Calculating Effective Dose 
The absorbed dose to selected organs (red bone-marrow), colon, lung, stomach, breast, gonads, 
bladder, oesophagus, liver, thyroid, brain, salivary glands and remaining tissues: adrenals, 
extrathoracic region, gall bladder, heart, kidneys, oral mucosa, pancreas, prostate, small 
intestine, spleen, thymus, uterus/cervix) and eye.  ED were calculated from average measured 
absorbed doses to the organs using both the adult and paediatric phantoms.  The absorbed dose 
to the eyes were measured for the purpose of quantifying the detrimental effects to see if exceed 
the threshold level proposed by ICRP.  
In order to calculate the ED using the absorbed dose measurements the following procedure 
was followed.  The absorbed doses for each organ and tissue were summed and then an 
averaged, this figure was then multiplied by a radiation weighting factors (a radiation weight 
factor of 1 was used since all experiments involved X-ray photons) as reported by ICRP in their 
103 report, (2007) (ICRP, 2007c) using the following equation. 
HT  = WR . DT, R 
Where HT  is the equivalent dose. 
          WR  is the radiation weighting factor  
         DT, R  is the absorbed dose in the tissue (T) by radiation type (R). 
116 
 
Organ and tissue doses were measured for the CT head imaging protocols (helical and 
sequential) using MOSFET dosimeters (adult and paediatric).  Only helical protocols were 
tested for paediatric CT head imaging as this was thought to best reflect current clinical trends.  
The methodology used to measure and evaluate ED are discussed in sections (5.7.1) and (5.7.2) 
on pages 110 and 113 for MOSFET methods, respectively. 
Radiation and tissue weighting factors are provided by the International Commission on 
Radiological Protection (ICRP) and the factors are updated over time based on advances in the 
scientific understanding of the effects of radiation on the human body (Table 5-14).   
Table 5-14: Tissue weighing factors from ICRP 103 (ICRP, 2007d). 
Organ Tissue Weighting Factor 
Gonads 0.08 
Bone marrow 0.12 
Colon 0.12 
Lung 0.12 
Stomach 0.12 
Breast 0.12 
Bladder 0.04 
Liver 0.04 
Oesophagus 0.04 
Thyroid 0.04 
Skin 0.01 
Bone (surface) 0.01 
Salivary Glands 0.01 
Brain 0.01 
Remainder: Adrenals, 
Extrathoracic (ET) region, Gall 
bladder, Heart, Kidneys, 
Lymphatic nodes, Muscle, Oral 
mucosa, Pancreas, Prostate (♂), 
Small intestine, Spleen, Thymus, 
Uterus/cervix (♀). 
0.12 
TOTAL 1.00 
The most recent recommendations of tissue weighting factors which published in 2007 are 
contained in ICRP Publication 103 (ICRP 103) (ICRP, 2007b; Jack Valentin, 2007), which 
updated ICRP Publication 60 (ICRP 60) (ICRP, 1991b) that having been in use for about 20 
years.  Contributions to ED were assessed from all tissues except for bone surface, skin, 
lymphatic nodes, and muscle, which did not have locations for dosimeters within the ATOM 
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phantoms.  The absorbed dose for each tissue was multiplied by the tissue weighting factor to 
determine the contribution of each tissue toward effective dose using equation below.  
(Table 5-15) representing an example of calculating ED from organs and tissues absorbed dose 
for both adult and paediatric protocols.  For bones which contained bone marrow, the organ 
dose data were multiplied by its relevant percentage of active bone marrow as recommended 
by Cristy, 1981 (Cristy, 1981) see (Section 5.8.3) below on page 118.   
E = Ʃ WT . HT 
Where E  is the effective dose to the whole body 
          WT =tissue weighting factor of tissue (T) defined by ICRP 103 
         HT equivalent dose absorbed by tissue (T) 
Table 5-15: An example of an ED calculation, mGy. 
Organ Absorbed Dose (mGy) 
Tissue Weighting 
Factor Effective Dose (mSv) 
Brain 27.482 0.01 0.275 
ABM 2.261 0.12 0.271 
Eyes 32.050 0 0.000 
Thyroid 0.362 0.04 0.014 
Oesophagus 0.000 0.04 0.000 
Lungs 0.255 0.12 0.031 
Breasts 0.012 0.12 0.001 
Liver 0.072 0.04 0.003 
Stomach 0.063 0.12 0.008 
Bladder 0.096 0.04 0.004 
Colon 0.112 0.12 0.013 
Salivary Glands 3.008 0.01 0.030 
Testes 0.039 0.08 0.003 
Total     0.654 
Remaining Organs     
Thymus 0.105  
 
 
 
0.12 
 
 
 
 
 
 
  
Spleen 0.117   
Kidneys 0.039   
Adrenals 0.144   
Heart 0.000   
Pancreas 0.011   
Gall Bladder 0.046   
Prostate 0.295   
Oral Mucosa 3.008   
Small Intestine 0.028   
Extrathoracic 1.035   
Total 4.829     
Grand Total 4.829/11= 0.439 0.439*0.12 = 0.053 0.053+0.654 = 0.706 
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5.8.1 Calculating Substituted Organ Absorbed Dose 
The ATOM dosimetry phantom does not model all organs and tissues listed in ICRP 60 and 
ICRP 103 and often other organ absorbed doses are used as a substitute to approximate these 
doses (Z Brady, Cain, & Johnston, 2012).  For tissues where there is no specific location to site 
a dosimeter within the phantom e.g. oral mucosa and salivary glands, the absorbed dose to the 
mandible was used.  Similarly, the extrathoracic region (ET) is not specified in the dosimetry 
phantom and instead a point identified as the cervical spine (C2) and the superior margin of the 
oesophagus were used as surrogates.  The measurement for this MOSFET was used for the 
extrathoracic region absorbed dose and was also combined with the other cervical spine and 
oesophageal MOSFET measurements to calculate the average cervical spine and oesophagus 
absorbed dose.  These approximations are also used by the ImPACT group, (2011); The ICRP 
Publication No. 66, (1994); Roberts et al., (2014); Theodorakou et al., (2014) and Tootell et al., 
(2014).  MOSFET dosimeters which are placed at the location of the lens of the eye, this is not 
specified in the organs and tissues at risk of stochastic effects by the ICRP.  The dose to the eye 
was measured in order to assess deterministic effects but was not used in any ED calculations 
(ImPACT, 2011). 
5.8.2 Measuring Absorbed Dose to Colon 
The absorbed dose to the colon as specified by the ICRP 103 Recommendations (ICRP, 2007b) 
is calculated as the mass-weighted mean of the absorbed dose to the upper large intestine (DULI) 
and lower large intestine (DLLI). The upper large intestine was listed as a remainder organ in 
ICRP 60 (ICRP, 1991a) and the lower large intestine absorbed dose was used for the colon 
absorbed dose, although this definition was revised in ICRP Publication 69 (ICRP, 1995). The 
absorbed dose to the ULI is the mass-weighted average of the absorbed dose to the ascending 
(Dasc) and transverse colon (Dtrans) and the absorbed dose to the LLI is the mass-weighted 
average of the absorbed dose to the descending (Ddesc) and recto-sigmoid colon (Drecto) (ICRP 
103).  
5.8.3 Measuring Absorbed Dose to Active Bone Marrow 
The active bone marrow is distributed into nine different bone tissues within the human body 
as follows: (cranium, mandible, vertebrae spine, clavicle, sternum, scapular, ribs, pelvis and 
femora).  As reported by M. Cristy; 1981, the quantity of marrow in each bone has been 
expressed as a percentage of the whole marrow in each cadaver, and then these values are 
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averaged (Cristy, 1981).  Absorbed dose to active bone marrow was calculated using the data 
for age 1 and 40 years in active bone marrow distribution from Christy (Table 5-16), by 
averaging the absorbed radiation dose to each bone marrow tissue and multiplying by their 
relevant percentage of active bone marrow using equation below.  Then the overall active bone 
marrow dose is added and multiplied by its tissue weighting factor.   
ܦ௔௕௠෍ܣ݇	.		ܦ݇
௞
 
Where         Dabm = Dose to active bone marrow 
                   Ak = proportion of active bone marrow described by Cristy, (ƩAk = 1)  
Table 5-16: Active bone marrow (ABM) in a given bone expressed as a percentage of 
active bone marrow in the body (Cristy, 1981). 
                                          Percentage of active marrow at various ages 
              Bone 0 1 5 10 15 25 40 
Cranium 25.3 (27.0)a 24.2 (25.1) 15.9 11.6 9.2 7.7 7.6 
Mandible 2.5 (2.5) 2.4 (2.4) 1.6 1.1 0.9 0.8 0.8 
Scapulae 2.3 (2.7) 2.5 (2.7) 2.7 2.9 3.3 2.9 2.8 
Clavicles 0.7 (0.8) 0.8 (0.8) 0.9 0.9 1.0 0.8 0.8 
Sternum 1.4 (0) 1.5 (0.8) 1.7 2.1 2.7 3.0 3.1 
Ribs 7.0 (9.2) 7.6(8.9) 8.8 10.9 13.6 15.2 16.1 
Cervical vertebrae 1.7 (3.4) 1.9 (2.8) 2.2 2.7 3.3 3.7 3.9 
Thoracic vertebrae 7.1 (8.3) 7.7(8.4) 8.9 10.9 13.7 15.3 16.1 
Lumbar vertebrae 5.4 (2.4) 5.9(4.3) 6.8 8.4 10.5 11.7 12.3 
Sacrum 4.3 (0.1) 4.7 (2.4) 5.5 6.7 8.4 9.4 9.9 
Os coxae 11.2 (9.2) 12.1 (11.1) 13.1 15.6 18.5 19.5 17.5 
Femora, upper half 3.3 (3.7) 3.9(4.1) 6.8 9.4 9.2 7.4 6.7 
Femora, lower half 3.3 (3.7) 3.6(3.9) 6.3 6.1 2.0 0 0 
Tibiae, fibulae, patellae 7.0 (8.0) 8.1 (8.7) 9.0 5.5 0 0 0 
Ankle and foot bones 7.2 (8.3) 4.4 (4.7) 2.5 0 0 0 0 
Humeri, upper half 2.2 (2.3) 2.3 (2.4) 2.4 2.5 3.1 2.5 2.3 
Humeri, lower half 2.2 (2.3) 2.2 (2.3) 2.2 1.6 0.7 0 0 
Ulnae and radii 2.4 (2.5) 2.4 (2.5) 2.0 1.1 0 0 0 
Wrist and hand bones 3.4 (3.6) 1.9 (1.9) 0.9 0 0 0 0 
a Numbers in parentheses following the age nought and age one values are adjustments 
the model values. 
Basis for these adjustments is discussed in conjunction with table 6. 
 
5.9 Lifetime Risk Estimation  
The life-time risks of fatal cancer induction associated with the standardized clinical helical and 
sequential adult protocols and standard helical paediatric protocol were calculated using the 
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equation below.  The calculation involves collecting absorbed dose data of different organs and 
tissues then using factors of organ-specific radiation-induced cancer risk published by The 
Nuclear and Radiation Studies board, BEIR VII phase 2 report for ages 0 to 15 with an interval 
gap of 5 years and from 20 to 80 years with an interval gap of 10 years for both males and 
females (Table 5-17) (BEIR VII, 2006).   
Table 5-17: Organ-specific radiation-induced cancer risk factors published by 
American National Academy of Sciences (BEIR VII, 2006). 
TABLE 12D-1 Lifetime Attributable Risk of Cancer Incidencea 
Age at Exposure (years)
Cancer Site 0 5 10 15 20 30 40 50 60 70 80 
Males 
Stomach 76 65 55 46 40 28 27 25 20 14 7 
Colon 336 285 241 204 173 125 122 113 94 65 30 
Liver 61 50 43 36 30 22 21 19 14 8 3 
Lung 314 261 216 180 149 105 104 101 89 65 34 
Prostate 93 80 67 57 48 35 35 33 26 14 5 
Bladder 209 177 150 127 108 79 79 76 66 47 23 
Other 1123 672 503 394 312 198 172 140 98 57 23 
Thyroid 115 76 50 33 21 9 3 1 0.3 0.1 0.0 
All solid 2326 1667 1325 1076 881 602 564 507 407 270 126 
Leukemia 237 149 120 105 96 84 84 84 82 73 48 
All cancers 2563 1816 1445 1182 977 686 648 591 489 343 174 
Females 
Stomach 101 85 72 61 52 36 35 32 27 19 11 
Colon 220 187 158 134 114 82 79 73 62 45 23 
Liver 28 23 20 16 14 10 10 9 7 5 2 
Lung 733 608 504 417 346 242 240 230 201 147 77 
Breast 1171 914 712 553 429 253 141 70 31 12 4 
Uterus 50 42 36 30 26 18 16 13 9 5 2 
Ovary 104 87 73 60 50 34 31 25 18 11 5 
Bladder 212 180 152 129 109 79 78 74 64 47 24 
Other 1339 719 523 409 323 207 181 148 109 68 30 
Thyroid 634 419 275 178 113 41 14 4 1 0.3 0.0 
All solid 4592 3265 2525 1988 1575 1002 824 678 529 358 177 
Leukemia 185 112 86 76 71 63 62 62 57 51 37 
All cancers 4777 3377 2611 2064 1646 1065 886 740 586 409 214 
NOTE: Number of cases per 100,000 persons exposed to a single dose of 0.1 Gy. 
aThese estimates are obtained as combined estimates based on relative and absolute risk 
transport and have been adjusted by a DDREF of 1.5, except for leukemia, which is 
based on a linear-quadratic model. 
The absorbed dose determined for the adult and paediatric examinations was scaled by these 
gender specific factors to calculate the estimated future risk of cancer induction.  (Table 5-18) 
and (Table 5-19) are two examples of calculating lifetime cancer risk induced cancer for both 
adult and paediatric CT brain examinations, respectively.  
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Where R= effective risk 
rT = life time radiation attributable tissue –specific cancer risks (per unit equivalent dose to 
tissue T) 
HT = is the equivalent dose absorbed by tissue (T)  
In this thesis, the number of cases of cancer induction is per 1 000 000 persons exposed to a 
single dose of 100 mGy.   
Table 5-18: An example of calculating adult cancer risk case/106 for 10 years old female. 
Organ Absorbed Dose (mGy) 
Organ-specific 
radiation-induced 
cancer risk factors 
Organ Effective risk 
case/106 
Stomach 0.100 0.72 0.072 
Colon 0.035 1.58 0.055 
Lungs 0.277 5.04 1.397 
Breasts 0.341 7.12 2.424 
Uterus 0.067 0.36 0.024 
Ovary 0.034 0.73 0.025 
Thyroid  1.744 2.75 4.795 
bladder 0.067 1.52 0.102 
Liver  0.085 0.2 0.017 
Total     8.912 
Remaining Organs     
Thymus 0.317   
  
  
  
5.23 
  
  
  
  
  
  
  
Spleen 0.108   
Kidneys 0.033   
Adrenals 0.000   
Heart 0.214   
Pancreas 0.035   
Gall Bladder 0.028   
ABM 3.773   
Brain 45.082   
Small Intestine 0.1034   
Extrathoracic 3.668   
Total 53.360     
Grand Total 53.360/11= 4.851 4.851*5.23 = 25.370 25.370 + 8.912 = 34 
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Table 5-19: An example of calculating paediatric cancer risk case/106 for 0 years old 
female. 
Organ Absorbed Dose (mGy) 
Organ-specific 
radiation-induced 
cancer risk factors 
Organ Effective risk 
case/106 
Stomach 0.271 1.01 0.273 
Colon 0.086 2.2 0.190 
Lungs 0.740 7.33 5.422 
Breasts 0.881 11.71 10.311 
Uterus 0.064 0.5 0.032 
Ovary 0.044 1.04 0.046 
Thyroid  5.460 6.34 34.616 
bladder 0.074 2.12 0.157 
Liver  0.183 0.28 0.051 
Total     51.099 
Remaining Organs     
Thymus 1.205   
  
  
  
13.39 
  
  
  
  
  
  
  
Spleen 0.183   
Kidneys 0.144   
Adrenals 0.454   
Heart 0.468   
Pancreas 0.222   
Gall Bladder 0.056   
ABM 7.987   
Brain 27.544   
Small Intestine 0.0122   
Extrathoracic 3.805   
Total 42.078     
Grand Total 42.078/11= 3.825 3.825*13.39 = 51.220 51.220+51.099 = 102 
 
5.9.1 Lifetime Cancer Risk Estimation Tool  
Using the effective risk data an Excel spreadsheet was created for both paediatric and adult 
clinical head CT protocols and the resultant data represents the number of cancer induction 
cases per 1,000,000 in relation to each protocol.  The spreadsheet can be used to look up the 
estimated risk associated with a brain CT scan according to patient age and gender and the 
relevant protocol.  The tool can also be used to compare the risks associated with a variety of 
different protocols.  The tool is presented in chapter 6 (results), page 157.  The (Figure 6-24) 
illustrates the different parameters within the risk estimation tool (detector configuration [mm] 
, pitch factors / helical pitch, sure Exp. 3D [ATC], tube rotation time [S], tube angulation 
[degrees], protocol number, estimated number of exposures [1-5], and eye dose [mGy]) and 
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(Figure 6-25) on page 158, represents the tool outcome (lifetime risk of cancer [case/106] for 
both males and females aged from 0-5 and 10-80 for paediatric and adult respectively.   
The tool provides a theoretical approach to consider eye dose and lifetime cancer risk from 
brain CT.  The purpose of the tool is to demonstrate an approach to displaying the absorbed eye 
dose and lifetime risk of cancer from brain CT scans, for use by practitioners.  The tool enables 
the practitioner to specify the settings they are considering using and view the resultant 
estimated absorbed eye dose and lifetime risk for a range of patients of different ages and 
genders, of which they can select the most relevant to their patient. The tool can also be used 
to estimate the accumulative dose and risk that are likely to occur in patients as a result of 
repeated brain CT scans. This may be useful where the patient is expected to require multiple 
brain CT scans in the future.  The novelty of this tool is it enables practitioners to consider the 
risk prospectively and may therefore inform practitioner decision making.  It is emphasised that 
currently this spreadsheet is only applicable for a Toshiba Aquilion 16 CT scanner (Toshiba 
Medical Systems, Tokyo, Japan).  
The tool can be used by downloading and opening the workbook in Microsoft Excel.  There are 
two workbooks.  Workbook 1 displays the paediatric eye dose and lifetime risk of cancer for 
paediatrics (male and female) 0 (newborn) and 5 years.  Workbook 2 displays the estimated eye 
dose and lifetime risk of cancer for 10, 15, 20, 30, 40, 50, 60, 70 and 80-year-old males and 
females.  The spreadsheet is interactive and enables the eye dose and risk data to be displayed 
for a specified protocol/s by using the downward arrows in row 3 to modify the acquisition 
parameter/s, protocol number and/or estimated number of exposures.  The risk estimation tool 
together with an instruction manual are both included on a CD-ROM in the back of this thesis. 
5.10 Statistical Analysis 
All data were analysed using SPSS version 24 (IBM Corp, Armonk, NY).  The figures and 
tables represent the mean values plus or minus the standard deviation unless otherwise stated.  
For inferential statistics, a p-value of less than 0.05 was deemed significant.  Data presented on 
the lifetime risk of cancer, was rounded to the nearest integer.  When lifetime risk of cancer 
was estimated to be below 1, risk was rounded up to 1 in 1 million.  
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5.10.1 Normality Test 
An assessment of the normality of data is a prerequisite for many statistical tests because normal 
data is an underlying assumption in parametric testing.  There are two well-known tests of 
normality, namely the Kolmogorov-Smirnov Test and the Shapiro-Wilk Test.  Shapiro-Wilk 
Test is more appropriate for small sample sizes (< 50 samples).  For this reason, the Shapiro-
Wilk test is used as a numerical means of assessing normality.  Tests for normality were 
performed for the ED estimated for the following acquisition parameters: (1) gantry rotation 
time (S), (2) gantry angulation (degrees), (3) detector configuration (mm), (4) helical pitch 
(mm) and (5) sure Exp. 3D settings (ATCM).  The initial tests showed that the data were not 
normally distributed, hence the decision to split the data into two groups based on the tube 
rotation times.  After splitting all data presented within this thesis were normally distributed, 
thus parametric tests were subsequently used to compare means between groups.  
5.10.2 Inferential Statistics 
A paired-samples t-test was used to make comparisons between two variables.  Where more 
than two variables were compared, analysis of variance (ANOVA) was performed.  An 
ANOVA was performed to determine the effect of different acquisition parameters on ED.  To 
calculate the variation in ED, for each CT protocol, both correlation and regression analyses 
were undertaken to see which parameters had the most impact on the ED.  
5.10.3 Association Statistics 
A common task in data analysis is to investigate an association between two variables.  This 
can be a correlation to see if two variables vary together, or a regression to see how one variable 
affects another. 
 
A correlation test was used to test the variation among the different CT protocol parameters and 
the ED.  This include the following variables: (1) gantry rotation time (S), (2) gantry angulation 
(degrees), (3) detector configuration (mm), (4) helical pitch (mm) and (5) sure Exp. 3D settings 
(ATCM) and Pearson correlation was used for this purpose.  
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The Intraclass Correlation Coefficient (ICC) was used to determine the reliability of the 
MOSFET dosimetry measurements.  The reliability of a dosimeter is the ability of that 
dosimeter to produce consistent results under the same measurement conditions over time.  This 
was calculated for the data obtained on both the adult and paediatric (1-year) ATOM phantom 
models for three sets of measurements using MOSFET, under the same conditions.  The main 
aim of repeating the experiment is not to test statistical significance, but rather to test the 
feasibility and the validity of the methods and data collection dosimetry and in turn minimise 
error that might arise in the main study.   
 
Regression is used when there is a reason to believe that changes in one variable cause the 
changes in the other.  In this thesis, a regression analysis was performed to establish a reliable 
regression equation to predict the ED.  The regression model included multiple factors 
(independent variables): (1) gantry rotation time (S), (2) gantry angulation (degrees), (3) 
detector configuration (mm), (4) helical pitch (mm) and (5) sure Exp. 3D settings (ATCM) and 
therefore multiple linear regression was performed.  A stepwise approach was used during 
which the variables within the model and the order in which they were inserted was dependent 
on the strength of their association with the measured effective dose and their statistical 
significance. 
5.11 Chapter Summary  
This chapter explained the method used to estimate ED for adult and paediatric brain CT scan 
examinations of helical and sequential adult protocols and helical paediatric protocols.  This 
approach was the direct measurement method using the two ATOM phantoms representing of 
adult and 1-years old child examined with solid-state dosimeters MOSFET.  Finally, the 
attributable lifetime risk was calculated for both males and females according to the data 
published by American National Academy of Sciences in their report (BEIR VII – Phase 2), 
2006.  Full results from the experiments and the subsequent attributable lifetime cancer risk 
calculations, including the spreadsheet are described in the results chapter (6) within sections 
(6.1 – 6.7).
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Chapter 6 : Results 
6.1 Results Overview 
This chapter presents the results of a series of dosimetry experiments carried out at the 
University of Salford using a Toshiba 16 Aquilion CT scanner with ATOM phantoms 
representing an adult and one year old child.  The data was assessed for normality and then, a 
number of inferential stats (ANOVA, correlation and regression) were undertaken to compare 
the data and to see if there was correlation as well as to see the effect of each variable on 
effective dose.  The results will be presented in descriptive format using means and standard 
deviations (SD), tables and graphs.  The main purpose of conducting this study was to provide 
data necessary for the novel calculations of the lifetime risk from CT brain scan protocols for 
different ages and both genders, when considering individual acquisition parameters.  To 
improve the usability of this data, towards to end of this result section a mode for the 
presentation of the data has been suggested (interactive Excel spreadsheet).  The purpose of this 
is to (1) estimate the lifetime attributable cancer risk for brain CT examinations in adult and 
paediatric to improve the ability of practitioners to ascertain estimated risk for a patient 
prospectively, (2) investigate using direct dose measurement method the effect of varying CT 
brain protocols parameters on effective radiation dose and risk for adult and paediatric patients 
to enable practitioners to consider the accumulative risk for patients who may be subject to 
multiple CT brain scans within a time frame, see aims and objectives (Sections 1.2 and 1.3) on 
page 5. 
6.2 Summary of Dosimetry Calculations 
Data collection in the study was conducted using two ATOM phantoms, an adult and a one year 
old paediatric phantom.  For each phantom, a variety of CT brain protocols were undertaken 
and repeated three times.  For both phantoms, organ dose measurements were obtained using 
MOSFET dosimeters.   
Effective doses, were calculated from mean absorbed organ and tissue dose using the MOSFET 
dosimeters for each protocol.  The values of effective dose were calculated for each of the 
original locations of 281 dosimetry data sets in the adult phantom and 167 in the paediatric 
phantom.  These were obtained using the helical settings for paediatric CT brain examinations 
and both sequential and helical protocols for adult CT brain examinations.  An example of the 
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absorbed and effective dose calculations for a single protocol are presented in (Table 6-1).  
These exemplary data were obtained using the following protocol parameters: 0.5 second tube 
rotation time, 0o gantry angle, 2 mm image thickness, 0.5 x 16 mm detector configuration, detail 
(0.688 / HP 11.0) pitch factor, a High Quality Sure Exp. 3D setting (SD 1.8) and scan length 
140 mm. 
Table 6-1: An example of the absorbed and effective radiation doses to body organs and 
tissues from an adult CT brain scan. 
Organ  Measuring Points 
Average Absorbed 
Dose (mGy) 
Tissue Weighting 
Factors (ICRP 103)
Weighted Dose 
(mSv) 
Brain 11 27.48 0.01 0.28 
ABM 85 2.26 0.12 0.27 
Eyes 2 32.05 0 0.00 
Thyroid 6 0.36 0.04 0.01 
Oesophagus 3 0.00 0.04 0.00 
Lungs 36 0.26 0.12 0.03 
Breasts 2 0.01 0.12 0.001 
Liver 29 0.07 0.04 0.003 
Stomach 14 0.06 0.12 0.01 
Bladder 16 9.581E-02 0.04 0.004 
Colon 11 0.112 0.12 0.01 
Salivary Glands 6 3.01  0.01 0.03 
Testes 2 0.04 0.08 0.003 
Total 223 0.65 
Remaining Organs  
0.12   
Thymus 4 0.11 
Spleen 12 0.12 
Kidneys 16 0.04 
Adrenals 2 0.14 
Heart 2 0.00 
Pancreas 5 0.01 
Gall Bladder 5 0.05 
Prostate 3 0.30 
Oral Mucosa 6 3.01 
Small Intestine 5 0.03 
Extrathoracic 2 1.04 
Total 62 4.83 
Grand Total 285 0.444.83/11=  0.050.44*0.12 =  0.710.65+0.05 = 
 
The relationships between different CT scan parameters and effective doses are provided in 
subsequent tables and graphs presented in (Sections 6.3 and 6.4) on pages 128 and 140.  The 
presentation of the results is organised into three distinct themes: one focuses on data obtained 
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from the adult phantom / protocols and the second on paediatric brain CT examinations.  The 
third theme focuses on estimating attributable cancer risk from brain CT scan protocols for 
different ages and genders and is a distinctly novel aspect of this thesis.  The third theme 
includes the development of a risk estimation tool as a way of displaying the potential utility of 
such information for clinical practice. 
6.3 Adult Phantom Effective Dose Calculations (using MOSFET) 
6.3.1 Descriptive Data - Statistical Tests 
 
Before carrying out any inferential statistical tests, the data was assessed for normality using 
histograms and the Shapiro-Wilk test.  The results of both analyses revealed that the dosimetry 
data were normally distributed across all the CT parameters investigated (P> 0.05), except for 
helical pitch experiments where the corresponding p value for the Shapiro-Wilk test was less 
than 0.05.  Further analysis of the data suggested the reason the helical pitch data was not 
normally distributed was a result of the automatic tube current modulation (ATCM) system not 
correctly modulating the mA for some acquisitions (as illustrated in Figure 6-1).  The ATCM 
is used to adjust the mA according to the patient size which will reduce the radiation dose (tube 
current) to the patient as discussed in chapter three (section 3.3.3.3) on page 34.  The ATCM 
option on the Toshiba Aquilion 16 CT scanner is called Sure Exp. 3D which has a variety of 
options available for controlling the noise levels (High quality [SD 1.80], Standard [SD 2.00] 
and Low dose [SD 2.20]).  Selecting one of these settings during a CT scan will preset the 
required noise level according to the chosen standard deviation (SD) value.  In some instances, 
the CT scanner struggled to reduce the noise to an acceptable level due to the limited anatomical 
information available within the dosimetry phantom.  As the scanner struggled to accurately 
assess the noise level it increased the tube current to a maximum level.  This created problems 
when assessing the Sure Exp. 3D data and this will be subject to further discussion within this 
thesis.  To verify that the ATCM was not modulating the tube current as would have been 
expected, a t-test was conducted to determine whether there were significant differences in 
mean effective dose between 0.5 and 1.0 tube rotation times.  The t-test indicated a statistically 
significant difference in the effective dose (0.5 seconds, mean = 0.60, SD = 0.13 mSv; 1.0 
seconds, mean = 0.91, SD = 0.20 mSv, p≤0.001).  The difference in the mean effective dose 
between the two rotation times was 0.30 mSv.  
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Figure 6-1: Angular and longitudinal mA modulation. 
To overcome this issue the data collected were split into two groups according to the CT gantry 
rotation time (0.5 and 1.0 Secs).  A normality test was run again and the results showed a normal 
distribution (P > 0.05); hence from this point forward parametric statistical tests were used.   
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The results of descriptive statistics and test of normality for the adult phantom, data obtained at 
0.5 and 1.0 second rotation times are illustrated in (Table 6-2) and (Table 6-3).  The paediatric 
data are included in (Appendix M) within (Table M - 1) on page 251, for normality tests. 
Table 6-2: Adult effective dose (mSv) summary statistics including an indication of the 
normality of the data (0.5 second rotation time) 
Protocol Parameters Mean, SD Minimum Maximum 
P -Value 
Shapiro-
Wilk
Gantry angulation 
 (degree) 
0o 0.61 ± 0.11 0.43 0.76 0.20 
15o 0.56 ± 0.13 0.34 0.81 0.20 
27o 0.62 ± 0.14 0.42 0.88 0.20 
Detector 
configuration 
(mm) 
0.5x16 0.60 ± 0.14 0.39 0.88 0.18 
1.0x16 0.57 ± 0.14 0.34 0.81 0.20 
2.0x16 0.62 ± 0.09 0.43 0.82 0.20 
Helical Pitch 
(mm/rotation) 
11 0.73 ± 0.07 0.60 0.88 0.20 
15 0.60 ± 0.06 0.47 0.71 0.20 
23 0.47 ± 0.07 0.34 0.62 0.20 
Sure Exp. 3D (SD) 
1.80 0.63 ± 0.13 0.39 0.88 0.20 
2.00 0.60 ± 0.12 0.38 0.83 0.20 
2.20 0.55 ± 0.11 0.34 0.78 0.20 
 
Table 6-3: Adult effective dose (mSv) summary statistics including an indication of the 
normality of the data (1.0 second rotation time) 
Parameter/Factor Mean, SD Minimum Maximum P -Value Shapiro -Wilk
Gantry angulation 
(degree) 
0 0.95 ± 0.16 0.64 1.24 0.20 
15 0.85 ± 0.20 0.58 1.35 0.18 
27 0.93 ± 0.21 0.56 1.55 0.17 
Detector 
configuration 
(mm) 
0.5x16 0.89 ± 0.15 0.64 1.25 0.13 
1.0x16 0.99 ± 0.24 0.64 1.55 0.20 
2.0x16 0.84 ± 0.17 0.56 1.12 0.20 
Helical Pitch 
(mm/rotation) 
11 1.03 ± 0.22 0.62 1.55 0.20 
15 0.87 ± 0.18 0.56 1.24 0.20 
23 0.82 ± 0.12 0.64 1.12 0.20 
Sure Exp. 3D (SD) 
1.80 1.02 ± 0.20 0.70 1.55 0.20 
2.00 0.91 ± 0.18 0.64 1.28 0.20 
2.20 0.79 ± 0.14 0.56 1.10 0.18 
 
 
The association statistics were used in this thesis to measure the statistical strength of the 
relationship on the variables of interest (tube rotation time, CT gantry angulation, detector 
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configuration, sure exposure (ATCM) and helical pitch); these measures of strength, or 
association, can be described in several ways, depending on the analysis.  The correlation 
coefficient is a measure of the degree of linear association between two continuous variables 
(describes the strength of an association between two variables), i.e. when plotted together, how 
close to a straight line is the scatter of points.  Correlation simply measures the degree to which 
the two vary together.  A positive correlation indicates that as the values of one variable increase 
the values of the other variable increase, whereas a negative correlation indicates that as the 
values of one variable increase the values of the other variable decrease.  Regression is used to 
examine the magnitude of the relationship between one dependent and one independent 
variable. After performing an analysis, the regression statistics can be used to predict the 
dependent variable when the independent variable is known. 
6.3.1.2.1 Correlation 
The Pearson product-moment correlation coefficient (r) was conducted for normally-distributed 
(parametric) data, and the Spearman rank-order correlation coefficient (rs) was used for data 
that are not normally distributed (non-parametric data).  Both vary from +1 (perfect correlation) 
through 0 (no correlation) to –1 (perfect negative correlation) (Field, 2015; Millar, 2001). 
The result of correlation tests are represent in (Table 6-4).  This table shows the correlation of 
different CT parameters with effective dose (for the 162 adult protocols).  The analysis reveals 
that there is a weak negative correlation between effective dose (mSv) and helical pitch, 
moderate positive correlation between effective dose and tube rotation time and finally negative 
weak correlation between effective dose and ATCM, respectively.  The other CT parameters 
(gantry angulation and detector configuration) were, not significantly correlated with effective 
dose. 
Table 6-4: Adult CT brain protocol correlation test results. 
 
Tube 
Rotation 
Time 
(seconds) 
Gantry 
Angulation 
(Degrees) 
Detector 
Configuration 
(mm) 
Helical 
Pitch 
 
Sure 
Exp. 3D 
(ATC) 
Effective 
Dose (mSv) 
Pearson 
Correlation 0.687
** -0.019 -0.015 -0.402 -0.285** 
Sig. (1-tailed) 0.000 0.406 0.426 0.000 0.000 
N 162 162 162 162 162 
**. Correlation is significant at the 0.01 level (2-tailed). 
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6.3.1.2.2 Linear Regression 
Regression is used when we have reason to believe that changes in one variable cause changes 
in the other.  The end result of such tests is a probability (P) that the ‘null hypothesis’ (which 
always states that there is no difference between the sets of data) is true.   The regression was 
conducted to predicate the relationship between the independent variables and effective dose 
and if the change in effective dose is influenced by the intendant factors.   
Given that the data were analysed using linear regression, the value of R2 is 0.751, which tells 
us that the CT gantry angulation, detector configuration, helical pitch and Sure Exp. 3D (ATC) 
can account for 75.1% of the variation in effective dose.  The F-ratio of the model mean squares 
(MSM) divided by the residual mean squares (MSR) and as reported by Field (2015) indicates a 
reliable model should have a large F-ratio (greater than 1).  The F-ratio value of regression 
model is 68.8, which is significant at P< 0.001, this tells us that there is less than a 0.1% chance 
that an F-ratio this large would happen if the null hypothesis were true.  In short, the regression 
model overall predicts effective dose significantly well.  The contribution of each of the 
parameters to the R2, i.e. the R2 value for CT gantry angulation 1%, detector configuration 14%, 
helical pitch 0.02% and sure expos 39%.  The most influential was the R2 value for tube rotation 
time which was 62.1%.  The regression model can, however, predict up to 75.1% of effective 
dose variability. 
Regression equation: ED = 0.729 + 0.621 x tube rotation time -0.01 x CT gantry angulation – 
0.01 x detector configuration + 0.14 x Helical pitch – 0.393 x sure Exp. 3D  
R square = 75.1%. 
6.3.2 Helical Acquisitions 
The values of effective dose estimated from the CT experiments (helical protocol, gantry 
angulations 0o, 15o & 27o) are given below.  The results for all 162 protocols are illustrated in 
(Appendix D) within (Table D - 1) to (Table D - 6) on pages 222 to 227 and are summarised 
by the acquisition angulation.   
The main effect of varying the acquisition parameters of tube rotation time, detector 
configuration, helical pitch and Sure Exp. 3D (ATCM) for the three different gantry angulations 
(0o, 15o and 27o) on effective dose are described below: - 
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This data shows the effect of tube rotation time and CT gantry angle on the effective dose.   As 
shown in table (Table 6-5) and (Figure 6-2), the effective dose for the two tube rotation times, 
at three different CT gantry angulations, indicate there is an increase in the effective dose by 
around 39%, as a result of the increase in rotation time from 0.5 to 1.0 second.    
Table 6-5: Adult helical effective doses estimates for the three gantry angulations at the 
two different tube rotation times (mean/SD). 
Gantry Angulation (Degrees) Tube Rotation Time (Seconds) 0.5 1.0  P values 
0o 0.71 ± 0.01 (mSv) 1.17 ± 0.01 (mSv) 0.01 
15o 0.81 ± 0.01 (mSv) 1.25 ± 0.02 (mSv) 0.05 
27o 0.88 ± 0.01 (mSv) 1.13 ± 0.01 (mSv) 0.03 
P values >0.05 >0.05  
 
Figure 6-2: A bar chart comparing the effective dose and the tube rotation time for the three 
different gantry angulations.  Error bars denote the standard deviation of the data.   
 
This data shows the effect of detector configuration and CT gantry angle on the effective dose.  
As shown in (Table 6-6) and (Figure 6-3) the gantry angulation and detector configuration has 
no effect on effective dose.  
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Table 6-6: Adult helical effective dose estimates for three different detector configurations 
across three different gantry angulations (mean/SD). 
Detector 
Configuration (mm) 
Gantry Angulation (Degrees) 
0o 15o 27o P values
0.5x16 0.71 ± 0.01 (mSv) 0.81 ± 0.05 (mSv) 0.88 ± 0.03 (mSv) >0.05 
1.0x16 0.76 ± 0.01 (mSv) 0.70 ± 0.03 (mSv) 0.81± 0.05 (mSv) >0.05 
2.0x16 0.73 ± 0.04 (mSv) 0.79 ± 0.07 (mSv) 0.82 ± 0.08 (mSv) >0.05 
P values >0.05 >0.05 >0.05  
 
Figure 6-3: A bar chart comparing the effective dose for three different detector 
configurations at three different gantry angulations.  Error bars denote the standard deviation 
of the data.   
 
This data shows the effect of helical pitch and CT gantry angle on the effective dose.  As shown 
in (Table 6-7) and (Figure 6-4) the effective dose estimates for the three helical pitch factors, 
at the three CT gantry angulations, are described below.  The results indicate that as the helical 
pitch increases the effective dose decreased.  There was only a slight decrease in effective dose 
when moving from detail to standard but a more noticeable decrease between detail and fast, 
see (Table 6-7) and (Figure 6-4).  Accordingly, the change in helical pitch from detail to fast 
resulted in the effective dose being decreased by 35% for the 0o gantry angulation and by 47% 
for the 15o and 27o gantry angulations. 
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Table 6-7: Adult effective dose estimates for three different helical pitch factors at 
three different gantry angulations (mean/SD). 
Helical Pitch 
Gantry Angulation (Degrees) 
0
o
 15
o
27
o
 P values
Detail 0.71 ± 0.01 (mSv) 0.81± 0.05 (mSv) 0.88 ± 0.04 (mSv) 0.04 
Standard 0.63 ± 0.03 (mSv) 0.58 ± 0.02 (mSv) 0.70 ± 0.05 (mSv) 0.16 
Fast 0.46 ± 0.01 (mSv) 0.43 ± 0.01 (mSv) 0.47 ± 0.01 (mSv) 0.03 
P values <0.05 <0.05 <0.05  
 
Figure 6-4: A bar chart showing the effective dose against the three gantry angulations for the 
three different helical pitch factors.  Error bars denote the standard deviation of the data.   
 
This data shows the effect of ATCM and CT gantry angle on the effective dose.  The values of 
effective dose obtained at three different ATCM settings are shown in (Table 6-8) and are 
plotted in (Figure 6-5).  As is illustrated from the graph all the three ATCM settings have the 
same effect on effective dose at 0o CT gantry angulation, however, there is a slight increase in 
effective dose for the two other gantry angulations (15o and 27o) from low dose through to the 
high quality setting. 
 Table 6-8: Adult effective dose estimates for three different ATCM settings at three 
different gantry angulations (mean/SD). 
ATCM setting 
CT Gantry Angulation (Degrees) 
0
o
 15
o
 27
o
 P values 
High Quality 0.71 ± 0.09 (mSv) 0.81 ± 0.04 (mSv) 0.88 ± 0.05 (mSv) >0.05 
Standard 0.70 ± 0.09 (mSv) 0.72 ± 0.09 (mSv) 0.83 ± 0.03 (mSv) >0.05 
Low Dose 0.70 ± 0.09 (mSv) 0.68 ± 0.09 (mSv) 0.78 ± 0.02 (mSv) >0.05 
P values >0.05 >0.05 >0.05  
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Figure 6-5: A bar chart illustrating the effective dose values for different gantry angulations 
for the three different ATCM settings.  Error bars denote the standard deviation of the data.    
6.3.3 Sequential Acquisitions 
This section provides the results of 54 brain sequential protocols obtained using the following 
parameters: two different gantry rotation times (0.5 and 1.0 seconds), three different detector 
configurations (0.5 x 4, 1.0 x 4 and 2.0 x 4 mm) and three different ATCM settings (high quality, 
standard and low dose).  All the measurements were conducted at three different gantry 
angulations, 0o, 15o and 27o. 
Comparison of the estimated effective dose for different scan parameters is provided in the 
figures below for an adult sequential brain CT examination.  
 
The effective dose calculations for two rotation times and three different gantry angulations are 
outlined in (Table 6-9).  The effective dose values for the two rotation times are illustrated in 
(Figure 6-6).  This data shows there is significant different in effective dose values, as the 
rotation time changed from 0.5 seconds to 1 second the effective dose increased by 48.7% for 
0o CT gantry angulation. 
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Table 6-9: Effective dose estimates for an adult sequential protocol for two rotation times 
and three different gantry angulations (mean/SD). 
CT Gantry Rotation 
Time (S) 
CT Gantry Angulation (Degrees) 
0o 15o 27o P values 
0.5 0.37 ± 0.01 (mSv) 0.30 ± 0.01 (mSv) 0.38 ± 0.01 (mSv) >0.05 
1.0 0.55 ± 0.02 (mSv) 0.64 ± 0.01 (mSv) 0.75 ± 0.02 (mSv) >0.05 
P values 0.02 0.01 <0.001  
 
Figure 6-6: A bar chart representing the effective dose for adult sequential protocols, at three 
different gantry angulations and for two different tube rotation times (S, seconds).  Error bars 
denote the standard deviation of the data.   
 
Table 6-10 shows the effective dose estimates for the three different gantry angulations across 
the two rotation times (0.5 and 1.0 second).  The difference in effective dose as the gantry 
angulation and the tube rotation time's change are shown in (Figure 6-7), as the rotation time 
increases the effective dose also increases (P<0.05).  By contrast, changing the gantry 
angulation has no statistically significant effect on effective dose (P>0.05).  However, as can 
be seen from the data in (Table 6-10), for 1 second tube rotation times, the effective dose 
increases from 0.55 to 0.75 mSv when angling the gantry, this equates to a 27% increase in 
dose.   
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Table 6-10: Adult brain sequential protocol effective dose estimates for three different CT 
gantry angulations and two different rotation times (mean/SD). 
CT Gantry Angulations (Degrees) Tube Rotation Time (seconds) 0.5 1.0 P values
0o 0.37 ± 0.02 (mSv) 0.55 ± 0.02 (mSv) 0.005 
15o 0.30 ± 0.03 (mSv) 0.64 ± 0.06 (mSv) 0.005 
27o 0.38 ± 0.03 (mSv) 0.75 ± 0.06 (mSv) 0.004 
P values 0.06 0.06  
 
Figure 6-7: A bar chart illustrating the effective dose for adult brain sequential protocols at 
three different CT gantry angulation degrees and two rotation times.   Error bars denote the 
standard deviation of the data.   
 
A comparison of the effective dose estimates obtained at three gantry angulations with three 
different detector configurations are presented in (Table 6-11).  These data are plotted 
graphically showing there are statistically significant differences ED across the three detector 
configurations (P<0.05), (Figure 6-8).  
Table 6-11: Effective dose estimates for different CT detector configurations and 
angulations (mean/SD). 
Detector 
Configuration (mm) 
CT Gantry Angulation (Degrees) 
0o 15o 27o P values
0.5 x 4 0.37 ± 0.02 (mSv) 0.30 ± 0.02 (mSv) 0.38 ± 0.02 (mSv) 0.06 
1.0 x 4 0.43 ± 0.03 (mSv) 0.39 ± 0.02 (mSv) 0.44 ± 0.02 (mSv) 0.19 
2.0 x 4 0.61 ± 0.05 (mSv) 0.51 ± 0.02 (mSv) 0.63 ± 0.03 (mSv) 0.09 
P values 0.007 <0.001 <0.001  
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Figure 6-8: A bar chart showing the effect of different detector configurations on effective 
dose for the three different gantry angulations.  Error bars denote the standard deviation of the 
data.   
 
The data presented here shows the different effective dose values obtained for three different 
ATCM settings at three different CT gantry angulations.  Comparison of effective dose values 
for a range of different automatic tube current modulation settings and gantry angulations are 
illustrated in (Table 6-12).  The range of effective dose calculated for ATCM settings are shown 
in (Figure 6-9).  At 0o gantry angulation there were no differences in effective dose values 
between high quality and low dose mA modulation techniques, however, as the CT gantry 
changed to 27o the effective dose is decreased by 10.5%. 
Table 6-12: Effective dose estimates for the three different gantry angulations and the 
three-automatic tube current modulation settings (mean/SD). 
ATCM 
setting 
CT Gantry Angulation (Degrees) 
0o 15o 27o P values 
High Quality 0.37 ± 0.01 (mSv) 0.30 ± 0.09 (mSv) 0.38 ± 0.09 (mSv) >0.05 
Standard 0.33 ± 0.08 (mSv) 0.32 ± 0.07 (mSv) 0.39 ± 0.08 (mSv) >0.05 
Low Dose 0.37 ± 0.05 (mSv) 0.27 ± 0.08 (mSv) 0.34 ± 0.09 (mSv) >0.05 
P values >0.05 >0.05 >0.05  
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Figure 6-9: A bar chart of effective dose estimates for adult CT brain examinations using 
three different ATCM settings, for three different gantry angulations.  Error bars denote the 
standard deviation of the data.   
6.4 Paediatric Phantom Effective Dose Estimates (using MOSFET) 
This section presents the results of effective dose calculations from absorbed dose 
measurements to organs and tissue using MOSFET dosimeters in 167 locations using a one 
year old representative paediatric ATOM phantom.  Dose estimates were obtained using two 
different approaches, one using all possible scanning options available and the second used a 
protocol for a CT brain examination for children aged from 3 months to 3 years creating 162 
protocols and the other different fixed values of tube current and voltage as well as different 
CT angulations and rotation times creating 54 protocols, see (Appendix F) which displays the 
full list of protocols within tables NO. (Table F - 1) to (Table F - 6) on pages 234 to 236.   
6.4.1 Descriptive Data - Statistical Tests 
 
Testing normality of the data from the 162 protocols was necessary to examine the 
appropriateness of the overall data for further analysis.  Data were again analysed using 
histograms and the Shapiro-Wilk test.  For the data presented in this section the Shapiro-Wilk 
test demonstrated that the data conformed to a normal distribution (P > 0.05), see (Appendix 
M), (Table M - 1) on page 251.   
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6.4.1.2.1 Correlations 
The data also, checked using correlation to assess the characterization of relationships among 
multiple protocol factors, the correlation statistical test results are show in (Table 6-13).  This 
table shows the correlation of different CT parameters with effective dose (for the 162 
paediatric protocols).  The analysis reveals that there is a moderate negative correlation between 
effective dose (mSv) and both detector configuration and ATCM, respectively.  The other CT 
parameters (tube rotation time, gantry angulation and helical pitch) were, not significantly 
correlated with effective dose (mSv). 
Table 6-13: Paediatric CT brain protocol correlation test results. 
 
Tube 
Rotation 
Time 
(seconds) 
Gantry 
Angulation 
(Degrees) 
Detector 
Configuration 
(mm) 
Helical 
Pitch 
 
Sure Exp. 
3D (ATC)
Effective 
Dose 
(mSv) 
Pearson 
Correlation 0.021 -0.091 -.604** 0.075 -.674** 
Sig. (2-tailed) 0.000 0.252 0.000 0.341 0.000 
N 162 162 162 162 162 
**. Correlation is significant at the 0.01 level (2-tailed). 
   
6.4.1.2.2 Linear Regression 
The linear regression models have been established for further assessment of the relationship 
between effective radiation doses for each parameter used to acquire the absorbed dose in order 
to investigate the possibility of predicting individual effective dose.  The linear regression the 
value of R2 is 0.858, which tells us that the rotation time, the CT gantry angulation, detector 
configuration, helical pitch and Sure Exp. 3D (ATC) can account for 85.8% of the variation in 
effective dose.   The contribution of each of the parameter was to the R2, i.e. the R2 value for 
tube rotation time was 7.2%, CT gantry angulation 1.3%, helical pitch 0.6% and sure expos 
17%.  The most influential was the R2 value for detector configuration 67.5%.   
6.4.2 Paediatric Helical Brain CT Protocols using ATCM 
The difference in the estimated effective dose between four scan parameters was investigated 
for three gantry angulations.  Protocol variations include CT gantry angulation, tube rotation 
time, detector configuration, helical pitch and ATCM settings. 
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Effective dose was calculated from absorbed dose measured at two different tube rotation times 
(0.5 and 0.75 seconds) and three different gantry angulations (0o, 15o and 27o).  81 protocols 
were tested for each CT scan tube rotation time giving a total of 162 protocols.  The effective 
dose values and the relationship between the two rotation times are shown in (Table 6-14) and 
illustrated in (Figure 6-10).  There was no significant effect of tube rotation time or gantry 
angulation on the effective dose (p>0.05). 
Table 6-14: Paediatric effective dose estimates for the two tube rotation times across the 
three different gantry angulations (mean/SD). 
CT Gantry Angulation (Degrees) Tube Rotation Time (seconds) 0.5 0.75 P values 
0o 2.01 ± 0.02 (mSv) 1.95 ± 0.02 (mSv) 0.23 
15o 1.82 ± 0.02 (mSv) 1.76 ± 0.01 (mSv) 0.27 
27o 1.73 ± 0.01 (mSv) 1.73 ± 0.01 (mSv) 0.20 
P values 0.44 0.14  
 
Figure 6-10: A bar chart comparing the effective dose and tube rotation times for three 
different gantry angulations.  Error bars denote the standard deviation of the data. 
 
The effective dose was calculated for three setting of detector configuration (0.5x16 mm, 
1.0x16 mm and 2.0x16 mm) at three different gantry angulations (0o, 15o and 27o).  As shown 
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in (Table 6-15) and (Figure 6-11) the effective dose decreased significantly according to the 
change in detector configuration from 0.5x16 mm through to 2.0x16 mm.   
Table 6-15: Effective dose estimates for different detector configurations and gantry 
angulations (mean/SD). 
Detector 
Configuration (mm) 
Gantry Angulation (Degrees) 
0o 15o 27o P values
0.5 x 16 2.01 ± 0.07 (mSv) 1.82 ± 0.04 (mSv) 1.73 ± 0.09 (mSv) 0.36 
1.0 x 16 1.02 ± 0.08 (mSv) 0.98 ± 0.06 (mSv) 0.93 ± 0.07 (mSv) 0.46 
2.0 x 16 0.71 ± 0.04 (mSv) 0.63 ± 0.02 (mSv) 0.66 ± 0.09 (mSv) 0.98 
P values <0.001 <0.001 <0.001  
 
 
Figure 6-11: A bar chart comparing effective dose across the three different detector 
configurations, for the three gantry angulations.  Error bars denote the standard deviation of 
the data. 
 
The helical protocol for the Toshiba Aquilion 16 scanner has three different helical pitch values.  
These are Detail PF 0.688 / HP 11.0, Standard PF 0.938 / HP 15.0 and Fast PF 1.438 / HP 23.0.  
The estimated effective dose for the three different helical pitch factors at three gantry 
angulations are presented in (Table 6-16).  The comparison of the effective dose between 
helical pitch factors and gantry angulations are illustrated graphically in (Figure 6-12).  This 
highlights there was a reduction in effective dose from 0o through to 27o using a detailed, 
standard and fast helical pitch factors (when changing from detail to standard helical pitch factor 
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the reduction was 14.9% and changing helical pitch setting from detail to fast the reduction was 
21.4%. 
Table 6-16: A comparison of the effective dose for different helical pitch factors and CT 
gantry angulations (mean/SD). 
Helical Pitch Gantry Angulations (Degrees) 0o 15o 27o P values 
Detail 2.01 ± 0.07 (mSv) 1.82 ± 0.06 (mSv) 1.73 ± 0.06 (mSv) 0.94 
Standard 1.71 ± 0.06 (mSv) 1.58 ± 0.05 (mSv) 1.50 ± 0.05 (mSv) 0.94 
Fast 1.58 ± 0.04 (mSv) 1.52 ± 0.04 (mSv) 1.49 ± 0.04 (mSv) 0.91 
P values 0.05 0.05 0.05  
 
Figure 6-12: A bar chart comparing effective dose for the three helical pitch factors across 
the three CT gantry angulations.  Error bars denote the standard deviation of the data.   
 
Table 6-17 below reports the effective dose estimates for three different ATCM settings 
including High Quality (SD 4.00), Standard (SD 6.00) and Low Dose (SD 8.00) for the different 
gantry angulations.  The relationship between these parameters and effective dose are 
represented graphically in (Figure 6-13).  The effective dose was reduced by 66% when 
changing the ATCM settings from high quality to low dose.  The effective dose was reduced 
by 12% when changing the CT gantry angle from 0o to 27o. 
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Table 6-17: Effective dose estimates for ATCM settings across three gantry angulations 
(mean/SD). 
ATCM setting Gantry Angulations 0o 15o 27o P values 
High Quality 2.01 ± 0.05 (mSv) 1.82 ± 0.06 (mSv) 1.73 ± 0.07 (mSv) 0.4 
Standard 1.08 ± 0.05 (mSv) 0.99 ± 0.03 (mSv) 0.90 ± 0.07 (mSv) 0.4 
Low Dose 0.68 ± 0.06 (mSv) 0.61 ± 0.05 (mSv) 0.60 ± 0.02 (mSv) 0.2 
P values <0.001 <0.001 <0.001  
 
Figure 6-13: A bar chart comparing the effective dose for three ATCM settings obtained at 
three different gantry angulations.  Error bars denote the standard deviation of the data. 
6.4.3 Paediatric Helical Brain CT Protocol Using Different Values of Fixed Tube 
Current and Tube Potential 
The protocol for helical paediatric brain CT scan was further varied and created a further 54 
protocols to investigate additional effect.  The detector configuration was kept fixed at 0.5 x 16 
mm.  The tube potential was varied between 100 and 120 kVp together with three different 
values of tube current 120, 160 and 200mA.  The rotation time was also varied at 0.5, 0.75 and 
1.0 seconds.  All parameters were examined at three different CT gantry angulations including 
0o, 15o and 27o.  The results of this section were divided into four groups to investigate the 
relationship between effective dose and the following parameters: tube rotation time, tube 
current and tube potential.  See (Appendix G) which displays the full list of protocols within 
(Table G - 1) to (Table G - 3) on page 240. 
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Data shown in (Table 6-18) illustrates the effect of changing tube rotation time on effective 
dose estimates for a range of gantry angulations.  As represented in (Figure 6-14) there was 
only a small reduction in effective dose when changing gantry angle from 0o to 15o or 27o, 
approximately 6%.  On the contrary, increasing the rotation time from 0.5 seconds to 1 second 
increased the effective dose by 86.0%.   
Table 6-18:  A comparison of effective dose for different tube rotation times and gantry 
angulations (mean/SD). 
Tube Rotation 
Time (seconds) 
Gantry Angulation (Degrees) 
0o 15o 27o P values 
0.5 1.07 ± 0.03 (mSv) 1.01 ± 0.03 (mSv) 1.01 ± 0.03 (mSv) 0.95 
0.75 1.49 ± 0.04 (mSv) 1.50 ± 0.04 (mSv) 1.53 ± 0.03 (mSv) 0.98 
1.0 1.99 ± 0.05 (mSv) 1.88 ± 0.04 (mSv) 2.02 ± 0.05 (mSv) 0.88 
P values 0.05 0.05 0.04  
 
Figure 6-14: A bar chart illustrating effective dose estimates for different gantry angulations 
for three tube rotation times.  Error bars denote the standard deviation of the data. 
 
Two values of tube potential (kVp) were used in these paediatric protocols and the results on 
effective dose are illustrated in (Table 6-19) and (Figure 6-15).  In this experiment, the 
effective dose increased by 39.3%, 39.6% and 58.4% when changing the tube kilovoltage from 
100 to 120 kVp for the three CT gantry angulation 0o, 15o and 27o, respectively.    
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Table 6-19: Effective dose estimates obtained at two tube potentials (100 and 120 kVp) for 
three different gantry angulations (mean/SD). 
Tube potential 
(kVp) 
Gantry Angulation (Degrees) 
0o 15o 27o P values 
100 1.07 ± 0.04 (mSv) 1.01 ± 0.04 (mSv) 1.01 ± 0.04 (mSv) 0.99 
120 1.49 ± 0.07 (mSv) 1.41 ± 0.06 (mSv) 1.60 ± 0.06 (mSv) 0.95 
P values 0.03 0.04 0.01  
 
 
Figure 6-15: A bar chart illustrating the effect of changing tube potential on effective dose for 
three different gantry angulations.  Error bars denote the standard deviation of the data.  
 
The main effect of tube current on effective dose was investigated by varying the values of mA 
within the paediatric protocol and the results were illustrated in (Table 6-20) and (Figure 6-16).  
By calculating the percentage difference between the different values of effective dose 
obtained, the dose was increased on average by approximately 43% when raising the tube 
current from 120 to 200 mA. 
Table 6-20: Effective dose for different tube currents at different gantry angulations 
(mean/SD). 
Tube Current 
(mA) 
Gantry Angulations (Degrees) 
0o 15o 27o P values
120  1.07 ± 0.04 (mSv) 1.01 ± 0.04 (mSv) 1.01 ± 0.4 (mSv) 0.99 
160  1.49 ± 0.05 (mSv) 1.23 ± 0.05 (mSv) 1.61 ± 0.04 (mSv) 0.90 
200  1.72 ± 0.06 (mSv) 1.76 ± 0.05 (mSv) 1.58 ± 0.07 (mSv) 0.96 
P values 0.02 0.02 0.03  
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Figure 6-16: A bar chart illustrating a comparison of effective dose for different fixed tube 
currents at three different gantry angulations.  Error bars denote the standard deviation of the 
data. 
6.5 Eye Dose 
The eye lens is an example of an organ with an attributed deterministic radiation effect: If the 
eye is exposed to a dose above a certain threshold, a cataract will develop.  It is assumed that 
the minimum dose required to produce a detectable cataract is about 2 Gy for a single exposure 
and 5 Gy for fractionated or protracted exposure (ICRP, 2012).  To avoid irradiation of the eyes, 
brain CT is normally planned to exclude the eyes from the imaged area.  However as discussed 
in chapter three, in helical CT, over-ranging extends the irradiated area on both ends of the 
planned scanning range.  Thus, the eyes receive a radiation dose, even though no images are 
reconstructed from data obtained in that area.  The eye lens dose largely depends on the 
scanning parameters that control over-ranging (detector collimation and pitch), as well as on 
the actual distance from the eyes to the edge of the imaged volume (Schilham et al., 2010).  The 
calculated eye dose for a typical helical CT examination of the head for an adult and paediatric 
when the eyes are outside of the imaged volume are illustrated below. 
6.5.1 Adult Absorbed Eye Dose 
Absorbed eye dose was measured for all 162 brain protocols and the data are presented in 
(Table H - 1) in (Appendix (H) on page 243.  An example of eye dose for the adult helical 
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protocol using the following settings: (rotation time 0.5 seconds, detector configuration of 0.5 
x 16, pitch factors / Helical Pitch [Detail PF 0.688 / HP 11.0] and Sure Exp. 3D (ATC) [High 
Quality SD 1.80]) is shown in (Table 6-21) and (Figure 6-17).  The eye dose decreased slightly 
according to the change in gantry angulations from 0o to 15o whereas there is a statistical 
significant decrease in eye dose when changing CT gantry angulations from 0o to 27o.  The 
percentage decrease in absorbed dose, according to gantry angulation settings is 5.5% change 
referring to the dose reduction between 0o and 15o and 51.3% to the reduction between 0o and 
27o.  
Table 6-21: Adult eye absorbed dose (mean/SD). 
Gantry Angulation 0o 15o 27o 
Eye Dose (mGy) 32.1 ± 4 30.3 ± 3 15.6 ± 7 
 
Figure 6-17: A bar chart illustrating a comparison of adult eye dose for three different gantry 
angulations for a representative protocol.  Error bars denote the standard deviation of the data. 
The Box & Whisker graph in (Figure 6-18) shows that the adult eye absorbed dose decreases 
as the CT gantry angulation increased across the range of protocols.   
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Figure 6-18: Box & Whisker graph showing the absorbed eye dose (mGy) for the adult 
helical protocols.   Ends of the whiskers correspond to the maximum and minimum values, 
end of the boxes correspond to 1st and 3rd quartiles and the horizontal line refers to the 
median.    
6.5.2 Paediatric Absorbed Eye Dose  
Eye lenses absorbed dose was measured for 162 paediatric brain helical protocols and the results 
of the dose are illustrated in (Table H - 2) in (Appendix H) on page 244.  An example of eye 
absorbed dose for paediatric helical protocol using the following settings: (rotation time 0.5 
seconds, detector configuration of 0.5 x 16, Pitch Factors / Helical Pitch [Detail PF 0.688 / HP 
11.0] and Sure Exp. 3D (ATC) [High Quality SD 4.00]) is shown in (Table 6-22) and 
(Figure 6-19) the eye dose decreased slightly according to the change in gantry angulations.  
The percent of reduction in effective dose, according to gantry angulation settings was 9.53% 
change referring to the dose reduction between 0o and 15o degree and 24.36% to the reduction 
between 0o and 27o.  Accordingly, as illustrated in the Box & Whisker graph in (Figure 6-20) 
paediatric eye absorbed doses decreased when CT gantry angulation increased.   
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Table 6-22: Paediatric eye absorbed dose (mean/SD). 
Gantry Angulation 0o 15o 27o 
Eye Dose (mGy) 33.05 ± 3 29.90 ± 1 25.00 ± 3 
 
Figure 6-19: A bar chart illustrating a comparison of paediatric eye dose for three different 
gantry angulations for a representative protocol.  Error bars denote the standard deviation of 
the data. 
 
Figure 6-20: Box & Whisker graph showing absorbed eye dose (mGy) for the paediatric 
helical protocols.   Ends of the whiskers correspond to the maximum and minimum values, 
end of the boxes correspond to 1st and 3rd quartiles and the horizontal line refers to the 
median.    
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6.6 Estimating Attributable Radiation Lifetime Cancer Risk 
The attributable lifetime cancer risk estimation, based on BEIR VII modelling, was calculated 
for both male and female ages from 0 to 80 years old.  Risk estimates were facilitated using the 
absorbed dose measurements (MOSFET) for the adult and paediatric ATOM phantoms. The 
attributable lifetime risk (number of cancer cases per million) was calculated for all 216 
protocols for the adult phantom (including both sequential and helical protocols) and 162 
protocols for the paediatric, and for both males and females.  As an example, the lifetime 
attributable cancer risk for males and females for 9 protocols are illustrated in (Table 6-23) and 
(Table 6-24), respectively.  The box and whisker plots summarise the lifetime risk data for the 
male and female groups with age across all protocols.  The lifetime risk for male and females 
of cancer increases as age decreases (Figure 6-21) and (Figure 6-22).  As can be seen from 
(Figure 6-23), the gender differences are most apparent below the age of 30.  Importantly, the 
selection of the brain CT protocol has the greatest impact on lifetime risk below the age of 
twenty as demonstrated by the length of the whiskers.  The full range of lifetime cancer risk for 
both male and females are illustrated in (Table I - 1) and (Table J - 1) within (Appendix’s I 
& J) on pages 245 to 248.  When referring to (Table 6-23) and (Table 6-24) full protocol 
acquisition parameters are presented in (Appendix B) within (Table B - 1) on pages 204 and 
in (Appendix C) within (Table C - 1) on page 213 for adult and paediatric respectively. 
 
 
 
Table 6-23: Male lifetime attributable cancer risk case/106 
 Age 
Protocol No. 0 5 10 15 20 30 40 50 60 70 80 
1 46 29 14 11 8 5 5 4 3 2 1 
2 24 15 13 11 8 5 5 4 3 2 1 
3 16 10 12 9 8 5 4 3 3 2 1 
4 39 24 11 9 7 4 4 3 2 1 1 
5 23 14 10 8 6 4 4 3 2 1 1 
6 15 11 10 8 6 4 3 3 2 1 1 
7 33 21 8 7 5 3 3 2 2 1 <1
8 24 15 8 6 5 3 3 2 2 1 <1
9 17 10 7 6 5 3 3 2 2 1 <1
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Figure 6-21: Box & Whisker graph showing male lifetime cancer risk cases/106.   Ends of the 
whiskers correspond to the maximum and minimum values, end of the boxes correspond to 1st 
and 3rd quartiles and the horizontal line refers to the median.    
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Table 6-24: Female lifetime attributable cancer risk case/106 
 Age 
Protocol No. 0 5 10 15 20 30 40 50 60 70 80 
1 102 64 18 14 11 7 6 5 4 2 1 
2 55 34 19 15 12 7 6 5 4 2 1 
3 36 23 20 15 12 7 6 5 4 2 1 
4 82 51 17 13 10 6 5 4 3 2 1 
5 53 33 15 12 9 6 5 4 3 2 1 
6 32 20 15 11 9 5 4 4 3 2 1 
7 78 49 12 9 7 4 4 3 2 1 1 
8 55 34 12 9 7 4 4 3 2 1 1 
9 40 25 12 9 7 4 4 3 2 1 1 
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Figure 6-22: Box & Whisker graph showing female lifetime cancer risk cases/106 increases 
with as age decreases.  Ends of the whiskers correspond to the maximum and minimum 
values, end of the boxes correspond to 1st and 3rd quartiles and the horizontal line refers to the 
median. 
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Figure 6-23: Box & Whisker male & female combined graph showing increase in lifetime 
cancer risk cases/106 for female and as the age of both male and female decreased. 
6.7 A Tool to Estimate the Prospective Effective Risk for a Patient  
The risk data presented above provides a useful summary of the relationships between risk, 
gender and age, however in order for the data to be informative for clinical practice a tool is 
necessary to understand the risk to a particular patient within a clinical scenario.  To do this a 
Microsoft Excel Workbook has been developed that enables a practitioner to filter through the 
216 protocols (adult) or 162 protocols (paediatric) based on the acquisition factors they are 
considering using.  This enables them to easily compare the estimated attributable lifetime 
cancer risk associated with several protocols (or parameter changes) that they are considering.  
This demonstrates how the novel data generated from this thesis could be useful in informing 
radiographer decision-making prior to initiating a CT scan.  Current clinical practices are for 
radiation dose assessment to be a retrospective process and commonly based on only CTDIvol 
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and DLP dose estimates.  CTDIvol and DLP have accepted limitations and the radiation estimate 
method proposed in thesis builds upon this.  The worksheet also incorporates an option to select 
the accumulative risk for multiple brain CT scans.  This may be useful in a situation where a 
patient has a long-term condition where multiple brain CT scans are expected to have to take 
place.  Again, this approach to the prospective consideration of radiation risk for patients in a 
step change in radiographic practice.  Although the data presented here are only applicable for 
the Toshiba 16 Aquilion CT scanner, from which dosimetry data were collected, similar data 
for CT scanners used in clinical practice could be collected and presented in a similar manner.  
The proposed risk estimation workbook has been published alongside a brief instruction manual 
within an online data repository known as Figshare, however, for the purpose of this thesis 
supplementary information on CD-ROM are included on the back of the thesis.  A screen shot 
of the Microsoft Excel Workbook has been displayed in (Figure 6-24) and (Figure 6-25) 
illustrating the protocols and parameters available for selection and the subsequent predicted 
lifetime cancer risk for males and females.  
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Figure 6-24: Effective risk prediction tool (Excel Workbook) showing the protocol 
parameters options. 
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Figure 6-25: Effective risk prediction tool showing lifetime risk for males and females (tool 
outcome). 
 159 
 
Chapter 7 : Discussion 
7.1 Chapter Overview 
For CT examinations it can be beneficial to estimate both absorbed dose and effective dose in 
order to assess the risk and evaluate methods aimed at reducing dose.  The primary aim of the 
dose measurements and calculations in this thesis were to estimate the attributable lifetime 
cancer risk.  This specifically focused on assessing the risk of inducing cancer during the 
lifetime of an individual undergoing a CT brain scan.  The secondary aim of this study was to 
understand the impact of different CT scan acquisition factors including gantry angle, both for 
paediatric and adults on the effective dose.  To achieve these aims, a set of objectives were 
formulated, see chapter one, section (1.3) on page 5.  From these objectives, a research question 
was proposed; how do changes in CT protocols affect the effective risk from CT head scans in 
adults and children?  The research question has been methodically tested and the results are 
presented in chapter (6) items (6.1 to 6.7) on pages 126 to 155. 
In this chapter, the results answering the research question will be discussed in two parts.  The 
first part will examine the clinical implications of the absorbed and effective doses for helical 
and sequential protocols as well as the differences in radiation dose due to changes in CT scan 
parameters.  Secondly, the results from the estimations of effective risk will be addressed.  
Fundamentally it was important to assess if patients having CT brain scans could be being 
exposed to high levels of radiation which could lead to the development of cancer during a 
patient’s lifetime, especially in the young.  This thesis will provide, for the first time, a 
prospective proactive method of estimating radiation risk (including age and gender) which is 
available prior to the start of the CT scan.  Such a development is a major change from how CT 
scans are currently undertake and optimised. 
7.2 Absorbed Dose (mGy) 
In the literature, there are a limited number of studies providing information on organ and tissue 
absorbed doses for CT examinations on children (Brenner and Hall, 2007; Coursey et al., 2008; 
Fujii et al., 2007).  This is largely due to the complexity of undertaking these types of 
measurements and the lack of resources and time for performing dosimetry experiments in the 
clinical environment.  Furthermore, where studies exist, it is often difficult to make direct 
comparisons due to the many different variables that have considerable effect on the radiation 
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dose.  These include the type of experimental or computational method for dosimetry, the 
representative age and type of anthropomorphic phantom used, the modelling of the CT 
scanner, if applicable, and/or the CT examination parameters (e.g. kVp, mAs, collimation, pitch 
and scan length).    
Twenty-four organ and tissue doses, in both ATOM phantoms representing an adult and 1-year-
old child, were obtained using MOSFET dosimeters for a range of head CT protocols (in total 
432 protocols, 216 for each adult and paediatric phantoms, respectively).  The results were used 
to calculate effective dose and for estimating induced cancer risk; see (Table 6-1) on page 127, 
which shows an example of measured absorbed dose and calculated effective dose for a single 
protocol.  The comparison of organ doses for helical adult brain protocols demonstrates that the 
highest dose was received by the brain tissue and eye lenses from 13.4 to 27.5 mGy and 16.2 
to 32.1 mGy, respectively (Table D - 1) to (Table D - 6) in appendix D on pages 222 - 227.  
However, changing the CT gantry angulation form 0o to 27o reduced the eye lens dose by 50% 
(from 32.05 to 15.60 mGy), see (Table 6-21) on page 149.  In terms of a head CT scan, there 
is a focus on bone marrow, thyroid gland and eye dose, due to the fact that these are the most 
radiosensitive.  The lens of the eye does not need to be considered for stochastic effects such as 
cancer induction.  However, it is useful to consider the deterministic effects, such as cataract 
formation, which have a threshold of about 0.5 Gy (ICRP, 2011).  According to the ICRP 103 
(2007) report, the tissue weighting factors for bone marrow and thyroid gland are 0.12 and 0.04, 
respectively.  The major concern in a CT brain examination is the radiation administered to the 
eye lens, and that scans are potentially being overused (Owlia et al., 2014).  This is because in 
routine clinical practice the CT gantry positioned will often be at 0°, making all or part of the 
patient’s eye lens inevitably irradiated by the primary X-ray beam.  As indicated in the ICRP 
103 annual report, the lens of the eye is known to be radiosensitive, thus for CT brain 
examinations, as discussed later in the discussion (section 7.5), it is important to reduce the 
absorbed dose to the lens of the eye by tilting the CT gantry to prevent them from an attributed 
deterministic radiation effect.   
Organs on the periphery of the scan volume can have a significant variation in absorbed dose 
across the organ due to partial irradiation.  The overall dose to the active bone marrow (ABM) 
was in the range 1.2 to 2.3 mGy and the dose to thyroid gland ranged from 0.6 to 1.0 mGy.  The 
locations used to measure the absorbed dose to red bone marrow (RBM) are shown in appendix 
A (Table A - 1) and (Table A - 2) pages 197 to 199 for both adult and paediatric ATOM 
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phantoms, respectively.  The absorbed doses for this tissue is not based on the simple average 
of multiple dosimeters in each organ (as detailed in the methods section 5.8.3 on page 118) and 
has therefore been provided individually.  The measured absorbed doses vary considerably for 
the locations selected for the RBM calculations.  This is expected since these locations range 
from the skull to the pelvis and therefore may be directly irradiated, partially irradiated or 
completely outside of the scanned volume and reach of scattered radiation.  This is evident in 
the variation (mean, SD) of measured absorbed doses for all protocols, although it can be most 
readily seen in the brain where the absorbed dose to the skull ranges from 2.2 ± 0.5 – 35.1 ± 2.3 
mGy, while all other locations are less than 1 mGy.  Similar values of ABM absorbed dose have 
been obtained on a study conducted by Lee et al. (2011); they indicate a received ABM absorbed 
dose of 1.8 mGy/100 mAs at 120 kVp in the head, whereas the thyroid dose was 0.3 mGy/100 
mAs at 120 kVp in the head scan (Lee et al., 2011).  According to Lee et al., (2007), the vertical 
placement of the thyroid can lead to significant differences in absorbed dose estimates as the 
thyroid will receive some shielding from the mandible bones.  The calculated effective dose 
ranged from 0.34 – 1.55 mSv and from 0.27 – 1.13 mSv for helical and sequential CT brain 
protocols, respectively.  The absorbed dose to thyroid gland for helical brain protocols received 
up to 1.5 times higher dose than for sequential CT protocols.  The absorbed dose to ABM from 
the CT helical protocols were 2 to 4 times greater than for sequential protocols.  The choice of 
using helical or sequential protocols are dependent on the reason the patient is having the CT 
scan.  Helical mode is used for situations requiring faster scanning to reduce the potential for 
motion artefacts, whereas sequential scanning provides better image quality, especially for 
small structures with low tissue contrast (Pace & Zarb, 2015).  Differences in the absorbed dose 
between the two protocols are likely to be the result of differences in the scan lengths (over-
scanning) between the helical and sequential scanning modes.  However, the scan range can be 
defined as actual imaging volume plus an additional half cycle at the beginning and the end of 
scanning volume to reconstruct the first and last slice in helical scanning mode.  It must be a 
multiple of scan coverage less the overlapping zones in sequential scans.  Also, the organs and 
tissues located inside the scan volume, or close to it, will receive a high dose compared to those 
located far from it.  The percentage of ABM is age dependent, as recommended by ICRP report 
70 (1995), and has a high tissue weighting factor of 0.12.  For an adult aged 40 years old the 
ABM is distributed as 7.6% in the cranium, which is located within the brain scanning volume, 
0.8% in mandible and 3.9% in C-spine which is located closely to the scanning volume.  
Whereas in a one-year old child the percentage of ABM is distributed as 25.1% in cranium, 
2.4% in mandible and 2.8% in C-spine.  As reported by Cohnen et al., (2000), the radiation 
 162 
 
exposure to the bone marrow in the skull may be important because this is irradiated directly 
during a head CT scan and is radiosensitive.  In particular, there are concerns regarding the risk 
of leukaemia induction as a result of exposure which is believed to represent 5% to 10% of the 
total marrow in adults.  Thus, an approximate effective dose of 0.1 mSv may be applied during 
‘‘standard’’ cranial CT.  In children, CT of the brain results in a possible effective dose of up 
to 0.4 mSv to the calvarium, in which 25% to 30% of the bone marrow is localised.  Since 
multiple scans may be performed in paediatric patients, (e.g., shunt and ventricle size control), 
emphasis should be placed on radiation protection and lowering exposure where possible.  Also, 
the helical thyroid dose is high primarily because the thyroid is located in the thinnest region of 
the patient (the neck) and definitely outside on the periphery of the scan volume with scattered 
radiation exposure only (van der Molen and Geleijns, 2007). 
Overall, it can be suggested that the decrease in organ dose observed with sequential scans may 
be due to one or a combination of differences in scan mechanics between the two modes, 
including (a) in helical scans, wherein the X-ray beam has to ramp up and ramp down the beam 
at the beginning and end of each scan, which are at different locations, or/and (b) a difference 
in physical beam collimation between axial and helical scan modes, or/and (c) inaccurate or 
imprecise table speed in helical mode (McDermott et al., 2009). 
The comparison of organ and tissue absorbed doses measured in this thesis against those 
reported in the literature for paediatric CT relies on examining the work by Brenner et al. (2001; 
2007).  The absorbed doses measured in their first study (Brenner et al., 2001) are considerably 
higher than those measured in this thesis.  One of the assumptions of their initial study was that 
adult CT parameters were being used on children (Paterson et al., 2001) and the corresponding 
organ absorbed dose estimates were made accordingly.  For a paediatric patient, they calculated 
the brain dose to be 50 mGy from a single ‘typical’ CT scan of the head.  This subsequently 
decreased to 35 mGy in their subsequent studies (Brenner et al., 2001; Brenner & Hall, 2007), 
which is still higher than the values measured in this thesis for a CT brain examinations (range 
from 2.1 to 27.5 mGy) depending on the protocol used.  Similarly, the absorbed dose measured 
for the ABM was also higher than reported in this thesis which was 5 mGy in both of their 
studies (Brenner et al., 2001; 2007).  In this thesis, these were approximately half (range 8.0 to 
2.17 mGy).   
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7.3 Organ Positioning 
As discussed in the methodology chapter (five), it is not feasible to conduct in vivo dosimetry 
in humans.  However, an anthropomorphic ATOM phantom which simulates the human body 
can be used for this purpose.  These type of phantoms provide the best representation of the 
human organs and tissues for dosimetry purposes and are more realistic than other phantoms 
available in terms of mimicking the real life situation (CIRS, 2006; Varchena, 2002).  
Differences between phantoms in terms of organ depth, the exterior shape of the trunk and 
diameter relative to the incoming radiation beam will affect the dose (Lee et al., 2007a; Zankl 
et al., 2005).  Therefore, it is expected that there will be some variation in the calculated doses.  
Organs positioned inside the planned scan volume received higher absorbed doses compared to 
the other organs that were positioned at the border of the field of interest (e.g. eye lenses), or 
definitely outside with exposure to scattered radiation only (e.g. oral mucosa, salivary glands, 
thyroid gland and extrathoracic region).  Oral mucosa received between 2.15 and 3.08 mGy, 
salivary glands between 2 to 3 mGy, thyroid gland between 0.36 and 0.76 mGy and 
extrathoracic region (ET) between 0.88 to 1.04 mGy for the helical adult brain protocol.  
However, comparing organ values to values calculated from sequential brain protocols, the 
absorbed dose for these organs almost all decreased by half.  Whereas the radiation doses to the 
same organs for paediatric helical protocols were three times higher when compared to the dose 
obtained for helical adult brain protocol, that is due to the relative size and length of the adult 
phantom compared to the paediatric one as well as the size of the organs and the measuring 
points between phantoms in each organ.  
Absorbed doses to the thyroid and ET region for CT brain examinations demonstrate a wide 
variation between the different scanning protocol parameters used for both paediatric and adult.  
Lee et al. (2011) have previously identified that the vertical placement of the thyroid can lead 
to significant differences in absorbed dose estimates.  In both ATOM phantoms, the thyroid is 
located in the neck region, whereas for some other phantoms it is partially in the upper trunk 
region.  In this more realistic anatomy, the thyroid will also receive some shielding from the 
facial bones (Lee et al., 2007a), but may also be directly irradiated in a head examination when 
changing CT gantry angulation, leading to variations in dose calculations.  For this exposure 
situation, when these organs are located higher within the phantom, they are closer to the direct 
scan volume or are even positioned partially within it leading to the higher absorbed doses.  
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Anatomical variations in thyroid position between individuals should, therefore, be factored 
into any dosimetry comparisons.   
Abdominal organs such as the adrenals, pancreas and kidneys are typically positioned lower in 
relation to the intended CT brain scanning volume (Lee et al., 2011).  Therefore, for the CT 
brain examination the absorbed doses to these organs tend to be lower when compared to brain 
tissues.  For this situation, when these organs are located lower within the phantom they are not 
closer to the direct scan volume, or are even positioned partially close to it leading to the lower 
absorbed doses. 
The location of the testes can also lead to a difference in absorbed dose, which is evident in 
their location further away from the primary scan volume.  The testes location can vary between 
phantoms (Lee et al., 2011).  Therefore, if the angle of the CT gantry changes, the testes may 
be fully or partially subjected to scattered radiation depending on the phantom length.  This 
location relative to the brain scanning volume is observed in the lower absorbed dose to the 
testes in the ATOM phantom representing an adult compared with the ATOM phantom 
representing one year old where the scan length and phantom length are different on both 
phantoms.  Also, the absorbed doses to the testes predominantly vary according the changes in 
protocols parameters which are likely to result from differing levels of scattered radiation.   
In addition to the overall size of a phantom, there are other internal disparities such as the 
location of organs that will also potentially affect dose estimates.  In smaller phantoms, such as 
the one representing a one-year old child, the closer relative proximity of organs to the scanned 
volume will increase the dose.  For an adult phantom, these organs will be further away from 
the directly irradiated area and as such the absorbed dose to these organs is decreased.  This is 
an important point and will also vary in real life patients, it will, therefore need to be accepted 
that due to size variations dose estimates cannot be completely accurate for all (Lee et al., 2007; 
Zankl et al., 2005; Lee et al., 2011). 
7.4 Absorbed Dose to Organ Substitution 
The ATOM phantoms do not model all of the organs and tissues listed in ICRP 60 and ICRP 
103 and often other organ absorbed doses are used as a substitute to approximate these doses.  
In this thesis, similar to Ludlow and colleagues (2008 & 2006); Roberts et al. (2009); 
Suomalainen et al. (2009); Tootell et al. (2014); Theodorakou et al. (2014) and ICRP 66 (1994), 
it was assumed that, for example, for measurements made in these physical phantoms, the 
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second measuring point of the cervical spine and oesophagus could be used to approximate the 
absorbed dose to the ET region.  Also, the absorbed dose to the salivary glands and oral mucosa 
were approximated from by absorbed dose to the mandible from four measuring points (ICRP, 
1994; Theodorakou et al., 2014).   
In the ATOM phantoms the absorbed doses to the skin, muscles, lymph nodes and bone surface 
could not be measured nor included in the effective dose calculation as measuring points were 
not available for determining the absorbed dose to these organs.  The effect of organ absorbed 
dose substitution can be seen in the high absorbed doses assigned to the salivary glands and 
oral mucosa in the both phantoms calculations, representing an adult and paediatric for the CT 
brain examinations.  Also absorbed dose to these organs in paediatrics is higher compared to 
adult due to the phantom size variations as previously discussed.  Results in this thesis, for all 
proposed protocols, demonstrates the absorbed dose to these tissues are in fact considerably 
less than the absorbed dose to the brain.  This will also influence both the effective dose estimate 
and the effective risk calculation.  As indicated in chapter 5 (section 5.5.3) on page 107, other 
studies have used a varying number of measurement locations, ranging from 20 to 66 for 
measuring absorbed dose.  This thesis used 167 and 281 for the paediatric and adult ATOM 
phantoms, respectively.   
The number of dosimeters per organ may cause additional uncertainty when deriving the mean 
absorbed dose to individual organs or tissues (Toivonen et al., 1996; Smith-Bindman et al., 
2009).  Aschan et al. (1999) and Brady et al. (2011) stated that the maximum error, caused by 
the use of one point instead of sampling the whole organ was found to be more than 11%.  The 
organ used in their approximation was the kidney, the volume of which was estimated from the 
literature to be 150 cm3.  In their study, one or only a few reference points were used to represent 
the smallest organs, but dozens of reference points were needed for large organs.   
Uncertainty can be caused by the use of multiple dose reference points, representing the entire 
volume of the organ and is estimated to be around 3%.  The amount of inaccuracy from 
measuring one point within the organ versus the whole organ is dependent on the organ size, as 
indicated by Brady et al. (2011).  Here it was found that the absorbed dose varied by up to 21% 
depending on the organ size.  This variation in dose highlighted the necessity to use multiple 
measurement locations in organs and tissues, particularly those that are large, in order to 
accurately determine the mean organ or tissue absorbed dose.  Also, an uncertainty of 
approximately 5% is generated in soft tissues close in contact with bone through interface 
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effects (Toivonen et al., 1996; Biswas et al., 2009).  In this thesis, the method used is considered 
to be superior to several previously published studies in that multiple sampling points within 
different organs and tissues were used, and not just a single sampling point.  
7.5 Eye Dose 
CT scans of the brain, sinuses and petrous bones are commonly performed as the initial imaging 
test for a variety of indications, including trauma, suspected tumour, complicated infections and 
inflammatory conditions, as well as suspected congenital abnormalities and have the potential 
to expose the eye-lens to ionising radiation.   
As reported by Schilham et al., (2010) the eye lens is an example of an organ with an attributed 
deterministic radiation effect, if the eye is exposed to a radiation dose above a certain threshold, 
a cataract will be formed.  It is assumed that by ICRP 103 (2007) and ICRP 21 (1991) the 
minimum dose required to produce a detectable cataract is around 2 Gy for a single exposure 
and 5 Gy for fractionated or protracted exposure.  In paediatrics, as indicated by ICRP 30 (2000) 
report, this threshold is even lower, with the development of cataracts having been documented 
at less than half this dose of radiation.  Therefore, it is of paramount importance to shield the 
paediatric orbit from any unnecessary radiation during CT.   
Typically, the dose to the eye is about 50 mGy, depending on the CT scanner characteristics 
and protocol that is used, see (Appendix H) within (Table H - 1) and (Table H - 2) on pages 
243 and 244, respectively.  CT Brain scans are normally planned to exclude the eyes from the 
imaging volume and avoid irradiation.  However, in helical CT, over-ranging extends the 
irradiated area on both ends of the planned scanning range.  Thus, the eyes can receive a direct 
radiation dose, even though no images are reconstructed from data obtained from this area.   
The eye lens dose largely depends on the scanning parameters that control over-ranging, which 
are detector collimation and pitch as well as the actual distance from the eyes to the edge of the 
imaged volume.  In this thesis, due to the lack of movement of the head and neck in the ATOM 
phantom, there was some restriction in the position of the phantom.  Clinically, avoidance of 
the primary beam irradiating through the eye lens region can be minimised by tilting the head 
(Schilham et al., 2010).  Where this is not possible the CT gantry has to be tilted superiorly in 
order to avoid or minimise the extent of primary beam irradiation of the patient's orbit to keep 
the eyes outside the scan volume.  A study by Wai-Keung LAI, (2015) found a drastic reduction 
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in the entrance surface dose (ESD) to the eye lens region by 92.5% when the CT gantry was 
tilted from 0° (overall ESD=30.7 mGy) to 30°crainially (overall ESD=2.4 mGy).  This result 
agrees with the results of previous studies conducted by Heaney & Norvill, (2006); and Keil et 
al., (2008).   
The calculated eye dose for the helical brain CT examination experiments undertaken within 
this thesis found a significant reduction to the eye lens dose when angling the gantry, and the 
percentages vary widely according to the helical protocol parameters used for both adult and 
paediatric phantoms.  For adult results the reduction ranged from 12% to 41% when the CT 
gantry was tiled from 0o (overall dose range 10.4 to 60.2 mGy) to 27o (overall dose range from 
9.2 to 35.6 mGy).  Whereas the percentage reduction in eye lens doses for paediatrics ranged 
from 24% to 30% when changing CT gantry angulation from 0o (overall dose range from 3.0 
to 33.1 mGy) to 27o (overall dose range from 2.1 to 25.0 mGy).  The percentage dose reductions 
mentioned above were calculated when comparing the maximum and minimum absorbed dose 
for between the two CT gantry angulations 0o and 27o.   Maximum (highest) doses were 
obtained when the eyes were in the scan volume (CT gantry not tilted). 
Matsubara et al., (2011) demonstrated that the application of CT gantry tilting during CT brain 
examination (i.e., tilting the CT gantry towards the supra-orbital line of the patient in order to 
avoid or minimise the extent of primary X-ray beam irradiate the patient's orbit) could 
effectively reduce the overall dose delivered to the eye lens region by approximately 92%.  
Results of brain CT sequential protocol in this thesis found an excessive reduction in the 
absorbed dose to the eye lens region by 51.4% to 77% when the CT gantry was tilted from 0° 
(overall eye lens dose = 7 – 47.8 mGy) to 27°crainially (overall eye lens dose = 3.4 - 11 mGy).     
Therefore, increasing gantry angle can be used as a way of reducing eye dose, examples of eye 
dose reductions for different protocols are illustrated by (Table 6-21), (Figure 6-17) on page 
149, (Figure 6-18) on page 150 and (Table 6-22), (Figure 6-19), (Figure 6-20) on page 151 
for adult and paediatric, respectively.  Consequently, strategies to reduce eye lens dose during 
CT brain examinations still remain important to prevent deterministic effects.  Comparing the 
absorbed dose to the eye for adult common clinical CT brain helical and sequential protocols, 
the percentage difference between the two protocols at 0o angulation was 33% and the different 
between them at 27o was 49%.  In helical CT, over-ranging extends the irradiated area on both 
ends of the planned scanning range.  Thus, the eyes receive a significant dose, even though no 
images are reconstructed from data obtained in that area.  The eye lenses were positioned at the 
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border of the field of interest- a region is irradiated for which no images can be reconstructed.  
As stated by van der Molen and Geleijns (2007), an important factor that affects the absorbed 
dose to organs at the start and end of a scan volume is the additional length included for data 
interpolation for helical examinations.  The exposed length is longer than the imaged length 
and depends on the pitch, beam collimation and reconstruction algorithm.  These three different 
tilting options of the gantry angle can reduce the radiation dose to the eye lens effectively by 
avoiding direct exposure of this tissue.   However, the dose drop-off is obvious once the eye 
lens is outside the primary beam.  The absorbed dose drop-off suggests that the contribution 
from scattered radiation to the eye lens dose is small, probably because the eye lenses are 
located at the body surface where there is less scatter build-up than at locations at depth within 
the body. 
7.6 CT Parameters 
Tube potential, beam collimation, rotation time, tube current–time product or mA modulation 
indices are the starting points of the optimisation process to keep the dose ‘as low as reasonably 
practicable’ for diagnostic purposes  (IR(ME)R, 2017).  As in conventional radiography, a 
linear relationship exists between the tube current-time product and radiation dose; i.e. all dose 
quantities will change by the directly proportional amount as the applied mAs.  When the tube 
potential is increased, both the tube output and the penetrating power of the beam are improved, 
while image contrast is adversely affected. 
As reported in the literature, tube current is the most important parameter in CT that effects 
radiation dose followed by tube rotation time and tube kilovoltage.  In CT, the tube current 
exposure time and tube potential can all be altered to give the appropriate exposure to the 
patient.  However, users most commonly standardise the tube potential and gantry rotation time 
for a given clinical application.  The fastest rotation time should typically be used to minimize 
motion blurring and artefacts, and the lowest kV consistent with the patient size should be 
selected to maximize image contrast.  Hence tube current is the primary parameter that is 
adapted to patient size.  Numerous investigators have shown that the manner in which mA 
should be adjusted as a function of patient size should be related to the overall attenuation, or 
thickness, of the anatomy of interest (McCollough et al., 2009).  The exception is for imaging 
of the head, where attenuation is relatively well defined by age, since the primary attenuation 
comes from the skull and the process of bone formation in the skull is age dependent.  For CT 
imaging of the head, the mAs reduction from an adult to a newborn of approximately a factor 
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of 2 to 2.5 is appropriate (Funama et al., 2005; McCollough et al., 2006 & 2009; Smith-
Bindman et al., 2009).   
In this thesis, it was found that, when using 100 kVp and 100 mA instead of 120 kVp, organ 
dose reductions of 19, 22 and 10% were found for the thyroid, eye lens and breast, respectively.  
However, the effective dose values were increased by 43% when increasing tube current from 
120 to 200 mA and by 37% when changing the tube kilovoltage from 100 to 120 kV, see 
(Table 6-19), (Figure 6-15) and (Table 6-20), (Figure 6-16)  on pages 147 and 148, 
respectively.  The trend in radiation dose change is expected but the amount of increase was 
much greater than would be expected in some cases; similar results have been reported by 
Funama et al. (2005) when changing the kV from 90 to 120 resulted in a dose increase of 30%.  
However, Raman et al. (2013), findings were consistent with Funama’s, they stated that 
decreasing the tube potential from 120 to 100 kVp can result in a dose reduction of roughly 
33%, and decreasing the tube potential further from 120 to 80 kVp can result in up to a 65% 
reduction in dose (Raman et al., 2013).  Brody et al. (2007), indicated that the same CT 
examination parameters can be used for both for children and adults.  Using the same CT 
parameters in children will have no effect on diagnostic accuracy of the CT scan but the 
radiation exposure may have been unnecessarily high.  In fact, a change in these parameters 
with a resultant reduction in dose, ranging from approximately 50% to 90%, has been shown to 
be satisfactory for a paediatric CT examination (Brody et al., 2007).   
A number of helical CT protocols, for both the adult and paediatric ATOM phantoms, made 
use of automatic tube current modulation, in which the tube current values varied during the 
examination to reduce dose to the patient whilst maintaining adequate image quality, this in 
turn had an effect on organ and effective doses.  In this thesis, X-Y-Z tube current modulation 
was used, but the effects on organ absorbed and ED for adult phantom as the rotation time 
changed from 0.5 to 1.0 (S) almost doubled, see (Table 6-5) and (Figure 6-2) on page 133.  For 
example, scanning the adult phantom brain with ‘high quality’ tube current modulation the 
effective dose was 0.71 and 1.17 mSv, respectively.  The ED data does not, however, follow 
the same trend for the paediatric data, see (Table 6-13) and (Figure 6-10) on page 141.  By 
investigating the ATCM function for both adult and paediatric brain protocols, it appears that 
the tube current modulation was not functioning correctly for the majority of the adult brain 
protocols, see (Figure 6-1) on page 129.  The most recent report from the quality control tests 
performed on the Toshiba CT scanner used in this thesis indicated that the ATCM was working 
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within expected tolerances during the study period.  Possible reasons behind the functionality 
issues for the ATCM are likely to be related to the construction of the phantom and the lack of 
anatomical noise (i.e. brain structures).  ATCM, for a Toshiba scanner, is based on expected 
noise values (SD) and it is possible that the ATCM system was not able to distinguish between 
the regions of highest and lowest attenuations.  Toshiba uses a combined system called Sure 
Exposure 3D.  This ACTM system makes use of the frontal and lateral patient diameters and 
the detector intensities from the scout view to account for the oscillating tube current 
modulation during each gantry rotation.  The system allows the operator to define the range 
within which the tube current can be modulated by selecting minimum and maximum mA 
limits.  A clinical CT examination often covers different anatomic regions with variable 
attenuation values.  Since the tube current is selected based on the region with the highest 
attenuation or the region that requires the highest image quality, the tube current is usually set 
to a high level when an ATCM system is not in use.  Toshiba uses three different values of Sure 
Exposure 3D (ATCM), High Quality [SD 1.80], Standard [SD 2.00], Low Dose [SD 2.20] and 
also the same parameters with different values of SD, High Quality [SD 4.00], Standard SD 
[6.00] and Low Dose [SD 8.00] for adult and paediatric protocols, respectively.  The effective 
dose calculations for the three parameters for the adult phantom were almost identical 0.71, 
0.70 and 0.70 mSv, respectively with a <1% difference, see (Table 6-8) and (Figure 6-5) on 
page 135.  The percentage difference in effective dose values between detail and standard 
helical pitch factors were very small (approximately 11%), however, there was large percentage 
difference in effective dose between detail and fast helical pitch factors (around 35% reduction) 
as illustrated by (Table 6-7) and (Figure 6-4) on page 135.  The calculated ED reductions based 
on the paediatric phantom and the selected mA modulation values represent a larger difference 
in dose reduction, 47% and 66% between high quality and standard and high quality and low 
dose, respectively as shown in (Table 6-16) and (Figure 6-13) on page 144.  The helical pitch 
factors represent a small percentage difference in effective dose between detail and standard 
and detail and fast (15% and 21%, respectively) as shown in (Table 6-15) and (Figure 6-12) 
on page 143.  This reduction is related to the time that the X-ray beam is on, for a fast pitch the 
anatomy is covered quicker and the resultant dose to the patient is decreased.  Papadakis et al. 
(2008) conducted study to assess the potential of a modern X, Y, Z ATCM system and fixed 
tube current (in a paediatric phantom, tube current (83 mAs) and effective tube current (mAseff) 
/ quality 150 and in the adult phantom tube current (176 mAs) and effective tube current 
(mAseff) / quality 320) for CT head dose reduction in paediatric and adult MSCT.  In AP 
ATCM scans, the dose reduction ranged between 15.4 and 30.9% for a 1 year old, and 15.5 and 
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57.4% for adult.  In lateral ATCM scans, the corresponding dose reduction ranged between 27.2 
and 35.7% and 15.0 and 61.7%, respectively.  Similar results were achieved by Papadakis et al. 
in 2011, they again estimated the effective dose associated with fixed tube current and ATCM 
examinations and the relationship between the average reduction of tube current achieved by 
ATCM and the reductions in organ and effective dose.  The percent organ dose reduction 
achieved when ATCM was activated in standard head and neck CT scans and ranged from 8.1% 
to 63.8% for a 1-year-old and 16.3% to 50.1% for an adult.  Using the 1-year-old phantom, the 
ED values ranged from 1.71 to 2.82 mSv for fixed tube current and 0.99 to 2.38 mSv for ATCM 
scans.  In the adult phantom, the ED ranged from 3.39 to 8.06 mSv for fixed tube current and 
2.28 to 3.83 mSv for ATCM scans.  Mean mAs reduction was linearly related to the ED 
reduction (r2 = 0.807, P < 0.0001).  The absolute percentage difference between % tube current 
and %EDMEAS reduction was in most cases higher than 15%. 
7.7 Helical and Sequential Protocols 
The typical clinical adult protocols used for the dose calculations included helical and sequential CT 
brain examination.  Helical and sequential CT scanning are both routine ways of imaging the 
brain.  While helical scanning offers better multi-planar imaging operations, sequential 
scanning provides over-ranging free measurements and reduces z-axis blur.  The examinations 
were performed with a tilted gantry to minimise dose to the lens of the eye as this is the standard clinical 
protocol.  It is useful to examine the extent of the differences between the protocols when calculating 
adult CT doses.  When evaluating differences between the maximum and minimum effective doses, the 
largest ratios were observed in helical CT protocol examinations, where the max/min ratios were 0.71 
and 0.43 mSv, respectively, see helical protocols ED in (Appendix D) within (Table D - 1) to 
(Table D - 6) and (Figure D - 1) to (Figure D - 5) on pages 222 to 230 and the sequential 
protocols ED results in (Appendix E) within (Table E - 1) to (Table E - 3) and (Figure E - 1) 
to (Figure E - 4) on pages 231 to 233.  The spiral CT scanning resulted in large increases in 
ED due to large number of examinations performed and the average ‘scanned patient volume’ 
per examination, whereas the maximum and minimum ED calculated for sequential protocols 
were 0.31 and 0.51 mSv, respectively.  In this study, helical scanning demonstrates wide 
variations in the radiation dose across the different protocols when compared to similar 
sequential CT brain examinations.  As expected, the CT protocol used can dramatically affect 
the radiation dose received during a single CT examination, and this has a significant effect on 
annual population doses which may in turn lead to significant changes in the likelihood of 
adverse biologic changes due to exposure to medical radiation (Moorin et al., 2013).  This is 
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particularly important when considering patients that may have multiple CT scans.  Similar 
findings  in a study conducted by Bischoff et al. (2010) state that although the sequential 
scanning mode significantly reduced radiation dose by 68% relative to the helical mode from 
11.2 mSv to 3.6mSv (p <0.001), the median diagnostic image quality scores were comparable 
in both groups (Bischoff et al., 2010). 
As discussed in (Section 7.3) from this chapter, both the organ location in a phantom and the 
scan length difference between the child and adult will affect the absorbed dose to organs at the 
periphery of the imaging volume.  Lechel et al. (2009) had similar findings with respect to 
organs on the border or partly inside the scan volume.  In this work, they recommended that 
organ absorbed dose comparisons between different protocols could only be reliably made for 
those organs completely irradiated in both phantoms.  Also, Li et al. (2011) and Turner et al. 
(2011) confirmed this finding for brain CT examinations.  As stated by Van der Molen and 
Geleijns (2007), another important factor that affects the absorbed dose to organs at the start 
and end of a scan volume is the additional length included for data interpolation for helical 
examinations.  The exposed length is longer than the imaged length and this depends on the 
pitch, beam collimation and reconstruction algorithm.  For example, the over-ranging length 
for a pitch of 1-1.25 is approximately 5-6 cm (van der Molen and Geleijns, 2007), with half of 
this length added to each end of the scan. 
The effects of over-ranging on absorbed dose due to the use of helical CT protocols assessed in 
this thesis and is clearly demonstrated on the dosimeter measurements that show the additional 
doses outside of the imaged scan volume are higher for helical examinations compared to 
sequential examinations.  However, in helical CT examinations the scan volume was uniformly 
irradiated from all directions by a beam with constant output and a continuously moving table.  
The absorbed dose measured in this thesis to the organs outside the scan volume for common 
helical brain CT protocol were almost doubled when considered against those from sequential 
protocols (the absorbed dose to eyes, oral mucosa and salivary glands were 58.11, 5.30, 5.32 
mGy and 39.15, 2.56, 2.57 mGy for helical and sequential protocols, respectively).  
7.8 Effective Dose (mSv) 
Although the overall effective dose (ED) reflects a patient’s exposure to radiation, organ-
specific doses may be more appropriate when estimating the lifetime cancer risk for non-
uniform exposures such as CT.  For example, if a patient undergoes an imaging study that 
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radiates only the brain, the patient's risk of cancer from that examination will primarily reflect 
the increased risk of brain cancer and that of the other organs as well.   
The ED quantity was created in order to provide a metric that was related to the probability of 
health detriment due to stochastic effects from exposure to low doses of ionizing radiation.  
More reliance is often placed on ED values and risk estimates based on ED. Martin (2014) 
reviewed the uncertainties in the estimated values of ED and the associated risk coefficients for 
a reference patient in order to provide an indication of how much reliance can be placed on ED 
as an indicator of patient risk.  There are uncertainties in the quantity ED that has been employed 
in many applications for which it was never intended and much greater accuracy has been 
attributed to it than is justified (Martin, 2014).  ED is not intended to provide an individual 
(personalised) dose, but the dose to a reference (average) person.  The relative uncertainty in 
estimated values of ED for medical exposures for a reference patient is seen to be about ±40%.  
It is therefore reasonable that ED should only be used to assess and compare the relative risks 
for a ‘reference’ patient, which are then described in general terms such as low, very low, 
minimal and negligible.  The estimated risk of cancer may be a factor of three higher or lower 
when applied to a reference patient, and will be more variable when applied to an individual 
with height and weight variations (Martin, 2014).  
Peer-reviewed scientific literature on radiation dosimetry, published between 1980 and 2007, 
providing values of ED relating to adults were reviewed by Mettler et al. (2008).  They 
concluded that the representative values and ranges of EDs reported in the literature for various 
examinations and procedures wee 0.9 – 4.0 mSv and the average ED was 2 mSv, depending on 
the technical factors (voltage and/or tube current–time product and pitch factor).  It was also 
reported that EDs to the neonate, for a head CT examination, were markedly higher than for 
adults, the EDs are usually within 50% of the adult dose.  The ED calculated in this thesis were 
much lower than mentioned above and ranged from 0.54 – 1.8 mSv and 0.30 – 1.1 mSv for 
adult brain CT helical and sequential protocols, respectively, and according to the protocol 
parameters used.  Whereas the calculated ED for helical paediatric protocols ranged from 0.40 
to 2.1 mSv dependent in the protocol setting used.  However, ED is a calculated as an all organs-
averaged value that is used as a robust measure to compare detriment from cancer and 
hereditary effects due to various procedures involving ionizing radiation.  Martin (2007), has 
pointed out a number of limitations in its use, including about 40% uncertainty for a reference 
‘average’ patient. 
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In a study by Christner et al. (2010), two common methods used to estimate ED for adult CT 
examinations were compared: first, the gold standard method using MC simulations based on 
organ dose estimates that explicitly uses tissue-weighting coefficients as specified by ICRP; 
and, second, the computationally more simple method based on the DLP and a DLP to ED 
conversion coefficient, referred to as “k,” which depends on only the an atomic region 
examined.  Their compared results of ED for head CT calculations based in MC simulations 
and those calculated from DLP and k coefficients, results ranged from 0.4 - 0.9 mSv and from 
0.5 – 1.3 mSv, respectively.  These results are more or less very comparable to the results 
obtained in this thesis for adult helical brain CT protocols (0.43 – 1.5 mSv). 
Using a standard head CT protocol, the ED for a 1-year old was calculated by Papadakis et al. 
(2011), using two different methods. The first was based on the DLP concept.  The second 
method was based on the measurement of the absorbed dose in all radiosensitive organs of each 
phantom using TLDs.  ED measured with TLDs was 1 mSv whereas that calculated from DLP 
was 3.4 mSv.  The measured ED based on absorbed dose calculations fall within the range of 
ED doses measured within this thesis, however, the ED dose estimated using DLP was higher 
by 88.2% and 38.2% above the minimum and maximum rage measured in this thesis (0.4 – 2.1 
mSv).  
McCollough et al. (2012) reported on a CT community summit which brought together 
participants from academia, clinical practice, industry, and regulatory and funding agencies to 
identify the steps required to reduce the effective dose from routine CT examinations to less 
than 1 mSv, which is below annual background levels of ionizing radiation.  They stated that 
scanner settings must be tailored to the size of the individual patient, ED is defined for scanner 
output values (volume CT dose index values) appropriate to an individual of similar size and 
shape as the ICRP’s reference person (a 70–80-kg adult).  This yields typical ED values of 1–2 
mSv for routine head CT.  The ED measured within this thesis was in the range supported by 
this report (0.43 – 1.5 mSv and 0.40 – 2.1 mSv for adult and paediatrics, respectively). 
Also, the summit members stated that, current commercially available techniques such as 
ATCM, optimization of tube potential, beam-shaping filters, and dynamic z-axis collimators 
are important, and education to successfully implement these methods routinely is critically 
needed.  Other methods that are just becoming widely available, such as iterative reconstruction, 
noise reduction, and post-processing algorithms, will also have an important role.  Together, 
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these existing techniques can reduce dose by a factor of two to four and should be incorporated 
into routine clinical practice.  
As mentioned previously the literature reported that tube current is the most important 
parameter in CT that effects radiation dose followed by tube rotation time and tube kilovoltage.  
This is consistent with the findings from this thesis, where the increase in tube current led to an 
increase in ED which was proportional to the mA used (ED increased from 1.8 to 3.1 mSv, as 
the mA changed from 120 to 200, when other parameters were kept consistent).  Whereas 
changing the tube rotation time from 0.5 to 1 seconds, with 100kV and 100 mA, the ED value 
almost doubled (1.3 mSv and 2.4 mSv, respectively).  However, the tube potential change from 
100 kV to 120 kV, lead to increase in effective dose from 1.3 to 1.8 mSv, respectively.  For the 
paediatric results reported in this thesis, manipulating the tube current values from 100, 120 to 
200 mA resulted in an ED increase ranging from 38.5% to 61.5%.  Whereas changing the 
rotation time from 0.5, 0.75 to 1 seconds, the ED dose increase ranged from 22.2% to 84.5% 
when other parameters were kept consistent. However, changing the tube potential from 100 
kV to 120 kV was resulted in ED increase by 38.5%.  Whereas in study by McCollough et al. 
(2012) switching tube potentials from 80 and 100 kV allowed for a dose reduction of up to 50% 
compared with a tube potential of 120 kV. 
The ICRP defines ED as a parameter for expressing stochastic risk from radiation exposure and 
recommends its use only for radiation protection purposes (ICRP, 2007b).  However, effective 
dose has found widespread application in evaluating doses from medical exposure due to its 
effectiveness in condensing a complex set of parameters for any exposure situation into a single 
quantity (McCollough et al., 2010).  It is routinely used to compare doses resulting from 
variations in protocols or from different modalities.  However, while taking into account the 
nature of the exposure, characteristics of specific individuals are not considered.  Hence, 
effective dose provides a broad, generic estimate and is an indication only of the typical dose.  
Although it should not be applied to the individual, it is often used for dose assessments 
following radiation incident and other situations involving specific patients to express a relative 
risk.  
ED, as reported by Wall et al. (2011), has several limitations when applied to medical 
populations.  There are a number of important limitations in using ED for further details see 
(Chapter 4 section 4.5) on page 73.  ED (and ICRP’s nominal probability coefficients for 
radiation-induced cancer and heritable effects) should not be used to assess risks to individual 
 176 
 
patients of specific age, sex and nationality.  These are applications for which it was not 
intended.  It can, however, be a valuable tool for comparing the doses (and risks of aggregated 
detriment) to a reference person (of ‘average’ age, gender and nationality) from different 
medical diagnostic procedures and from other sources of radiation exposure (Martin, 2014). 
Risk estimates based on ED are highly generic and include, for example, hereditary effects that 
are unlikely to be significant at doses relevant to diagnostic radiology.  In addition, the 
weighting factors used in the calculation of ED do not take into account the strong variations 
of radiosensitivity with age and gender (Hall & Brenner, 2008) and as such newer methods are 
required.  A number of national and international bodies have developed radiation risk models 
in recent years from which it is possible to calculate the lifetime risks of radiation-induced 
cancer as a function of the age and sex of the exposed person (BEIR VII, 2006; UNSCEAR, 
2006; ICRP, 2007).  All three models are primarily based on the same epidemiological data 
from the Japanese atomic bomb survivors’ lifespan study (LSS) but with some significant 
differences in the risk projection and transfer models used by the three bodies (brief summaries 
of the main features of the risk models developed by ICRP, BEIR and UNSCEAR are given 
elsewhere by Wall et al. (2011)).  The dependence of the radiation-induced cancer risk on sex 
and age at exposure varies with cancer sites in all three models.  In this thesis, the BEIR risk 
models described in BEIR Publication VII (BEIR, 2006) were used to calculate the lifetime 
risks of radiation-induced cancer per unit dose as a function of organ, sex and age at exposure.  
The BEIR models were chosen because they are from a recognised international authority on 
radiation protection and provide a nominal probability coefficient for radiation-induced cancer 
for an age range from 0 to 80 years, for male and female persons.  
Typical CT doses and associated radiation risks are not well understood.  Primarily this is 
because the doses are not accurately known or easily calculated.  Furthermore, there are large 
uncertainties, in addition to a lack of consensus, regarding the risk from radiation exposure at 
low doses.  The BEIR VII Report supports the linear no threshold (LNT) model as the best 
descriptor of the relationship between solid cancer incidence and low dose radiation exposure 
(NRC, 2006).  The LNT theory is widely accepted (Brenner et al., 2003) as the most plausible 
model for radiation induced cancers for low dose exposures and is also adopted by the 
International Commission on Radiological Protection (ICRP) as the basis of the international 
system of radiation protection (ICRP, 2007b). 
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Cancer risk estimation based on BEIR VII modelling is limited by the uncertainties that exist 
from using the Life Span Study (LSS) data to derive radiation induced cancer risk.  The sources 
of uncertainty arise from transporting the cancer incidence and mortality from the Japanese 
atomic bomb survivors to a Western population.  Furthermore, the biggest source of uncertainty 
involves the LSS data being extrapolated to low dose and different dose rate exposure 
situations.  The risk modelling of BEIR VII is also affected by sampling variability in the model 
parameter estimates for the LSS data.  Despite these inherent uncertainties, one of the most 
useful applications of the BEIR VII radiation risk models is for estimating the detriment from 
exposure situations where doses differ substantially across the body.  The data is particularly 
useful in these situations i.e. CT brain examinations.  The BEIR VII data develops risk estimates 
for cancer from exposure to low-level ionizing radiation using the most current data and 
epidemiological models available, incorporating data from atomic bomb survivor studies as 
well as medical and occupational radiation studies.  Its review of available data supports the so-
called linear no-threshold (LNT) risk model for low-dose exposures to low linear energy 
transfer radiation such as X-rays, whereby the risk of cancer proceeds in linear fashion with no 
lower threshold.   Other studies have also applied the BEIR VII attributable cancer risks to CT 
exposures on the basis that it is the best method currently available (Little et al., 2009; 
Berrington et al., 2009; Brenner et al., 2001a; Brenner and Hall, 2007; Einstein et al., 2007a; 
Smith-Bindman et al., 2009). 
There are conflicting opinions in the literature between those who believe that low radiation 
doses are more damaging than in a linear model; there are also those who believe that low 
radiation doses are less damaging than a linear model would predict or even that they are 
beneficial (Hall & Brenner, 2008).  However, it is not necessary to take a position on this LNT 
controversy because the doses involved in CT scans, which account for the majority of the 
collective dose from diagnostic radiology, are just within the range where we have credible and 
direct epidemiological evidence for an increased cancer risk in human populations (ICRP, 1991 
& 2005; ANS, 2001; BEIR, 2006; Andrew et al., 2007; Hall & Brenner, 2008). 
This thesis is the first study to investigate the cancer risks associated with specific CT protocols, 
full details of these risk will be discussion in (Section 7.9).  Data was collected for brain CT 
examinations for adults and paediatrics.  Cancer risk gives a much more individualised risk 
estimate and is a new approach which enables easily accessible information of the risk 
associated with a protocol to be ascertained by practitioners prospectively.  Although this data 
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was limited to brain CT examinations, the methodological principle for the collection and 
presentation of data could be applied to other types of CT scan.  In this thesis, the cancer risks 
associated with the radiation exposures from brain CT scans are calculated by measuring the 
organ doses involved as a function of age, gender and type of CT exam, and then applying 
estimates of age, gender, and organ specific risk-per-unit dose data that were ultimately derived 
from atom bomb survivors.   Therefore, the risk estimates on an organ-by-organ basis, and 
finally, simply summed up the estimated risks for all the different organs, see (Method 
section 5.9) on page 119.  As discussed by Hall & Brenner, (2008) the organ doses for a typical 
CT study involving two or three scans are in the range where there is direct statistically 
significant evidence of increased cancer risk, and thus the corresponding CT-related risks can 
be directly assessed from epidemiological data, without the need to extrapolate measured risks 
to lower doses. 
7.9 Effective Risk 
CT accounts for only 5% of all X-ray examinations but represents between 40% and 67% of 
the total medical radiation dose received by the population (Bernier et al., 2012).  Owing to the 
ease and speed of image acquisition linked to technological developments, proliferation of 
procedures has occurred and in turn has led to increased doses to patients.  Ionising radiation 
from CT has become a public health concern, as there is a possible attributable future cancer 
risk (Bernier et al., 2012).  Assessment of cancer risk after childhood radiation exposure 
remains a concern regardless of the radioprotection used for children.  Children actually present 
an increased radiosensitivity of certain tissues compared with that of adults, which, combined 
with a longer life expectancy, could generate a greater cancer incidence (Bernier et al., 2012). 
Hall and Brenner (2008) reported that ED is the only quantity available that provides a dose 
metric related to the risk of health detriment.  It is argued that to define a new, simple, less 
confusing, easy-to-estimate quantity, based on defensible science, which more directly does the 
job of comparing the risks associated with different inhomogeneous doses, the new quantity 
should not only refer to cancer risks but should also be age dependent, or at least distinguish 
between paediatric and adult risks.  These are the properties that one would ideally want of a 
quantity describing low-dose radiation risks from an inhomogeneous dose distribution, which 
would allow science-based comparisons between different exposure scenarios. 
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The risk to an individual from brain CT exposures is assessed from the mean absorbed dose to 
radiosensitive organs and tissues.  Since the probability of cancer induction depends on the 
anatomy exposed, the level of exposure and the age and gender of the individual, these factors 
were also considered within this thesis (ICRP, 2007a).  The absorbed dose homogeneity in an 
organ or tissue depends on the exposure situation and also the size or physical distribution of 
that organ or tissue in the phantom.  For CT examinations, the exposure is a partial irradiation 
of the body which leads to heterogeneity of the absorbed dose distribution in some organs and 
tissues, particularly those that are not completely located within the scan volume.  Furthermore, 
distributed tissues such as the skin and bone marrow will always exhibit a varying absorbed 
dose distribution for CT examinations due to the nature of the exposure.  Consequently, these 
factors contribute to the difficulty and variability in CT organ dosimetry.  Pearce et al. (2012), 
reported that the most recent risk projections suggest that, for children with normal life 
expectancy, the lifetime excess risk of any incidence of cancer for a head CT scan (with typical 
dose levels used in the USA) is about one cancer case per 1000 head CT scans for young 
children (<5 years), decreasing to about one cancer per 2000 scans for exposure at age 15 years.  
The estimated number of CT scans that will lead to the development of a cancer varied widely 
depending on the specific type of CT examination (protocol variations) and the patient’s age 
and gender.  An estimated 1 in 8100 women who had a routine head CT scan at age 40 years (1 
in 11 080 men).  For 20-year-old patients, the risks were approximately doubled, and for 60-
year-old patients, they were approximately 50% lower (Smith-Bindman et al., 2010).  The 
lifetime cancer risk of any incidence of cancer for brain CT estimated in this thesis, for 0 years 
old child was ranged from 21 – 102 and 7 – 46 cases per million for females and males, 
respectively.  
The risk of exposure will also depend on the type of radiation, expressed by the equivalent dose 
that represent the absorbed dose multiplied by the radiation weighting factor (ICRP, 2007b), 
although for CT scan examinations this is numerically equal to the absorbed dose.  The effective 
dose reflects the combined detriment from the risk of stochastic effects in different organs and 
tissues averaged over all ages and both genders.  The ICRP makes recommendations regarding 
radiation and tissue weighting factors, which are revised to take account of new scientific 
information regarding the biological effectiveness of radiation and tissue and organ 
radiosensitivity.  The recommendations in ICRP Publication 60 (ICRP, 1991) have been in use 
for many years and these have been revised in ICRP Publication 103 (ICRP, 2007b). 
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In the clinical environment of diagnostic radiology, it is beneficial to estimate both absorbed 
dose and ED from CT examinations for assessment of risk and to reduce the dose to the patient.  
Furthermore, the need for epidemiological research studies has been highlighted by the BEIR 
VII Report (NRC, 2006), especially to follow-up children receiving CT examinations.  Several 
studies have investigated the effects of low dose radiation (Bernier et al., 2012; Hricak et al., 
2011; Pearce et al., 2011) and these require consideration for paediatric CT doses.  Therefore, 
CT dose calculation methods that are applicable to children are required in both the clinical and 
research contexts. 
Direct methods of estimating CT dose have been investigated in this thesis.  Actual clinical 
scenarios have been evaluated by using typical CT protocols that a one-year old child may 
undergo at a children's hospital as well as adult protocols (helical and sequential).  According 
to this there are several important influencing factors on the directly measured and calculated 
absorbed doses that need to be considered.  Consequently, these include the models that can be 
used to represent the organs and their position in the body, the type or model of CT scanner 
being used and/or modelled in the calculation and the scan parameters used in simulating the 
X-ray exposure.  As reported in the literature the clinical conditions could not be matched 
exactly in the computational methods and therefore various assumptions and approximations 
had to be made.  Consequently, the variables associated with each method could not be strictly 
controlled, but rather the conditions that have been used for each method provide the closest 
match to the clinical scenario (Lee et al., 2011).  Effective risk is more defensible than the 
effective dose, which would be easier to interpret: it would be an effective lifetime radiation-
attributable cancer risk (‘‘× per 1 000 000’’ individuals).   
As illustrated in results chapter 6 (Section 6.6) on page 152, the effective risk was calculated 
using the BEIR VII (2006) risk estimates which provides a method to estimate a cancer based 
on the magnitude of a single radiation exposure and a patient’s age at the time of that exposure.  
This thesis estimated the number of patients undergoing CT that would lead to the development 
of radiation-induced cancer, by type of CT brain examination, age at the time of exposure, and 
gender.  The derived number of cancer incidence cases using the BEIR VII report indicates a 
substantially higher lifetime attributable risk of cancer incidence in females compared with 
males, and also in younger patients as illustrated by (Table 6-23), (Table 6-24) and 
(Figure 6-21) to (Figure 6-23) on pages 152 to 155.  For example, the number of lifetime risks 
calculated in this thesis at birth was 102 and 46 case/1 000 000 for females and males, 
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respectively and the lifetime risk at birth and 30-years for females were 102 and 7 cases/ 
1000000, respectively.  As indicated by Brody et al. (2007) there is a difference in cancer risk 
from radiation exposure to children when compared with adults.  He suggested several reasons 
for this difference.  First, for the most part, tissues and organs that are growing and developing 
are more sensitive to radiation effects than those that are fully mature.  Second, the oncogenic 
effect of radiation may have a long (for example, decades) latent period.  This latent period 
varies with the type of malignancy.  Leukemia has a shorter period (approximately ≤10 years) 
than solid malignancies.  An infant or child, therefore, has a longer life expectancy in which to 
manifest the potential oncogenic effects of radiation compared with older adults. For example, 
a solid radiation-induced malignancy with a 30-year latent period will more likely occur in a 
10-year-old than in a 50-year-old, on the basis of life expectancy.  Also, they summarized the 
radiation cancer risk at different ages and stated that those exposed at 50 years of age have 
approximately one third of the risk of a 30-year-old and that “projection of lifetime risks for 
those exposed at age 10 is more uncertain.  Third, in the case of CT scanning, the radiation 
exposure from a fixed set of CT parameters results in a dose that is relatively higher for a child’s 
smaller cross-sectional area compared with an adult.   A cohort study by Krille et al. (2015) was 
taken to assess the risk of developing cancer, specifically leukaemia, tumours of the central 
nervous system and lymphoma, before the age of 15 years in children previously exposed to 
CT in Germany.  Data for children with at least one CT between 1980 and 2010 were extracted 
from 20 hospitals.  Cancer cases occurring between 1980 and 2010 were identified by stochastic 
linkage with the German Childhood Cancer Registry (GCCR).  Cases were only included if 
diagnosis occurred at least 2 years after the first CT and no signs of cancer were recorded in the 
radiology reports.  The cohort included information on 71,073 CT examinations in 44,584 
children contributing 161,407 person-years at risk with 46 cases initially identified through 
linkage with the GCCR. 
Radiation doses have varied significantly between the different types of CT studies.  As 
reported in the literature the overall median effective doses ranged from 2 millisieverts (mSv) 
for a routine head CT scan to 31 mSv for a multiphase abdomen and pelvis CT scan (depending 
on the scan protocol) (Smith-Bindman et al., 2009).  Within each type of CT study, effective 
doses varied significantly within and across institutions, with a mean 13-fold variation between 
the highest and lowest dose for each study type (McCollough et al., 2009; Smith-Bindman et 
al., 2009).  The estimated number of CT scans that will lead to the development of a cancer 
varied widely depending on the specific type of CT examination and the patient’s age and 
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gender.  In this thesis, an estimated 6 in 106 women who underwent a single helical CT head 
scan at the age of 40 years would develop cancer as a result of having that CT scan (5 in 106 
men), compared with an estimated 3 in 106 women who had a routine (sequential) head CT scan 
at the same age (2 in 106 men).  For 20-year-old patients and less, the risks were approximately 
doubled, and for 60-year-old patients and more, they were approximately 93% lower.  
According to the example above, an important aspect of risk calculation is to push the concept 
that we should not only consider risk associated with one CT examination but also for serial CT 
imaging in patients i.e. those with hydrocephalus. 
The calculated cancer incidence risk for CT brain examinations were also applied to the entire 
0-80 years age group, see appendix I, (Table I - 1) on page 245 and appendix J, (Table J - 1) 
on pages 248.  As the data was obtained using an ATOM phantom representing a one-year old 
child they were utilised to calculate the risk for ages of 0 and 5 years and adult phantom data 
for ages from 10 to 80 years, the risks will be underestimated for infants, whilst being 
overestimated for adolescents and hence will provide an intermediate estimate of the level of 
risk for the entire protocols.  In addition to reduced CT parameters for younger, smaller children 
and higher site-specific radiation risk coefficients for younger children, there can also be 
variations in different organs with age.  For example, almost all bone marrow is active (red 
bone marrow) at birth and with age gradually becomes inactive, with only about a third 
remaining active in adulthood (ICRP, 2002).  Therefore, the bone marrow absorbed dose which 
directly correlates with risk of cancer incidence will vary with age, particularly in childhood.  
The radiation risks calculated for a CT scan undertaken on a phantom representing a one-year 
old child provides a reasonable benchmark for the average risk across the 0-5-year age band.  
The radiation risks calculated for a CT scan using an adult phantom is more suitable for the 
average risk across the age band from 10-80 years.   
As discussed in chapter 4 (Section 4.6) on page 78, paediatric CT is different from adult CT 
and also from any other sort of radiological examinations.  The organ doses are clearly higher 
for children than for adults.  Also, paediatric CT is increasing in frequency quite rapidly and 
probably more so than adult CT, and children are much more sensitive to radiation-induced 
cancer than adults (McCollough et al., 2009; Muhogora et al., 2010).  Brenner et al. (2007), 
estimated that more than 62 million CT scans per year are currently performed in the United 
States, including at least 4 million on children.  The growth of CT in paediatrics has been driven 
primarily by the decrease in the time needed to perform a scan (now less than 1 second) and 
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has largely eliminating the need for anaesthesia to prevent the child from moving during image 
acquisition.  According to McDermott et al. (2009), approximately 2.7 million CT examinations 
were performed on paediatric patients under the age of 15 years, and about one-third of children 
who undergo CT will have three or more examinations.  Multiple CT examinations expose 
patients to increased radiation dose, which is a concern to the medical community (McDermott 
et al., 2009).  As mentioned by Dougeni et al., (2012), monitoring trends in CT dose is currently 
particularly important, especially in paediatrics, as the technology is evolving rapidly.  The 
organ doses delivered from a common CT scan result in an increased risk of radiation induced 
carcinogenesis, particularly for children (Dougeni et al., 2012).  According to the BEIR VII 
report, developing and growing organs are more sensitive to radiation than those that are fully 
mature, which in addition to a longer life expectancy, and possible increased repeated 
examinations, produces a greater paediatric risk of potential radiation damage.  Brenner et al. 
(2001), reported a paediatric fatal cancer risk of 0.11% and 0.055% (approximately 1 in 900 
and 1 in 1800) for abdominal or head CT respectively, for a single slice CT scan of a 1-year old 
child.  CT is of particular interest because of its relatively high radiation dose and wide use.  
Consensus statements on radiation risk suggest that it is reasonable to act on the assumption 
that low-level radiation may have a small risk of causing cancer.  However, the medical 
community should seek ways to decrease radiation exposure by using radiation doses as low as 
reasonably achievable and by performing these studies only when necessary (Strauss & Kaste, 
2006; Brody et al., 2007).  There is wide agreement that the benefits of clinically justified CT 
scan far outweigh the risks.  Paediatric health care professionals’ roles in the use of CT on 
children include deciding when a CT scan is justified and discussing the risk with patients and 
families.  Radiologists should be a source of consultation when forming imaging strategies and 
should create specific protocols, in conjunction with radiographers, regarding the scanning 
techniques optimised for paediatric patients.  Families and patients should be encouraged to ask 
questions about the risks and benefits of CT scanning (Brody et al., 2007). 
Organ doses are larger in a child when compared to an adult.  For example, if an organ located 
on the proximal side of the body relative to the X-ray source it will receive roughly the same 
dose in both adult and child.  However, as the X-ray source rotates, that same organ will be on 
the distal side of the body relative to the X-ray source; now that organ is partly shielded by the 
body tissue proximal to it, reducing the organ dose.  But for this reduction in dose, partial 
shielding will be much less for a thin individual, such as a child, compared to a thicker adult.  
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Also, there is a need to think about the issue of multiple CT scans in patients.  Data reported by 
Brenner, (2002) showed that, 30% of patients who undergo CT have at least 3 scans, 7% have 
at least 5, and 4% have at least 9.  In study by Krille et al., (2015), data capture from more than 
44,584 patients from 20 hospitals; generated 71,073 eligible examinations and 161,407 person-
years of data with a mean follow-up of 4.1 years.  About 71% of the cohort were only exposed 
to one CT and 7% had four or more CTs with a maximum of 49 CT examinations (a case of 
hydrocephalus).  37% of all CT scans were performed in children younger than 5 years, 29% 
in children aged 5–<10 years and 34% in children aged 10–<15 years.  Among children who 
had only one CT, 68% had received head CTs and 10% chest CTs.  Among those with more 
than one CT, about 76% had received at least one head CT.  Based on the published doses by 
Miglioretti et al. (2013), average cumulative radiation doses of 11.7 mGy were estimated here 
for the bone marrow, 34.4 mGy for the brain and 5.8 mGy for the colon per person in the cohort.  
Thus, to better understand the cumulative dose and risk from multiple CT scans, the dose should 
be multiplied by the number of CT scans that any given individual will have.  Accordingly, 
clinical scenarios can be simulated to predict the cumulative lifetime risk of cancer from 
commonly used Toshiba Aquilion paediatric CT brain protocols presented in (Table 7-1) 
below: 
Table 7-1: Toshiba Aquillion protocols for paediatric CT head scans 
Size of child kV mA Rotation Time Helical/axial Acquisition Slice Thickness
3mths - 3years 100 180 0.5 Helical 0.5 
3 - 5 years 100 200 0.75 Helical 0.5 
6 – 12 years 120 200 0.75 Helical 0.5 
First scenario (trauma), if a 7-year-old girl was riding a bike and suddenly fell and injured her 
head and was admitted to the Emergency Department at her local hospital.  On admission, she 
was transferred to the X-ray department for a brain CT scan.  In this case, for Toshiba CT 
scanner the protocol that would have to be used is a helical brain CT (6 – 12 years).  In this 
thesis, the effective dose calculated for this protocol was 3.58 mSv and the estimated lifetime 
cancer risk is in the range from 107 to 77 per 106 for 5 and 10 years, respectively.  If she 
deteriorated then she might undergo for a follow-up scan, still as an in-patient, to evaluate the 
situation further and then possibly a follow-up scan after 6 months.  This means that both her 
cumulative effective dose (10.74 mSv) and lifetime cancer risk (321 to 231 per 106 for 5 and 
10 years, respectively) would rise by factor of 3.   
Second scenario, in the case of a suspected space occupying lesion, if a 5-year-old boy 
presented complaining of a headache and a recent seizure he is then likely to be referred for an 
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urgent brain CT scan.  According to his age a brain CT protocol for 3 – 5 year old’s would be 
used.  The calculated effective dose for this protocol is 2.41 mSv and the estimated lifetime 
cancer risk is 35 per 106.  If he was admitted to hospital for surgery, a pre-operative CT brain 
scan is likely to be required to guide the surgeon and after surgery a CT brain scan might be 
performed to look for complications.  He could then have another CT scan after six months for 
follow up.  All these scans will increase the cumulative effective dose (9.64 mSv) and lifetime 
cancer risk (140 per 106) by factor of 4.   
The third scenario is the case of epilepsy, for example if newborn girl is diagnosed with epilepsy 
then a CT brain scan could be performed yearly to follow up her progress.  In this case the three 
different CT protocols as described in the above table will be used.  The 3 months to 3 years 
protocol for the first three years once/year and the 3 – 5 years protocol for 2 years and 6 – 12 
years protocol for 5 years.  This could mean that her cumulative effective dose and lifetime risk 
in the first three years is 4.77 mSv and 42 – 69 per 106, respectively and when aged from 3 to 
5 years 4.82 mSv and 71 – 115 per 106, respectively.  Whereas from 6 to 10 years the cumulative 
effective dose 17.9 mSv and the risk ranged from 77 – 107 per 106.  
In contrast, if a 40-year-old man was working for a construction company and suddenly fell and 
injured his head and was admitted to the Emergency Department referred for a brain CT scan.  
In this case for the Toshiba CT scanner the protocol that would have to be used is an adult 
helical brain CT.  In this thesis, for his age and the protocol used, the effective dose would be 
1.3 mSv and the estimated lifetime cancer risk is 8 per 106.  He could go for a follow-up scan 
after 6 months.  This means the cumulative effective dose will be 2.6 mSv and the cumulative 
of lifetime cancer risk induction is 16 per 106 for 5 and 10 years, respectively.   
The risk prediction model developed for estimating lifetime cancer risk in this thesis can be 
used pre-scanning to prospectively predict the probability of inducing cancer in future 
according to the selected CT scan protocol parameters.  The data obtained and calculated for 
the two ATOM phantoms (adult and one-year old child) could be implemented to estimate the 
risk for ages from 0 to 80 years old patients, which might for children underestimate the risk to 
ages less than one year old and overestimate to ages more than one year.  This model can be 
further developed by using additional phantoms to represent the different age groups to 
calculate the lifetime cancer risk induction, and be used by CT venders to develop CT scanners 
which incorporate software algorithms for cancer risk calculations and in turn display the 
probability on the operator console.   
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As stated by Brenner and Hall (2007), the risk to the individual from diagnostic radiation 
exposure is small and in most cases, for a properly justified procedure, the benefit to the 
individual will outweigh any risk.  However, with increasing rates of CT usage the application 
of small levels of risk to a large population produces a health concern.  Based on CT usage in 
2007, it is estimated that 1.5% to 2.0% of all cancers in the US may be caused by CT imaging 
(Brenner and Hall, 2007).  The total number of CT scans in the US has increased annually by 
8% to 15%, which is a greater rate than population growth (Mettler et al., 2009, 2008; NCRP, 
2009) and similar trends are seen in the UK (Hall and Brenner, 2008).   
Potential increases in future cancer risk, attributable to the rapid expansion in CT use have been 
estimated with risk projection models, which are derived mainly from studies of survivors of 
the atomic bombs in Japan.  These studies have been criticised because of concerns about how 
applicable the findings from this group are to the relatively low doses of radiation exposure 
from CT scans and to non-Japanese populations.  Some investigators claim that there are no 
risks, or even beneficial effects, associated with low-dose radiation.  Only a few direct studies 
of cancer risk in patients who have undergone CT scans have been undertaken to date.  Pearce 
et al. (2012), conducted a study to directly assess the question of whether cancer risks are 
increased after CT scans in childhood and young adulthoods.  They assess the risks of leukaemia 
and brain tumours because they are the endpoints of greatest concern as the RBM and brain are 
highly radiosensitive tissues, especially in childhood.  Furthermore, these tissues are also some 
of the most highly exposed to ionising radiation from childhood CT scans, and leukaemias and 
brain tumours are the most common childhood cancers.    Their results show significant 
associations between the estimated radiation doses from CT scans to the RBM and brain and 
subsequent incidence of leukaemia and brain tumours.   
Assuming typical doses for scans in children aged younger than 15 years, cumulative ionising 
radiation doses from 2 to 3 head CTs (ie, ~60 mGy) could almost triple the risk of brain tumours 
and 5 to 10 head CTs (~50 mGy) could triple the risk of leukaemia.  The absorbed dose to the 
brain for an ATOM phantom representing a one-year old child ranged from 2.2 to 28.1 mGy 
depending on the individual CT brain protocol used.  This means that the cumulative absorbed 
dose for three brain CT scans would be in the region of 6.6 to 84.1 mGy and would imply a 
heightened risk of leukaemia or brain tumour induction.   
As we know, CT is a valuable diagnostic modality technique in which new clinical applications 
continue to be identified and the benefits generally outweigh individual risks.  However, as CT 
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images are easy, painless and quick to obtain, although the immediate benefit to the individual 
patient can be substantial, and since radiation doses are among the highest from all diagnostic 
procedures, the justification criteria should be reinforced and careful consideration of the use 
of CT is necessary, given the increasing frequency of such examinations, perhaps by carefully 
considering the protocol used (by simply applying the risk estimation tool created in this thesis).   
Radiologists and CT operators must understand the radiation dose estimates associated with 
this modality and the need to optimize image quality and dose for the clinical objective of the 
examination.  Careful selection of CT scan parameters is imperative to optimize the imaging 
protocol and to generate diagnostic quality CT images with the least radiation exposure.  
However, according to the scenarios mentioned above there is evidence which suggests that 
cumulative radiation exposure will increase future risk of malignancy and that it should be 
modelled and considered proactively when undertaking examinations.  This is not a finding- 
we of course know that having more scans will increase risk.  The point of this is that it enables 
practitioners to balance the protocol they use along with the projected number of CT scans that 
will be required for the patient, and therefore this enables them to clearly and simply understand 
the impact of their acquisition factors on the patients’ risk of induced cancer.   
Wiest et al. (2002) reported that in 2001, 30% of patients had more than three CT examinations 
in their medical histories, 7% had more than five examinations, and 4% had more than nine 
examinations. Specific patient populations with chronic conditions or recurrent symptoms have 
been found to have high rates of repeat imaging.  Sodickson et al. (2009), found high rates of 
recurrent CT imaging, exceeding those of Wiest et al. (2002), with 33% of patients having 
undergone more than five CT examinations, and 5% of patients having undergone at least 22 
CT examinations in their administrative database over the 22-year study period.  15% of the 
cohort had accrued cumulative CT effective doses in excess of 100 mSv, 4% receiving over 
250 mSv, and 1% receiving over 399 mSv, these are in the dose realm in which there is 
convincing epidemiologic evidence of increased cancer risk.  Their LAR calculations predict 
that CT imaging of this cohort would produce 98 additional radiation-induced cancers, 
including 62 fatal cancers.   
A cohort study was undertaken in Australia by Mathews et al. (2013), to assess the cancer risk 
in children and adolescents following exposure to low dose ionising radiation from diagnostic 
CT scans.  The study included 10.9 million people identified from Australian Medicare records, 
aged 0-19 years on 1 January 1985 or born between 1 January 1985 and 31 December 2005; all 
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exposures to CT scans were funded by Medicare during 1985-2005 and were identified for this 
cohort.  The cohort study results showed, 60 674 cancers were recorded, including 3150 in 680 
211 people exposed to a CT scan at least one year before any cancer diagnosis.  The mean 
duration of follow-up after exposure was 9.5 years.  Overall cancer incidence was 24% greater 
for exposed than for unexposed people, after accounting for age, sex, and year of birth 
(incidence rate ratio (IRR) 1.24 (95% confidence interval 1.20 to 1.29); P<0.001). They 
reported a dose-response relationship, and the IRR increased by 0.16 (0.13 to 0.19) for each 
additional CT scan.  The IRR was greater after exposure at younger ages (P<0.001).  At 1-4, 5-
9, 10-14, and 15 or more years since first exposure, IRRs were 1.35 (1.25 to 1.45), 1.25 (1.17 
to 1.34), 1.14 (1.06 to 1.22), and 1.24 (1.14 to 1.34), respectively.  The absolute excess 
incidence rate for all cancers combined was 9.38 per 100 000-person years at risk.  The average 
effective radiation dose per scan was estimated as 4.5 mSv. 
Absolute excess risk estimates are necessary to put the risks into perspective with the benefits 
of the scans.  It is essential that radiologists, radiographers and medical physicists are aware of 
the radiation doses and their lifetime cancer risks of using CT for young people, particularity 
children.  It is necessary to find the acceptable threshold of image quality with the minimum 
possible radiation exposure to the patient, in agreement with the ALARA principle.  It is worth 
reminding ourselves that in this thesis image quality has not been considered at any point; 
however, the lowest dose image cannot be accepted as image quality may not be sufficient for 
diagnostic purposes which could lead to repeat the CT scan that should be avoided at any point 
to reduce the patient cumulative dose and risk.  Patients (and carers, in the case of paediatric 
patients) should be made aware of the calculated risks corresponding to their radiological 
examination.  Thus, it is useful to have a software program that can calculate the probability of 
lifetime risk of cancer induction and display this information on CT console prior to making an 
exposure which takes into account the imaging parameters, age and gender of the patient.   
7.10 Lifetime Risk Excel Spreadsheet Calculation Tool 
In this thesis, calculated lifetime attributable risks were made for all the possible selections of 
CT brain protocols parameters by developing a Microsoft Excel workbook which included the 
functionality to enable the user to select acquisition parameters, gender, age and number of 
expected scans and see the estimated the risk of cancer induction (and absorbed eye dose) for 
the chosen CT protocol/s.  As stated the spreadsheet enables estimation based not only on 
acquisition parameters but also gender and age.  This spreadsheet is unique, in terms of the 
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philosophical concept and the data contained within it.  Although this spreadsheet is only 
applicable for the CT scanner used in this thesis, the methodological approach applied in this 
thesis could be translated to any CT scanner for any manufacturer.  Perhaps a way forwards 
would be to develop new Monte Carlo methodologies for each CT scanner, in order to provide 
anticipated estimates of effective risk specific to the actual patient (being based upon CT 
scanner characteristics, protocol specifics as well as age and gender).  Further mathematical 
modeling could also be provided, whereby the probability of further imaging could be 
introduced, thereby taking into account a scenario like ‘this patient may require 5 CT scans over 
the next year’.  As represented in the results chapter (Sections 6.6 and 6.7) on pages 152 to 155, 
the risk estimation workbook has been published alongside a brief instruction manual within an 
online data repository, this is not yet publically available (embargo period 12 months), but for 
the purpose of this thesis access has been granted to the examiners (enclosed on a CD in the 
back of this thesis, supplementary item 1).  The limitation of this workbook is it is only 
applicable to estimate the lifetime cancer risk induction for a Toshiba 16 Aquilion CT scanners.  
This approach can be adopted by CT scanner vendors to be turned into software to calculate the 
number of estimated cancer risk cases per 106 for all available clinical protocol options in use 
prior to expose the patient to radiation.  This will help the radiologist and radiographers to 
justify the examination and reduce the dose to the patient by adjusting the scan parameters.       
7.11 Study Limitations 
Although this thesis makes a significant contribution to estimating lifetime attributable cancer 
risks for male and females from 0 to 80 years, and how they might contribute to the induction 
of cancer among patients accessing brain CT procedures, it does have number of limitations: -   
1. Only two ATOM phantoms representing a one-year old child and adult were used for the 
lifetime cancer risk estimates.  This is a limitation as it may not be representative of the 
entire patient population.  Usually, patients with a smaller size receive higher organ dose 
when the same scanning technique is used.  However, there is only a small variation in 
terms of the head size for adult patients.  Therefore, the dose variations among patients 
should be small.  Paediatric patients will receive higher organ doses for the same scanning 
protocols.  As previously stated the 1 year old and adult phantoms used only represent 
‘average’ sizes and that there is no account within this work for variations within an age 
group.   
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2. The ATOM phantoms do not model all organs and tissues listed in ICRP 60 and ICRP 103 
and often other organ absorbed doses are used as a substitute to approximate these doses.  
Also, to calculate the effective dose, the organ dose for bone surface, skin, lymphatic nodes 
and muscles were set to zero.  The error introduced by this step was expected to be small, 
given that each of these organs had a weighting factor of 1%.  Furthermore, lymphatic 
nodes and muscles were not irradiated directly and the skin and bone surface were only 
partially irradiated.  
3. The adult phantom data represent some errors from the ATCM functionality, previously 
explained within the discussion that might be due to the lack of internal brain structures 
and noise detection ability of the CT ATCM software.    
7.12 Recommendations for Future Work 
1. This study should be replicated using a different range of ATOM phantoms representing 
age groups of (neonate, and 5-year-old; male and female) to estimate the effective risk for 
different size of phantoms. 
2. A prospective study should be conducted to compare directly measured effective dose 
estimates with those determined from mathematical models including k factors and 
ImpACT software. 
3. A similar study should be conducted using dose optimisation and image quality techniques, 
as there needs to be a study, with practitioners and patients, evaluating the risk cancer 
prediction tool and how it can be developed and implemented. 
4. CT manufacturers should introduce effective risk estimates within their systems, prior to 
exposures being made.  The effectiveness of such introductions would need appropriate 
evaluation using a careful designed research study.    
7.13 Thesis Novelty 
No other study has estimated the lifetime cancer risks for patients undergoing CT brain 
examinations for different ages, from 0 to 80 years for both male and female.  In this thesis, the 
variations in absorbed dose to organs and tissues for brain CT protocols using helical and 
sequential for adult, and helical only for the one year old on two different ATOM phantoms, 
were measured and used to calculate the lifetime cancer induction as reported by BEIR VII 
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report (2006).  Consequently, prior to this study, there was no up to date knowledge on the 
relationship between paediatric CT brain examinations and the possibility of developing cancer 
risk among patients accessing CT procedures. 
This thesis adds new knowledge to academic/clinical literature because it shows that lifetime 
cancer risk from CT brain examinations can be calculated according to the patient's age and 
gender for all possible CT protocol options prior to exposing the patients to ionising radiation.  
Also, it provides healthcare professionals with the information needed in order to make 
decisions about the justification and the necessity of CT examinations.  Furthermore, it helps 
the practitioner to choose the appropriate protocol for the patient age and size as well 
implementing the dose reduction techniques such as ATCM, or altering the protocol parameters 
to suite the patient being scanned.  Manufacturers should develop ways of displaying the 
radiation risk at the CT console prior to performing the scan.  Findings from this thesis creates 
the need for raising awareness of the stochastic radiation risks for patients undergoing CT 
examinations, especially for paediatrics and young patients and also those undergoing repeated 
CT examinations.  
This thesis has proposed a simple yet scientifically reliable tool for prospectively calculating 
radiation cancer risk for ages from 0 to 80 including male and female for different CT brain 
protocols used on the Toshiba 16 Aquilion CT scanner, which allow the operator or the 
researcher an opportunity to estimate the risk prior to exposing the patient to ionising radiation.  
This is a new philosophical concept in radiation risk management and could lead to changes in 
practices and developments on scanner software.  
7.14 Thesis Recommendations  
1. There is the need to create awareness of the stochastic risks for CT scans, in particular 
when scanning children.  
2. Risk of cancer increase as age decreases.  The potential radiation dose for children is very 
high and needs to be controlled.  CT dose optimisation in children has a big impact on 
effective dose and overall radiation risk. 
3. Where applicable, ATCM should be used for brain scans to reduce the radiation absorbed 
dose and cancer risk.  
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4. CT vendors should consider providing, on their CT equipment, radiation risk assessment 
software that can prospectively display the risks of inducing cancer at the scanner console.  
This would help CT operators and radiographers to better understand protocol selection 
and the effect of acquisition parameter adjustments. 
5. Referrals for patients, especially young people, should not be accepted for CT scans if there 
are other imaging modalities available such as MRI or US, or if CT is not capable of 
providing the necessary diagnostic information.  
6. Adult protocols should not be used to scan children.  If the adult protocol has been selected 
then the scan parameters should be manipulated to suit the patient size and weight. 
7.15 Conclusion   
The aim of this thesis was to assess the medical radiation exposure of adult and paediatric 
patients from brain CT examinations.  Radiation risk coefficients that are specific to the site of 
cancer induction, the age at exposure and gender are made available in the BEIR VII Report 
(NRC, 2006).  These risks are applied to organ absorbed doses in order to assess age and gender 
specific radiation detriment.  However, determining organ absorbed doses for CT exposure is 
complex, which is evidenced by the large number of mostly indirect methods currently 
available.  Furthermore, few publications addressed experimental organ dosimetry methods in 
paediatric CT or the magnitude of organ absorbed doses for clinically used protocols. 
Within this work, absorbed doses to organ and tissues have been measured for CT brain 
examinations using MOSFETs loaded in ATOM phantoms representing of an adult and 1-year 
old child and for the Toshiba 16 Aquilion CT scanner.  The results for this study demonstrate 
effective doses from the CT head examinations ranging from 0.34 – 1.55 mSv and 0.31 – 2.01 
mSv for adults and paediatrics, respectively.  Some values of effective dose were lower than 
has been previously reported in the literature (e.g. McCollough and Yu, 2009).  Typical 
effective dose values of 1 to 14 mSv have been reported for head CT examinations.   
The MOSFET measurements for estimating the average absorbed dose to an organ or tissue 
demonstrated that directly and fully irradiated organs and tissues lead to more consistent dose 
measurements throughout their volume.  Organs and tissues in the periphery of the scan volume 
had a range of dose measurements and were also affected by over-ranging in helical scanning.  
Even organs distant from the scanned volume had a small amount of radiation exposure, likely 
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the result of exposure to scattered radiation.  MOSFETs were also investigated and found to be 
have suitable agreement with TLDs, overall, they offered a higher dose on (average 10% 
higher), although being a more practical alternative for regular use in the clinical environment. 
MOSFETs offer an alternative dosimetry method that is fast and easy to use.  However, they 
do require initial calibration and conversion factors must be derived for all beam qualities and 
energies that are to be used.  This is performed at acceptance and is labour intensive.  Further 
studies are required to assess the necessary frequency of calibration, both over time and relative 
to the cumulative dose that each MOSFET receives.  Furthermore, MOSFETs have a lifespan 
related to cumulative exposure and hence must be replaced on a semi-regular basis.  Also, 
MOSFETs are small, fragile and require careful handling and provide a real-time result.  
MOSFETs are finding increased application as a potential dosimetry tool for medical 
exposures.  However, considering that effective dose is intended to be a broad estimate of 
typical dose, the real-time nature of MOSFETs may lead to the acceptance of some of these 
limitations. 
Experiments within this thesis confirm that increasing pitch proportionately reduces patient 
radiation dose on a helical CT scanner when other parameters are held constant.  Also, ATCM 
did not modulated correctly for some of the adult helical protocols; however, a reduction in 
effective dose, particularly when changing from high quality to low dose techniques, have been 
shown.   
From the measured absorbed doses, effective doses were derived based on ICRP 103.  Effective 
dose is not a physical quantity but an estimate of biological detriment reflecting the risk from 
radiation exposure.  It is a useful generic quantity that can be used for optimisation in diagnostic 
radiology.  However, differences between the ICRP 60 and ICRP 103 tissue weighting factors 
arise from the changes that reflect the lower weighting now applied to the brain for direct 
irradiation, the increased assessed radiosensitivity of the breast and the remainder organs 
collectively and the decrease in assessed radiosensitivity for the gonads. 
CT is an extremely important imaging modality for infants and children.  Despite this 
importance, and increasing use, the risks of radiation and a lack of attention to these risks are 
only recently being addressed.  Paediatric health care providers are an essential element in the 
selection of CT evaluation of children.  Because of this, it is necessary to understand the benefits 
and radiation risks of CT and work with radiologists to develop strategies that reduce exposure 
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from CT in infants and children.  Also monitoring of trends in CT patient doses is currently 
particularly important, especially in paediatrics, as the technology is evolving rapidly.  The 
organ doses delivered from a common CT scan result in an increased risk of radiation induced 
carcinogenesis, particularly for children.  Our experiment results showed paediatric and young 
people are at higher risk of cancer incidence than adults, and also that the risk much higher in 
females than males.  
Because the risks to individuals from diagnostic radiation exposures are generally small, it is 
often difficult to study them directly.  However, because of the large number of people exposed 
annually, even small risks could translate into a considerable number of future cancers.  
Referring medical practitioners need guidance to determine whether an imaging study is needed 
and, if an imaging study is required, which type of imaging study will yield the necessary 
clinical information at the lowest achievable radiation dose, because reducing radiation 
exposure from diagnostic procedures is a shared responsibility of the referring medical 
practitioner and the radiological medical practitioner.  Thus, in the future, better metrics, such 
as lifetime attributable cancer risk, will hopefully become the norm.   
The best strategies for radiologists and technologists to reduce the radiation to patients who 
undergo CT examinations is by modifying basic scanning parameters such as peak kilovoltage, 
milliampere-second, and pitch; they can also alter their scanning protocols by reducing the 
number of images or data sets acquired during a CT study. 
The best way to reduce the radiation dose to paediatric patients is to avoid unnecessary CT 
exams and to look for alternative diagnostic imaging modalities with less or no exposure to 
ionising radiation.  Paediatric protocols with scanning parameters specifically designed for 
children must be used.  These protocols usually include tube current modulation, a child-size 
bowtie filter and scanning field of view (FOV), or a weight or size-based technique chart that 
can determine the appropriate kV and/or mAs for each patient. 
For children undergoing CT examinations, providing a better understanding of the lifetime 
attributable radiation risks will hopefully lead to better justification for scans in the future. 
Furthermore, it will be a driver for undertaking dose optimisation at institutions where the doses 
are much higher.  Overall, the risk due to radiation exposure for an appropriately justified and 
well optimized CT scan for an ill hospitalized child will almost always be much lower than the 
risk associated with not performing the scan.  The risk projections in this thesis must be 
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considered in the context of the substantial diagnostic and/or treatment benefit gained from a 
justified and optimised CT scan. 
There is no question that the benefit of an appropriately indicated CT scan far exceeds the 
associated estimated risk or that CT providers need to prescribe the minimal amount of radiation 
required to obtain images adequate for evaluating the patient’s condition.  Additionally, the 
medical community needs to better educate the public to the risks and benefits associated with 
CT, such that they can make informed decisions regarding their healthcare.  
This thesis proposes a novel method to estimate effective lifetime risk of radiation-induced 
cancer from CT brain examinations in order to compare different brain CT protocols 
(acquisition parameters).  Absorbed dose measurements when considered in relation to the age 
and gender of the patient can help provide prospective estimations of effective risk, a potentially 
more useful indicator of the possible effects of radiation exposure from CT head examinations.  
This risk estimation method can be used to prospectively compare different CT brain protocol 
parameters immediately prior to imaging.  Risk data, using this method, can be prospectively 
taken into account when planning a CT brain examination, especially for young ages and those 
undergoing serial imaging.  Using the prospective proactive evaluation of radiation risk data 
(spreadsheet) provided in this thesis, or via the CT console can help to estimate the probability 
of cancer induction and cataract formation from specific CT brain protocols and can be used by 
practitioners and manufacturers when developing CT technology and protocols in the future. 
Overall, there is a large variability in scanning protocols and a resultant large range of effective 
doses, reflecting the increasing complexity of CT scanning.  High radiation doses were 
observed in some paediatric protocols undertaken with high quality imaging parameters.  
Feedback and education about these parameters is needed to avoid inappropriate high radiation 
doses.  It is important that the CT technique is tailored to the child, is only used when there are 
good clinical indications and that the radiation risk is proactively considered prior to scanning.  
In brief, among this thesis the following can be concluded:  
– Increasing kV from 100 to 120 kVp lead to up 33% increase in ED. 
– Increasing mA from 120 to 200 mA resulted in 39% increase in ED. 
– Slow (detail) to a fast helical pitch showed 36% reduction in ED. 
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– Detector configuration change (0.5 to 2.0 x 16 mm) illustrated 2 to 25% increase in ED, 
depending on pitch used. 
– Changing in CT gantry angles have no change to ED but do affect eye lens dose.  
– Risk of cancer induction increases as age decrease.  The potential dose for children is very 
high and needs to be actively controlled.  CT dose optimization in children has big impact 
on both ED and ER and accurate estimations of both parameters are needed prior to the scan. 
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Appendices 
Appendix A: Location and number of dosimeters within the sections of the 
adult and paediatric ATOM phantoms 
Table A - 1: Location and number of dosimeters within the slices of the adult ATOM phantom 
(Adult). 
Organs Phantom slice number 
Number of 
Dosimeters 
Total Organ 
Dosimeters 
Brain 2 1 
11 Brain 3 4 Brain 4 4 
Brain 5 2 
Cranium Active Bone Marrow (ABM) 3 4 4 
85 
Mandible (ABM) Lt + Rt 7 2 
6 Mandible (ABM) Lt + Rt 8 2 
Mandible (ABM) Lt + Rt 9 2 
C-Spine (ABM) 8 1 2 C-Spine (ABM) 10 1 
Clavicle (ABM) Lt + Rt 12 4 10 Clavicle (ABM) Lt + Rt 13 6 
Sternum (ABM) 13 1 
4 Sternum (ABM) 14 1 Sternum (ABM) 16 1 
Sternum (ABM) 18 1 
T/L Spine (ABM) 13 1 
9 
T/L Spine (ABM) 16 1 
T/L Spine (ABM) 19 1 
T/L Spine (ABM) 22 1 
T/L Spine (ABM) 25 1 
T/L Spine (ABM) 27 1 
T/L Spine (ABM) 29 1 
T/L Spine (ABM) 31 1 
T/L Spine (ABM) 33 1 
Ribs (ABM) Lt + Rt 14 6 
18 Ribs (ABM) Lt + Rt 17 6 
Ribs (ABM) Lt + Rt 20 6 
Scapular (ABM) Lt + Rt 14 4 
10 Scapular (ABM) Lt + Rt 15 2 Scapular (ABM) Lt + Rt 16 2 
Scapular (ABM) Lt + Rt 17 2 
Pelvis (ABM) Lt + Rt 30 4 
16 
Pelvis (ABM) Lt + RT 31 4 
Pelvis (ABM) Lt + RT 32 2 
Pelvis (ABM) Lt + Rt 34 4 
Pelvis (ABM) Lt + Rt 36 2 
Pelvis (ABM) Lt + Rt 33 2 2 
Femora (ABM) Lt + Rt 35 2 4 Femora (ABM) Lt + Rt 38 2 
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Continued (Table A - 1)  
Organs Phantom slice number 
Number of 
Dosimeters 
Total Organ 
Dosimeters 
Eyes Lt + Rt 5 2 2 
Thyroid Lt + Rt 10 2 
6 Thyroid Lt + Rt 11 2 
Thyroid Lt + Rt 12 2 
Oesophagus 12 1 
3 Oesophagus 15 1 
Oesophagus 19 1 
Lungs Lt + Rt 12 2 
36 
Lungs Lt + Rt 14 6 
Lungs Lt + Rt 16 10 
Lungs Lt + Rt 18 11 
Lungs Lt + Rt 20 7 
Thymus Lt + Rt 13 2 4 
Thymus Lt + Rt 14 2 
Breast Lt + Rt 17 2 male/8 Female 10 
Heart 17 1 2 
Heart 18 1 
Spleen 20 2 
12 Spleen 21 3 
Spleen 22 4 
Spleen 23 3 
Adrenals Lt 20 1 2 
Adrenals Rt 22 1 
Liver 20 13 
29 
Liver 22 7 
Liver 23 4 
Liver 24 3 
Liver 25 2 
Stomach 21 2 
14 Stomach 22 4 
Stomach 24 4 
Stomach 26 4 
Kidneys 21 1 
16 
Kidneys Lt 22 2 
Kidneys Lt + Rt 23 3 
Kidneys Rt + Lt 24 4 
Kidneys Lt + Rt 25 3 
Kidneys Rt 26 2 
Kidneys Rt 27 1 
 
 
 
 
 199 
 
Continued (Table A - 1) 
Organs Phantom slice number 
Number of 
Dosimeters 
Total Organ 
Dosimeters 
Pancreas 23 2 
5 Pancreas 24 3 
Gall Bladder 24 2 5 Gall Bladder 25 3 
Intestine Lt + Rt 27 4 
16 
Intestine Lt + Rt 29 5 
Intestine 31 5 
Intestine 33 1 
Intestine 35 1 
Bladder 32 4 
16 Bladder 33 4 Bladder 34 4 
Bladder 35 4 
Prostate 35 3 3 
Testes Lt + Rt 38 2 2 
                                  Total Dosimeters 281 
 
Table A - 2: Location and number of dosimeters within the slices of the ATOM phantom (Paediatric). 
No Organ Phantom Slice No Depth Number of Dosimeters 
Total Organ 
Dosimeters 
1 Brain 1 2 10 
3 
9 
2 Brain 2 2 10 
3 Brain 3 2 10 
4 Brain 4 3 15 
3 5 Brain 5 3 15 
6 Brain 6 3 15 
7 Brain 7 4 20 
3 8 Brain 8 4 20 
9 Brain 9 4 20 
10 Eye 1 4 15 2 2 11 Eye 2 4 15 
12 Cranium ABM 1 4 3 
4 4 13 Cranium ABM 2 4 3 14 Cranium ABM 3 4 3 
15 Cranium ABM 4 4 3 
16 C-Spine (ABM) 1 6 5 1 1 
17 Mandible (ABM) 1 6 3 
3 3 18 Mandible (ABM) 2 6 3 
19 Mandible (ABM) 3 6 13 
20 C-Spine (ABM) 2 7 5 1 1 
21 Thyroid 1 7 20 2 2 22 Thyroid 2 7 20 
23 Oesophagus 1 8 3 1 1 
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Continued (Table A - 2) 
No Organ Phantom Slice No Depth Number of Dosimeters 
Total Organ 
Dosimeters 
24 Clavicle (ABM) 1 8 10 2 2 25 Clavicle (ABM) 2 8 10 
26 Lung 1 9 5 
4 4 27 Lung 2 9 5 28 Lung 3 9 5 
29 Lung 4 9 5 
30 Rib 1 9 3 
4 4 31 Rib 2 9 3 32 Rib 3 9 3 
33 Rib 4 9 3 
34 Scapulae (ABM) 1 9 3 
4 4 35 scapulae (ABM) 2 9 3 36 scapulae (ABM) 3 9 3 
37 scapulae (ABM) 4 9 3 
38 T/L Spine (ABM) 1 9 5 1 1 
39 Thymus 1 9 3 1 1 
40 Sternum (ABM) 1 9 3 1 1 
41 Thymus 2 9 3 1 1 
42 Sternum (ABM) 2 10 3 1 1 
43 Lung 5 10 5 
5 5 
44 Lung 6 10 5 
45 Lung 7 10 5 
46 Lung 8 10 5 
47 Lung 9 10 5 
48 Breast 1 10 12 2 2 49 Breast 2 10 12 
50 Oesophagus 2 10 5 1 1 
51 Heart 1 10   1 1 
52 Rib 5 11 3 
6 6 
53 Rib 6 11 3 
54 Rib 7 11 3 
55 Rib 8 11 3 
56 Rib 9 11 3 
57 Rib 10 11 3 
58 Sternum (ABM) 3 11 3 1 1 
59 T/L Spine (ABM) 2 11 5 1 1 
60 Lung 10 11 5 
7 7 
61 Lung 11 11 5 
62 Lung 12 11 5 
63 Lung 13 11 5 
64 Lung 14 11 5 
65 Lung 15 11 5 
66 Lung 16 11 5 
67 Heart 2 11   1 1 
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Continued (Table A - 2) 
No Organ Phantom Slice No Depth Number of Dosimeters 
Total Organ 
Dosimeters 
68 Rib 11 12 3 
6 6 
69 Rib 12 12 3 
70 Rib 13 12 3 
71 Rib 14 12 3 
72 Rib 15 12 3 
73 Rib 16 12 3 
74 Stomach 1 12 17 1 1 
75 Oesophagus 3 12 5 1 1 
76 Lung 17 12 5 
9 9 
77 Lung 18 12 5 
78 Lung 19 12 5 
79 Lung 20 12 5 
80 Lung 21 12 5 
81 Lung 22 12 5 
82 Lung 23 12 5 
83 Lung 24 12 5 
84 Lung 25 12 5 
85 T/L Spine (ABM) 3 13 5 1 1 
86 Stomach 2 13 4 1 1 
87 Stomach 3 13 4 1 1 
88 Stomach 4 13 4 1 1 
89 Stomach 5 13 20 1 1 
90 Stomach 6 13 20 1 1 
91 Pancreas 1 13 5 1 1 
92 Pancreas 2 13 5 1 1 
93 Pancreas 3 13 5 1 1 
94 Spleen 1 13 20 1 1 
95 Spleen 2 13 20 1 1 
96 Spleen 3 13 3 1 1 
97 Liver 1 13 5 1 1 
98 Liver 2 13 5 1 1 
99 Liver 3 13 5 1 1 
100 Adrenal 1 13 11 1 1 
101 Adrenal 2 13 19 1 1 
102 Kidney 1 13 19 1 1 
103 Kidney 2 14 20 1 1 
104 Kidney 3 14 20 1 1 
105 Kidney 4 14 4 1 1 
106 Kidney 5 14 12 1 1 
107 Kidney 6 14 12 1 1 
108 Gallbladder 1 14 18 1 1 
109 Spleen 4 14 13 1 1 
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Continued (Table A - 2) 
No Organ Phantom Slice No Depth Number of Dosimeters 
Total Organ 
Dosimeters 
110 Liver 4 14 5 1 1 
111 Liver 5 14 5 1 1 
112 Liver 6 14 5 1 1 
113 Liver 7 15 5 1 1 
114 Liver 8 15 5 1 1 
115 Kidney 7 15 3 1 1 
116 Kidney 8 15 13 1 1 
117 T/L Spine (ABM) 4 15 5 1 1 
118 Gallbladder 2 15 3 1 1 
119 Intestine 1 15 5 1 1 
120 Intestine 2 15 5 1 1 
121 Intestine 3 15 5 1 1 
122 Intestine 4 16 5 1 1 
123 Intestine 5 16 5 1 1 
124 Intestine 6 16 5 1 1 
125 Intestine 7 16 5 1 1 
126 Pelvis 1 17 3 1 1 
127 Pelvis 2 17 3 1 1 
128 T/L Spine (ABM) 5 17 5 1 1 
129 Ovaries 1 17 15 1 1 
130 Ovaries 2 17 15 1 1 
131 Uterus 1 17 21 1 1 
132 Intestine 8 17 5 1 1 
133 Intestine 9 17 5 1 1 
134 Intestine 10 17 5 1 1 
135 Intestine 11 17 5 1 1 
136 Intestine 12 18 5 1 1 
137 Pelvis 3 18 5 1 1 
138 Pelvis 4 18 5 1 1 
139 T/L Spine (ABM) 6 18 5 1 1 
140 Bladder 1 18 3 1 1 
141 Bladder 2 18 18 1 1 
142 Bladder 3 18 18 1 1 
143 Bladder 4 18 18 1 1 
144 Bladder 5 18 18 1 1 
145 Bladder 6 19 7 1 1 
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Continued (Table A - 2) 
No Organ Phantom Slice No Depth Number of Dosimeters 
Total Organ 
Dosimeters 
146 Upper ½ Femora (ABM)  1 19 5 1 1 
147 Upper ½ Femora (ABM)  2 19 5 1 1 
148 Testes 1 20 22 1 1 
149 Testes 2 20 22 1 1 
150 Upper ½ Femora (ABM) 3 20 5 1 1 
151 Upper ½ Femora (ABM) 4 20 5 1 1 
152 Lowe ½ Femora (ABM) 1 22 5 1 1 
153 Lowe ½ Femora (ABM)  2 22 5 1 1 
154 Lowe ½ Femora (ABM) 3 23 5 1 1 
155 Lowe ½ Femora (ABM) 4 23 5 1 1 
156 Tibiae, Fibulae (ABM)  1 25 5 1 1 
157 Tibiae, Fibulae (ABM) 2 25 5 1 1 
158 Tibiae, Fibulae (ABM) 3 28 5 1 1 
159 Tibiae, Fibulae (ABM) 4 28 5 1 1 
160 Humeri (ABM) 1 Right Arm   1 1 161 Humeri (ABM) 2   1 1 
162 Radii, Ulnae (ABM) 1 Right Arm   1 1 
163 Radii, Ulnae (ABM) 2   1 1 
164 Humeri (ABM) 3 Left Arm   1 1 165 Humeri (ABM) 4   1 1 
166 Radii, Ulnae (ABM) 3 Left Arm   1 1 167 Radii, Ulnae (ABM)  4   1 1 
Total Dosimeters 167 
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Appendix B: Full Details of Adult Helical and Sequential CT protocols Parameters Examined Using MOSFET 
Dosimeters 
Table B - 1: Details of adult brain helical protocol parameters used. 
No Tube Rotation Time (Secs) 
Tube Angulations 
(Degrees) 
Image 
Thicknesses (mm)
Detector 
Configuration (mm) 
Pitch Factors / Helical 
Pitch Sure Exp. 3D (ATC) 
1 0.5 0 2 0.5x16 Detail PF 0.688 / HP 11.0 High Quality SD 1.80 
2 0.5 0 2 0.5x16 Detail PF 0.688 / HP 11.0 Standard SD 2.00 
3 0.5 0 2 0.5x16 Detail PF 0.688 / HP 11.0 Low Dose SD 2.20 
4 0.5 0 2 0.5x16 Standard PF 0.938 / HP 15.0 High Quality SD 1.80 
5 0.5 0 2 0.5x16 Standard PF 0.938 / HP 15.0 Standard SD 2.00 
6 0.5 0 2 0.5x16 Standard PF 0.938 / HP 15.0 Low Dose SD 2.20 
7 0.5 0 2 0.5x16 Fast PF 1.438 / HP 23.0 High Quality SD 1.80 
8 0.5 0 2 0.5x16 Fast PF 1.438 / HP 23.0 Standard SD 2.00 
9 0.5 0 2 0.5x16 Fast PF 1.438 / HP 23.0 Low Dose SD 2.20 
10 0.5 15 2 0.5x16 Detail PF 0.688 / HP 11.0 High Quality SD 1.80 
11 0.5 15 2 0.5x16 Detail PF 0.688 / HP 11.0 Standard SD 2.00 
12 0.5 15 2 0.5x16 Detail PF 0.688 / HP 11.0 Low Dose SD 2.20 
13 0.5 15 2 0.5x16 Standard PF 0.938 / HP 15.0 High Quality SD 1.80 
14 0.5 15 2 0.5x16 Standard PF 0.938 / HP 15.0 Standard SD 2.00 
15 0.5 15 2 0.5x16 Standard PF 0.938 / HP 15.0 Low Dose SD 2.20 
16 0.5 15 2 0.5x16 Fast PF 1.438 / HP 23.0 High Quality SD 1.80 
17 0.5 15 2 0.5x16 Fast PF 1.438 / HP 23.0 Standard SD 2.00 
18 0.5 15 2 0.5x16 Fast PF 1.438 / HP 23.0 Low Dose SD 2.20 
19 0.5 27 2 0.5x16 Detail PF 0.688 / HP 11.0 High Quality SD 1.80 
20 0.5 27 2 0.5x16 Detail PF 0.688 / HP 11.0 Standard SD 2.00 
21 0.5 27 2 0.5x16 Detail PF 0.688 / HP 11.0 Low Dose SD 2.20 
22 0.5 27 2 0.5x16 Standard PF 0.938 / HP 15.0 High Quality SD 1.80 
23 0.5 27 2 0.5x16 Standard PF 0.938 / HP 15.0 Standard SD 2.00 
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Continued (Table B - 1) 
No Tube Rotation Time (Secs) 
Tube Angulations 
(Degrees) 
Image 
Thicknesses (mm) 
Detector 
Configuration (mm) 
Pitch Factors / Helical 
Pitch Sure Exp. 3D (ATC) 
24 0.5 27 2 0.5x16 Standard PF 0.938 / HP 15.0 Low Dose SD 2.20 
25 0.5 27 2 0.5x16 Fast PF 1.438 / HP 23.0 High Quality SD 1.80 
26 0.5 27 2 0.5x16 Fast PF 1.438 / HP 23.0 Standard SD 2.00 
27 0.5 27 2 0.5x16 Fast PF 1.438 / HP 23.0 Low Dose SD 2.20 
28 0.5 0 4 1.0x16 Detail PF 0.688 / HP 11.0 High Quality SD 1.80 
29 0.5 0 4 1.0x16 Detail PF 0.688 / HP 11.0 Standard SD 2.00 
30 0.5 0 4 1.0x16 Detail PF 0.688 / HP 11.0 Low Dose SD 2.20 
31 0.5 0 4 1.0x16 Standard PF 0.938 / HP 15.0 High Quality SD 1.80 
32 0.5 0 4 1.0x16 Standard PF 0.938 / HP 15.0 Standard SD 2.00 
33 0.5 0 4 1.0x16 Standard PF 0.938 / HP 15.0 Low Dose SD 2.20 
34 0.5 0 4 1.0x16 Fast PF 1.438 / HP 23.0 High Quality SD 1.80 
35 0.5 0 4 1.0x16 Fast PF 1.438 / HP 23.0 Standard SD 2.00 
36 0.5 0 4 1.0x16 Fast PF 1.438 / HP 23.0 Low Dose SD 2.20 
37 0.5 15 4 1.0x16 Detail PF 0.688 / HP 11.0 High Quality SD 1.80 
38 0.5 15 4 1.0x16 Detail PF 0.688 / HP 11.0 Standard SD 2.00 
39 0.5 15 4 1.0x16 Detail PF 0.688 / HP 11.0 Low Dose SD 2.20 
40 0.5 15 4 1.0x16 Standard PF 0.938 / HP 15.0 High Quality SD 1.80 
41 0.5 15 4 1.0x16 Standard PF 0.938 / HP 15.0 Standard SD 2.00 
42 0.5 15 4 1.0x16 Standard PF 0.938 / HP 15.0 Low Dose SD 2.20 
43 0.5 15 4 1.0x16 Fast PF 1.438 / HP 23.0 High Quality SD 1.80 
44 0.5 15 4 1.0x16 Fast PF 1.438 / HP 23.0 Standard SD 2.00 
45 0.5 15 4 1.0x16 Fast PF 1.438 / HP 23.0 Low Dose SD 2.20 
46 0.5 27 4 1.0x16 Detail PF 0.688 / HP 11.0 High Quality SD 1.80 
47 0.5 27 4 1.0x16 Detail PF 0.688 / HP 11.0 Standard SD 2.00 
48 0.5 27 4 1.0x16 Detail PF 0.688 / HP 11.0 Low Dose SD 2.20 
49 0.5 27 4 1.0x16 Standard PF 0.938 / HP 15.0 High Quality SD 1.80 
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Continued (Table B - 1) 
No Tube Rotation Time (Secs) 
Tube Angulations 
(Degrees) 
Image Thicknesses 
(mm) 
Detector 
Configuration (mm) 
Pitch Factors / Helical 
Pitch Sure Exp. 3D (ATC) 
50 0.5 27 4 1.0x16 Standard PF 0.938 / HP 15.0 Standard SD 2.00 
51 0.5 27 4 1.0x16 Standard PF 0.938 / HP 15.0 Low Dose SD 2.20 
52 0.5 27 4 1.0x16 Fast PF 1.438 / HP 23.0 High Quality SD 1.80 
53 0.5 27 4 1.0x16 Fast PF 1.438 / HP 23.0 Standard SD 2.00 
54 0.5 27 4 1.0x16 Fast PF 1.438 / HP 23.0 Low Dose SD 2.20 
55 0.5 0 8 2.0x16 Detail PF 0.688 / HP 11.0 High Quality SD 1.80 
56 0.5 0 8 2.0x16 Detail PF 0.688 / HP 11.0 Standard SD 2.00 
57 0.5 0 8 2.0x16 Detail PF 0.688 / HP 11.0 Low Dose SD 2.20 
58 0.5 0 8 2.0x16 Standard PF 0.938 / HP 15.0 High Quality SD 1.80 
59 0.5 0 8 2.0x16 Standard PF 0.938 / HP 15.0 Standard SD 2.00 
60 0.5 0 8 2.0x16 Standard PF 0.938 / HP 15.0 Low Dose SD 2.20 
61 0.5 0 8 2.0x16 Fast PF 1.438 / HP 23.0 High Quality SD 1.80 
62 0.5 0 8 2.0x16 Fast PF 1.438 / HP 23.0 Standard SD 2.00 
63 0.5 0 8 2.0x16 Fast PF 1.438 / HP 23.0 Low Dose SD 2.20 
64 0.5 15 8 2.0x16 Detail PF 0.688 / HP 11.0 High Quality SD 1.80 
65 0.5 15 8 2.0x16 Detail PF 0.688 / HP 11.0 Standard SD 2.00 
66 0.5 15 8 2.0x16 Detail PF 0.688 / HP 11.0 Low Dose SD 2.20 
67 0.5 15 8 2.0x16 Standard PF 0.938 / HP 15.0 High Quality SD 1.80 
68 0.5 15 8 2.0x16 Standard PF 0.938 / HP 15.0 Standard SD 2.00 
69 0.5 15 8 2.0x16 Standard PF 0.938 / HP 15.0 Low Dose SD 2.20 
70 0.5 15 8 2.0x16 Fast PF 1.438 / HP 23.0 High Quality SD 1.80 
71 0.5 15 8 2.0x16 Fast PF 1.438 / HP 23.0 Standard SD 2.00 
72 0.5 15 8 2.0x16 Fast PF 1.438 / HP 23.0 Low Dose SD 2.20 
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Continued (Table B - 1) 
No Tube Rotation Time (Secs) 
Tube Angulations 
(Degrees) 
Image Thicknesses 
(mm) 
Detector 
Configuration (mm) 
Pitch Factors / Helical 
Pitch Sure Exp. 3D (ATC) 
73 0.5 27 8 2.0x16 Detail PF 0.688 / HP 11.0 High Quality SD 1.80 
74 0.5 27 8 2.0x16 Detail PF 0.688 / HP 11.0 Standard SD 2.00 
75 0.5 27 8 2.0x16 Detail PF 0.688 / HP 11.0 Low Dose SD 2.20 
76 0.5 27 8 2.0x16 Standard PF 0.938 / HP 15.0 High Quality SD 1.80 
77 0.5 27 8 2.0x16 Standard PF 0.938 / HP 15.0 Standard SD 2.00 
78 0.5 27 8 2.0x16 Standard PF 0.938 / HP 15.0 Low Dose SD 2.20 
79 0.5 27 8 2.0x16 Fast PF 1.438 / HP 23.0 High Quality SD 1.80 
80 0.5 27 8 2.0x16 Fast PF 1.438 / HP 23.0 Standard SD 2.00 
81 0.5 27 8 2.0x16 Fast PF 1.438 / HP 23.0 Low Dose SD 2.20 
82 1.0 0 2 0.5x16 Detail PF 0.688 / HP 11.0 High Quality SD 1.80 
83 1.0 0 2 0.5x16 Detail PF 0.688 / HP 11.0 Standard SD 2.00 
84 1.0 0 2 0.5x16 Detail PF 0.688 / HP 11.0 Low Dose SD 2.20 
85 1.0 0 2 0.5x16 Standard PF 0.938 / HP 15.0 High Quality SD 1.80 
86 1.0 0 2 0.5x16 Standard PF 0.938 / HP 15.0 Standard SD 2.00 
87 1.0 0 2 0.5x16 Standard PF 0.938 / HP 15.0 Low Dose SD 2.20 
88 1.0 0 2 0.5x16 Fast PF 1.438 / HP 23.0 High Quality SD 1.80 
89 1.0 0 2 0.5x16 Fast PF 1.438 / HP 23.0 Standard SD 2.00 
90 1.0 0 2 0.5x16 Fast PF 1.438 / HP 23.0 Low Dose SD 2.20 
91 1.0 15 2 0.5x16 Detail PF 0.688 / HP 11.0 High Quality SD 1.80 
92 1.0 15 2 0.5x16 Detail PF 0.688 / HP 11.0 Standard SD 2.00 
93 1.0 15 2 0.5x16 Detail PF 0.688 / HP 11.0 Low Dose SD 2.20 
94 1.0 15 2 0.5x16 Standard PF 0.938 / HP 15.0 High Quality SD 1.80 
95 1.0 15 2 0.5x16 Standard PF 0.938 / HP 15.0 Standard SD 2.00 
96 1.0 15 2 0.5x16 Standard PF 0.938 / HP 15.0 Low Dose SD 2.20 
97 1.0 15 2 0.5x16 Fast PF 1.438 / HP 23.0 High Quality SD 1.80 
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Continued (Table B - 1) 
No Tube Rotation Time (Secs) 
Tube Angulations 
(Degrees) 
Image 
Thicknesses (mm) 
Detector 
Configuration (mm) 
Pitch Factors / Helical 
Pitch Sure Exp. 3D (ATC) 
98 1.0 15 2 0.5x16 Fast PF 1.438 / HP 23.0 Standard SD 2.00 
99 1.0 15 2 0.5x16 Fast PF 1.438 / HP 23.0 Low Dose SD 2.20 
100 1.0 27 2 0.5x16 Detail PF 0.688 / HP 11.0 High Quality SD 1.80 
101 1.0 27 2 0.5x16 Detail PF 0.688 / HP 11.0 Standard SD 2.00 
102 1.0 27 2 0.5x16 Detail PF 0.688 / HP 11.0 Low Dose SD 2.20 
103 1.0 27 2 0.5x16 Standard PF 0.938 / HP 15.0 High Quality SD 1.80 
104 1.0 27 2 0.5x16 Standard PF 0.938 / HP 15.0 Standard SD 2.00 
105 1.0 27 2 0.5x16 Standard PF 0.938 / HP 15.0 Low Dose SD 2.20 
106 1.0 27 2 0.5x16 Fast PF 1.438 / HP 23.0 High Quality SD 1.80 
107 1.0 27 2 0.5x16 Fast PF 1.438 / HP 23.0 Standard SD 2.00 
108 1.0 27 2 0.5x16 Fast PF 1.438 / HP 23.0 Low Dose SD 2.20 
109 1.0 0 4 1.0x16 Detail PF 0.688 / HP 11.0 High Quality SD 1.80 
110 1.0 0 4 1.0x16 Detail PF 0.688 / HP 11.0 Standard SD 2.00 
111 1.0 0 4 1.0x16 Detail PF 0.688 / HP 11.0 Low Dose SD 2.20 
112 1.0 0 4 1.0x16 Standard PF 0.938 / HP 15.0 High Quality SD 1.80 
113 1.0 0 4 1.0x16 Standard PF 0.938 / HP 15.0 Standard SD 2.00 
114 1.0 0 4 1.0x16 Standard PF 0.938 / HP 15.0 Low Dose SD 2.20 
115 1.0 0 4 1.0x16 Fast PF 1.438 / HP 23.0 High Quality SD 1.80 
116 1.0 0 4 1.0x16 Fast PF 1.438 / HP 23.0 Standard SD 2.00 
117 1.0 0 4 1.0x16 Fast PF 1.438 / HP 23.0 Low Dose SD 2.20 
118 1.0 15 4 1.0x16 Detail PF 0.688 / HP 11.0 High Quality SD 1.80 
119 1.0 15 4 1.0x16 Detail PF 0.688 / HP 11.0 Standard SD 2.00 
120 1.0 15 4 1.0x16 Detail PF 0.688 / HP 11.0 Low Dose SD 2.20 
121 1.0 15 4 1.0x16 Standard PF 0.938 / HP 15.0 High Quality SD 1.80 
122 1.0 15 4 1.0x16 Standard PF 0.938 / HP 15.0 Standard SD 2.00 
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Continued (Table B - 1) 
No Tube Rotation Time (Secs) 
Tube Angulations 
(Degrees) 
Image 
Thicknesses (mm) 
Detector 
Configuration (mm)
Pitch Factors / Helical 
Pitch Sure Exp. 3D (ATC) 
123 1.0 15 4 1.0x16 Standard PF 0.938 / HP 15.0 Low Dose SD 2.20 
124 1.0 15 4 1.0x16 Fast PF 1.438 / HP 23.0 High Quality SD 1.80 
125 1.0 15 4 1.0x16 Fast PF 1.438 / HP 23.0 Standard SD 2.00 
126 1.0 15 4 1.0x16 Fast PF 1.438 / HP 23.0 Low Dose SD 2.20 
127 1.0 27 4 1.0x16 Detail PF 0.688 / HP 11.0 High Quality SD 1.80 
128 1.0 27 4 1.0x16 Detail PF 0.688 / HP 11.0 Standard SD 2.00 
129 1.0 27 4 1.0x16 Detail PF 0.688 / HP 11.0 Low Dose SD 2.20 
130 1.0 27 4 1.0x16 Standard PF 0.938 / HP 15.0 High Quality SD 1.80 
131 1.0 27 4 1.0x16 Standard PF 0.938 / HP 15.0 Standard SD 2.00 
132 1.0 27 4 1.0x16 Standard PF 0.938 / HP 15.0 Low Dose SD 2.20 
133 1.0 27 4 1.0x16 Fast PF 1.438 / HP 23.0 High Quality SD 1.80 
134 1.0 27 4 1.0x16 Fast PF 1.438 / HP 23.0 Standard SD 2.00 
135 1.0 27 4 1.0x16 Fast PF 1.438 / HP 23.0 Low Dose SD 2.20 
136 1.0 0 8 2.0x16 Detail PF 0.688 / HP 11.0 High Quality SD 1.80 
137 1.0 0 8 2.0x16 Detail PF 0.688 / HP 11.0 Standard SD 2.00 
138 1.0 0 8 2.0x16 Detail PF 0.688 / HP 11.0 Low Dose SD 2.20 
139 1.0 0 8 2.0x16 Standard PF 0.938 / HP 15.0 High Quality SD 1.80 
140 1.0 0 8 2.0x16 Standard PF 0.938 / HP 15.0 Standard SD 2.00 
141 1.0 0 8 2.0x16 Standard PF 0.938 / HP 15.0 Low Dose SD 2.20 
142 1.0 0 8 2.0x16 Fast PF 1.438 / HP 23.0 High Quality SD 1.80 
143 1.0 0 8 2.0x16 Fast PF 1.438 / HP 23.0 Standard SD 2.00 
144 1.0 0 8 2.0x16 Fast PF 1.438 / HP 23.0 Low Dose SD 2.20 
145 1.0 15 8 2.0x16 Detail PF 0.688 / HP 11.0 High Quality SD 1.80 
146 1.0 15 8 2.0x16 Detail PF 0.688 / HP 11.0 Standard SD 2.00 
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Continued (Table B - 1) 
No Tube Rotation Time (Secs) 
Tube Angulations 
(Degrees) 
Image 
Thicknesses (mm) 
Detector 
Configuration (mm)
Pitch Factors / Helical 
Pitch Sure Exp. 3D (ATC) 
147 1.0 15 8 2.0x16 Detail PF 0.688 / HP 11.0 Low Dose SD 2.20 
148 1.0 15 8 2.0x16 Standard PF 0.938 / HP 15.0 High Quality SD 1.80 
149 1.0 15 8 2.0x16 Standard PF 0.938 / HP 15.0 Standard SD 2.00 
150 1.0 15 8 2.0x16 Standard PF 0.938 / HP 15.0 Low Dose SD 2.20 
151 1.0 15 8 2.0x16 Fast PF 1.438 / HP 23.0 High Quality SD 1.80 
152 1.0 15 8 2.0x16 Fast PF 1.438 / HP 23.0 Standard SD 2.00 
153 1.0 15 8 2.0x16 Fast PF 1.438 / HP 23.0 Low Dose SD 2.20 
154 1.0 27 8 2.0x16 Detail PF 0.688 / HP 11.0 High Quality SD 1.80 
155 1.0 27 8 2.0x16 Detail PF 0.688 / HP 11.0 Standard SD 2.00 
156 1.0 27 8 2.0x16 Detail PF 0.688 / HP 11.0 Low Dose SD 2.20 
157 1.0 27 8 2.0x16 Standard PF 0.938 / HP 15.0 High Quality SD 1.80 
158 1.0 27 8 2.0x16 Standard PF 0.938 / HP 15.0 Standard SD 2.00 
159 1.0 27 8 2.0x16 Standard PF 0.938 / HP 15.0 Low Dose SD 2.20 
160 1.0 27 8 2.0x16 Fast PF 1.438 / HP 23.0 High Quality SD 1.80 
161 1.0 27 8 2.0x16 Fast PF 1.438 / HP 23.0 Standard SD 2.00 
162 1.0 27 8 2.0x16 Fast PF 1.438 / HP 23.0 Low Dose SD 2.20 
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Table B - 2: Adult sequential brain protocol parameters used. 
No Tube Rotation Time (Secs) 
Tube Angulations 
(Degrees) 
Image 
Thicknesses (mm) 
Detector 
Configuration (mm) Sure Exp. 3D (ATC) 
163 0.5 0 2 0.5x4 High Quality SD 1.80 
164 0.5 0 2 0.5x4 Standard SD 2.00 
165 0.5 0 2 0.5x4 Low Dose SD 2.20 
166 0.5 0 4 1.0x4 High Quality SD 1.80 
167 0.5 0 4 1.0x4 Standard SD 2.00 
168 0.5 0 4 1.0x4 Low Dose SD 2.20 
169 0.5 0 8 2.0x4 High Quality SD 1.80 
170 0.5 0 8 2.0x4 Standard SD 2.00 
171 0.5 0 8 2.0x4 Low Dose SD 2.20 
172 0.5 15 2 0.5x4 High Quality SD 1.80 
173 0.5 15 2 0.5x4 Standard SD 2.00 
174 0.5 15 2 0.5x4 Low Dose SD 2.20 
175 0.5 15 4 1.0x4 High Quality SD 1.80 
176 0.5 15 4 1.0x4 Standard SD 2.00 
177 0.5 15 4 1.0x4 Low Dose SD 2.20 
178 0.5 15 8 2.0x4 High Quality SD 1.80 
179 0.5 15 8 2.0x4 Standard SD 2.00 
180 0.5 15 8 2.0x4 Low Dose SD 2.20 
181 0.5 27 2 0.5x4 High Quality SD 1.80 
182 0.5 27 2 0.5x4 Standard SD 2.00 
183 0.5 27 2 0.5x4 Low Dose SD 2.20 
184 0.5 27 4 1.0x4 High Quality SD 1.80 
185 0.5 27 4 1.0x4 Standard SD 2.00 
186 0.5 27 4 1.0x4 Low Dose SD 2.20 
187 0.5 27 8 2.0x4 High Quality SD 1.80 
188 0.5 27 8 2.0x4 Standard SD 2.00 
189 0.5 27 8 2.0x4 Low Dose SD 2.20 
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Continued (Table B - 2) 
No Tube Rotation Time (Secs) 
Tube Angulations 
(Degrees) 
Image 
Thicknesses (mm)
Detector 
Configuration (mm) Sure Exp. 3D (ATC) 
190 1.0 0 2 0.5x4 High Quality SD 1.80 
191 1.0 0 2 0.5x4 Standard SD 2.00 
192 1.0 0 2 0.5x4 Low Dose SD 2.20 
193 1.0 0 4 1.0x4 High Quality SD 1.80 
194 1.0 0 4 1.0x4 Standard SD 2.00 
195 1.0 0 4 1.0x4 Low Dose SD 2.20 
196 1.0 0 8 2.0x4 High Quality SD 1.80 
197 1.0 0 8 2.0x4 Standard SD 2.00 
198 1.0 0 8 2.0x4 Low Dose SD 2.20 
199 1.0 15 2 0.5x4 High Quality SD 1.80 
200 1.0 15 2 0.5x4 Standard SD 2.00 
201 1.0 15 2 0.5x4 Low Dose SD 2.20 
202 1.0 15 4 1.0x4 High Quality SD 1.80 
203 1.0 15 4 1.0x4 Standard SD 2.00 
204 1.0 15 4 1.0x4 Low Dose SD 2.20 
205 1.0 15 8 2.0x4 High Quality SD 1.80 
206 1.0 15 8 2.0x4 Standard SD 2.00 
207 1.0 15 8 2.0x4 Low Dose SD 2.20 
208 1.0 27 2 0.5x4 High Quality SD 1.80 
209 1.0 27 2 0.5x4 Standard SD 2.00 
210 1.0 27 2 0.5x4 Low Dose SD 2.20 
211 1.0 27 4 1.0x4 High Quality SD 1.80 
212 1.0 27 4 1.0x4 Standard SD 2.00 
213 1.0 27 4 1.0x4 Low Dose SD 2.20 
214 1.0 27 8 2.0x4 High Quality SD 1.80 
215 1.0 27 8 2.0x4 Standard SD 2.00 
216 1.0 27 8 2.0x4 Low Dose SD 2.20 
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Appendix C: Full Details of Paediatric Helical CT protocols Parameters used. 
Table C - 1: Paediatric helical brain protocol parameters used. 
No Tube Rotation Time (Secs) 
Tube Angulations 
(Degrees) 
Image 
Thicknesses (mm)
Detector 
Configuration (mm) 
Pitch Factors / Helical 
Pitch Sure Exp. 3D (ATC) 
1 0.5 0 2 0.5x16 Detail PF 0.688 / HP 11.0 High Quality SD 4.00 
2 0.5 0 2 0.5x16 Detail PF 0.688 / HP 11.0 Standard SD 6.00 
3 0.5 0 2 0.5x16 Detail PF 0.688 / HP 11.0 Low Dose SD 8.00 
4 0.5 0 2 0.5x16 Standard PF 0.938 / HP 15.0 High Quality SD 4.00 
5 0.5 0 2 0.5x16 Standard PF 0.938 / HP 15.0 Standard SD 6.00 
6 0.5 0 2 0.5x16 Standard PF 0.938 / HP 15.0 Low Dose SD 8.00 
7 0.5 0 2 0.5x16 Fast PF 1.438 / HP 23.0 High Quality SD 4.00 
8 0.5 0 2 0.5x16 Fast PF 1.438 / HP 23.0 Standard SD 6.00 
9 0.5 0 2 0.5x16 Fast PF 1.438 / HP 23.0 Low Dose SD 8.00 
10 0.5 15 2 0.5x16 Detail PF 0.688 / HP 11.0 High Quality SD 4.00 
11 0.5 15 2 0.5x16 Detail PF 0.688 / HP 11.0 Standard SD 6.00 
12 0.5 15 2 0.5x16 Detail PF 0.688 / HP 11.0 Low Dose SD 8.00 
13 0.5 15 2 0.5x16 Standard PF 0.938 / HP 15.0 High Quality SD 4.00 
14 0.5 15 2 0.5x16 Standard PF 0.938 / HP 15.0 Standard SD 6.00 
15 0.5 15 2 0.5x16 Standard PF 0.938 / HP 15.0 Low Dose SD 8.00 
16 0.5 15 2 0.5x16 Fast PF 1.438 / HP 23.0 High Quality SD 4.00 
17 0.5 15 2 0.5x16 Fast PF 1.438 / HP 23.0 Standard SD 6.00 
18 0.5 15 2 0.5x16 Fast PF 1.438 / HP 23.0 Low Dose SD 8.00 
19 0.5 27 2 0.5x16 Detail PF 0.688 / HP 11.0 High Quality SD 4.00 
20 0.5 27 2 0.5x16 Detail PF 0.688 / HP 11.0 Standard SD 6.00 
21 0.5 27 2 0.5x16 Detail PF 0.688 / HP 11.0 Low Dose SD 8.00 
22 0.5 27 2 0.5x16 Standard PF 0.938 / HP 15.0 High Quality SD 4.00 
23 0.5 27 2 0.5x16 Standard PF 0.938 / HP 15.0 Standard SD 6.00 
24 0.5 27 2 0.5x16 Standard PF 0.938 / HP 15.0 Low Dose SD 8.00 
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Continued (Table C - 1) 
No Tube Rotation Time (Secs) 
Tube Angulations 
(Degrees) 
Image 
Thicknesses (mm)
Detector 
Configuration (mm) 
Pitch Factors / Helical 
Pitch Sure Exp. 3D (ATC) 
25 0.5 27 2 0.5x16 Fast PF 1.438 / HP 23.0 High Quality SD 4.00 
26 0.5 27 2 0.5x16 Fast PF 1.438 / HP 23.0 Standard SD 6.00 
27 0.5 27 2 0.5x16 Fast PF 1.438 / HP 23.0 Low Dose SD 8.00 
28 0.5 0 4 1.0x16 Detail PF 0.688 / HP 11.0 High Quality SD 4.00 
29 0.5 0 4 1.0x16 Detail PF 0.688 / HP 11.0 Standard SD 6.00 
30 0.5 0 4 1.0x16 Detail PF 0.688 / HP 11.0 Low Dose SD 8.00 
31 0.5 0 4 1.0x16 Standard PF 0.938 / HP 15.0 High Quality SD 4.00 
32 0.5 0 4 1.0x16 Standard PF 0.938 / HP 15.0 Standard SD 6.00 
33 0.5 0 4 1.0x16 Standard PF 0.938 / HP 15.0 Low Dose SD 8.00 
34 0.5 0 4 1.0x16 Fast PF 1.438 / HP 23.0 High Quality SD 4.00 
35 0.5 0 4 1.0x16 Fast PF 1.438 / HP 23.0 Standard SD 6.00 
36 0.5 0 4 1.0x16 Fast PF 1.438 / HP 23.0 Low Dose SD 8.00 
37 0.5 15 4 1.0x16 Detail PF 0.688 / HP 11.0 High Quality SD 4.00 
38 0.5 15 4 1.0x16 Detail PF 0.688 / HP 11.0 Standard SD 6.00 
39 0.5 15 4 1.0x16 Detail PF 0.688 / HP 11.0 Low Dose SD 8.00 
40 0.5 15 4 1.0x16 Standard PF 0.938 / HP 15.0 High Quality SD 4.00 
41 0.5 15 4 1.0x16 Standard PF 0.938 / HP 15.0 Standard SD 6.00 
42 0.5 15 4 1.0x16 Standard PF 0.938 / HP 15.0 Low Dose SD 8.00 
43 0.5 15 4 1.0x16 Fast PF 1.438 / HP 23.0 High Quality SD 4.00 
44 0.5 15 4 1.0x16 Fast PF 1.438 / HP 23.0 Standard SD 6.00 
45 0.5 15 4 1.0x16 Fast PF 1.438 / HP 23.0 Low Dose SD 8.00 
46 0.5 27 4 1.0x16 Detail PF 0.688 / HP 11.0 High Quality SD 4.00 
47 0.5 27 4 1.0x16 Detail PF 0.688 / HP 11.0 Standard SD 6.00
48 0.5 27 4 1.0x16 Detail PF 0.688 / HP 11.0 Low Dose SD 8.00 
49 0.5 27 4 1.0x16 Standard PF 0.938 / HP 15.0 High Quality SD 4.00 
50 0.5 27 4 1.0x16 Standard PF 0.938 / HP 15.0 Standard SD 6.00 
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Continued (Table C - 1) 
No Tube Rotation Time (Secs) 
Tube Angulations 
(Degrees) 
Image Thicknesses 
(mm) 
Detector 
Configuration (mm) 
Pitch Factors / Helical 
Pitch Sure Exp. 3D (ATC) 
51 0.5 27 4 1.0x16 Standard PF 0.938 / HP 15.0 Low Dose SD 8.00 
52 0.5 27 4 1.0x16 Fast PF 1.438 / HP 23.0 High Quality SD 4.00 
53 0.5 27 4 1.0x16 Fast PF 1.438 / HP 23.0 Standard SD 6.00 
54 0.5 27 4 1.0x16 Fast PF 1.438 / HP 23.0 Low Dose SD 8.00 
55 0.5 0 8 2.0x16 Detail PF 0.688 / HP 11.0 High Quality SD 4.00 
56 0.5 0 8 2.0x16 Detail PF 0.688 / HP 11.0 Standard SD 6.00 
57 0.5 0 8 2.0x16 Detail PF 0.688 / HP 11.0 Low Dose SD 8.00 
58 0.5 0 8 2.0x16 Standard PF 0.938 / HP 15.0 High Quality SD 4.00 
59 0.5 0 8 2.0x16 Standard PF 0.938 / HP 15.0 Standard SD 6.00 
60 0.5 0 8 2.0x16 Standard PF 0.938 / HP 15.0 Low Dose SD 8.00 
61 0.5 0 8 2.0x16 Fast PF 1.438 / HP 23.0 High Quality SD 4.00 
62 0.5 0 8 2.0x16 Fast PF 1.438 / HP 23.0 Standard SD 6.00 
63 0.5 0 8 2.0x16 Fast PF 1.438 / HP 23.0 Low Dose SD 8.00 
64 0.5 15 8 2.0x16 Detail PF 0.688 / HP 11.0 High Quality SD 4.00 
65 0.5 15 8 2.0x16 Detail PF 0.688 / HP 11.0 Standard SD 6.00 
66 0.5 15 8 2.0x16 Detail PF 0.688 / HP 11.0 Low Dose SD 8.00 
67 0.5 15 8 2.0x16 Standard PF 0.938 / HP 15.0 High Quality SD 4.00 
68 0.5 15 8 2.0x16 Standard PF 0.938 / HP 15.0 Standard SD 6.00 
69 0.5 15 8 2.0x16 Standard PF 0.938 / HP 15.0 Low Dose SD 8.00 
70 0.5 15 8 2.0x16 Fast PF 1.438 / HP 23.0 High Quality SD 4.00 
71 0.5 15 8 2.0x16 Fast PF 1.438 / HP 23.0 Standard SD 6.00 
72 0.5 15 8 2.0x16 Fast PF 1.438 / HP 23.0 Low Dose SD 8.00 
73 0.5 27 8 2.0x16 Detail PF 0.688 / HP 11.0 High Quality SD 4.00 
74 0.5 27 8 2.0x16 Detail PF 0.688 / HP 11.0 Standard SD 6.00 
75 0.5 27 8 2.0x16 Detail PF 0.688 / HP 11.0 Low Dose SD 8.00 
76 0.5 27 8 2.0x16 Standard PF 0.938 / HP 15.0 High Quality SD 4.00 
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Continued (Table C - 1) 
No Tube Rotation Time (Secs) 
Tube Angulations 
(Degrees) 
Image Thicknesses 
(mm) 
Detector 
Configuration (mm) 
Pitch Factors / Helical 
Pitch Sure Exp. 3D (ATC) 
77 0.5 27 8 2.0x16 Standard PF 0.938 / HP 15.0 Standard SD 6.00 
78 0.5 27 8 2.0x16 Standard PF 0.938 / HP 15.0 Low Dose SD 8.00 
79 0.5 27 8 2.0x16 Fast PF 1.438 / HP 23.0 High Quality SD 4.00 
80 0.5 27 8 2.0x16 Fast PF 1.438 / HP 23.0 Standard SD 6.00 
81 0.5 27 8 2.0x16 Fast PF 1.438 / HP 23.0 Low Dose SD 8.00 
82 0.75 0 2 0.5x16 Detail PF 0.688 / HP 11.0 High Quality SD 4.00 
83 0.75 0 2 0.5x16 Detail PF 0.688 / HP 11.0 Standard SD 6.00 
84 0.75 0 2 0.5x16 Detail PF 0.688 / HP 11.0 Low Dose SD 8.00 
85 0.75 0 2 0.5x16 Standard PF 0.938 / HP 15.0 High Quality SD 4.00 
86 0.75 0 2 0.5x16 Standard PF 0.938 / HP 15.0 Standard SD 6.00 
87 0.75 0 2 0.5x16 Standard PF 0.938 / HP 15.0 Low Dose SD 8.00 
88 0.75 0 2 0.5x16 Fast PF 1.438 / HP 23.0 High Quality SD 4.00 
89 0.75 0 2 0.5x16 Fast PF 1.438 / HP 23.0 Standard SD 6.00 
90 0.75 0 2 0.5x16 Fast PF 1.438 / HP 23.0 Low Dose SD 8.00 
91 0.75 15 2 0.5x16 Detail PF 0.688 / HP 11.0 High Quality SD 4.00 
92 0.75 15 2 0.5x16 Detail PF 0.688 / HP 11.0 Standard SD 6.00 
93 0.75 15 2 0.5x16 Detail PF 0.688 / HP 11.0 Low Dose SD 8.00 
94 0.75 15 2 0.5x16 Standard PF 0.938 / HP 15.0 High Quality SD 4.00 
95 0.75 15 2 0.5x16 Standard PF 0.938 / HP 15.0 Standard SD 6.00 
96 0.75 15 2 0.5x16 Standard PF 0.938 / HP 15.0 Low Dose SD 8.00 
97 0.75 15 2 0.5x16 Fast PF 1.438 / HP 23.0 High Quality SD 4.00 
98 0.75 15 2 0.5x16 Fast PF 1.438 / HP 23.0 Standard SD 6.00 
99 0.75 15 2 0.5x16 Fast PF 1.438 / HP 23.0 Low Dose SD 8.00 
   
 217 
 
2
1
7
 
Continued (Table C - 1) 
No Tube Rotation Time (Secs) 
Tube Angulations 
(Degrees) 
Image Thicknesses 
(mm) 
Detector 
Configuration (mm) 
Pitch Factors / Helical 
Pitch Sure Exp. 3D (ATC) 
100 0.75 27 2 0.5x16 Detail PF 0.688 / HP 11.0 High Quality SD 4.00 
101 0.75 27 2 0.5x16 Detail PF 0.688 / HP 11.0 Standard SD 6.00 
102 0.75 27 2 0.5x16 Detail PF 0.688 / HP 11.0 Low Dose SD 8.00 
103 0.75 27 2 0.5x16 Standard PF 0.938 / HP 15.0 High Quality SD 4.00 
104 0.75 27 2 0.5x16 Standard PF 0.938 / HP 15.0 Standard SD 6.00 
105 0.75 27 2 0.5x16 Standard PF 0.938 / HP 15.0 Low Dose SD 8.00 
106 0.75 27 2 0.5x16 Fast PF 1.438 / HP 23.0 High Quality SD 4.00 
107 0.75 27 2 0.5x16 Fast PF 1.438 / HP 23.0 Standard SD 6.00 
108 0.75 27 2 0.5x16 Fast PF 1.438 / HP 23.0 Low Dose SD 8.00 
109 0.75 0 4 1.0x16 Detail PF 0.688 / HP 11.0 High Quality SD 4.00 
110 0.75 0 4 1.0x16 Detail PF 0.688 / HP 11.0 Standard SD 6.00 
111 0.75 0 4 1.0x16 Detail PF 0.688 / HP 11.0 Low Dose SD 8.00 
112 0.75 0 4 1.0x16 Standard PF 0.938 / HP 15.0 High Quality SD 4.00 
113 0.75 0 4 1.0x16 Standard PF 0.938 / HP 15.0 Standard SD 6.00 
114 0.75 0 4 1.0x16 Standard PF 0.938 / HP 15.0 Low Dose SD 8.00 
115 0.75 0 4 1.0x16 Fast PF 1.438 / HP 23.0 High Quality SD 4.00 
116 0.75 0 4 1.0x16 Fast PF 1.438 / HP 23.0 Standard SD 6.00 
117 0.75 0 4 1.0x16 Fast PF 1.438 / HP 23.0 Low Dose SD 8.00 
118 0.75 15 4 1.0x16 Detail PF 0.688 / HP 11.0 High Quality SD 4.00 
119 0.75 15 4 1.0x16 Detail PF 0.688 / HP 11.0 Standard SD 6.00 
120 0.75 15 4 1.0x16 Detail PF 0.688 / HP 11.0 Low Dose SD 8.00 
121 0.75 15 4 1.0x16 Standard PF 0.938 / HP 15.0 High Quality SD 4.00 
122 0.75 15 4 1.0x16 Standard PF 0.938 / HP 15.0 Standard SD 6.00 
123 0.75 15 4 1.0x16 Standard PF 0.938 / HP 15.0 Low Dose SD 8.00 
124 0.75 15 4 1.0x16 Fast PF 1.438 / HP 23.0 High Quality SD 4.00 
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Continued (Table C - 1) 
No Tube Rotation Time (Secs) 
Tube Angulations 
(Degrees) 
Image Thicknesses 
(mm) 
Detector 
Configuration (mm) Pitch Factors / Helical Pitch Sure Exp. 3D (ATC) 
125 0.75 15 4 1.0x16 Fast PF 1.438 / HP 23.0 Standard SD 6.00 
126 0.75 15 4 1.0x16 Fast PF 1.438 / HP 23.0 Low Dose SD 8.00 
127 0.75 27 4 1.0x16 Detail PF 0.688 / HP 11.0 High Quality SD 4.00 
128 0.75 27 4 1.0x16 Detail PF 0.688 / HP 11.0 Standard SD 6.00 
129 0.75 27 4 1.0x16 Detail PF 0.688 / HP 11.0 Low Dose SD 8.00 
130 0.75 27 4 1.0x16 Standard PF 0.938 / HP 15.0 High Quality SD 4.00 
131 0.75 27 4 1.0x16 Standard PF 0.938 / HP 15.0 Standard SD 6.00 
132 0.75 27 4 1.0x16 Standard PF 0.938 / HP 15.0 Low Dose SD 8.00 
133 0.75 27 4 1.0x16 Fast PF 1.438 / HP 23.0 High Quality SD 4.00 
134 0.75 27 4 1.0x16 Fast PF 1.438 / HP 23.0 Standard SD 6.00 
135 0.75 27 4 1.0x16 Fast PF 1.438 / HP 23.0 Low Dose SD 8.00 
136 0.75 0 8 2.0x16 Detail PF 0.688 / HP 11.0 High Quality SD 4.00 
137 0.75 0 8 2.0x16 Detail PF 0.688 / HP 11.0 Standard SD 6.00 
138 0.75 0 8 2.0x16 Detail PF 0.688 / HP 11.0 Low Dose SD 8.00 
139 0.75 0 8 2.0x16 Standard PF 0.938 / HP 15.0 High Quality SD 4.00 
140 0.75 0 8 2.0x16 Standard PF 0.938 / HP 15.0 Standard SD 6.00 
141 0.75 0 8 2.0x16 Standard PF 0.938 / HP 15.0 Low Dose SD 8.00 
142 0.75 0 8 2.0x16 Fast PF 1.438 / HP 23.0 High Quality SD 4.00 
143 0.75 0 8 2.0x16 Fast PF 1.438 / HP 23.0 Standard SD 6.00 
144 0.75 0 8 2.0x16 Fast PF 1.438 / HP 23.0 Low Dose SD 8.00 
145 0.75 15 8 2.0x16 Detail PF 0.688 / HP 11.0 High Quality SD 4.00 
146 0.75 15 8 2.0x16 Detail PF 0.688 / HP 11.0 Standard SD 6.00 
147 0.75 15 8 2.0x16 Detail PF 0.688 / HP 11.0 Low Dose SD 8.00 
148 0.75 15 8 2.0x16 Standard PF 0.938 / HP 15.0 High Quality SD 4.00 
149 0.75 15 8 2.0x16 Standard PF 0.938 / HP 15.0 Standard SD 6.00 
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Continued (Table C - 1) 
No Tube Rotation Time (Secs) 
Tube Angulations 
(Degrees) 
Image Thicknesses 
(mm) 
Detector 
Configuration (mm) Pitch Factors / Helical Pitch Sure Exp. 3D (ATC) 
150 0.75 15 8 2.0x16 Standard PF 0.938 / HP 15.0 Low Dose SD 8.00 
151 0.75 15 8 2.0x16 Fast PF 1.438 / HP 23.0 High Quality SD 4.00 
152 0.75 15 8 2.0x16 Fast PF 1.438 / HP 23.0 Standard SD 6.00 
153 0.75 15 8 2.0x16 Fast PF 1.438 / HP 23.0 Low Dose SD 8.00 
154 0.75 27 8 2.0x16 Detail PF 0.688 / HP 11.0 High Quality SD 4.00 
155 0.75 27 8 2.0x16 Detail PF 0.688 / HP 11.0 Standard SD 6.00 
156 0.75 27 8 2.0x16 Detail PF 0.688 / HP 11.0 Low Dose SD 8.00 
157 0.75 27 8 2.0x16 Standard PF 0.938 / HP 15.0 High Quality SD 4.00 
158 0.75 27 8 2.0x16 Standard PF 0.938 / HP 15.0 Standard SD 6.00 
159 0.75 27 8 2.0x16 Standard PF 0.938 / HP 15.0 Low Dose SD 8.00 
160 0.75 27 8 2.0x16 Fast PF 1.438 / HP 23.0 High Quality SD 4.00 
161 0.75 27 8 2.0x16 Fast PF 1.438 / HP 23.0 Standard SD 6.00 
162 0.75 27 8 2.0x16 Fast PF 1.438 / HP 23.0 Low Dose SD 8.00 
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Table C - 2: Paediatric helical CT brain protocol parameters changes. 
No Angle Rot. Time (S) Slice thickness (mm) KV mA (fixed) 
01 0 0.5   0.5x16 100 120 
02 0 0.75   0.5x16 100 120 
03 0 1  0.5x16 100 120 
04 15 0.5   0.5x16 100 120 
05 15 0.75   0.5x16 100 120 
06 15 1  0.5x16 100 120 
07 27  0.5   0.5x16 100 120 
08 27  0.75   0.5x16 100 120 
09 27 1  0.5x16 100 120 
10 0 0.5   0.5x16 100 160 
11 0 0.75   0.5x16 100 160 
12 0 1  0.5x16 100 160 
13 15 0.5   0.5x16 100 160 
14 15 0.75   0.5x16 100 160 
15 15 1  0.5x16  100  160 
16 27  0.5   0.5x16 100 160 
17 27  0.75   0.5x16 100 160 
18 27 1  0.5x16 100 160 
19 0 0.5   0.5x16 100 200 
20 0 0.75   0.5x16 100 200 
21 0 1  0.5x16 100 200 
22 15 0.5   0.5x16 100 200 
23 15 0.75   0.5x16 100 200 
24 15 1  0.5x16 100 200 
25 27  0.5   0.5x16 100 200 
26 27  0.75   0.5x16 100 200 
27 27 1  0.5x16 100 200 
28 0 0.5   0.5x16 120 120 
29 0 0.75   0.5x16 120 120 
30 0 1  0.5x16 120 120 
31 15 0.5   0.5x16 120 120 
32 15 0.75   0.5x16 120 120 
33 15 1  0.5x16 120 120 
34 27  0.5   0.5x16 120 120 
35 27  0.75   0.5x16 120 120 
36 27 1  0.5x16 120 120 
37 0 0.5   0.5x16 120 160 
38 0 0.75   0.5x16 120 160 
39 0 1  0.5x16 120 160 
40 15 0.5   0.5x16 120 160 
41 15 0.75   0.5x16 120 160 
42 15 1  0.5x16 120 160 
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Continued (Table C - 2) 
No Angle Rot. Time (Secs) Slice thickness (mm) KV mA (fixed) 
43 27  0.5   0.5x16 120 160 
44 27  0.75   0.5x16 120 160 
45 27 1  0.5x16 120 160 
46 0 0.5   0.5x16 120 200 
47 0 0.75   0.5x16 120 200 
48 0 1  0.5x16 120 200 
49 15 0.5   0.5x16 120 200 
50 15 0.75   0.5x16 120 200 
51 15 1  0.5x16 120 200 
52 27  0.5   0.5x16 120 200 
53 27  0.75   0.5x16 120 200 
54 27 1  0.5x16 120 200 
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Appendix D: Tables and graphs of adult helical effective dose results 
obtained using MOSFET 
Table D - 1: Adult helical effective dose calculated for 0.5 CT gantry rotation time and CT gantry angle of 
0o. 
Detector Configuration (mm) Pitch Factors / Helical Pitch Sure Exp. 3D (ATC) ED (mSv) 
0.5x16 Detail PF 0.688 / HP 11.0 High Quality SD 1.80 0.71 
0.5x16 Detail PF 0.688 / HP 11.0 Standard SD 2.00 0.70 
0.5x16 Detail PF 0.688 / HP 11.0 Low Dose SD 2.20 0.70 
0.5x16 Standard PF 0.938 / HP 15.0 High Quality SD 1.80 0.63 
0.5x16 Standard PF 0.938 / HP 15.0 Standard SD 2.00 0.56 
0.5x16 Standard PF 0.938 / HP 15.0 Low Dose SD 2.20 0.55 
0.5x16 Fast PF 1.438 / HP 23.0 High Quality SD 1.80 0.46 
0.5x16 Fast PF 1.438 / HP 23.0 Standard SD 2.00 0.45 
0.5x16 Fast PF 1.438 / HP 23.0 Low Dose SD 2.20 0.43 
1.0x16 Detail PF 0.688 / HP 11.0 High Quality SD 1.80 0.76 
1.0x16 Detail PF 0.688 / HP 11.0 Standard SD 2.00 0.74 
1.0x16 Detail PF 0.688 / HP 11.0 Low Dose SD 2.20 0.75 
1.0x16 Standard PF 0.938 / HP 15.0 High Quality SD 1.80 0.64 
1.0x16 Standard PF 0.938 / HP 15.0 Standard SD 2.00 0.61 
1.0x16 Standard PF 0.938 / HP 15.0 Low Dose SD 2.20 0.55 
1.0x16 Fast PF 1.438 / HP 23.0 High Quality SD 1.80 0.48 
1.0x16 Fast PF 1.438 / HP 23.0 Standard SD 2.00 0.46 
1.0x16 Fast PF 1.438 / HP 23.0 Low Dose SD 2.20 0.43 
2.0x16 Detail PF 0.688 / HP 11.0 High Quality SD 1.80 0.73 
2.0x16 Detail PF 0.688 / HP 11.0 Standard SD 2.00 0.71 
2.0x16 Detail PF 0.688 / HP 11.0 Low Dose SD 2.20 0.63 
2.0x16 Standard PF 0.938 / HP 15.0 High Quality SD 1.80 0.67 
2.0x16 Standard PF 0.938 / HP 15.0 Standard SD 2.00 0.69 
2.0x16 Standard PF 0.938 / HP 15.0 Low Dose SD 2.20 0.63 
2.0x16 Fast PF 1.438 / HP 23.0 High Quality SD 1.80 0.62 
2.0x16 Fast PF 1.438 / HP 23.0 Standard SD 2.00 0.62 
2.0x16 Fast PF 1.438 / HP 23.0 Low Dose SD 2.20 0.56 
PF = Pitch Factor 
HP = Helical Pitch 
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Table D - 2: Adult helical effective dose calculated for 1.0 CT gantry rotation time and CT gantry angle of 
0o. 
Detector Configuration (mm) Pitch Factors / Helical Pitch Sure Exp. 3D (ATC) ED (mSv) 
0.5x16 Detail PF 0.688 / HP 11.0 High Quality SD 1.80 1.17 
0.5x16 Detail PF 0.688 / HP 11.0 Standard SD 2.00 1.03 
0.5x16 Detail PF 0.688 / HP 11.0 Low Dose SD 2.20 0.98 
0.5x16 Standard PF 0.938 / HP 15.0 High Quality SD 1.80 0.91 
0.5x16 Standard PF 0.938 / HP 15.0 Standard SD 2.00 0.82 
0.5x16 Standard PF 0.938 / HP 15.0 Low Dose SD 2.20 0.78 
0.5x16 Fast PF 1.438 / HP 23.0 High Quality SD 1.80 0.83 
0.5x16 Fast PF 1.438 / HP 23.0 Standard SD 2.00 0.74 
0.5x16 Fast PF 1.438 / HP 23.0 Low Dose SD 2.20 0.64 
1.0x16 Detail PF 0.688 / HP 11.0 High Quality SD 1.80 1.24 
1.0x16 Detail PF 0.688 / HP 11.0 Standard SD 2.00 1.20 
1.0x16 Detail PF 0.688 / HP 11.0 Low Dose SD 2.20 0.92 
1.0x16 Standard PF 0.938 / HP 15.0 High Quality SD 1.80 1.08 
1.0x16 Standard PF 0.938 / HP 15.0 Standard SD 2.00 0.93 
1.0x16 Standard PF 0.938 / HP 15.0 Low Dose SD 2.20 0.95 
1.0x16 Fast PF 1.438 / HP 23.0 High Quality SD 1.80 0.89 
1.0x16 Fast PF 1.438 / HP 23.0 Standard SD 2.00 0.77 
1.0x16 Fast PF 1.438 / HP 23.0 Low Dose SD 2.20 0.75 
2.0x16 Detail PF 0.688 / HP 11.0 High Quality SD 1.80 1.11 
2.0x16 Detail PF 0.688 / HP 11.0 Standard SD 2.00 1.08 
2.0x16 Detail PF 0.688 / HP 11.0 Low Dose SD 2.20 0.86 
2.0x16 Standard PF 0.938 / HP 15.0 High Quality SD 1.80 1.08 
2.0x16 Standard PF 0.938 / HP 15.0 Standard SD 2.00 1.01 
2.0x16 Standard PF 0.938 / HP 15.0 Low Dose SD 2.20 0.76 
2.0x16 Fast PF 1.438 / HP 23.0 High Quality SD 1.80 1.11 
2.0x16 Fast PF 1.438 / HP 23.0 Standard SD 2.00 1.12 
2.0x16 Fast PF 1.438 / HP 23.0 Low Dose SD 2.20 0.84 
PF = Pitch Factor 
HP = Helical Pitch 
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Table D - 3: Adult helical effective dose calculated for 0.5 CT gantry rotation time and CT gantry 
angle of 15o. 
Detector Configuration (mm) Pitch Factors / Helical Pitch Sure Exp. 3D (ATC) ED (mSv) 
0.5x16 Detail PF 0.688 / HP 11.0 High Quality SD 1.80 0.81 
0.5x16 Detail PF 0.688 / HP 11.0 Standard SD 2.00 0.72 
0.5x16 Detail PF 0.688 / HP 11.0 Low Dose SD 2.20 0.68 
0.5x16 Standard PF 0.938 / HP 15.0 High Quality SD 1.80 0.58 
0.5x16 Standard PF 0.938 / HP 15.0 Standard SD 2.00 0.57 
0.5x16 Standard PF 0.938 / HP 15.0 Low Dose SD 2.20 0.52 
0.5x16 Fast PF 1.438 / HP 23.0 High Quality SD 1.80 0.43 
0.5x16 Fast PF 1.438 / HP 23.0 Standard SD 2.00 0.41 
0.5x16 Fast PF 1.438 / HP 23.0 Low Dose SD 2.20 0.39 
1.0x16 Detail PF 0.688 / HP 11.0 High Quality SD 1.80 0.70 
1.0x16 Detail PF 0.688 / HP 11.0 Standard SD 2.00 0.69 
1.0x16 Detail PF 0.688 / HP 11.0 Low Dose SD 2.20 0.64 
1.0x16 Standard PF 0.938 / HP 15.0 High Quality SD 1.80 0.55 
1.0x16 Standard PF 0.938 / HP 15.0 Standard SD 2.00 0.52 
1.0x16 Standard PF 0.938 / HP 15.0 Low Dose SD 2.20 0.53 
1.0x16 Fast PF 1.438 / HP 23.0 High Quality SD 1.80 0.39 
1.0x16 Fast PF 1.438 / HP 23.0 Standard SD 2.00 0.38 
1.0x16 Fast PF 1.438 / HP 23.0 Low Dose SD 2.20 0.34 
2.0x16 Detail PF 0.688 / HP 11.0 High Quality SD 1.80 0.79 
2.0x16 Detail PF 0.688 / HP 11.0 Standard SD 2.00 0.67 
2.0x16 Detail PF 0.688 / HP 11.0 Low Dose SD 2.20 0.60 
2.0x16 Standard PF 0.938 / HP 15.0 High Quality SD 1.80 0.68 
2.0x16 Standard PF 0.938 / HP 15.0 Standard SD 2.00 0.60 
2.0x16 Standard PF 0.938 / HP 15.0 Low Dose SD 2.20 0.47 
2.0x16 Fast PF 1.438 / HP 23.0 High Quality SD 1.80 0.51 
2.0x16 Fast PF 1.438 / HP 23.0 Standard SD 2.00 0.51 
2.0x16 Fast PF 1.438 / HP 23.0 Low Dose SD 2.20 0.43 
PF = Pitch Factor 
HP = Helical Pitch 
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Table D - 4: Adult helical effective dose calculated for 1.0 CT gantry rotation time and CT gantry 
angle of 15o. 
Detector Configuration (mm) Pitch Factors / Helical Pitch Sure Exp. 3D (ATC) ED (mSv) 
0.5x16 Detail PF 0.688 / HP 11.0 High Quality SD 1.80 1.25 
0.5x16 Detail PF 0.688 / HP 11.0 Standard SD 2.00 0.99 
0.5x16 Detail PF 0.688 / HP 11.0 Low Dose SD 2.20 0.78 
0.5x16 Standard PF 0.938 / HP 15.0 High Quality SD 1.80 0.99 
0.5x16 Standard PF 0.938 / HP 15.0 Standard SD 2.00 0.84 
0.5x16 Standard PF 0.938 / HP 15.0 Low Dose SD 2.20 0.73 
0.5x16 Fast PF 1.438 / HP 23.0 High Quality SD 1.80 0.84 
0.5x16 Fast PF 1.438 / HP 23.0 Standard SD 2.00 0.74 
0.5x16 Fast PF 1.438 / HP 23.0 Low Dose SD 2.20 0.69 
1.0x16 Detail PF 0.688 / HP 11.0 High Quality SD 1.80 1.35 
1.0x16 Detail PF 0.688 / HP 11.0 Standard SD 2.00 1.18 
1.0x16 Detail PF 0.688 / HP 11.0 Low Dose SD 2.20 1.08 
1.0x16 Standard PF 0.938 / HP 15.0 High Quality SD 1.80 1.08 
1.0x16 Standard PF 0.938 / HP 15.0 Standard SD 2.00 0.90 
1.0x16 Standard PF 0.938 / HP 15.0 Low Dose SD 2.20 0.64 
1.0x16 Fast PF 1.438 / HP 23.0 High Quality SD 1.80 0.70 
1.0x16 Fast PF 1.438 / HP 23.0 Standard SD 2.00 0.71 
1.0x16 Fast PF 1.438 / HP 23.0 Low Dose SD 2.20 0.66 
2.0x16 Detail PF 0.688 / HP 11.0 High Quality SD 1.80 0.87 
2.0x16 Detail PF 0.688 / HP 11.0 Standard SD 2.00 0.74 
2.0x16 Detail PF 0.688 / HP 11.0 Low Dose SD 2.20 0.62 
2.0x16 Standard PF 0.938 / HP 15.0 High Quality SD 1.80 0.77 
2.0x16 Standard PF 0.938 / HP 15.0 Standard SD 2.00 0.64 
2.0x16 Standard PF 0.938 / HP 15.0 Low Dose SD 2.20 0.58 
2.0x16 Fast PF 1.438 / HP 23.0 High Quality SD 1.80 0.92 
2.0x16 Fast PF 1.438 / HP 23.0 Standard SD 2.00 0.80 
2.0x16 Fast PF 1.438 / HP 23.0 Low Dose SD 2.20 0.74 
PF = Pitch Factor 
HP = Helical Pitch 
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Table D - 5: Adult helical effective dose calculated for 0.5 CT gantry rotation time and CT gantry angle 
of 27o. 
Detector Configuration (mm) Pitch Factors / Helical Pitch Sure Exp. 3D (ATC) ED (mSv) 
0.5x16 Detail PF 0.688 / HP 11.0 High Quality SD 1.80 0.88 
0.5x16 Detail PF 0.688 / HP 11.0 Standard SD 2.00 0.83 
0.5x16 Detail PF 0.688 / HP 11.0 Low Dose SD 2.20 0.78 
0.5x16 Standard PF 0.938 / HP 15.0 High Quality SD 1.80 0.70 
0.5x16 Standard PF 0.938 / HP 15.0 Standard SD 2.00 0.66 
0.5x16 Standard PF 0.938 / HP 15.0 Low Dose SD 2.20 0.57 
0.5x16 Fast PF 1.438 / HP 23.0 High Quality SD 1.80 0.47 
0.5x16 Fast PF 1.438 / HP 23.0 Standard SD 2.00 0.47 
0.5x16 Fast PF 1.438 / HP 23.0 Low Dose SD 2.20 0.44 
1.0x16 Detail PF 0.688 / HP 11.0 High Quality SD 1.80 0.81 
1.0x16 Detail PF 0.688 / HP 11.0 Standard SD 2.00 0.76 
1.0x16 Detail PF 0.688 / HP 11.0 Low Dose SD 2.20 0.67 
1.0x16 Standard PF 0.938 / HP 15.0 High Quality SD 1.80 0.61 
1.0x16 Standard PF 0.938 / HP 15.0 Standard SD 2.00 0.61 
1.0x16 Standard PF 0.938 / HP 15.0 Low Dose SD 2.20 0.52 
1.0x16 Fast PF 1.438 / HP 23.0 High Quality SD 1.80 0.45 
1.0x16 Fast PF 1.438 / HP 23.0 Standard SD 2.00 0.42 
1.0x16 Fast PF 1.438 / HP 23.0 Low Dose SD 2.20 0.42 
2.0x16 Detail PF 0.688 / HP 11.0 High Quality SD 1.80 0.82 
2.0x16 Detail PF 0.688 / HP 11.0 Standard SD 2.00 0.74 
2.0x16 Detail PF 0.688 / HP 11.0 Low Dose SD 2.20 0.60 
2.0x16 Standard PF 0.938 / HP 15.0 High Quality SD 1.80 0.71 
2.0x16 Standard PF 0.938 / HP 15.0 Standard SD 2.00 0.64 
2.0x16 Standard PF 0.938 / HP 15.0 Low Dose SD 2.20 0.58 
2.0x16 Fast PF 1.438 / HP 23.0 High Quality SD 1.80 0.56 
2.0x16 Fast PF 1.438 / HP 23.0 Standard SD 2.00 0.58 
2.0x16 Fast PF 1.438 / HP 23.0 Low Dose SD 2.20 0.51 
PF = Pitch Factor 
HP = Helical Pitch 
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Table D - 6: Adult helical effective dose calculated for 1.0 CT gantry rotation time and CT gantry angle 
of 27o. 
Detector Configuration (mm) Pitch Factors / Helical Pitch Sure Exp. 3D (ATC) ED (mSv) 
0.5x16 Detail PF 0.688 / HP 11.0 High Quality SD 1.80 1.13 
0.5x16 Detail PF 0.688 / HP 11.0 Standard SD 2.00 1.00 
0.5x16 Detail PF 0.688 / HP 11.0 Low Dose SD 2.20 0.87 
0.5x16 Standard PF 0.938 / HP 15.0 High Quality SD 1.80 1.01 
0.5x16 Standard PF 0.938 / HP 15.0 Standard SD 2.00 0.83 
0.5x16 Standard PF 0.938 / HP 15.0 Low Dose SD 2.20 0.75 
0.5x16 Fast PF 1.438 / HP 23.0 High Quality SD 1.80 0.88 
0.5x16 Fast PF 1.438 / HP 23.0 Standard SD 2.00 0.88 
0.5x16 Fast PF 1.438 / HP 23.0 Low Dose SD 2.20 0.83 
1.0x16 Detail PF 0.688 / HP 11.0 High Quality SD 1.80 1.55 
1.0x16 Detail PF 0.688 / HP 11.0 Standard SD 2.00 1.28 
1.0x16 Detail PF 0.688 / HP 11.0 Low Dose SD 2.20 1.10 
1.0x16 Standard PF 0.938 / HP 15.0 High Quality SD 1.80 1.24 
1.0x16 Standard PF 0.938 / HP 15.0 Standard SD 2.00 1.19 
1.0x16 Standard PF 0.938 / HP 15.0 Low Dose SD 2.20 0.97 
1.0x16 Fast PF 1.438 / HP 23.0 High Quality SD 1.80 0.87 
1.0x16 Fast PF 1.438 / HP 23.0 Standard SD 2.00 0.79 
1.0x16 Fast PF 1.438 / HP 23.0 Low Dose SD 2.20 0.77 
2.0x16 Detail PF 0.688 / HP 11.0 High Quality SD 1.80 0.92 
2.0x16 Detail PF 0.688 / HP 11.0 Standard SD 2.00 0.75 
2.0x16 Detail PF 0.688 / HP 11.0 Low Dose SD 2.20 0.66 
2.0x16 Standard PF 0.938 / HP 15.0 High Quality SD 1.80 0.76 
2.0x16 Standard PF 0.938 / HP 15.0 Standard SD 2.00 0.75 
2.0x16 Standard PF 0.938 / HP 15.0 Low Dose SD 2.20 0.56 
2.0x16 Fast PF 1.438 / HP 23.0 High Quality SD 1.80 0.98 
2.0x16 Fast PF 1.438 / HP 23.0 Standard SD 2.00 0.90 
2.0x16 Fast PF 1.438 / HP 23.0 Low Dose SD 2.20 0.78 
PF = Pitch Factor 
HP = Helical Pitch 
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Figure D - 1: Graphs showing the relationship of CT gantry rotation time with detector configurations, CT 
gantry angulations, helical pitch and sure Exp. 3D (ATC). 
  
 
  
Figure D - 2: Graphs showing the relationship of CT gantry angulations with CT gantry rotation time, detector 
configurations, helical pitch and sure Exp. 3D (ATC). 
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Figure D - 3: Graphs showing the relationship of detector configurations with CT gantry rotation time, CT 
gantry angulations, helical pitch and sure Exp. 3D (ATC). 
    
    
Figure D - 4: Graphs showing the relationship of helical pitch with CT gantry rotation time, CT gantry 
angulations, detector configurations and sure Exp. 3D (ATC). 
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Figure D - 5: Graphs showing the relationship of helical pitch with CT gantry rotation time, CT gantry 
angulations, detector configurations and sure Exp. 3D (ATC). 
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Appendix E: Tables and graphs of adult sequential effective dose results 
obtained using MOSFET 
 
 
 
Table E - 3: Sequential effective dose calculated for CT gantry angle of 27o. 
Tube Rotation Time (S) Detector Configuration (mm) Sure Exp. 3D (ATC) ED (mSv) 
0.5 0.5x4 High Quality SD 1.80 0.38 
0.5 0.5x4 Standard SD 2.00 0.39 
0.5 0.5x4 Low Dose SD 2.20 0.34 
0.5 1.0x4 High Quality SD 1.80 0.44 
0.5 1.0x4 Standard SD 2.00 0.43 
0.5 1.0x4 Low Dose SD 2.20 0.39 
0.5 2.0x4 High Quality SD 1.80 0.63 
0.5 2.0x4 Standard SD 2.00 0.58 
0.5 2.0x4 Low Dose SD 2.20 0.56 
1 0.5x4 High Quality SD 1.80 0.75 
1 0.5x4 Standard SD 2.00 0.66 
1 0.5x4 Low Dose SD 2.20 0.63 
1 1.0x4 High Quality SD 1.80 0.87 
1 1.0x4 Standard SD 2.00 0.73 
1 1.0x4 Low Dose SD 2.20 0.73 
1 2.0x4 High Quality SD 1.80 1.13 
1 2.0x4 Standard SD 2.00 0.96 
1 2.0x4 Low Dose SD 2.20 0.78 
 
Table E - 1: Sequential effective dose calculated 
for CT gantry angle of 0o. 
Tube 
Rotation 
Time (S) 
Detector 
Configurat
ion (mm) 
Sure Exp. 3D (ATC) ED (mSv)
0.5 0.5x4 High Quality SD 1.80 0.37 
0.5 0.5x4 Standard SD 2.00 0.33 
0.5 0.5x4 Low Dose SD 2.20 0.37 
0.5 1.0x4 High Quality SD 1.80 0.43 
0.5 1.0x4 Standard SD 2.00 0.36 
0.5 1.0x4 Low Dose SD 2.20 0.40 
0.5 2.0x4 High Quality SD 1.80 0.61 
0.5 2.0x4 Standard SD 2.00 0.51 
0.5 2.0x4 Low Dose SD 2.20 0.48 
1 0.5x4 High Quality SD 1.80 0.55 
1 0.5x4 Standard SD 2.00 0.54 
1 0.5x4 Low Dose SD 2.20 0.52 
1 1.0x4 High Quality SD 1.80 0.72 
1 1.0x4 Standard SD 2.00 0.69 
1 1.0x4 Low Dose SD 2.20 0.65 
1 2.0x4 High Quality SD 1.80 0.98 
1 2.0x4 Standard SD 2.00 0.85 
 1 2.0x4 Low Dose SD 2.20 0.77 
Table E - 2: Sequential effective dose calculated 
for CT gantry angle of 15o. 
Tube 
Rotation 
Time (S)
Detector 
Configuration 
(mm) 
Sure Exp. 3D (ATC) ED (mSv)
0.5 0.5x4 High Quality SD 1.80 0.30 
0.5 0.5x4 Standard SD 2.00 0.32 
0.5 0.5x4 Low Dose SD 2.20 0.27 
0.5 1.0x4 High Quality SD 1.80 0.39 
0.5 1.0x4 Standard SD 2.00 0.36 
0.5 1.0x4 Low Dose SD 2.20 0.35 
0.5 2.0x4 High Quality SD 1.80 0.51 
0.5 2.0x4 Standard SD 2.00 0.49 
0.5 2.0x4 Low Dose SD 2.20 0.47 
1 0.5x4 High Quality SD 1.80 0.64 
1 0.5x4 Standard SD 2.00 0.58 
1 0.5x4 Low Dose SD 2.20 0.52 
1 1.0x4 High Quality SD 1.80 0.71 
1 1.0x4 Standard SD 2.00 0.65 
1 1.0x4 Low Dose SD 2.20 0.66 
1 2.0x4 High Quality SD 1.80 0.98 
1 2.0x4 Standard SD 2.00 0.91 
1 2.0x4 Low Dose SD 2.20 0.75 
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Figure E - 1: Graphs showing the relationship of CT gantry rotation time with CT gantry angulations, detector 
configurations and Sure Exp. 3D (ATC). 
   
   
Figure E - 2: Graphs showing the relationship of CT gantry angulations with CT gantry rotation time, detector 
configurations and Sure Exp. 3D (ATC). 
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Figure E - 3:  Graphs showing the relationship of detector configurations with CT gantry rotation time, CT 
gantry angulations, and Sure Exp. 3D (ATC). 
    
  
Figure E - 4: Graphs showing the relationship of sure Exp. 3D (ATC) with CT gantry rotation time, CT gantry 
angulations and detector configurations. 
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Appendix F: Tables and graphs of Paediatric helical effective dose results 
obtained using MOSFET 
Table F - 1: Paediatric helical protocols effective dose calculated for 0.5 CT gantry rotation time and CT 
gantry angle of 0o. 
Detector Configuration (mm) Pitch Factors / Helical Pitch Sure Exp. 3D (ATC) ED (mSv) 
0.5x16 Detail PF 0.688 / HP 11.0 High Quality SD 4.00 2.01 
0.5x16 Detail PF 0.688 / HP 11.0 Standard SD 6.00 1.08 
0.5x16 Detail PF 0.688 / HP 11.0 Low Dose SD 8.00 0.68 
0.5x16 Standard PF 0.938 / HP 15.0 High Quality SD 4.00 1.71 
0.5x16 Standard PF 0.938 / HP 15.0 Standard SD 6.00 1.02 
0.5x16 Standard PF 0.938 / HP 15.0 Low Dose SD 8.00 0.62 
0.5x16 Fast PF 1.438 / HP 23.0 High Quality SD 4.00 1.58 
0.5x16 Fast PF 1.438 / HP 23.0 Standard SD 6.00 1.15 
0.5x16 Fast PF 1.438 / HP 23.0 Low Dose SD 8.00 0.77 
1.0x16 Detail PF 0.688 / HP 11.0 High Quality SD 4.00 1.02 
1.0x16 Detail PF 0.688 / HP 11.0 Standard SD 6.00 0.59 
1.0x16 Detail PF 0.688 / HP 11.0 Low Dose SD 8.00 0.41 
1.0x16 Standard PF 0.938 / HP 15.0 High Quality SD 4.00 1.00 
1.0x16 Standard PF 0.938 / HP 15.0 Standard SD 6.00 0.53 
1.0x16 Standard PF 0.938 / HP 15.0 Low Dose SD 8.00 0.40 
1.0x16 Fast PF 1.438 / HP 23.0 High Quality SD 4.00 1.22 
1.0x16 Fast PF 1.438 / HP 23.0 Standard SD 6.00 0.69 
1.0x16 Fast PF 1.438 / HP 23.0 Low Dose SD 8.00 0.43 
2.0x16 Detail PF 0.688 / HP 11.0 High Quality SD 4.00 0.71 
2.0x16 Detail PF 0.688 / HP 11.0 Standard SD 6.00 0.42 
2.0x16 Detail PF 0.688 / HP 11.0 Low Dose SD 8.00 0.33 
2.0x16 Standard PF 0.938 / HP 15.0 High Quality SD 4.00 0.65 
2.0x16 Standard PF 0.938 / HP 15.0 Standard SD 6.00 0.39 
2.0x16 Standard PF 0.938 / HP 15.0 Low Dose SD 8.00 0.31 
2.0x16 Fast PF 1.438 / HP 23.0 High Quality SD 4.00 0.75 
2.0x16 Fast PF 1.438 / HP 23.0 Standard SD 6.00 0.46 
2.0x16 Fast PF 1.438 / HP 23.0 Low Dose SD 8.00 0.33 
PF = Pitch Factor 
HP = Helical Pitch 
 
Table F - 2: Paediatric helical protocols effective dose calculated for 0.75 CT gantry rotation time and CT 
gantry angle of 0o. 
Detector Configuration (mm) Pitch Factors / Helical Pitch Sure Exp. 3D (ATC) ED (mSv) 
0.5x16 Detail PF 0.688 / HP 11.0 High Quality SD 4.00 1.95 
0.5x16 Detail PF 0.688 / HP 11.0 Standard SD 6.00 1.06 
0.5x16 Detail PF 0.688 / HP 11.0 Low Dose SD 8.00 0.71 
0.5x16 Standard PF 0.938 / HP 15.0 High Quality SD 4.00 1.74 
0.5x16 Standard PF 0.938 / HP 15.0 Standard SD 6.00 0.93 
0.5x16 Standard PF 0.938 / HP 15.0 Low Dose SD 8.00 0.61 
0.5x16 Fast PF 1.438 / HP 23.0 High Quality SD 4.00 2.06 
0.5x16 Fast PF 1.438 / HP 23.0 Standard SD 6.00 1.14 
0.5x16 Fast PF 1.438 / HP 23.0 Low Dose SD 8.00 0.75 
1.0x16 Detail PF 0.688 / HP 11.0 High Quality SD 4.00 1.05 
1.0x16 Detail PF 0.688 / HP 11.0 Standard SD 6.00 0.62 
1.0x16 Detail PF 0.688 / HP 11.0 Low Dose SD 8.00 0.45 
1.0x16 Standard PF 0.938 / HP 15.0 High Quality SD 4.00 1.02 
1.0x16 Standard PF 0.938 / HP 15.0 Standard SD 6.00 0.58 
1.0x16 Standard PF 0.938 / HP 15.0 Low Dose SD 8.00 0.40 
1.0x16 Fast PF 1.438 / HP 23.0 High Quality SD 4.00 1.25 
1.0x16 Fast PF 1.438 / HP 23.0 Standard SD 6.00 0.64 
1.0x16 Fast PF 1.438 / HP 23.0 Low Dose SD 8.00 0.46 
2.0x16 Detail PF 0.688 / HP 11.0 High Quality SD 4.00 0.72 
2.0x16 Detail PF 0.688 / HP 11.0 Standard SD 6.00 0.44 
2.0x16 Detail PF 0.688 / HP 11.0 Low Dose SD 8.00 0.37 
2.0x16 Standard PF 0.938 / HP 15.0 High Quality SD 4.00 0.62 
2.0x16 Standard PF 0.938 / HP 15.0 Standard SD 6.00 0.40 
2.0x16 Standard PF 0.938 / HP 15.0 Low Dose SD 8.00 0.35 
2.0x16 Fast PF 1.438 / HP 23.0 High Quality SD 4.00 0.85 
2.0x16 Fast PF 1.438 / HP 23.0 Standard SD 6.00 0.51 
2.0x16 Fast PF 1.438 / HP 23.0 Low Dose SD 8.00 0.35 
PF = Pitch Factor 
HP = Helical Pitch 
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Table F - 3:  Paediatric helical protocols effective dose calculated for 0.5 CT gantry rotation 
time and CT gantry angle of 15o. 
Detector Configuration (mm) Pitch Factors / Helical Pitch Sure Exp. 3D (ATC) ED (mSv) 
0.5x16 Detail PF 0.688 / HP 11.0 High Quality SD 4.00 1.82 
0.5x16 Detail PF 0.688 / HP 11.0 Standard SD 6.00 0.99 
0.5x16 Detail PF 0.688 / HP 11.0 Low Dose SD 8.00 0.61 
0.5x16 Standard PF 0.938 / HP 15.0 High Quality SD 4.00 1.58 
0.5x16 Standard PF 0.938 / HP 15.0 Standard SD 6.00 0.91 
0.5x16 Standard PF 0.938 / HP 15.0 Low Dose SD 8.00 0.57 
0.5x16 Fast PF 1.438 / HP 23.0 High Quality SD 4.00 1.52 
0.5x16 Fast PF 1.438 / HP 23.0 Standard SD 6.00 0.95 
0.5x16 Fast PF 1.438 / HP 23.0 Low Dose SD 8.00 0.68 
1.0x16 Detail PF 0.688 / HP 11.0 High Quality SD 4.00 0.98 
1.0x16 Detail PF 0.688 / HP 11.0 Standard SD 6.00 0.51 
1.0x16 Detail PF 0.688 / HP 11.0 Low Dose SD 8.00 0.39 
1.0x16 Standard PF 0.938 / HP 15.0 High Quality SD 4.00 0.86 
1.0x16 Standard PF 0.938 / HP 15.0 Standard SD 6.00 0.53 
1.0x16 Standard PF 0.938 / HP 15.0 Low Dose SD 8.00 0.38 
1.0x16 Fast PF 1.438 / HP 23.0 High Quality SD 4.00 1.15 
1.0x16 Fast PF 1.438 / HP 23.0 Standard SD 6.00 0.62 
1.0x16 Fast PF 1.438 / HP 23.0 Low Dose SD 8.00 0.47 
2.0x16 Detail PF 0.688 / HP 11.0 High Quality SD 4.00 0.63 
2.0x16 Detail PF 0.688 / HP 11.0 Standard SD 6.00 0.40 
2.0x16 Detail PF 0.688 / HP 11.0 Low Dose SD 8.00 0.32 
2.0x16 Standard PF 0.938 / HP 15.0 High Quality SD 4.00 0.62 
2.0x16 Standard PF 0.938 / HP 15.0 Standard SD 6.00 0.40 
2.0x16 Standard PF 0.938 / HP 15.0 Low Dose SD 8.00 0.30 
2.0x16 Fast PF 1.438 / HP 23.0 High Quality SD 4.00 0.81 
2.0x16 Fast PF 1.438 / HP 23.0 Standard SD 6.00 0.44 
2.0x16 Fast PF 1.438 / HP 23.0 Low Dose SD 8.00 0.36 
PF = Pitch Factor 
HP = Helical Pitch 
 
Table F - 4: Paediatric helical protocols effective dose calculated for 0.75 CT gantry rotation time 
and CT gantry angle of 15o.
Detector Configuration (mm) Pitch Factors / Helical Pitch Sure Exp. 3D (ATC) ED (mSv) 
0.5x16 Detail PF 0.688 / HP 11.0 High Quality SD 4.00 1.76 
0.5x16 Detail PF 0.688 / HP 11.0 Standard SD 6.00 1.01 
0.5x16 Detail PF 0.688 / HP 11.0 Low Dose SD 8.00 0.64 
0.5x16 Standard PF 0.938 / HP 15.0 High Quality SD 4.00 1.59 
0.5x16 Standard PF 0.938 / HP 15.0 Standard SD 6.00 0.83 
0.5x16 Standard PF 0.938 / HP 15.0 Low Dose SD 8.00 0.57 
0.5x16 Fast PF 1.438 / HP 23.0 High Quality SD 4.00 1.78 
0.5x16 Fast PF 1.438 / HP 23.0 Standard SD 6.00 0.98 
0.5x16 Fast PF 1.438 / HP 23.0 Low Dose SD 8.00 0.66 
1.0x16 Detail PF 0.688 / HP 11.0 High Quality SD 4.00 0.93 
1.0x16 Detail PF 0.688 / HP 11.0 Standard SD 6.00 0.53 
1.0x16 Detail PF 0.688 / HP 11.0 Low Dose SD 8.00 0.42 
1.0x16 Standard PF 0.938 / HP 15.0 High Quality SD 4.00 0.91 
1.0x16 Standard PF 0.938 / HP 15.0 Standard SD 6.00 0.52 
1.0x16 Standard PF 0.938 / HP 15.0 Low Dose SD 8.00 0.36 
1.0x16 Fast PF 1.438 / HP 23.0 High Quality SD 4.00 1.21 
1.0x16 Fast PF 1.438 / HP 23.0 Standard SD 6.00 0.62 
1.0x16 Fast PF 1.438 / HP 23.0 Low Dose SD 8.00 0.46 
2.0x16 Detail PF 0.688 / HP 11.0 High Quality SD 4.00 0.69 
2.0x16 Detail PF 0.688 / HP 11.0 Standard SD 6.00 0.41 
2.0x16 Detail PF 0.688 / HP 11.0 Low Dose SD 8.00 0.31 
2.0x16 Standard PF 0.938 / HP 15.0 High Quality SD 4.00 0.65 
2.0x16 Standard PF 0.938 / HP 15.0 Standard SD 6.00 0.39 
2.0x16 Standard PF 0.938 / HP 15.0 Low Dose SD 8.00 0.33 
2.0x16 Fast PF 1.438 / HP 23.0 High Quality SD 4.00 0.82 
2.0x16 Fast PF 1.438 / HP 23.0 Standard SD 6.00 0.49 
2.0x16 Fast PF 1.438 / HP 23.0 Low Dose SD 8.00 0.36 
PF = Pitch Factor 
HP = Helical Pitch 
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Table F - 5: Paediatric helical protocols effective dose calculated for 0.5 CT gantry rotation 
time and CT gantry angle of 27o. 
Detector Configuration (mm) Pitch Factors / Helical Pitch Sure Exp. 3D (ATC) ED (mSv)
0.5x16 Detail PF 0.688 / HP 11.0 High Quality SD 4.00 1.73 
0.5x16 Detail PF 0.688 / HP 11.0 Standard SD 6.00 0.90 
0.5x16 Detail PF 0.688 / HP 11.0 Low Dose SD 8.00 0.60 
0.5x16 Standard PF 0.938 / HP 15.0 High Quality SD 4.00 1.50 
0.5x16 Standard PF 0.938 / HP 15.0 Standard SD 6.00 0.82 
0.5x16 Standard PF 0.938 / HP 15.0 Low Dose SD 8.00 0.56 
0.5x16 Fast PF 1.438 / HP 23.0 High Quality SD 4.00 1.49 
0.5x16 Fast PF 1.438 / HP 23.0 Standard SD 6.00 0.99 
0.5x16 Fast PF 1.438 / HP 23.0 Low Dose SD 8.00 0.62 
1.0x16 Detail PF 0.688 / HP 11.0 High Quality SD 4.00 0.93 
1.0x16 Detail PF 0.688 / HP 11.0 Standard SD 6.00 0.54 
1.0x16 Detail PF 0.688 / HP 11.0 Low Dose SD 8.00 0.34 
1.0x16 Standard PF 0.938 / HP 15.0 High Quality SD 4.00 0.85 
1.0x16 Standard PF 0.938 / HP 15.0 Standard SD 6.00 0.46 
1.0x16 Standard PF 0.938 / HP 15.0 Low Dose SD 8.00 0.31 
1.0x16 Fast PF 1.438 / HP 23.0 High Quality SD 4.00 1.06 
1.0x16 Fast PF 1.438 / HP 23.0 Standard SD 6.00 0.59 
1.0x16 Fast PF 1.438 / HP 23.0 Low Dose SD 8.00 0.39 
2.0x16 Detail PF 0.688 / HP 11.0 High Quality SD 4.00 0.66 
2.0x16 Detail PF 0.688 / HP 11.0 Standard SD 6.00 0.37 
2.0x16 Detail PF 0.688 / HP 11.0 Low Dose SD 8.00 0.30 
2.0x16 Standard PF 0.938 / HP 15.0 High Quality SD 4.00 0.66 
2.0x16 Standard PF 0.938 / HP 15.0 Standard SD 6.00 0.35 
2.0x16 Standard PF 0.938 / HP 15.0 Low Dose SD 8.00 0.28 
2.0x16 Fast PF 1.438 / HP 23.0 High Quality SD 4.00 0.85 
2.0x16 Fast PF 1.438 / HP 23.0 Standard SD 6.00 0.53 
2.0x16 Fast PF 1.438 / HP 23.0 Low Dose SD 8.00 0.37 
PF = Pitch Factor 
HP = Helical Pitch 
Table F - 6: Paediatric helical protocols effective dose calculated for 0.75 CT gantry rotation 
time and CT gantry angle of 27o. 
Detector Configuration 
(mm) Pitch Factors / Helical Pitch Sure Exp. 3D (ATC)  ED (mSv) 
0.5x16 Detail PF 0.688 / HP 11.0 High Quality SD 4.00 1.73 
0.5x16 Detail PF 0.688 / HP 11.0 Standard SD 6.00 0.89 
0.5x16 Detail PF 0.688 / HP 11.0 Low Dose SD 8.00 0.62 
0.5x16 Standard PF 0.938 / HP 15.0 High Quality SD 4.00 1.51 
0.5x16 Standard PF 0.938 / HP 15.0 Standard SD 6.00 0.82 
0.5x16 Standard PF 0.938 / HP 15.0 Low Dose SD 8.00 0.56 
0.5x16 Fast PF 1.438 / HP 23.0 High Quality SD 4.00 1.77 
0.5x16 Fast PF 1.438 / HP 23.0 Standard SD 6.00 0.96 
0.5x16 Fast PF 1.438 / HP 23.0 Low Dose SD 8.00 0.60 
1.0x16 Detail PF 0.688 / HP 11.0 High Quality SD 4.00 0.89 
1.0x16 Detail PF 0.688 / HP 11.0 Standard SD 6.00 0.52 
1.0x16 Detail PF 0.688 / HP 11.0 Low Dose SD 8.00 0.39 
1.0x16 Standard PF 0.938 / HP 15.0 High Quality SD 4.00 0.86 
1.0x16 Standard PF 0.938 / HP 15.0 Standard SD 6.00 0.53 
1.0x16 Standard PF 0.938 / HP 15.0 Low Dose SD 8.00 0.33 
1.0x16 Fast PF 1.438 / HP 23.0 High Quality SD 4.00 1.04 
1.0x16 Fast PF 1.438 / HP 23.0 Standard SD 6.00 0.59 
1.0x16 Fast PF 1.438 / HP 23.0 Low Dose SD 8.00 0.41 
2.0x16 Detail PF 0.688 / HP 11.0 High Quality SD 4.00 0.63 
2.0x16 Detail PF 0.688 / HP 11.0 Standard SD 6.00 0.37 
2.0x16 Detail PF 0.688 / HP 11.0 Low Dose SD 8.00 0.31 
2.0x16 Standard PF 0.938 / HP 15.0 High Quality SD 4.00 0.58 
2.0x16 Standard PF 0.938 / HP 15.0 Standard SD 6.00 0.35 
2.0x16 Standard PF 0.938 / HP 15.0 Low Dose SD 8.00 0.28 
2.0x16 Fast PF 1.438 / HP 23.0 High Quality SD 4.00 0.83 
2.0x16 Fast PF 1.438 / HP 23.0 Standard SD 6.00 0.56 
2.0x16 Fast PF 1.438 / HP 23.0 Low Dose SD 8.00 0.33 
PF = Pitch Factor 
HP = Helical Pitch 
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Figure F - 1: Graphs showing the relationship of CT gantry rotation times with CT gantry angulations, detector 
configurations, helical pitch and sure Exp. 3D (ATC). 
     
    
 
Figure F - 2: Graphs showing the relationship of CT gantry angulations with CT gantry rotation times, detector 
configurations, helical pitch and sure Exp. 3D (ATC). 
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Figure F - 3: Graphs showing the relationship of detector configurations with CT gantry rotation times, CT 
gantry angulations, helical pitch and sure Exp. 3D (ATC). 
     
    
Figure F - 4: Graphs showing the relationship of helical pitch with CT gantry rotation times, CT gantry 
angulations, detector configurations and sure Exp. 3D (ATC). 
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Figure F - 5: Graphs showing the relationship of sure Exp. 3D (ATC) with CT gantry rotation times, CT gantry 
angulations, detector configurations and helical pitch. 
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Appendix G: Tables and graphs of varying parameters of Paediatric helical 
protocols, effective dose results obtained using MOSFET 
Table G - 2: Paediatric protocol parameters 
changes effective dose at 15o angle. 
Rotation 
Time (Secs)
Detector 
Configuration 
(mm) 
KVp mA (fixed) 
Effective 
Dose (mSv) 
0.5 0.5x16 100 120 1.01 
0.75 0.5x16 100 120 1.50 
1 0.5x16 100 120 1.88 
0.5 0.5x16 100 160 1.23 
0.75 0.5x16 100 160 1.82 
1 0.5x16 100 160 2.49 
0.5 0.5x16 100 200 1.76 
0.75 0.5x16 100 200 2.35 
1 0.5x16 100 200 2.94 
0.5 0.5x16 120 120 1.41 
0.75 0.5x16 120 120 2.06 
1 0.5x16 120 120 2.90 
0.5 0.5x16 120 160 1.82 
0.75 0.5x16 120 160 2.93 
1 0.5x16 120 160 3.95 
0.5 0.5x16 120 200 2.48 
0.75 0.5x16 120 200 3.66 
1 0.5x16 120 200 4.89 
  
 
 
 
 
 
 
 
 
 
 
 
Table G - 1: Paediatric protocol parameters changes 
effective dose at 0o angle. 
Rotation 
Time 
(Secs) 
Detector 
Configuration 
(mm) 
KVp mA (fixed) 
Effective 
Dose (mSv) 
0.5 0.5x16 100 120 1.07 
0.75 0.5x16 100 120 1.49 
1 0.5x16 100 120 1.99 
0.5 0.5x16 100 160 1.49 
0.75 0.5x16 100 160 1.86 
1 0.5x16 100 160 2.63 
0.5 0.5x16 100 200 1.72 
0.75 0.5x16 100 200 2.49 
1 0.5x16 100 200 3.30 
0.5 0.5x16 120 120 1.49 
0.75 0.5x16 120 120 2.19 
1 0.5x16 120 120 3.08 
0.5 0.5x16 120 160 2.11 
0.75 0.5x16 120 160 2.95 
1 0.5x16 120 160 3.84 
0.5 0.5x16 120 200 2.57 
0.75 0.5x16 120 200 3.72 
1 0.5x16 120 200 4.72 
Table G - 3: Paediatric protocol parameters changes 
effective dose 27o angle. 
Rotation 
Time (Secs)
Detector 
Configuration (mm) KVp 
mA 
(fixed) 
Effective 
Dose (mSv) 
0.5 0.5x16 100 120 1.01 
0.75 0.5x16 100 120 1.53 
1 0.5x16 100 120 2.02 
0.5 0.5x16 100 160 1.61 
0.75 0.5x16 100 160 1.94 
1 0.5x16 100 160 2.65 
0.5 0.5x16 100 200 1.58 
0.75 0.5x16 100 200 2.16 
1 0.5x16 100 200 3.33 
0.5 0.5x16 120 120 1.60 
0.75 0.5x16 120 120 2.38 
1 0.5x16 120 120 2.97 
0.5 0.5x16 120 160 1.96 
0.75 0.5x16 120 160 2.97 
1 0.5x16 120 160 3.86 
0.5 0.5x16 120 200 2.41 
0.75 0.5x16 120 200 3.57 
1 0.5x16 120 200 4.81 
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Figure G - 1: Graphs showing the relationship of CT gantry rotation time with tube kilovoltage (KVp), tube 
current (mA) and CT gantry angulations. 
    
  
Figure G - 2: Graphs showing the relationship of tube kilovoltage (KVp) with CT gantry rotation time, CT 
gantry angulations and tube current (mA). 
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Figure G - 3: Graphs showing the relationship of tube current (mA) with CT gantry rotation time, CT gantry 
angulations and tube kilovoltage (KVp). 
  
 
   
Figure G - 4: Graphs showing the relationship of scan lengths with CT gantry rotation time, CT gantry 
angulations, tube kilovoltage (KVp) and tube current (mA). 
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Appendix H: Tables of Adult and Paediatric Helical Protocols on Eye 
Absorbed dose, results obtained using MOSFET 
Table H - 1: Adult brain protocols, eye absorbed dose (mGy). 
Tube Rotation 
Time (S) 
Detector Configuration 
(mm) Pitch Factors / Helical Pitch Sure Exp. 3D (ATC) 
Eye Dose (mGy) / 
Gantry Angulations 
0o 15o 27o
0.5 0.5x16 Detail PF 0.688 / HP 11.0 High Quality SD 1.80 32.05 30.30 15.60 
0.5 0.5x16 Detail PF 0.688 / HP 11.0 Standard SD 2.00 32.00 28.95 11.75 
0.5 0.5x16 Detail PF 0.688 / HP 11.0 Low Dose SD 2.20 26.60 26.80 12.05 
0.5 0.5x16 Standard PF 0.938 / HP 15.0 High Quality SD 1.80 24.05 25.00 10.92 
0.5 0.5x16 Standard PF 0.938 / HP 15.0 Standard SD 2.00 20.75 22.35 14.30 
0.5 0.5x16 Standard PF 0.938 / HP 15.0 Low Dose SD 2.20 23.25 18.15 13.75 
0.5 0.5x16 Fast PF 1.438 / HP 23.0 High Quality SD 1.80 15.85 16.90 10.52 
0.5 0.5x16 Fast PF 1.438 / HP 23.0 Standard SD 2.00 16.95 13.40 14.35 
0.5 0.5x16 Fast PF 1.438 / HP 23.0 Low Dose SD 2.20 16.2 14.55 12.20 
0.5 1.0x16 Detail PF 0.688 / HP 11.0 High Quality SD 1.80 32.80 23.85 28.15 
0.5 1.0x16 Detail PF 0.688 / HP 11.0 Standard SD 2.00 24.15 28.05 18.35 
0.5 1.0x16 Detail PF 0.688 / HP 11.0 Low Dose SD 2.20 22.35 23.95 20.65 
0.5 1.0x16 Standard PF 0.938 / HP 15.0 High Quality SD 1.80 24.95 20.00 23.95 
0.5 1.0x16 Standard PF 0.938 / HP 15.0 Standard SD 2.00 21.40 22.15 16.20 
0.5 1.0x16 Standard PF 0.938 / HP 15.0 Low Dose SD 2.20 17.70 20.45 17.70 
0.5 1.0x16 Fast PF 1.438 / HP 23.0 High Quality SD 1.80 16.40 16.70 15.30 
0.5 1.0x16 Fast PF 1.438 / HP 23.0 Standard SD 2.00 15.85 14.50 14.85 
0.5 1.0x16 Fast PF 1.438 / HP 23.0 Low Dose SD 2.20 13.95 9.40 14.20 
0.5 2.0x16 Detail PF 0.688 / HP 11.0 High Quality SD 1.80 22.20 30.00 23.75 
0.5 2.0x16 Detail PF 0.688 / HP 11.0 Standard SD 2.00 25.95 21.80 23.60 
0.5 2.0x16 Detail PF 0.688 / HP 11.0 Low Dose SD 2.20 19.90 21.80 15.90 
0.5 2.0x16 Standard PF 0.938 / HP 15.0 High Quality SD 1.80 20.65 18.75 18.80 
0.5 2.0x16 Standard PF 0.938 / HP 15.0 Standard SD 2.00 16.85 17.75 19.90 
0.5 2.0x16 Standard PF 0.938 / HP 15.0 Low Dose SD 2.20 17.20 19.00 14.85 
0.5 2.0x16 Fast PF 1.438 / HP 23.0 High Quality SD 1.80 12.46 10.64 16.05 
0.5 2.0x16 Fast PF 1.438 / HP 23.0 Standard SD 2.00 16.25 10.96 9.24 
0.5 2.0x16 Fast PF 1.438 / HP 23.0 Low Dose SD 2.20 10.41 12.00 13.70 
1 0.5x16 Detail PF 0.688 / HP 11.0 High Quality SD 1.80 58.40 42.75 12.90 
1 0.5x16 Detail PF 0.688 / HP 11.0 Standard SD 2.00 51.75 37.35 12.75 
1 0.5x16 Detail PF 0.688 / HP 11.0 Low Dose SD 2.20 47.25 31.60 9.54 
1 0.5x16 Standard PF 0.938 / HP 15.0 High Quality SD 1.80 43.85 44.30 13.60 
1 0.5x16 Standard PF 0.938 / HP 15.0 Standard SD 2.00 32.90 34.70 12.05 
1 0.5x16 Standard PF 0.938 / HP 15.0 Low Dose SD 2.20 38.35 25.85 13.70 
1 0.5x16 Fast PF 1.438 / HP 23.0 High Quality SD 1.80 30.55 31.55 19.45 
1 0.5x16 Fast PF 1.438 / HP 23.0 Standard SD 2.00 30.40 28.30 27.80 
1 0.5x16 Fast PF 1.438 / HP 23.0 Low Dose SD 2.20 26.60 27.05 24.75 
1 1.0x16 Detail PF 0.688 / HP 11.0 High Quality SD 1.80 60.15 47.10 35.55 
1 1.0x16 Detail PF 0.688 / HP 11.0 Standard SD 2.00 52.40 50.75 32.25 
1 1.0x16 Detail PF 0.688 / HP 11.0 Low Dose SD 2.20 45.15 44.65 35.60 
1 1.0x16 Standard PF 0.938 / HP 15.0 High Quality SD 1.80 40.55 37.45 33.65 
1 1.0x16 Standard PF 0.938 / HP 15.0 Standard SD 2.00 39.45 42.30 31.70 
1 1.0x16 Standard PF 0.938 / HP 15.0 Low Dose SD 2.20 33.95 19.55 27.30 
1 1.0x16 Fast PF 1.438 / HP 23.0 High Quality SD 1.80 29.60 31.90 28.25 
1 1.0x16 Fast PF 1.438 / HP 23.0 Standard SD 2.00 27.90 29.30 26.75 
1 1.0x16 Fast PF 1.438 / HP 23.0 Low Dose SD 2.20 26.05 27.45 24.95 
1 2.0x16 Detail PF 0.688 / HP 11.0 High Quality SD 1.80 46.60 28.30 31.10 
1 2.0x16 Detail PF 0.688 / HP 11.0 Standard SD 2.00 34.70 21.65 25.45 
1 2.0x16 Detail PF 0.688 / HP 11.0 Low Dose SD 2.20 32.80 19.70 20.80 
1 2.0x16 Standard PF 0.938 / HP 15.0 High Quality SD 1.80 33.45 24.15 23.05 
1 2.0x16 Standard PF 0.938 / HP 15.0 Standard SD 2.00 31.05 19.10 21.35 
1 2.0x16 Standard PF 0.938 / HP 15.0 Low Dose SD 2.20 27.95 18.30 16.65 
1 2.0x16 Fast PF 1.438 / HP 23.0 High Quality SD 1.80 28.20 30.70 27.70 
1 2.0x16 Fast PF 1.438 / HP 23.0 Standard SD 2.00 21.45 18.40 21.75 
1 2.0x16 Fast PF 1.438 / HP 23.0 Low Dose SD 2.20 25.35 14.10 20.55 
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Table H - 2: Paediatric brain protocols, eye absorbed dose (mGy). 
Tube Rotation 
Time (S) 
Detector 
Configurations (mm) 
Pitch Factors / Helical 
Pitch Sure Exp. 3D (ATC) 
Eye Dose (mGy)/ Gantry 
Angulations 
0o 15o 27o
0.5 0.5x16 Detail PF 0.688 / HP 11.0 High Quality SD 4.00 33.05 29.90 25.00 
0.5 0.5x16 Detail PF 0.688 / HP 11.0 Standard SD 6.00 17.90 15.55 13.05 
0.5 0.5x16 Detail PF 0.688 / HP 11.0 Low Dose SD 8.00 11.75 9.80 8.86 
0.5 0.5x16 Standard PF 0.938 / HP 15.0 High Quality SD 4.00 26.20 28.05 21.85 
0.5 0.5x16 Standard PF 0.938 / HP 15.0 Standard SD 6.00 16.90 13.95 12.35 
0.5 0.5x16 Standard PF 0.938 / HP 15.0 Low Dose SD 8.00 9.62 7.86 7.03 
0.5 0.5x16 Fast PF 1.438 / HP 23.0 High Quality SD 4.00 22.50 21.40 21.35 
0.5 0.5x16 Fast PF 1.438 / HP 23.0 Standard SD 6.00 16.15 13.45 11.90 
0.5 0.5x16 Fast PF 1.438 / HP 23.0 Low Dose SD 8.00 10.35 8.93 7.06 
0.5 1.0x16 Detail PF 0.688 / HP 11.0 High Quality SD 4.00 15.65 15.40 12.30 
0.5 1.0x16 Detail PF 0.688 / HP 11.0 Standard SD 6.00 7.80 8.24 6.37 
0.5 1.0x16 Detail PF 0.688 / HP 11.0 Low Dose SD 8.00 5.62 4.35 4.27 
0.5 1.0x16 Standard PF 0.938 / HP 15.0 High Quality SD 4.00 14.20 12.35 10.35 
0.5 1.0x16 Standard PF 0.938 / HP 15.0 Standard SD 6.00 6.04 7.49 5.18 
0.5 1.0x16 Standard PF 0.938 / HP 15.0 Low Dose SD 8.00 4.90 4.60 3.67 
0.5 1.0x16 Fast PF 1.438 / HP 23.0 High Quality SD 4.00 15.15 16.05 13.10 
0.5 1.0x16 Fast PF 1.438 / HP 23.0 Standard SD 6.00 7.61 6.83 7.57 
0.5 1.0x16 Fast PF 1.438 / HP 23.0 Low Dose SD 8.00 4.78 4.63 3.49 
0.5 2.0x16 Detail PF 0.688 / HP 11.0 High Quality SD 4.00 9.12 7.95 6.78 
0.5 2.0x16 Detail PF 0.688 / HP 11.0 Standard SD 6.00 4.51 3.45 3.95 
0.5 2.0x16 Detail PF 0.688 / HP 11.0 Low Dose SD 8.00 2.94 2.70 3.17 
0.5 2.0x16 Standard PF 0.938 / HP 15.0 High Quality SD 4.00 8.32 6.46 6.60 
0.5 2.0x16 Standard PF 0.938 / HP 15.0 Standard SD 6.00 3.98 3.27 3.37 
0.5 2.0x16 Standard PF 0.938 / HP 15.0 Low Dose SD 8.00 2.54 2.57 2.89 
0.5 2.0x16 Fast PF 1.438 / HP 23.0 High Quality SD 4.00 6.79 5.86 6.72 
0.5 2.0x16 Fast PF 1.438 / HP 23.0 Standard SD 6.00 3.91 4.48 4.04 
0.5 2.0x16 Fast PF 1.438 / HP 23.0 Low Dose SD 8.00 3.17 2.95 3.27 
0.75 0.5x16 Detail PF 0.688 / HP 11.0 High Quality SD 4.00 33.20 29.90 24.85 
0.75 0.5x16 Detail PF 0.688 / HP 11.0 Standard SD 6.00 16.75 15.00 11.90 
0.75 0.5x16 Detail PF 0.688 / HP 11.0 Low Dose SD 8.00 10.35 9.75 8.96 
0.75 0.5x16 Standard PF 0.938 / HP 15.0 High Quality SD 4.00 26.55 26.25 22.80 
0.75 0.5x16 Standard PF 0.938 / HP 15.0 Standard SD 6.00 13.95 12.05 12.80 
0.75 0.5x16 Standard PF 0.938 / HP 15.0 Low Dose SD 8.00 9.34 7.95 7.06 
0.75 0.5x16 Fast PF 1.438 / HP 23.0 High Quality SD 4.00 30.80 29.20 24.55 
0.75 0.5x16 Fast PF 1.438 / HP 23.0 Standard SD 6.00 17.15 14.80 12.15 
0.75 0.5x16 Fast PF 1.438 / HP 23.0 Low Dose SD 8.00 9.18 9.32 7.97 
0.75 1.0x16 Detail PF 0.688 / HP 11.0 High Quality SD 4.00 17.55 14.25 13.20 
0.75 1.0x16 Detail PF 0.688 / HP 11.0 Standard SD 6.00 7.98 8.16 6.03 
0.75 1.0x16 Detail PF 0.688 / HP 11.0 Low Dose SD 8.00 5.53 4.53 4.46 
0.75 1.0x16 Standard PF 0.938 / HP 15.0 High Quality SD 4.00 15.90 12.75 10.43 
0.75 1.0x16 Standard PF 0.938 / HP 15.0 Standard SD 6.00 8.69 7.08 6.33 
0.75 1.0x16 Standard PF 0.938 / HP 15.0 Low Dose SD 8.00 4.67 4.05 3.94 
0.75 1.0x16 Fast PF 1.438 / HP 23.0 High Quality SD 4.00 18.30 16.05 12.00 
0.75 1.0x16 Fast PF 1.438 / HP 23.0 Standard SD 6.00 6.67 8.18 6.19 
0.75 1.0x16 Fast PF 1.438 / HP 23.0 Low Dose SD 8.00 5.23 4.96 4.71 
0.75 2.0x16 Detail PF 0.688 / HP 11.0 High Quality SD 4.00 7.08 7.96 7.74 
0.75 2.0x16 Detail PF 0.688 / HP 11.0 Standard SD 6.00 4.46 4.83 4.74 
0.75 2.0x16 Detail PF 0.688 / HP 11.0 Low Dose SD 8.00 3.01 3.09 3.12 
0.75 2.0x16 Standard PF 0.938 / HP 15.0 High Quality SD 4.00 6.67 6.47 6.49 
0.75 2.0x16 Standard PF 0.938 / HP 15.0 Standard SD 6.00 4.04 4.18 3.25 
0.75 2.0x16 Standard PF 0.938 / HP 15.0 Low Dose SD 8.00 3.16 2.67 2.40 
0.75 2.0x16 Fast PF 1.438 / HP 23.0 High Quality SD 4.00 8.02 6.60 6.77 
0.75 2.0x16 Fast PF 1.438 / HP 23.0 Standard SD 6.00 4.62 4.58 3.76 
0.75 2.0x16 Fast PF 1.438 / HP 23.0 Low Dose SD 8.00 3.64 2.90 2.09 
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Appendix I: Tables of Estimated Cases of Lifetime Cancer Risk for both 
adult and paediatric male and females ages from 10 to 80 years for 162 
helical brain CT scan protocols (case/106) 
Table I - 1: Adult and Paediatric helical brain protocols; Lifetime cancer risk for male and female case/106. 
protocol Female age (case/10
6) Male age (case/106) 
0 5 10 15 20 30 40 50 60 70 80 0 5 10 15 20 30 40 50 60 70 80 
1 102 64 18 14 11 7 6 5 4 2 1 46 29 14 11 8 5 5 4 3 2 1 
2 55 34 19 15 12 7 6 5 4 2 1 24 15 13 11 8 5 5 4 3 2 1 
3 36 23 20 15 12 7 6 5 4 2 1 16 10 12 9 8 5 4 3 3 2 1 
4 82 51 17 13 10 6 5 4 3 2 1 39 24 11 9 7 4 4 3 2 1 1 
5 53 33 15 12 9 6 5 4 3 2 1 23 14 10 8 6 4 4 3 2 1 1 
6 32 20 15 11 9 5 4 4 3 2 1 15 11 10 8 6 4 3 3 2 1 1 
7 78 49 12 9 7 4 4 3 2 1 1 33 21 8 7 5 3 3 2 2 1 <1
8 55 34 12 9 7 4 4 3 2 1 1 24 15 8 6 5 3 3 2 2 1 <1
9 40 25 12 9 7 4 4 3 2 1 1 17 10 7 6 5 3 3 2 2 1 <1
10 95 58 23 18 14 9 7 6 4 3 1 46 28 16 12 10 6 5 4 3 2 1 
11 52 32 19 15 12 7 6 5 4 2 1 23 14 14 11 9 6 5 4 3 2 1 
12 31 19 19 14 11 7 6 5 3 2 1 15 13 13 10 8 5 4 4 3 2 1 
13 84 52 15 12 9 6 5 4 3 2 1 39 25 11 9 7 4 4 3 2 1 1 
14 50 31 15 11 9 6 5 4 3 2 1 22 14 11 9 7 4 4 3 2 1 1 
15 32 20 14 11 8 5 4 4 3 2 1 14 10 10 8 6 4 3 3 2 1 1 
16 88 56 11 9 7 4 4 3 2 1 1 36 23 8 6 5 3 3 2 2 1 <1
17 53 33 11 8 6 4 3 3 2 1 1 24 15 8 6 5 3 3 2 2 1 <1
18 40 25 11 8 6 4 3 3 2 1 1 16 10 7 6 5 3 3 2 2 1 <1
19 96 60 23 18 14 9 8 6 5 3 1 44 27 17 13 11 7 6 5 3 2 1 
20 51 32 22 17 14 9 7 6 4 3 1 23 14 16 13 10 6 6 5 3 2 1 
21 35 22 22 17 13 8 7 5 4 3 1 17 15 15 11 9 6 5 4 3 2 1 
22 80 49 20 15 12 7 6 5 4 2 1 38 24 13 10 8 5 5 4 3 2 1 
23 46 29 19 14 11 7 6 5 3 2 1 20 13 12 10 8 5 4 3 2 1 1 
24 34 21 16 12 10 6 5 4 3 2 1 14 11 11 9 7 4 4 3 2 1 1 
25 89 56 13 10 7 5 4 3 2 2 1 38 24 9 7 6 4 3 3 2 1 <1 
26 57 36 13 10 8 5 4 3 2 2 1 25 15 9 7 5 4 3 3 2 1 <1
27 35 22 12 9 7 4 4 3 2 1 1 15 10 8 6 5 3 3 2 2 1 <1
28 52 32 19 14 11 7 6 5 3 2 1 23 14 13 10 8 5 4 4 3 2 1 
29 32 20 19 15 11 7 6 5 4 2 1 15 13 13 10 8 5 5 4 3 2 1 
30 25 19 19 15 11 7 6 5 4 2 1 14 13 13 10 8 5 4 4 3 2 1 
31 51 32 17 13 10 6 5 4 3 2 1 22 13 11 9 7 4 4 3 2 1 1 
32 29 18 17 13 10 6 5 4 3 2 1 12 10 10 8 6 4 3 3 2 1 <1
33 23 15 14 11 8 5 4 3 3 2 1 10 9 9 7 6 4 3 3 2 1 <1
34 66 42 12 9 7 4 3 3 2 1 1 26 16 8 6 5 3 3 2 2 1 <1
35 42 26 12 9 7 4 4 3 2 1 1 16 10 7 6 5 3 3 2 2 1 <1
36 23 14 10 8 6 4 3 3 2 1 1 10 6 7 6 4 3 2 2 1 1 <1
37 54 33 18 14 11 7 6 5 4 2 1 24 15 14 11 9 5 5 4 3 2 1 
38 28 17 18 14 11 7 6 5 3 2 1 15 13 13 10 8 5 4 4 3 2 1 
39 24 15 18 14 11 7 6 4 3 2 1 14 12 12 10 8 5 4 3 2 1 1 
40 47 30 15 11 9 5 5 4 3 2 1 20 13 11 8 7 4 4 3 2 1 1 
41 29 19 14 11 8 5 4 4 2 3 1 12 10 10 8 6 4 3 3 2 1 <1
42 24 15 15 12 9 6 5 4 3 2 1 11 9 9 7 6 4 3 3 2 1 <1
43 66 41 11 8 6 4 3 3 2 1 1 26 16 7 6 4 3 2 2 1 1 <1
44 41 26 10 8 6 4 3 3 2 1 1 16 10 7 5 4 3 2 2 1 1 <1
45 29 19 9 7 6 3 3 2 2 1 1 11 7 6 5 4 3 2 2 1 1 <1
46 56 35 23 18 14 8 7 6 4 3 1 23 15 16 12 10 6 5 4 3 2 1 
47 32 20 22 17 13 8 7 5 4 2 1 15 14 14 11 9 6 5 4 3 2 1 
48 19 12 18 14 11 7 6 5 4 2 1 14 13 13 10 8 5 5 4 3 2 1 
49 52 33 17 13 10 6 5 4 3 2 1 21 13 12 9 7 5 4 3 2 1 1 
50 29 18 17 13 10 6 5 4 3 2 1 12 11 11 8 7 4 4 3 2 1 1 
51 19 15 15 11 9 5 4 4 3 2 1 12 10 10 8 6 4 3 3 2 1 <1
52 65 41 12 9 7 4 4 3 2 1 1 26 17 8 6 5 3 3 2 2 1 <1
53 35 22 11 9 7 4 3 3 2 1 1 15 9 8 6 5 3 3 2 2 1 <1
54 25 16 13 10 8 5 4 3 2 1 1 10 8 8 6 5 3 3 2 2 1 <1
55 45 29 20 15 11 7 5 4 3 2 1 17 10 12 10 8 5 4 3 2 1 1 
56 27 17 20 15 11 6 5 4 3 2 1 13 11 11 9 7 4 4 3 2 1 1 
57 21 14 18 13 10 6 5 4 3 2 1 12 11 11 8 6 4 3 3 2 1 1 
58 41 26 17 13 10 6 5 4 3 2 1 15 9 11 8 7 4 4 3 2 1 1 
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Continued (Table I - 1) 
protocol Female age (case/10
6) Male age (case/106) 
0 5 10 15 20 30 40 50 60 70 80 0 5 10 15 20 30 40 50 60 70 80 
59 25 16 20 15 11 6 5 4 3 2 1 12 11 11 8 7 4 4 3 2 1 1 
60 22 18 18 13 10 5 4 3 2 2 1 12 10 10 7 6 4 3 2 2 1 <1
61 53 34 19 14 10 6 4 3 2 1 1 18 11 9 7 6 3 3 2 2 1 <1
62 34 22 18 13 9 5 4 3 2 1 1 11 7 9 7 5 3 3 2 2 1 <1
63 24 16 17 12 9 5 4 3 2 1 1 10 8 8 6 5 3 2 2 1 1 <1
64 40 25 22 17 13 8 6 5 4 2 1 16 14 14 11 9 5 5 4 3 2 1 
65 25 16 18 14 11 7 5 4 3 2 1 14 12 12 9 7 5 4 3 2 1 1 
66 23 15 16 12 10 6 5 4 3 2 1 13 11 11 8 7 4 4 3 2 1 1 
67 42 27 18 14 11 6 5 4 3 2 1 15 11 11 9 7 4 4 3 2 1 1 
68 24 16 15 11 9 5 4 4 3 2 1 12 10 10 8 6 4 3 3 2 1 <1
69 21 14 12 9 7 4 4 3 2 1 1 7 4 8 7 5 3 3 2 2 1 <1
70 58 37 13 10 7 4 4 3 2 1 1 20 12 8 7 5 3 3 2 2 1 <1
71 29 18 14 10 8 4 4 3 2 1 1 11 8 8 6 5 3 3 2 2 1 <1
72 26 17 12 9 7 4 3 3 2 1 1 9 7 7 6 4 3 2 2 1 1 <1
73 43 28 22 17 13 8 7 5 4 2 1 17 15 15 12 9 6 5 4 3 2 1 
74 25 16 20 15 12 7 6 5 4 2 1 15 14 14 11 8 5 5 4 3 2 1 
75 21 14 16 12 10 6 5 4 3 2 1 13 12 12 9 7 4 4 3 2 1 1 
76 44 28 19 14 11 7 8 5 3 2 1 16 12 12 10 8 5 4 3 2 1 1 
77 24 15 16 12 9 6 5 4 3 2 1 13 11 11 8 7 4 4 3 2 1 1 
78 20 13 17 13 10 6 5 4 3 2 1 12 10 10 8 6 4 3 3 2 1 <1
79 61 40 15 11 8 5 4 3 2 2 1 20 13 9 7 6 4 3 3 2 1 <1
80 38 25 18 13 10 6 4 3 2 1 1 12 9 9 7 6 3 3 2 2 1 <1
81 26 17 15 11 8 5 4 3 2 1 1 11 9 9 7 5 3 3 2 2 1 <1
82 97 60 32 25 19 12 10 8 6 4 2 46 28 21 17 13 8 7 6 4 3 1 
83 58 36 28 21 17 10 9 7 5 3 1 25 19 19 15 12 8 7 5 4 2 1 
84 39 25 26 20 15 10 8 7 5 3 1 20 18 18 14 11 7 6 5 4 2 1 
85 90 56 24 18 14 9 8 6 5 3 1 40 25 17 13 10 7 6 5 3 2 1 
86 47 29 23 17 13 8 7 5 4 3 1 21 15 15 12 9 6 5 4 3 2 1 
87 33 21 20 15 12 7 6 5 4 2 1 16 14 14 11 8 5 5 4 3 2 1 
88 101 63 23 18 14 8 7 6 4 3 1 45 28 15 12 9 6 5 4 3 2 1 
89 59 37 22 17 13 8 6 5 4 2 1 25 15 13 10 8 5 5 4 3 2 1 
90 40 25 18 13 10 6 5 4 3 2 1 16 12 12 9 7 5 4 3 2 1 1 
91 91 57 36 28 22 14 11 9 6 4 2 42 26 23 18 14 9 8 7 5 3 1 
92 57 36 28 21 17 10 9 7 5 3 1 24 15 16 15 12 7 6 5 4 2 1 
93 36 23 21 16 13 8 7 6 4 3 1 18 16 16 12 10 6 5 4 3 2 1 
94 85 52 27 21 16 10 8 7 5 3 1 40 25 19 15 12 8 7 5 4 2 1 
95 46 29 24 18 14 9 8 6 5 3 1 20 17 17 13 10 7 6 5 3 2 1 
96 34 21 21 16 12 8 6 5 4 2 1 16 14 14 11 8 5 5 4 3 2 1 
97 97 60 22 17 13 8 7 6 4 3 1 43 27 16 13 10 6 5 5 3 2 1 
98 53 33 21 16 12 8 6 5 4 2 1 24 15 14 11 9 6 5 4 3 2 1 
99 36 23 19 14 11 7 6 5 3 2 1 15 13 13 10 8 5 4 4 3 2 1 
100 94 59 32 24 19 12 10 8 6 4 2 42 26 22 18 14 9 8 6 4 3 1 
101 51 32 28 21 16 10 9 7 5 3 2 22 20 20 15 12 8 7 5 4 2 1 
102 36 23 25 19 14 9 7 6 5 3 1 18 17 17 13 10 7 6 5 3 2 1 
103 85 53 28 21 17 10 9 7 5 3 2 38 24 20 15 12 8 7 6 4 2 1 
104 46 29 23 18 14 9 7 6 5 3 1 20 17 17 13 10 7 6 5 3 2 1 
105 32 20 20 16 12 7 6 5 4 2 1 17 14 14 11 9 5 5 4 3 2 1 
106 97 60 24 18 14 9 7 6 5 3 1 44 27 17 13 10 7 6 5 3 2 1 
107 56 35 25 19 15 9 8 6 5 3 1 24 17 15 13 10 7 6 5 3 2 1 
108 35 22 23 17 13 8 7 6 4 3 1 17 16 16 12 10 6 5 4 3 2 1 
109 49 31 33 25 20 12 10 8 6 4 2 25 20 20 17 13 8 7 6 4 3 1 
110 33 21 33 25 20 12 10 8 6 4 2 21 19 19 16 13 8 7 6 4 2 1 
111 26 25 25 19 14 8 7 6 4 3 1 17 14 14 13 10 6 5 4 3 2 1 
112 50 32 27 20 16 10 8 7 5 3 1 21 13 18 14 11 7 6 5 4 2 1 
113 31 26 20 19 15 9 7 6 4 3 1 19 17 17 13 10 6 6 5 3 2 1 
114 27 25 25 20 15 9 8 6 4 3 1 17 15 15 12 9 6 5 4 3 2 1 
115 70 44 23 17 13 8 6 5 4 2 1 27 17 14 11 9 5 5 4 3 2 1 
116 38 24 22 17 13 8 6 5 4 2 1 15 13 13 10 8 5 4 4 3 2 1 
117 28 18 19 14 11 7 6 4 3 2 1 13 12 12 9 7 5 4 3 2 1 1 
118 50 30 38 29 23 14 12 10 7 5 2 23 15 26 20 16 10 9 7 5 3 1 
119 28 17 32 25 19 12 10 8 6 4 2 24 23 23 18 14 9 8 6 5 3 1 
120 27 21 21 23 18 11 9 8 6 4 2 22 20 18 16 13 8 7 6 4 2 1 
121 53 34 28 22 17 10 9 7 5 3 2 21 19 18 16 13 8 7 6 4 2 1 
122 32 25 25 19 15 9 8 6 5 3 1 20 18 18 14 11 7 6 5 4 2 1 
123 23 14 18 14 11 6 5 4 3 2 1 13 12 12 9 7 5 4 3 2 1 1 
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Continued (Table I - 1) 
protocol Female age (case/10
6) Male age (case/106) 
0 5 10 15 20 30 40 50 60 70 80 0 5 10 15 20 30 40 50 60 70 80 
124 73 47 20 15 12 7 6 5 4 2 1 27 17 14 11 8 5 5 4 3 2 1 
125 37 23 20 15 12 7 6 5 3 2 1 15 13 13 10 8 5 4 3 2 1 1 
126 27 18 17 13 10 6 5 4 3 2 1 13 12 12 9 7 5 4 3 2 1 1 
127 52 32 45 34 26 16 13 11 8 5 2 29 25 25 23 18 11 10 8 6 3 1 
128 32 20 35 27 21 13 11 9 7 4 2 27 25 25 20 16 10 9 7 5 3 1 
129 31 29 28 23 18 11 10 8 6 4 2 23 22 21 17 13 8 7 6 4 3 1 
130 52 33 35 27 21 13 11 8 6 4 2 21 13 22 17 14 9 8 6 4 3 1 
131 33 30 30 25 19 12 10 8 6 4 2 23 21 20 17 13 9 7 6 4 3 1 
132 20 13 27 20 16 10 8 7 5 3 1 8 5 18 14 11 7 6 5 4 2 1 
133 62 39 25 19 14 9 7 6 4 3 1 26 16 16 12 10 6 5 4 3 2 1 
134 38 24 21 16 12 8 6 5 4 3 1 17 15 15 11 9 6 5 4 3 2 1 
135 24 15 22 17 13 8 7 5 4 3 1 15 13 13 11 9 5 5 4 3 2 1 
136 44 28 28 21 16 10 8 7 5 3 1 19 17 17 14 11 7 6 5 4 2 1 
137 30 27 25 23 17 10 8 6 5 3 1 17 15 15 13 10 6 6 5 3 2 1 
138 26 23 21 18 13 8 7 5 4 2 1 15 13 13 11 9 6 5 4 3 2 1 
139 38 29 27 23 17 9 7 6 4 3 1 18 16 16 13 10 6 5 4 3 2 1 
140 27 23 23 20 15 9 7 5 4 3 1 16 14 14 12 9 6 5 4 3 2 1 
141 23 15 20 15 11 7 6 4 3 2 1 14 11 11 10 8 5 4 3 2 1 1 
142 57 37 34 25 18 10 7 6 4 3 1 19 17 16 13 10 6 5 4 3 2 1 
143 35 23 40 28 20 10 7 5 4 2 1 18 16 16 12 9 6 5 4 3 2 1 
144 26 24 24 18 13 7 5 4 3 2 1 15 13 13 10 8 5 4 3 2 1 1 
145 42 27 23 18 14 9 7 6 4 3 1 16 10 15 12 10 6 5 4 3 2 1 
146 27 19 17 14 11 7 6 5 4 2 1 14 12 12 10 8 5 5 4 3 2 1 
147 21 19 17 13 10 6 5 4 3 2 1 12 11 11 8 7 4 4 3 2 1 1 
148 43 28 19 14 11 7 6 5 4 2 1 15 13 13 11 8 5 5 4 3 2 1 
149 27 17 17 13 10 6 5 4 3 2 1 13 11 11 9 7 4 4 3 2 1 1 
150 24 15 16 12 9 6 5 4 3 2 1 12 10 10 8 6 4 3 3 2 1 1 
151 57 37 23 17 13 8 6 5 4 2 1 20 15 15 11 9 6 5 4 3 2 1 
152 36 23 21 16 12 7 6 5 4 2 1 12 8 13 10 8 5 4 4 3 2 1 
153 25 16 20 15 11 7 6 4 3 2 1 13 11 11 9 7 5 4 3 2 1 1 
154 40 26 25 19 15 9 7 6 4 3 1 17 16 15 13 10 7 6 5 3 2 1 
155 23 15 20 15 12 7 6 5 4 2 1 16 12 13 11 9 5 5 4 3 2 1 
156 22 14 17 13 10 6 5 4 3 2 1 12 11 11 9 7 5 4 3 2 1 1 
157 39 25 19 15 12 7 6 5 4 2 1 15 13 13 11 8 5 5 4 3 2 1 
158 24 16 20 15 11 7 6 5 3 2 1 13 11 11 10 8 5 4 3 2 1 1 
159 20 13 14 11 8 5 4 4 3 2 1 11 10 10 8 6 4 3 3 2 1 <1 
160 58 38 28 21 16 9 8 6 4 3 1 20 15 14 13 10 6 5 4 3 2 1 
161 44 29 24 18 14 8 7 5 4 3 1 16 14 14 12 9 6 5 4 3 2 1 
162 23 21 21 16 12 7 6 5 4 2 1 14 12 12 10 8 5 4 4 3 2 1 
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Appendix J: Adult Cancer Risk Estimated Cases for 54 Sequential 
Protocols for Male and Female aged from 10 to 80 years (case/106) 
Table J - 1: Adult brain sequential protocols; Lifetime cancer risk for male and female case/106. 
protocol )
6Female age (case/10 )6age (case/10 Male 
10 15 20 30 40 50 60 70 80 10 15 20 30 40 50 60 70 80 
163 10 7 6 4 3 3 2 1 1 6 5 4 3 2 2 1 1 <1 
164 9 7 5 3 3 2 2 1 <1 6 5 4 2 2 2 1 1 <1 
165 9 7 6 3 3 2 2 1 <1 5 4 3 2 2 2 1 1 <1 
166 11 8 6 4 3 3 2 1 1 7 6 5 3 3 2 2 1 <1 
167 10 8 6 4 3 2 2 1 1 7 5 4 3 2 2 1 1 <1 
168 9 7 6 4 3 2 2 1 1 7 5 4 3 2 2 1 1 <1 
169 16 13 10 6 5 4 3 2 1 10 8 6 4 4 3 2 1 1 
170 13 10 8 5 4 3 3 2 1 9 7 6 4 3 3 2 1 <1 
171 13 10 8 5 4 3 3 2 1 9 7 5 3 3 3 2 1 <1 
172 8 6 5 3 3 2 2 1 <1 6 5 4 2 2 2 1 1 <1 
173 9 7 5 3 3 2 2 1 <1 6 5 4 2 2 2 1 1 <1 
174 7 5 4 3 2 2 1 1 <1 5 4 3 2 2 1 1 1 <1 
175 10 8 6 4 3 3 2 1 1 7 6 5 3 3 2 1 1 <1 
176 10 8 6 4 3 3 2 1 1 7 5 4 3 2 2 1 1 <1 
177 10 8 6 4 3 3 2 1 1 7 5 4 3 2 2 1 1 <1 
178 14 11 8 5 4 4 3 2 1 10 8 6 4 4 3 2 1 1 
179 12 10 7 5 4 3 3 2 1 9 7 6 4 3 3 2 1 <1 
180 12 10 7 5 4 3 2 2 1 9 7 6 4 3 3 2 1 <1 
181 10 8 6 4 3 3 2 1 1 7 6 4 3 2 2 1 1 <1 
182 11 8 6 4 3 3 2 1 1 7 6 4 3 2 2 1 1 <1 
183 9 7 6 3 3 2 2 1 1 7 5 4 3 2 2 1 1 <1 
184 11 9 7 4 4 3 2 1 1 8 7 5 3 3 2 2 1 <1 
185 12 10 7 5 4 3 2 1 1 8 6 5 3 3 2 2 1 <1 
186 10 8 6 4 3 3 2 1 1 7 6 5 3 3 2 2 1 <1 
187 17 13 10 6 5 4 3 2 1 11 9 7 5 4 3 2 1 1 
188 15 12 9 6 5 4 3 2 1 11 8 7 4 4 3 2 1 1 
189 14 11 9 5 5 4 3 2 1 10 8 6 4 3 3 2 1 1 
190 15 11 9 5 5 4 3 2 1 10 8 6 4 3 3 2 1 1 
191 15 11 9 6 5 4 3 2 1 10 8 6 4 4 3 2 1 1 
192 14 11 8 5 4 4 3 2 1 10 8 6 4 3 3 2 1 <1 
193 19 15 11 7 6 5 4 2 1 14 11 9 5 5 4 3 2 1 
194 20 15 12 7 6 5 4 2 1 13 10 8 5 4 4 3 2 1 
195 18 14 11 7 5 4 3 2 1 12 9 7 5 4 3 2 1 1 
196 25 19 15 9 8 6 5 3 1 18 14 11 7 6 5 3 2 1 
197 22 17 13 8 7 6 4 3 1 16 13 10 6 5 5 3 2 1 
198 19 15 12 7 6 5 4 2 1 14 11 9 6 5 4 3 2 1 
199 17 13 10 6 5 4 3 2 1 12 9 7 5 4 3 2 1 1 
200 16 13 10 6 5 4 3 2 1 11 8 7 4 4 3 2 1 1 
201 15 11 9 5 5 4 3 2 1 10 8 6 4 4 3 2 1 1 
202 20 15 12 7 6 5 4 2 1 14 11 9 6 5 4 3 2 1 
203 18 14 11 7 6 5 3 2 1 13 10 8 5 4 4 3 2 1 
204 18 14 11 7 5 4 3 2 1 12 9 7 5 4 3 2 1 1 
205 27 21 16 10 8 7 5 3 1 18 14 11 7 6 5 4 2 1 
206 24 18 14 9 8 6 5 3 1 18 14 11 7 6 5 3 2 1 
207 20 15 12 8 7 5 4 3 1 15 12 9 6 5 4 3 2 1 
208 20 15 12 7 6 5 4 2 1 14 11 9 5 5 4 3 2 1 
209 19 14 11 7 6 5 4 2 1 13 10 8 5 4 4 3 2 1 
210 17 13 10 6 5 4 3 2 1 12 10 8 5 4 3 2 1 1 
211 25 19 15 9 8 6 5 3 1 17 13 10 7 6 5 3 2 1 
212 20 15 12 7 6 5 4 2 1 15 11 9 6 5 4 3 2 1 
213 20 16 12 8 6 5 4 2 1 14 11 9 6 5 4 3 2 1 
214 31 24 18 11 10 8 6 4 2 21 17 13 8 7 6 4 2 1 
215 26 20 15 10 8 7 5 3 1 19 15 11 7 6 5 4 2 1 
216 21 16 13 8 7 5 4 3 1 15 12 9 6 5 4 3 2 1 
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Appendix K: ED for Toshiba Aquilion 16 standard CT head scans protocols 
(adult and paediatric) 
Table K - 1: Toshiba Aquilion helical protocol for adult CT head scans 
Angle 
(Degrees) 
Rotation 
Time (S)
Image 
Thickness 
(mm) 
Detector 
Configuration 
(mm) 
Pitch 
factor / 
Helical 
Pitch 
Sure Exp. 
3D (ATC) kV 
Effective Dose 
(mSv) 
0 
1.0 5.0 0.5x16 
Detail 
PF 
0.688 / 
HP 11.0 
High 
Quality 
1.80 
120 
1.3 
15 1.5 
27 1.5 
 
Table K - 2: Toshiba Aquilion sequential protocol for adult CT head scans 
Angle 
(Degrees) 
Rotation 
Time (S)
Image Thickness
(mm) 
Detector 
Configuration 
(mm) 
Sure Exp. 3D 
(ATC) kV 
Effective Dose 
(mSv) 
0 
1.0 4.0 2.0x4.0 off 120 
0.81 
15 0.78 
27 0.83 
 
Table K - 3: Toshiba Aquilion 3 months -3years protocol for paediatric CT head scans 
Angle 
(Degrees) 
Rotation 
Time (S) 
Image 
Thickness (mm)
Detector 
Configuration 
(mm) 
kV mA (fixed) Effective Dose (mSv) 
0 
0.5 0.5 0.5x16 100 180 
1.5 
15 1.6 
27 1.7 
 
Table K - 4: Toshiba Aquilion 3 – 5 years protocol for paediatric CT head scans 
Angle 
(Degrees) 
Rotation 
Time (S) 
Image 
Thickness 
(mm) 
Detector 
Configuration 
(mm) 
kV mA (fixed) Effective Dose (mSv) 
0 
0.75 0.75 0.5x16 100 200 
2.4 
15 2.7 
27 2.5 
 
Table K - 5: Toshiba Aquilion 6 – 12 years protocol for paediatric CT head scans 
Angle 
(Degrees) 
Rotation 
Time (S) 
Image 
Thickness 
(mm) 
Detector 
Configuration 
(mm) 
kV mA (fixed) Effective Dose (mSv) 
0 
0.75 0.75 0.5x16 120 200 
3.6 
15 3.5 
27 3.6 
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Appendix L: Toshiba Aquilion 16 standard CT head scans protocols ER 
Estimated Cases for adult and paediatric protocols for male and female 
aged from 0 – 5 and 10 - 80 years (case/106), respectively 
Table L - 1: Toshiba Aquilion 16 adult brain standard helical protocol Lifetime cancer risk for male and 
female case/106. 
gantry 
angle 
)6Female age (case/10 )6age (case/10 Male 
10 15 20 30 40 50 60 70 80 10 15 20 30 40 50 60 70 80 
0o 34 26 20 12 10 8 6 4 2 23 18 14 9 8 6 4 3 1 
15o 41 32 25 15 13 11 8 5 2 28 22 18 11 10 8 6 3 1 
27o 43 32 25 15 13 11 8 5 2 29 23 18 11 10 8 6 3 1 
 
Table L - 2: Toshiba Aquilion 16 adult brain standard sequential protocol Lifetime cancer risk for male and 
female case/106. 
gantry 
angle 
)6Female age (case/10 )6age (case/10 Male 
10 15 20 30 40 50 60 70 80 10 15 20 30 40 50 60 70 80 
0o 22 17 13 8 7 5 4 3 1 15 12 9 6 5 4 3 2 1 
15o 22 17 13 8 7 6 4 3 1 15 12 10 6 5 4 3 2 1 
27o 23 18 14 8 7 6 4 3 1 16 12 10 6 5 4 3 2 1 
 
Table L - 3: Toshiba Aquilion 16 paediatric brain standard 3months -3years protocol Lifetime cancer risk for 
male and female case/106. 
gantry 
angle 
)6Female age (case/10 )6age (case/10 Male 
0 5 0 5 
0o 69 42 36 22 
15o 89 55 39 24 
27o 97 60 44 28 
 
Table L - 4: Toshiba Aquilion 16 paediatric brain standard 3 – 5 years protocol Lifetime cancer risk for male 
and female case/106. 
gantry 
angle 
)6Female age (case/10 )6age (case/10 Male 
0 5 0 5 
0o 115 71 57 35 
15o 148 89 78 48 
27o 144 88 68 42 
 
Table L - 5: Toshiba Aquilion 16 paediatric brain standard 6 – 12 years protocol Lifetime cancer risk for 
male and female case/106. 
gantry 
angle 
)6Female age (case/10 )6age (case/10 Male 
0 5 0 5 
0o 174 107 84 52 
15o 179 111 84 52 
27o 179 111 86 54 
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Appendix M: Paediatric Effective Dose Data Normality and Correlation 
Statistical Tests 
Table M - 1: Paediatric effective dose (mSv) summary statistics including an indication 
of the normality of the data. 
Protocol Parameters Mean, SD Minimum Maximum 
P -Value 
Shapiro-
Wilk
Tube rotation time 
(seconds) 
0.5 0.74 ± 0.05 0.28 2.01 0.20 
0.75 0.76 ± 0.05 0.28 2.06 0.21 
Gantry angulation 
 (degree) 
0o 0.80 ± 0.06 0.31 2.06 0.20 
15o 0.74 ± 0.06 0.30 1.82 0.20 
27o 0.71 ± 0.05 0.28 1.72 0.20 
Detector 
configuration 
(mm) 
0.5x16 1.10 ± 0.06 0.56 2.06 0.20 
1.0x16 0.66 ± 0.04 0.31 1.25 0.18 
2.0x16 0.49 ± 0.1 0.28 0.85 0.21 
Helical Pitch 
(mm/rotation) 
11 0.75 ± 0.06 0.30 2.01 0.20 
15 0.69 ± 0.05 0.28 1.74 0.20 
23 0.81 ± 0.06 0.33 2.06 0.21 
Sure Exp. 3D (SD) 
4.00 1.14 ± 0.06 0.58 2.06 0.20 
6.00 0.65 ± 0.03 0.35 1.15 0.20 
8.00 0.45 ± 0.02 0.28 0.77 0.21 
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Appendix N: List of Trainings Undertaken During the Course of the PhD 
 (All certified by the University of Salford, Manchester, UK) 
Session 
No. Title of training session Date 
Session 1 Seminar on doing Research – the scientific way   Ethics  10th February, 2014 
Session 2 
Introduction to Endnote X7 Reference Manager-beginners  
 Creating an EndNote Library  
 Importing references from databases  
 Creating references from PDF files  
18th February, 2014 
Session 3 
Doing a literature review 
 How to use keywords and MeSH headings to search 
for published literature 
19th February, 2014 
Session 4 Electronic resources for researchers 12th March, 2014 
Session 5 
Seminar on Myers Briggs Type Indicator personality tool  
 To improve effectiveness of communication, team 
working, decision making and problem solving  
 To help researchers understand themselves, the 
impact they have on others, and how different 
personality styles and preferences can work together 
in complementary ways in a research environment  
12th March, 2014 
Session 6 Endnote training (advanced) 19th March, 2014 
Session 7 TLDs training session - 1 1st April, 2014 
Session 8 TLDs training session - 2 2nd April, 2014 
Session 9 Completing a learning agreement and the PhD progression points 10
th April, 2014 
Session 10 
Introduction to SPSS statistics package – beginners  
 Input primary data and excel data into SPSS  
 Upload previously coded data  
 Label and manipulate dataset to generate results and 
summary  
17th April, 2014 
Session 11 
SPSS with Statistics – advanced  
 How to run parametric and non-parametric statistics  
 Edit graphical output from SPSS  
 How to report results from SPSS  
18th April, 2014 
Session 12 Referencing your work APA (Harvard) style 12th April, 2014 
Session 13 Supporting and Motivating your Research 22nd April, 2014 
Session 14 Critical Thinking at Postgraduate Level 25th April, 2014 
Session 15 Structuring your research 30th April, 2014 
Session 16 Writing research method section of a thesis  6th May,2014 
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Session 17 
Statistics with SPSS – Questions and answers session 
webinar  
 The facilitator answered questions from the previous 
two SPSS sessions  
23rd May, 2014 
Session 18 Word Scopus workshop (Scopus Writing) 10 Sessions-1.5 hour each 
Session 19 Research ideas, Questions and Theoretical Frameworks 5th November, 2014 
Session 20  Literature Searching and a Literary Review Skills  5th November, 2014 
Session 21 
Training on Endnote X7 Reference Manager-advanced  
 Creating groups in Endnote library  
 Creating in-text citations  
 Formatting bibliographies in Microsoft Word  
18th November, 2014
Session 22  Intellectual property rights for research students 2nd December, 2014 
Session 23 Structuring your Research Findings 31st January, 2015 
Session 24 How to get published with the IEEE 17th February, 2015 
Session 25 MOSFETs training course – Day 1 22nd May, 2015 
Session 26 MOSFETs training course – Day 2 23rd May, 2015 
Session 27 Thinking and Writing Critically 24th May, 2015 
Session 28 
Finding Journal Articles: Health and Social Care  
 Searching the SOLAR library catalogue  
 Finding journal articles for health and social care 
subjects  
 How to save favourites and search results  
25th February, 2016 
Session 29 
Critical Thinking and Critical Writing at Doctoral Level  
 Analyse and chart professional progression using a 
critical reflective process and learning style analysis  
 Develop skills to evaluate research critically and 
include an evidence-based research to promote 
optimal findings  
 Examine critically reflective practice, problem 
solving and creative ethical decision making  
18th May, 2016  
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Appendix O: List of Developed Skills 
No Type of skill
1 How to search for published literature using scientific databases  
2 How to critically analyse published literature  
3 How to use published literature for writing  
4 How to use Microsoft word, excel and PowerPoint at the advanced level  
5 How to conduct scientific research at the PhD level  
6 How to use Endnote reference manager for in-text citation  
7 How to operate and use the Computer Tomography (CT) machine  
8 How to use TLD system for the direct measurement of dose 
9 How to use MOSFET system for the direct measurement of dose 
10 How to write journal papers and design posters for conference presentation 
11 How to work effectively with people of different personality traits  
12 How to use the Unfors dosimeter for dose measurements and QA protocols 
13 How to use the SPSS statistical software to analyse data  
14 How to present at a conference  
15 A variety of reading skills  
16 How to think and write critically at the PhD level  
17 How to use the DR and CR X-ray machine  
18 How to use RadiAnt DICOM Viewer (64-bit) software for image manipulation  
19 How to use the ImageJ software for Hounsfield unit calculation  
20 How to use parametric and non-parametric statistical tests  
21 How to develop a questionnaire  
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